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Abstract/Résumé 
When mRNA folding rules gene expression: lessons from type I toxin-antitoxin systems 
Toxin-antitoxin (TA) systems are small genetic modules widely present in bacterial genomes. They usually 
code for a small toxic protein and its cognate antitoxin and can be classified into six types depending on the 
nature and mode of action of the antitoxin. This work focuses on the study of type I, for which the antitoxin 
is an antisense RNA that targets the toxin mRNA to inhibit its expression. We characterized the 
aapA3/IsoA3 system, encoded on the chromosome of the human gastric pathogen Helicobacter pylori. To 
date, most TAs have been studied using artificial expression systems, which do not allow the 
characterization of transcriptional or post-transcriptional regulation. Taking advantage of the lethality 
induced by the toxin chromosomal expression in the absence of antitoxin, we developed a high-throughput 
genetic selection of suppressor mutations revealed by Next-Generation Sequencing. This approach, named 
FASTBAC-Seq, allowed us to map a myriad of toxicity determinants located in both, coding and non-
coding regions, of the aapA3 toxic gene. More precisely, some suppressor mutations revealed the existence 
of transient RNA hairpins that act co-transcriptionally to prevent translation initiation while the toxin-
encoding mRNA is being made. Such functional RNA metastable structures are essential to uncouple the 
transcription and translation processes and allow the presence of these toxic genes on bacterial 
chromosomes. Although untranslated mRNAs become rapidly unstable, our work also revealed the 
presence of two protective stem-loops located at both mRNA ends that prevent from both, 5’ and 3’ 
exonucleolytic activity. Altogether, our work evidenced the consequences of the strong selection pressure 
to silence toxin expression under which the TAs evolve, and highlighted the key role of mRNA folding in 
the co- and post-transcriptional regulation of this family of genes. These RNA-based regulatory 
mechanisms may be exploited in the future for biotechnological (e.g., increased protein production through 
mRNA stabilization) or biomedical (e.g., development of alternative antimicrobial strategies aiming at the 
activation of toxin synthesis) applications.  
Toxin-antitoxin systems, Helicobacter pylori, gene expression, Next-Generation Sequencing, genetic suppressor 
mutations, RNA folding, RNA stability, transcription/translation coupling 
Lorsque le repliement de l’ARNm gouverne l’expression des gènes : leçons tirées des 
systèmes toxine-antitoxine de type I 
Les systèmes toxine-antitoxine (TA) sont de petits modules génétiques largement présents dans les 
génomes bactériens. Ils codent pour une petite protéine toxique et une antitoxine. Ils sont classés en six 
types en fonction de la nature et du mode d'action de l'antitoxine. Ce travail a porté sur l'étude du type I, 
pour lequel l'antitoxine est un ARN antisens qui cible l'ARNm de la toxine afin de réprimer son expression. 
Au cours de cette thèse, nous avons étudié le système aapA3/IsoA3, codé sur le chromosome du pathogène 
gastrique humain Helicobacter pylori. À ce jour, la plupart des systèmes TA ont été étudiés à l'aide de 
systèmes d'expression artificiels, qui ne permettent pas de caractériser la régulation transcriptionnelle ou 
post-transcriptionnelle. En utilisant la létalité induite par l’expression chromosomique de la toxine obtenue 
en absence d’antitoxine, nous avons développé une sélection génétique de mutants suppresseurs révélés par 
séquençage haut-débit. Cette approche, appelée FASTBAC-Seq, nous a permis de cartographier une 
myriade de déterminants de toxicité localisés dans les régions codantes et non codantes du gène de la 
toxine AapA3. En particulier, certaines de ces mutations ont révélé l'existence de tige-boucles ARN 
transitoires qui agissent de manière co-transcriptionnelle pour empêcher l'initiation de la traduction pendant 
la synthèse de l'ARNm codant pour la toxine. Ces structures ARN métastables fonctionnelles sont 
nécessaires pour découpler les processus de transcription et de traduction et permettent la présence de ces 
gènes toxiques sur le chromosome bactérien. Bien que les ARNm non traduits deviennent rapidement 
instables, nos travaux ont également révélé l'existence de deux tige-boucles protectrices situées aux deux 
extrémités de l'ARNm. Ces structures secondaires empêchent des activités exonucléolytiques agissant en 5' 
et 3'. Dans l’ensemble, notre travail met en évidence les conséquences de la forte pression de sélection pour 
limiter l'expression des toxines sous laquelle évoluent les systèmes TA. Cela nous a permis de mieux 
comprendre l’influence du repliement secondaire des ARNm, non seulement lors de la régulation post-
transcriptionnelle, mais aussi co-transcriptionnelle de l’expression de cette famille particulière de gènes. 
Ces caractéristiques de régulation basées sur l'ARN peuvent être exploitées à l'avenir pour des applications 
biotechnologiques (p. ex., production accrue de protéines par stabilisation d'ARNm) ou biomédicales (p.ex., 
développement de stratégies antimicrobiennes alternatives pour l'activation de la synthèse de toxines). 
Systèmes toxine-antitoxine, Helicobacter pylori, expression génique, séquençage haut débit, mutations suppresseurs, 
repliement de l'ARN, stabilité de l'ARN, couplage transcription/traduction 
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Résumé détaillé  
Contexte de la recherche 
Helicobacter pylori est une bactérie Gram-négative qui représente un des principaux agents 
pathogènes gastrique humain. Le génome de cette bactérie fut l’un des premiers séquencés (Tomb et 
al., 1997a) et seul un petit nombre de facteurs de transcription a pu être prédit sur ce petit génome de 
1,67 Mb (Thompson and de Reuse, 2002). En 2010, une combinaison d’approches bio-informatiques 
et d'analyse ARN par séquençage à grande échelle (dRNA-seq) a permis la caractérisation du 
transcriptome de H. pylori. Ces études ont révélé l'existence de plus de 60 petits ARN non codants 
(sRNAs) (Sharma et al., 2010). Jusqu’à présent, seul quatre d’entre eux ont été caractérisés. Parmi les 
plus abondants, il existe une famille intriguante de six ARN antisens homologues (nommés IsoA1 à 
IsoA6, inhibitor of small ORF family A, locus 1 à 6). Ces ARNs antisens sont exprimés dans le brin 
d’ADN opposé à une nouvelle classe de petits ARNm (nommés AapA1 à AapA6, représentant : 
antisense associated peptide family A) (Sharma et al., 2010). En effet des tests de traduction in vitro 
ont montré que chaque petit ARNm AapA code pour un peptide de 30 acides aminés dont l’expression 
est réprimée spécifiquement par le sARN IsoA.  De plus, l'ARNm AapA et le sRNA IsoA sont 
transcrits de manière constitutive (Sharma et al., 2010). De fait, ces modules d’expression, répétés à 
six loci différents sur le chromosome d’H. pylori, pourraient appartenir à une nouvelle famille de 
systèmes toxine antitoxine (TA) bactériens. 
Les systèmes TA sont de petits modules génétiques composés d'une toxine et d’une antitoxine. 
Cette dernière est plus instable et elle permet d’empêcher l’activité de la toxine. En fonction de la 
nature et du mode d’action de l’antitoxine, les systèmes TA peuvent être organisés en six classes (I-
VI). Il est important de noter que, les toxines sont toujours des protéines tandis que les antitoxines 
peuvent être des protéines (dans les systèmes TA de type II, IV, V et VI) ou des ARNs (dans les 
systèmes TA de type I et III) (pour une revue, voir Goeders et Van Melderen, 2014). Les antitoxines 
de type I sont des ARNs qui peuvent s'apparier avec l’ARNm de leur toxine cible pour inhiber 
l'initiation de la traduction (en bloquant l'accessibilité SD) et/ou favoriser la dégradation de l'ARNm 
de la toxine ou de l’heteroduplex d'ARN (pour une revue, voir (Fozo et al., 2010)). Une caractérisation 
plus poussée de la famille aapA/IsoA chez H. pylori a confirmé son identification comme étant la 
première famille de systèmes TA de type I identifié jusqu’à présent chez les epsilonprotéobactéries 
(Arnion et al., 2017; Sharma et al., 2010). 
Dans nos travaux récents (Arnion et al., 2017, et Korkut et al., in preparation), le module 
présent au locus I du chromosome d’ H. pylori (aapA1/IsoA1) a été caractérisé. Nous avons montré 
que le gène aapA1 code pour une petite protéine membranaire dont l'expression est toxique pour H. 
pylori. D’ailleurs, la synthèse de la protéine est réprimée par plusieurs mécanismes de régulation post-
transcriptionnelle. La transcription du gène aapA1 génère un ARNm de 250 nucléotides appelé 
aapA1-FL (pour « plein taille »), qui est inactif en traduction.  Ce même ARNm est raccourci par une 
coupure à son extrémité 3' pour générer une version tronquée de 225 nucléotides qui elle peut être 
traduite. Ce transcrit actif, noté aapA1-Tr (pour « tronqué »), s'apparie avec l'ARN antisens IsoA1 
pour former un hétéro-duplex d'ARN étendu qui est rapidement dégradé par la ribonucléase III (RNase 
III). En l'absence d'IsoA1, la toxine AapA1 est synthétisée, entraînant un arrêt de croissance de la 
bactérie et la mort cellulaire. 
À ce jour, la plupart des systèmes TA ont été étudiés à l'aide de vecteurs d'expression 
synthétiques ou chez des organismes hétérologues (Fozo et al., 2008; Jahn et Brantl, 2013; Unoson et 
Wagner, 2008), ce qui peut entraîner des erreurs d'interprétation des effets physiologiques de 
l'expression des toxines, qui ne se retrouveraient jamais à des niveaux aussi élevés que dans les 
conditions endogènes. Une autre limite de l'utilisation de tels systèmes d'expression est le fait qu’ils ne 
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Résultats 
 
1. Le repliement co-transcriptionnel contrôle l’efficacité d’initiation de la traduction 
Les résultats obtenus avec l’approche FASTBAC-Seq sont présentés dans la première partie du 
Chapitre 4 section 4.2 (article III). Dans le premier article nous avons montré que l’expression 
chromosomique de la toxine AapA3 est létale pour H. pylori.  En effet nous n’avons pas pu construire 
une souche inactivée pour le promoteur de l’antitoxine en absence de mutations non-sens dans le gène 
de la toxine. Nous avons utilisé le phénotype létal pour sélectionner des mutants suppresseurs.  
Environ 60000 clones bactériens contenant au moins une mutation ont été sélectionnés et séquencés 
par séquençage haut-débit. Nous avons obtenu majoritairement des mutations ponctuelles qui 
correspondent soit à des substitutions, des délétions ou des insertions. Les mutations responsables de 
la suppression de la toxicité chez H. pylori ont été cartographiées sur le gène de la toxine. Si la plupart 
des mutations ponctuelles sont localisés dans le cadre ouvert de la toxine AapA3 (et sont décrits dans 
le Chapitre 4 section 4.1 (article II)), un tiers correspond à des régions non-codantes du gène de la 
toxine. Nous avons analysé l’effet des mutations des régions non codantes sur la transcription, la 
traduction et la stabilité de l’ARNm de la toxine. Dans l’article III, nous nous sommes focalisés sur 
l’effet de mutations sur l’efficacité de traduction de la toxine. 
La traduction est un processus complexe où, globalement, toutes les étapes contribuent au 
niveau final de production des protéines. Cependant, chez les bactéries, l'initiation de la traduction 
reste l'étape limitante (Duval et al., 2015; Kozak, 2005; Nakagawa et al., 2017; Simonetti et al., 2009). 
Le mécanisme d’initiation de la traduction canonique implique l’interaction par appariement de base 
entre la séquence Shine-Dalgarno (SD, de séquence consensus AGGAG) dans l’ARNm et la séquence 
anti-SD de l’ARNr 16S incorporé dans la sous-unité ribosomale 30S (Shine et Dalgarno, 1974; Steitz 
et Jakes, 1975). Ensuite le facteur d'initiation 2 (IF-2) va reconnaitre un codon initiateur (c.-à-d. AUG 
ou UUG / GUG) situé à une distance optimale de la séquence SD (Chen et al., 1994). Ceci forme ce 
que l’on appelle « le complexe de d’initiation de la traduction ». Plusieurs études ont déjà souligné 
l’importance de l’accessibilité de la séquence SD pour l’initiation de la traduction (Bhattacharyya et 
al., 2018; Espah Borujeni et al., 2014; Kozak, 2005). Dans le Chapitre 4 section 4.2 (article III), nous 
avons présenté une partie des résultats obtenus de l’analyse du locus aapA3/IsoA3 avec FASTBAC-
Seq en se focalisant sur des mutations suppresseurs localisées dans des régions non-codantes. Nous 
avons montré que si certaines mutations agissent au niveau de la séquence primaire de l’ARNm (c.-à-
d. mutation dans la séquence SD), certaines mutations agissent au niveau du repliement de l’ARNm en 
permettant la séquestration de la séquence SD dans une structure tige-boucle très stable. Ces mutations 
agissent comme des pièges énergétiques piégeant l'ARNm de la toxine AapA3 dans des conformations 
qui ne sont pas traductibles. De manière très intéressante, nos résultats suggèrent que ces tige-boucles 
ARN sont en fait des reliques de structures transitoires formées lors de la transcription de l’ARNm de 
la toxine AapA3.  
En effet, nous avons montré que ces mutations ponctuelles agissent dans un contexte de 
séquence préexistant, en permettant de stabiliser des structures secondaires d'ARN qui masquent le 
site de fixation du ribosome. Habituellement ces structures sont formées de manière transitoire afin 
d’empêcher le démarrage de la traduction durant la synthèse de l’ARNm de la toxine. En effet ces 
structures métastables permettent de masquer la séquence SD temporairement en attendant qu’une 
structure plus stable soit formée entre les régions 5’ et 3’ de l’ARNm. Ce dernier adopte ainsi une 
structure dite « en trèfle à quatre feuilles » qui est très stable et non traduite, mais qui est lentement 
maturée en forme plus courte pour devenir traductible. C’est cette forme mature de l’ARNm qui est 
régulée exclusivement par l’ARN antitoxine. Une étude d’un système TA de type I très similaire (c.-à-
d. hok/Sok chez E. coli) avait décrit l'existence d'une tige-boucle métastable dans la voie de repliement 
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de l'ARNm de la toxine Hok (Repsilber et al., 1999). Ces études ont été réalisées in vitro en utilisant 
des versions d'ARNm tronqué en analysant par empreinte enzymatique les différentes structures 
formées. Toutefois, contrairement à notre étude qui a révélé l’existence de structures métastables par 
des mutations stabilisantes, l’étude in vivo sur l’ARNm Hok a révélé l’existence d’une tige-boucle 
métastable à l’aide d’une mutation déstabilisante (Møller-Jensen et al., 2001). De plus, il est important 
de noter que dans le cas de l'ARNm de Hok, la structure métastable ne joue pas de rôle direct dans la 
séquestration de la séquence SD pendant la transcription. Au lieu de cela, elle est requise pour 
l'interaction à longue distance entre les extrémités des ARNm 5 'et 3' (élément fold-back-inhibition, 
fbi) qui obstruent la séquence SD du peptide leader Mok dans le transcrit de plein taille Dans notre 
cas, les structures transitoires ne sont pas de simples structures intermédiaires dans le processus de 
repliement de l’ARNm, mais ces structures participent au contrôle traductionel de la toxine. Par 
conséquence, notre étude représente le premier exemple de structures secondaires transitoires qui 
agissent directement au niveau co-transcriptionnel sur le démarrage de la traduction, quel que soit le 
devenir de l’ARNm.  
 
2. Deux tige-boucle présentes aux extrémités 5’ et 3’ non traduites sont responsables de la très 
forte stabilité de l’ARNm codant pour la toxine AapA3 
Dans l'article III, nous avons décrit comment le repliement de l’ARNm codant pour la toxine AapA3 
permet de prévenir la traduction tout au long de sa synthèse. Toutefois il a été montré que la stabilité 
des ARNm est fortement diminuée en absence de ribosomes qui les protègent de l’action des 
ribonucléases. De fait que se passe-t-il dans le cas des ARNms codant pour des toxines de type I et qui 
échappent au couplage transcription/traduction. L’approche FASTBAC-Seq a identifié un très grand 
nombre de mutations suppresseurs capable d’accélérer la dégradation de l’ARNm codant pour la 
toxine. Nos travaux ont montré que ces mutations suppresseurs sont localisées dans des structures tige-
boucle très stables. Ces mutations permettent d’induire une très forte déstabilisation de ces structures 
par la création d’un seul mésappariement dans la tige. Cette approche a donc mis en évidence 
l’existence de deux tige-boucles qui permettent de stabiliser l’ARNm codant pour la toxine, de 
manière à ce qu’il puisse être traduit de manière efficace.  
Par ailleurs sachant que les structures secondaires des ARN influe fortement sur la plupart des 
activités exonucléases (et certaines endonucléases), nous avons cherché les exonucléases dont 
l’activité est bloquée par ces structures. Par exemple, il a été démontré chez E. coli que la 
Polynucélotide Phosphorylase (PNPase), la principale exonucléase 3’-5’ de H. pylori, dégrade 
l’extrémité 3’ de l’ARN jusqu’à ce qu’elle rencontre une structure tige-boucle énergétiquement 
suffisamment stable (Spickler et Mackie, 2000). De même, une forte sensibilité à la structure 
secondaire a été démontrée pour la seule exonucléase 5’-3’ identifiée chez H. pylori, la RNase J 
((Redko et al., 2013), montrée aussi chez E. coli, Even et al., 2005)). Le rôle clé des structures de 
l'ARN en 5 ' dans la stabilité des ARNm a été démontré il y a longtemps (Chen et al., 1991; Emory et 
al., 1992). Avec le développement récent de l’approche Term-Seq (Dar et al., 2016), un très grand 
nombre de structures protectrices localisées dans les extrémités 5 ’et 3’ des transcrits dans le 
transcriptome d’E. coli a été rapporté (Dar et Sorek, 2018). L'ARNm d'AapA3 mature possède deux 
structures en boucle-tige hautement stables aux deux extrémités de l'ARNm, ce qui garantit sa grande 
stabilité malgré l'absence de traduction. En effet nous avons montré que la structure tige-boucle 
présente à l'extrémité 3' fonctionne comme un barrage thermodynamique pour l'activité 3'-exonucléase 
de la PNPase, et elle est essentielle pour la maturation de l'ARNm de AapA3. En effet nos travaux 
suggèrent que l’activation de l’ARNm codant pour la toxine AapA3 requiert une dégradation 3’-5’ 
réalisé par la PNPase. De manière surprenante, des résultats similaires ont été obtenus avec l'antitoxine 
IsoA3, qui est lui aussi raccourci par une dégradation exonucléotidique 3’-5’ (réalisé par la PNPase) 
(section 4.4 du Chapitre 4). Dans l'ensemble, ce travail a mis en évidence le rôle clé de la structure de 
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l'ARN secondaire dans la stabilité et l'activation de l'ARNm codant pour la toxine AapA3, ainsi que 
pour le sARN IsoA3. 
Les ARN CRISPR (ARNcr) en sont un exemple intéressant. Ils sont généralement transcrits 
sous forme de molécules inactives de pleine longueur qui nécessitent d'être maturées pour générer les 
ARNcr actifs plus courts. La maturation des ARNcr représente un événement clé dans l'activation de 
CRISPR (Deltcheva et al., 2011), de même que la maturation des ARNm codant des toxines est 
essentielle pour l'activation des systèmes TA de type I (Masachis et Darfeuille, 2018). Cependant, 
contrairement aux ARNcr, pour lesquels les endoribonucléases responsables de son activation sont 
souvent codées dans le cadre du système (CasE, Cas6, Csy4) (Deltcheva et al., 2011), l'identification 
des activités impliquées dans l'activation de type I ARNm codant la toxine, ne faisant pas partie des 
modules TA, est difficile. À ce jour, un tel mécanisme d'activation n'a été signalé que dans quelques 
cas, y compris l'activation exonucléolytique en 3 'de l'ARNm de Hok (Franch et al., 1997) et 
l'activation en 5' de la TisB (Darfeuille et al., 2007), DinQ (Weel-Sneve et al., 2013), ShoB (Kawano 
et al., 2005) et ZorO (Wen et al., 2017). Cependant, l'identité des enzymes responsables est dans la 
plupart des cas inconnue. Dans cet article, nous avons cherché à explorer les déterminants de la 
stabilité de l'ARNm codant pour la toxine AapA3 et à comprendre comment ils influencent sa voie 
d'activation ainsi que la régulation du système. 
 
Les résultats de mes travaux de thèse ont mis en évidence la forte pression de sélection à laquelle les 
systèmes TA sont soumis afin d’éviter l'expression des toxines. Ainsi, les systèmes TA ont développé 
des stratégies de régulation de l’expression des gènes hautement sophistiquées. Pour cela, l’étude des 
systèmes TA représente un outil permettant la découverte des mécanismes de régulation de 
l’expression des gènes inexplorés et imprévisibles chez les bactéries. Notamment, cette étude nous a 
permis de mieux comprendre l’influence du repliement secondaire des ARNm, pas seulement lors de 
la régulation post-transcriptionnelle, mais aussi, co-transcriptionnelle de l’expression de cette famille 
particulière de gènes. A l’avenir, la compréhension de ces mécanismes régulateurs basées sur la 
structure de l’ARN pourrait être exploitée pour le développement des applications biotechnologiques 
(p. ex., production accrue de protéines par stabilisation d'ARNm) ou biomédicales (p.ex., 
développement de stratégies antimicrobiennes alternatives pour l'activation de la synthèse de toxines). 
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CHAPTER 1. Introduction 
1.1. Helicobacter pylori 
The human stomach, long believed to be a sterile organ, is, in reality, the niche for up to 200 different 
bacterial species. However, there is one species that, when present, tends to be numerically dominant 
(despite not changing the composition of the bacterial community), Helicobacter pylori (Bik et al., 
2006). The Helicobacter genus is composed of Gram-negative bacteria that belong to the epsilon 
subdivision of Proteobacteria. So far, more than 20 different species have been described as belonging 
to the Helicobacter genus (Fox, 2002). They can be divided into gastric helicobacters, specialized in the 
colonization of the gastric mucosae and epithelial layers of their host (e.g., H. pylori, colonizing the 
human stomach, and the H. hilmannii and H. felis, colonizing the stomach of animals but having 
zoonotic potential), and non-gastric helicobacter or enterohepatic helicobacters, that colonize the lower 
intestinal tract (i.e., intestine crypts) and the liver of animals -including humans- (e.g., H. canis, H. 
pullorum, H. cinaedi and H. fennelliae). Importantly, gastric species are not able to colonize the niche of 
enterohepatic species, and the same principle applies the other way around, which have important 
clinical consequences (Solnick and Schauer, 2001). Despite being a big family, among the various 
Helicobacter species, H. pylori colonizes the stomach of about 50% of the world’s population. 
Therefore, H. pylori has the highest impact in human health and is the most studied and well-
characterized species. 
1.1.1. Colonization and virulence 
H. pylori is uniquely specialized to live in the human stomach. This specialization is thought to have 
been taking place for at least the last 100,000 years (Moodley et al., 2012). Modern H. pylori strains 
have been assigned to different populations based on their geographic origin (hpEurope, hpSahul, 
hpEastAsia1, hpAsia2, hpNEAfrica, hpAfrica1 and hpAfrica2), and taking advantage of its 
characteristic early childhood oral transmission (i.e., fast transmission within families), they have even 
been used as tracers of complex demographic events in the human prehistory (Falush et al., 2003; 
Maixner et al., 2016; Moodley and Linz, 2009; Moodley et al., 2009; Wirth et al., 2004). H. pylori 
infection is associated with chronic gastritis (usually asymptomatic until adulthood), peptic ulcers, and 
in fewer cases, gastric cancer (Kusters et al., 2006; Moss, 2017; Plummer et al., 2015; Wroblewski et 
al., 2010), being therefore the only bacterium species classified within the group I carcinogens by the 
World Health Organization (1994). 
1.1.1.1. Adaptation to acidic pH: urease, taxis and cell shape  
The production of gastric acid results in a pH of 1-2 in the stomach lumen, which strongly limits 
luminal colonization. In order to survive, H. pylori needs to overcome the mucus layer in the stomach 
and rapidly migrate (within few minutes) to the gastric epithelial surface (Schreiber et al., 2005). To 
achieve this quick migration, H. pylori actively swims towards the mucous layer and the epithelial 
barrier guided by (a.k.a. taxis) pH (mediated by the TlpB chemotaxis receptor, Croxen et al., 2006), as 
well as several compounds, including mucin (mediated by CheY and CheA, Foynes et al., 2000), amino 
acids (Worku et al., 2004), sodium chloride (Mizote et al., 1997) and sodium bicarbonate, in a urease-
dependent manner (Nakamura et al., 1998). Indeed, having a functional urease activity is essential for 
H. pylori acid resistance as it buffers the pH in the periplasm (Sachs et al., 2002) and has been 
demonstrated to be essential for H. pylori chronic infection (Debowski et al., 2017). Additionally, 
urease-catalyzed production of ammonium ions can greatly improve motility, as it raises the pH to near 
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neutrality and this leads to a mucus gel transition to a viscoelastic solution through which H. pylori can 
efficiently swim (Celli et al., 2009; Jonathan P. Celli et al., 2007). Additionally, the helical shape of H. 
pylori cells facilitates motility through the viscous mucus layer by a corkscrew mechanism, and shape 
mutants show impaired colonization (Bonis et al., 2010; Sycuro et al., 2012). Interestingly, as 
highlighted by Keshavarz et al., (1999) and Cellini, (2014), there is a relationship between H. pylori 
motility, cell-shape, and phase of growth, that have great consequences in the colonization and virulence 
processes. As illustrated in Figure 1.1, in the exponential growth phase, cells are dividing and have 
helical shape with multiple polar flagella. These cells have optimal motility and are therefore able to 
rapidly colonize the niche, being abundantly found in the mucus layer. Moving towards the stationary 
growth phase, cells progressively become coccoïdal and shed the flagella. These cells, no longer divide 
(they are Viable But Non Cultivable Cells or VBNC) and loss their motility. Nevertheless, coccoïds are 
abundantly found in H. pylori biofilms, suggesting a role in persistent colonization (Carron et al., 2006; 
García et al., 2014; Hathroubi et al., 2018). 
 
Figure 1.1. Growth phase-dependent evolution of H. pylori cell morphology. During exponential growth, 
H. pylori cells are actively dividing and have typical helicoidal shape, which allows an optimum motility 
through the mucus layers of the human stomach to colonize and adhere to the epithelial cells. Approaching 
the stationary growth phase, cells progressively acquire coccoïdal shape, passing through the intermediates 
U-shape and pre-coccoïdal shape. At this stage, cells are no longer actively dividing (are what is called 
Viable But Non Cultivable Cells or VBNC), and they have lost their motility. However, it is well known that 
coccoïd cells, have increased tolerance of stress conditions and have important biological roles, as for 
instance, in H. pylori biofilms in the human stomach. 
 
1.1.1.2. Secreted effectors  
Once H. pylori crosses the mucus layer and reaches the epithelial surface, it can actively manipulate the 
host tissues to promote its own persistence by secreting (mainly) two protein effectors: VacA and CagA. 
The vacuolating cytotoxin A (VacA, 140 kDa) is harbored by all characterized H. pylori strains and 
interestingly presents sequence variation in several domains that are linked to expression levels and 
virulence (Palframan et al., 2012). VacA is able of upregulating chemokine expression in human 
eosinophils (causing inflammation) (Kim et al., 2007), increasing the paracellular epithelial 
permeability of polarized cells (Papini et al., 1998) and of using it to go through the disrupted tight 
junctions to inhibit T-cell proliferation (Sundrud et al., 2004). The second toxin is the cytotoxin-
associated gene A (CagA, 128 kDa), originally identified as an immunodominant antigen from patients 
infected with highly virulent vacA alleles (Covacci et al., 1993; Tummuru et al., 1993). CagA is 
translocated into host cells by the Cag type VI secretion system (T4SS), a needle-like encoded on the 
Growth phase
Exponential Stationary
helicoidal U-shaped coccoïdalpre-coccoïdal
Good	motility
Colonization
No	motility
Biofilm
Dividing Non-dividing
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cag pathogenicity island (cag-PAI) (Chang et al., 2018; Kusters et al., 2006; Murata-Kamiya, 2011; 
Olbermann et al., 2010). Once inside, CagA can get phosphorylated in the EPIYA motif by the SRC and 
ABL family kinases (Nagase et al., 2011) and tyrosine-phosphorylated by the focal-adhesion kinase Src 
(Kwok et al., 2007) leading to host phenotypes that confer nutritional benefits (Tan et al., 2011; Wu et 
al., 2013).  
 
1.1.2. Natural competence and homologous recombination 
H. pylori is a so-called naturally competent bacterium. Natural competence is defined as the ability to 
take up DNA from the environment and recombine it into the genome, leading to genetic 
transformation. Regarding the first step of competence, H. pylori is the sole competent bacterium 
described so far that uses a type IV secretion system (T4SS, the Com apparatus, shown as B7B9, B6B8, 
B10 and B4 in Figure 1.2) as an alternative to the type IV pilus apparatus (which is not present on its 
genome) to transport DNA through the inner and outer membranes (Fischer et al., 2001; Hofreuter et al., 
2001; Mell and Redfield, 2014). This strategy is surprising, as T4SS are more often used to translocate 
DNA (i.e., conjugative plasmids) (Grohmann et al., 2003) and proteins (e.g., effectors) (Alvarez-
Martinez and Christie, 2009; Boschiroli et al., 2002; den Hartigh et al., 2008) for virulence purposes. 
The H. pylori T4S Com apparatus has two main particularities: 1) it has an opposite polarity when 
compared to the other T4SS (the Com T4SS translocate DNA into the cell instead of exporting it), and 
2) it works with only one ATPase motor instead of the three found in other T4SS (e.g.., the VirB/D4 
T4SS of Agrobacterium tumefaciens (Atmakuri et al., 2004)) (for a review see, Christie et al., 2005). 
However, it uses at least one component for DNA transport that is highly conserved between all T4S, 
the ComEC protein (shown in light orange in Figure 1.2). 
Events occurring during natural transformation can be divided into two groups, 1) the 
presynaptic events, and 2) the postsynaptic events. Although the exact molecular underpinnings of 
competence and recombination are unclear, DNA uptake through the T4S Com apparatus likely leads to 
single-stranded cytosolic DNA fragments. This kind of DNA substrate is different from the one that is 
normally used during DNA repair, and may, therefore, be recombined through a distinct pathway (i.e., 
independent of the RecOR and AddAB proteins, (Humbert et al., 2011; Marsin et al., 2008, 2010)). As 
shown in Figure 1.2., once a single-stranded DNA enters the cytoplasm, DprA (DNA processing chain 
A) and RecA (recombinase A) cooperatively bind to it (Mortier-Barrière et al., 2007) (shown to be 
essential for H. pylori natural transformation, Schmitt et al., 1995; Smeets et al., 2000; Thompson and 
Blaser, 1995). Interestingly, the DprA protein in H. pylori has been shown to have a double function, it 
can not only inhibit the activity of restriction enzymes but also stimulate methyltransferases, thus, 
modulating the R-M barrier during inter-strain natural transformation (Dwivedi et al., 2013). Together 
with DprA and RecA, a putative resolvase homolog, DprB (shown in purple in Figure 1.2), is required 
for high-frequency natural transformation in H. pylori (Humbert et al., 2011) but not for DNA repair, 
suggesting that all three compose the presynaptic pathway for the homologous recombination of DNA 
substrates taken in by the T4S Com apparatus in H. pylori. 
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Figure 1.2. H. pylori natural competence. Double-stranded DNA is taken into the periplasm by the ComB 
apparatus (B7B9, B6B8, B10 and B4) and transported into the cytosol through the ComEC channel. If the 
DNA is from an unrelated strain, restriction enzymes may cleave it limiting the size of the DNA. RecA 
homology searching leads to the formation of a D-loop structure that is modified and extended during 
replication by RecG-mediated branch migration. Resolution can occur mediated by RuvC which cleaves the 
Holliday junction or by RuvC-independent mechanism in which RecG pushes the Holliday junction until the 
end of the invasive DNA fragment. After resolution, replication can restart unless a second 3’end invasive 
DNA fragment is present leading to the generation of double crossover products (not shown). The Figure 
was adapted from (Dorer et al., 2011). 
 
 
As shown in Figure 1.2., the two major actors of the postsynaptic events are the ATP-dependent 
DNA helicase RecG (shown in light blue in Figure 1.2), and the crossover junction 
endodeoxyribonuclease RuvC (shown in red in Figure 1.2), however, their role is still nowadays a 
controversial issue. Postsynaptic homologous recombination (HR) factors need to control the length of 
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the DNA that is to be integrated into the genome (Humbert et al., 2011). It is known that DNA length 
and sequence homology are key factors determining transformation efficiency. However, there is a 
certain degree of tolerance to mismatches, as a 4% difference was shown to have no effect on H. pylori 
transformation efficiency (Humbert et al., 2011). Furthermore, during transformation with heterologous 
DNA, longer integration lengths (~1 to 8 kb) have been measured when a whole gene was transferred 
(Humbert et al., 2011) than when one point mutation was integrated (~0.9-1.8 kb) (Lin et al., 2009), 
reflecting that longer flanking homologous DNA regions are needed for the integration of long DNA 
fragments. Consistently with this, RecG is able to increase the length of the integrated DNA by helping 
branch migration, whereas RuvC decreases the length by resolving the Holliday junction (Figure 1.2). 
Altogether, it seems that the HR pathway used for H. pylori natural transformation is different from that 
of DNA repair. Interestingly, RuvC defective mutants show reduced colonization (Loughlin et al., 
2003), suggesting an important role of natural transformation during infection. 
 
1.2.Transcriptional regulators in H. pylori  
 
Bacteria use transcriptional regulatory networks (TRN) to transduce environmental signals into a 
coordinated expression of their genomes, resulting in an appropriate adaptive response. Usually, 
prokaryotic TRNs are highly organized, multilayered, hierarchical structures involving hundreds of 
transcription factors (TFs), which make them highly challenging to study (Babu et al., 2009). The small 
H. pylori genome (1.67 Mb) encodes for a rather narrow range of transcription factors, including only 
three sigma factors (i.e., RpoD, FliA and RpoN) (Tomb et al., 1997), which make of it an interesting 
model for the study of TRN in bacterial pathogens (Danielli et al., 2010; Scarlato et al., 2001). Indeed, 
to date, only 17 bona fide TFs have been characterized in H. pylori, including only three regulatory two-
component systems (Scarlato et al., 2001; Tomb et al., 1997). Four main TRN origons have been 
identified in H. pylori, and are related key physiological responses during infection: 1) acid acclimation, 
2) heat and stress response, 3) taxis and motility, and 4) metal ion homeostasis (Danielli et al., 2010).  
In order to survive in the highly acidic conditions of the human stomach, H. pylori has a 
specialized set of genes termed acid acclimation genes (over 100 genes (Pflock et al., 2006), including 
the aliphatic amidase amiE and amiF (Pflock et al., 2006) and the ure urease operon (Pflock et al., 2004, 
2005)). Transcription of this set of genes is controlled by the housekeeping s80 factor and regulated by 
the essential response regulator ArsR (Acid responsive signaling). AsR together with the ArsS sensor 
kinase compose one of the three two-component systems of H. pylori (Beier and Frank, 2000). 
Interestingly, the nickel response regulator NikR was reported to control the expression of a subset of 
acid-responsive genes (Contreras et al., 2003). Now, considering that at low pH, the solubility of metal 
ions such as nickel increases, it has been proposed that acidic pH induces NikR expression by an 
increased bioavailability of nickel ions (van Vliet et al., 2002). Further, the ArsRS system is also 
regulated by the iron-responsive regulator Fur (ferric uptake regulator), which enters in competition 
with NikR to bind to the promoter region of asrR (Roncarati et al., 2016), connecting the acid 
acclimation with the metal ion homeostasis responses. Transcriptional regulation of stress and motility 
responses is mediated by the two transcriptional repressor proteins HrcA and HspR, which repress the 
expression of the groES-groEL and hrcA-grpE-dnaK operons (Roncarati et al., 2007). Flagellar and 
chemotaxis responses are more challenging to characterize, as often the genes involved are unclustered 
and scattered within multicistronic operons (Alm et al., 1999; Tomb et al., 1997). Furthermore, they are 
regulated by at least 7 different TFs, including the housekeeping s80 factor (rpoD), s54 (rpoN), s28 
(fliA), a NtrC-like response regulator FlgR, FlgS and CheA/CheY/CheY2 regulating chemotactic 
responses (Foynes et al., 2000; Jimenez-Pearson et al., 2005).  
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Interestingly, the H. pylori genome also encodes for two, poorly characterized but essential, 
response regulators that lack the histidine kinase component (so-called orphan response regulators), the 
HP1021 and HP1043. The HP1021 orphan response regulator has been shown to regulate the 
transcription of a gene cluster involved in the acetone metabolism (Pflock et al., 2007). The HP1043 (as 
the AsrR) is a member of the OmpR/PhoB subfamily of orphan response regulators, which is uniquely 
found in Epsilonproteobacteria and lacks the phosphorylation domains. It was initially described as a 
cell cycle regulator, controlling the expression of the methyl-accepting chemotaxis tlpB gene in 
response to growth phase (Delany et al., 2002). Strikingly, in 2016 it was related to the growth-phase 
dependent transcription of CncR1 by binding to the PcagP promoter (Vannini et al., 2016). CncRI is one 
of the only two trans-encoded small RNA (sRNA) so far characterized in H. pylori, and will be further 
discussed in the ‘Small regulatory RNAs in H. pylori’ subsection of this Chapter. Another recent study 
identified 37 new genes harboring a conserved HP1043 nucleotide sequence motif in their promoter or 
intragenic regions by using Chromatin Immunoprecipitation-sequencing (ChIP-seq) (Pelliciari et al., 
2017). Intriguingly, most of them correspond to genes involved in translation, thus a potential role of 
HP1043 provoking growth arrest by arresting protein synthesis have been described (Pelliciari et al., 
2017). But additionally, many of the newly identified targets are sRNAs, including RepG, which 
regulates the chemotaxis receptor TlpB (Pernitzsch et al., 2014), IsoA1, which acts as antitoxin 
inhibiting the translation of the AapA1 toxin (Arnion et al., 2017, see appendix 8.3 in Chapter 8), and 
IsoA3, antitoxin of the same family as IsoA1, impeding the expression of the AapA3 toxin,  which will 
be the focus of this thesis. All of these sRNAs will be extensively described in the ‘Small regulatory 
RNAs in H. pylori’ subsection of this Chapter. Additionally, the potential role of HP1043 in IsoA3 
regulation will be further discussed in Chapter 5 section 5.2.1. 
 
1.3. Post-transcriptional regulation in H. pylori  
Bacteria are extremely adaptable organisms, able to efficiently optimize biological processes in 
response to changes in the environment. Once a gene is transcribed, its expression is strongly 
determined by a myriad of events that occur in the time-window between transcription termination and 
translation initiation, the so-called post-transcriptional regulation events. Which, when and how these 
events act on the mRNA is fate changing. These events mainly include mRNA stability and 
translatability, although additional factors such as mRNA cellular location can also play a role. 
1.3.1. mRNA stability  
In almost all domains of life, information-carrying messengers are constantly actively destroyed. This 
can be seen as a waste of energy and resources; however, it is in the controlled destruction of RNAs that 
fast and accurate responses to environmental (and internal) stimuli can occur. Additionally, by rapidly 
destroying not useful transcripts, the costs of translation are reduced and ribonucleotide recycling is 
beneficial. Thus, it is an evolutionary requirement for any organism to develop mechanisms for RNA 
degradation. Bacteria have developed two main types of ribonucleases: 1) endonucleases and 2) 
exonucleases. The number and composition of such battery can strongly vary between clades. 
 
Endoribonucleases 
Considering all bacteria species, there are three major ribonucleases with endonuclease activity, 
including RNase E (and its homolog RNase G), RNase Y and RNase III. Additional minor 
endonucleases with specific functions, such as the RNase P, which maturates the tRNA 5’ ends and 
noncoding regions of some mRNAs (Li and Altman, 2003), and the RNase Z, which eliminates aberrant 
3’ ends on tRNAs (Dutta and Deutscher, 2009) as well as of some mRNAs (Perwez and Kushner, 
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2006), can also be found. RNase E is considered one of the most important activities governing mRNA 
decay. It is a homotetramer carrying the catalytic domain in the highly-conserved amino-terminal 
domain (McDowall and Cohen, 1996), a membrane-binding helix in the poorly-conserved carboxy-
terminal domain (Khemici et al., 2008), two arginine-rich RNA-binding domains, and a region that 
serves as a scaffold for the assembly of a ribonucleolytic complex known as the RNA degradosome 
(Carpousis et al., 1994; Causton et al., 1994; Ehretsmann et al., 1992; Py et al., 1994; Vanzo et al., 
1998), composed by the RNase E, the polynucleotide phosphorylase (PNPase), the RNA helicase B 
(RhlB) and the enolase (Miczak et al., 1996; Py et al., 1996). RNase E preferentially cuts AU-rich 
single-stranded RNA internally (McDowall et al., 1994). Strikingly, despite being able to act far away 
from the 5’ end, a strong preference for 5’monophosphorylated ends has been reported (Mackie, 1998). 
This phenomenon is explained by the presence of a 5’ end binding pocket in the catalytic domain that is 
only able to accommodate 5’ monophosphate but not di-or triphosphate, serving therefore as a 5’ end 
state sensor (Callaghan et al., 2005). Several studies have demonstrated the crucial role of the RNase E 
in both, mRNA (Khemici and Carpousis, 2004; Kushner, 2002; Lopez et al., 1999) and small RNAs (in 
a Hfq-dependent manner) (Masse et al., 2003; Morita et al., 2005) degradation, however, H. pylori lacks 
both, RNase E and Hfq (as 50% of all bacteria species). These characteristics make of H. pylori an 
appealing model for the study of novel post-transcriptional regulation mechanisms. 
Despite lacking RNase E, H. pylori possess RNase Y and RNase III activities. RNase Y has 
been described as the functional homolog of RNase E in bacteria lacking this activity. That of Bacillus 
subtilis possesses a transmembrane domain, a disordered coil-coil-domain, an RNA-binding KH 
domain, and a catalytic HD domain (Lehnik-Habrink et al., 2011). Several studies have pointed at 
RNase Y as a major regulator of mRNA decay (Laalami et al., 2013) and virulence in the pathogens 
Streptococcus pyogenes (Chen et al., 2013) and Staphylococcus aureus (Marincola et al., 2012). Unlike 
RNase E and RNase Y, RNase III is a double-strand-specific ribonuclease. It functions as a dimer with 
an endonucleolytic domain composed by two central catalytic sites that act independently (yielding to 
the characteristic 2-nt overhand at the 3’ end (Gan et al., 2006; Meng and Nicholson, 2008)), and 
double-stranded RNA-binding domain (Blaszczyk et al., 2004). Importantly, at least two turns of an 
RNA helix in length (~20 bp) are required for its activity in vivo (Robertson, 1982), thus being most 
natural stem-loop structures too short to be targets. Nevertheless, RNase III plays a role in ribosomal 
RNA maturation as well as mRNAs (e.g., autoregulation of the rnc-era-recO operon (Matsunaga et al., 
1996) and CRISPR RNAs (Deltcheva et al., 2011). Interestingly for us, it has been shown that RNase III 
is essential for the degradation of toxin-encoding mRNAs belonging to type I toxin-antitoxin (TA) 
systems in B. subitilis (Durand et al., 2012). However, we have shown that this is not the case in H. 
pylori (Arnion et al., 2017, see appendix 8.3 in Chapter 8) (see Paper III for further discussion). 
 
Exoribonucleases 
As degradation pathways are often initiated by endonucleolytic cleavages, exoribonucleases are 
required to quickly degrade decay intermediates that lack termini protection. There are three main types 
of exoribonuclease activity: 1) 3’ phosphohydrolytic (reversible, uses orthophosphate as nucleophile to 
produce nucleoside diphosphates), 2) 3’ hydrolytic (irreversible, yielding to monophosphate products), 
and 3) 5’ hydrolytic (same mechanism as the 3’hydrolytic but on the 5’ end of the target mRNA). The 
two major examples of 3’ phosphohydrolytic exonucleases are the RNase PH, involved in tRNA 
maturation in E. coli (Deutscher et al., 1988), and the polynucleotide phosphorylase PNPase, involved 
in mRNA decay of RNAs with a single-stranded 3’ end (Chen et al., 1991); both of them being 
members of the PDX family of enzymes (Zuo and Deutscher, 2001). H. pylori only possesses PNPase 
activity. Interestingly, its polymerase activity can add a single-stranded adenine-rich 3’ end tail that 
facilitates its 3’ hydrolytic activity (Xu and Cohen, 1995). Importantly, because the catalytically active 
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sites are located inside of a central channel (Narczyk et al., 2018; Štefanić et al., 2017; Symmons et al., 
2000), the 3’ end of the RNA must thread partway through the channel to reach them. As a result of this 
architecture, PNPase degrades the 3’ end of RNA processively until encountering a base-paired 
structure with sufficient thermodynamic stability (Chen et al., 1991). This phenomenon turned out to be 
of extreme importance for the co- and post-transcriptional regulation of the aapA3/IsoA3 type I TA 
system here studied, and will be extensively discussed in Chapters 6 and 7. In E. coli, PNPase can be 
assisted by the unwinding activity of the RNA helicase RhlB (Py et al., 1996) and lead to the release of 
a 5’ terminal dinucleotide (generally exonucleases cannot achieve RNA degradation to the 
mononucleotide level). Despite the absence of a RhlB homolog in H. pylori, another RNA helicase, the 
RhpA, has been associated to be part of a so-called minimal RNA degradosome together with the 5’ 
exoribonuclease RNase J (El Mortaji et al., 2018; Redko et al., 2013). The role of RhpA in the 
aapA3/IsoA3 mRNA processing will also be studied on this thesis in the Chapter 4 section 4.3 (Paper 
IV). 
 The two majors 3’ hydrolytic exonucleases are members of the RNR superfamily, the RNase II 
and RNase R. Despite sharing structural similarities (Cheng and Deutscher, 2002), RNase R has the 
intrinsic capacity of RNA unwinding, which allows its action with no need of external RNA helicase 
activity (Awano et al., 2010). H. pylori only encodes for the RNase R gene, which has been proposed to 
regulate the expression of motility and apoptosis-inducing genes (Tsao et al., 2009). Additionally, H. 
pylori have a 5’exonuclease activity (absent in E. coli), the RNase J, which is essential and which 
depletion has been shown to lead to massive changes in mRNA abundance, suggesting its involvement 
in the decay pathways of a large number of mRNAs (Redko et al., 2016). As above-mentioned, a 
minimal RNA degradosome composed of RNase J and the RNA helicase RhpA, has been proposed to 
exist in H. pylori (despite the lack of RNase E) (Redko et al., 2013). In this thesis, the possible 
cooperative activity of both proteins will be further studied in Chapters 6 and 7. Further, as in the case 
of the RNase E, RNase J has been shown to have a preference for 5’ monophosphate single-stranded 
ends (Mathy et al., 2007; Richards et al., 2011). Indeed, the RNase J is a dimer of dimers in which each 
subunit contains a bipartite metallo-b-lactamase domain, a b-CASP domain, and a carboxy-terminal 
domain. An RNA-binding channel leads deep inside the protein to a catalytic site at each dimer 
interface, where a monophosphorylated but not a triphosphorylated 5’ end can be accommodated 
(Dorléans et al., 2011; Mathy et al., 2007). Because this channel continues past the catalytic center and 
emerges on the other side, explains the ability of RNase J to also act as an endonuclease (Even et al., 
2005). This endonuclease activity turned out to be crucial for the degradation of the IsoA3 sRNA 
antitoxin and will be studied in the Chapter 4 section 4.3 (Paper IV). H. pylori has a Nudix hydrolase, 
the RppH, which is able to convert the 5’ terminal triphosphate of bacterial transcripts to a 
monophosphate, triggering RNA decay by deprotection of the 5’ end. In a recent study, its role in 
mRNA decay was examined by RNA-seq, and over 63 potential targets where identified, suggesting an 
important role of RppH in the post-transcriptional regulation of H. pylori (Bischler et al., 2017). In this 
thesis, the role of RppH is studied in the context of the IsoA3 sRNA decay mediated by RNase J (see 
Chapter 4 section 4.3 (Paper IV)).  
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Figure 1.3. Possible pathways of mRNA decay in H. pylori.  
 
Figure 1.3 summarizes possible pathways of mRNA decay in H. pylori. In primary transcripts, 
the 5’ exonuclease activity of RNase J is impeded by the 5’ triphosphate state. The 3’ exonuclease 
PNPase (together with other 3’exonuclease activities) can process the mRNA until reaching a stem-loop 
with high thermodynamic stability that serves as an energetic roadblock. At this point, the RppH can 
convert the 5’ triphosphate to monophosphate, triggering the activity of the 5’ exonuclease RNase J. 
Alternatively, the same results can be achieved by an endonuclease activity. Similarly to the PNPase, 
the RNase J gets blocked by highly stable secondary structures. At this point, PNPase can use its 
polymerase activity to add a poly-A tail that will facilitate its 3’ exonucleolytic activity. Alternatively, a 
helicase could help any of the exonucleases to unwind the highly stable secondary structures and trigger 
their activity. When very short fragments are left, the oligoribonuclease act yielding to mononucleotides 
products. 
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1.3.2. Translational regulation  
Translation has a great and immediate impact in the definition of the proteome (Picard et al., 2012), 
which is the ultimate element of adaption responses Interestingly, several studies have highlighted a 
poor correlation between mRNA and protein levels. Indeed, mRNA concentration only explains about 
50% of the protein concentration in E. coli (Corbin et al., 2003; Lu et al., 2007) and even less in other 
bacteria (e.g., Lactococcus lactis (Dressaire et al., 2010)), and protein stability playing a minor role 
(Maier et al., 2014). Therefore, the regulation of translation plays a major role in the generation of fast 
and optimized adaptation responses. Although several factors influence both, translation initiation and 
elongation rates, most regulatory mechanisms target the initiation step, making it the rate-limiting step 
of protein synthesis in bacteria (Gold, 1988; Kennell and Riezman, 1977). Canonical translation 
initiation involves the base-pairing interaction between the Shine-Dalgarno (SD) sequence in the mRNA 
with the anti-SD sequence located at the 3’ end of the 16S rRNA embedded in the 30S ribosomal 
subunit (Shine and Dalgarno, 1974; Steitz and Jakes, 1975). The 30S ribosomal subunit, together with 
the Initiation Factor 2 (IF-2), that kinetically assists the specific interaction between an anticodon 
present in the fMet-tRNAfMet and an optimally-spaced (Chen et al., 1994) start codon (AUG or 
UUG/GUG) in the mRNA, form the so-called translation initiation complex (Hartz et al., 1989; 
Simonetti et al., 2013; La Teana et al., 1993).  
 
Consequences of transcription/translation coupling 
Due to the lack of nuclear compartmentalization, transcription and translation (and degradation) 
processes can be coupled in time and space in bacteria (Burmann et al., 2010; Das et al., 1967; Proshkin 
et al., 2010). Thus, the physical interaction between the major components of all the three processes is a 
key determinant of gene expression in bacteria. Interestingly, two studies used time-resolved single cell 
imaging in E. coli to reveal a possible partial compartmentalization, on which ribosomal subunits can 
co-transcriptionally initiate translation in the nucleoid while at the periphery and membrane proximity 
polysomes are formed (Bakshi et al., 2012; Sanamrad et al., 2014). The universally conserved TF NusG, 
as well as the ribosomal protein S10, have been proposed to be involved in the interaction between the 
RNA polymerase and the 30S ribosomal subunit (Burmann et al., 2010; McGary and Nudler, 2013). 
Indeed, co-transcriptional translation (especially the pioneer ribosome) is thought to be beneficial as it 
avoids spontaneous backtracking of the RNA polymerase, aiding to read-through roadblocks (Herbert et 
al., 2006; McGary and Nudler, 2013; Proshkin et al., 2010). One additional implication of 
transcription/translation coupling is that it may make possible to transcribe at different speeds 
throughout the mRNA, being that of the 5’ UTR and start codon slower (Al-Hashimi and Walter, 2008). 
This is interesting as the mRNA folding dynamics have been shown to be influenced by the elongation 
speed of the RNA polymerase (Wickiser et al., 2005). Indeed, several studies have highlighted the role 
of the 5’ UTR structure in translation (Simonetti et al., 2009), and more specifically, the key role of the 
SD sequence accessibility for translation initiation (Bhattacharyya et al., 2018; Espah Borujeni et al., 
2014; Kozak, 2005), which has even been proposed to dictate N-terminal codon bias in E. coli 
(Bhattacharyya et al., 2018). In this thesis, the role of the SD sequence accessibility in the AapA3 toxin 
mRNA has been studied (see Chapter 4 section 4.2 (Paper III) for results, and Chapter 5 for further 
discussion) and was revealed to be an essential feature allowing the hostage of TA systems in bacterial 
genomes (for a review see (Masachis and Darfeuille, 2018) in the section 1.4.1 of this Chapter). 
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Regulatory proteins 
A large number of RNA-binding proteins (RBPs) also positively or negatively regulate translation 
initiation. For instance, binding of the S15 ribosomal protein (r-protein) to the rpsO mRNA (coding for 
the r-protein S15) results in SD inaccessibility in Thermus thermophilus (Serganov et al., 2003). 
Similarly, the carbon storage coordinator CsrA, inhibits translation initiation of a large set of genes 
(e.g., involved in carbon metabolism, quorum sensing and virulence) by binding to GGA motifs and 
competing with 30S ribosomal subunits to bind to the SD sequence (Duss et al., 2014; Fields et al., 
2016). However, translation regulation mediated by RBPs will not be the focus of this thesis. 
Regulation by sRNAs 
There is a large myriad of small regulatory RNAs (sRNAs) that act at the translational level to regulate 
the expression of their target mRNAs. In the next section, the biogenesis, mode of action and role within 
biological networks of sRNAs in bacteria will be discussed.  
 
1.3.3. Small regulatory RNA in bacteria  
Small regulatory RNAs are typically 50-200 nt length and do not code for proteins (non-coding RNAs), 
with the exception of the so-called dual-function sRNAs that also code for small proteins (i.e., the 
RNAIII (Balaban and Novick, 1995) and Psm-mec RNA(Kaito et al., 2011) in S. aureus, SRI in B. 
subitilis (Gimpel et al., 2010), SgrS in E. coli (Wadler and Vanderpool, 2007), and PeIRNA in 
Streptococcus (Mangold et al., 2004), for a review see (Gimpel and Brantl, 2017)). The role of RNA as 
regulators was discovered long ago (e.g., RNA I, inhibitor of ColE1 plasmid replication (Stougaard et 
al., 1981; Tomizawa et al., 1981), a small ~70 nt RNA inhibiting the translation of Tn10 transposase 
(Simons and Kleckner, 1983), and MicF, the first chromosomally-encoded sRNA, which inhibits the 
translation of the outer membrane protein OmpF (Mizuno et al., 1984)). However, their prevalence and 
biological significance initially received poor attention. Some years later, with the increasing 
availability of sequenced bacterial genomes, bioinformatic searches, together with microarray analyses, 
identified several new sRNAs in diverse bacterial species (Livny and Waldor, 2007; Raghavan et al., 
2011; Tsui et al., 2010; Weinberg et al., 2007), including H. pylori (Sharma et al., 2010). Further 
studies, demonstrated that sRNAs not only are widely present in bacterial genomes but also play crucial 
roles in the physiology and adaptive responses, such as quorum-sensing (for a review see (Svenningsen, 
2018)), carbon metabolism (Papenfort and Vogel, 2014) and even in bacteria-prophage communication 
(for a review see (Altuvia et al., 2018)). However, due to space limitations this topic will not be 
extensively discussed on this thesis.  
 
1.3.3.1. Biogenesis 
Although most sRNAs are known to be transcribed as independent genes, there is an increasing number 
of sRNAs reported to be derived from the 5’ and 3’ UTR sequences of mRNAs (Kawano et al., 2005). 
A recent study, described the existence of a prominent 3’ UTR-derived sRNA biogenesis pathway on 
which the RNA chaperone Hfq guides RNase E activity on sRNA-precursors to generate the sRNAs 
able to interact with their target mRNAs (Chao et al., 2017). This pathway was previously observed for 
the S. enterica CpxQ sRNA (Chao and Vogel, 2016). More recently, a study of the MicL sRNA, which 
despite being transcribed from an internal promoter, it needs to be cleaved to be functional (Guo et al., 
2014), has reported on the existence of a similar pathway and interestingly proposed to be directed by 
stem-loop structures that modulate RNase E activity (Updegrove et al., 2018). 
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1.3.3.2. Modes of action 
Few sRNAs act by binding to their protein target (e.g., the CsrB and CsrC sRNAs have multiple GGA 
motifs and thereby reduce the amount of CsrA protein able to interact with its target mRNAs 
(Weilbacher et al., 2003), for a review see (Storz et al., 2011)), however, the vast majority of sRNAs so 
far characterized, regulate gene expression by base-pairing with their target RNA. Base-pairing sRNAs 
can be divided into two groups: 1) cis-encoded sRNAs, and 2) trans-encoded sRNAs. 
 
 
Cis-encoded sRNAs 
Cis-encoded sRNAs (or antisense RNAs, asRNAs) are encoded on the opposite DNA strand of their 
target RNA and therefore share extensive regions of complementarity (75 nucleotides or more) with 
their targets (Wagner et al., 2002). However, despite being encoded in the same DNA region, they are 
independently transcribed as discrete RNA species and function in trans as diffusible molecules. As 
previously mentioned, the first asRNA discovered was RNAI in the ColE1 plasmid acting as an 
inhibitor of primer formation (Stougaard et al., 1981; Tomizawa et al., 1981), followed by the 
identification of a sRNA inhibiting Tn10 transposase activity (Simons and Kleckner, 1983). Soon after, 
one more sRNA, the Sok sRNA was discovered as being essential for the stability of the R1 in E. coli 
(i.e., acting as a Post-Segregational Killing (PSK) elements) (Gerdes et al., 1986; Greenfield and 
Weaver, 2000). Interestingly, subsequent studies revealed that the RNAI of the ColE1 plasmid is in fact 
the toxin component of a type I toxin-antitoxin (TA) system (the RNAI (re-named fst)/RNAII, (Franch 
et al., 1999)). Furthermore, the Sok sRNA was identified as the antitoxin component of the hok/Sok 
type I TA system in E. coli (Thisted et al., 1994). Type I TA systems are part of the main focus of this 
thesis and will, therefore, be extensively discussed throughout this work. 
As shown in Figure 1.4, cis-encoded sRNAs can be organized in three main groups according to 
their operon organization: 1) overlapping the 5’ UTR of the mRNA, 2) overlapping the Open Reading 
Frame (ORF), and 3) overlapping the 3’ UTR. An example of 5’ UTR-overlapping sRNA (Figure 1.4, 
left panel) is the antitoxin SymR, which inhibits the translation of the SOS-response toxin SymE in 
E.coli by occluding its Ribosome Binding Site (RBS) (defined as the region within the mRNA that is 
protected by the 30S ribosomal subunit in the initiation complex) (Figure 1.4, left panel A) (Kawano et 
al., 2007). 5’ UTR overlapping sRNAs can also function by promoting transcription termination through 
the formation of stable RNA heteroduplexes that mimic terminator structures, or by promoting the 
formation of terminator hairpin structures (Figure 1.4, left panel B). An example of this mechanism can 
be found in the case of the icsA mRNA of Shigella flexneri, whose 5’ UTR anti-terminator structure is 
abolished by the sRNA RnaG (Giangrossi et al., 2010). Interestingly, it has been recently shown the 
transcriptional attenuation caused by the RnaG sRNA can be alleviated by the master activator of 
virulence genes VirF through the inhibition of RnaG/icsA interaction (Giangrossi et al., 2017). 
Alternatively, sRNA binding to the 5’ UTR can disrupt an existing anti-terminator structure, leading to 
a positive regulation of the mRNA expression.  
Other asRNAs are encoded overlapping the coding region of mRNAs (Figure 1.4, central 
panel). In these cases, sRNA binding to the mRNA can stop translation elongation and lead to ribosome 
recycling (Figure 1.4, central panel A) or/and cause mRNA destabilization (Figure 1.4, central panel B). 
An example of this latter mechanism is observed in the regulation of the IsiA photosynthesis gene 
expression by the IsrR sRNA in the cyanobacteria Synechocystis (Duhring et al., 2006). Last, some 
sRNAs overlap the 3’ UTR of mRNAs (Figure 1.4, right panel). In these cases, positive regulation can 
be observed. Indeed, the binding of the sRNA to the 3’ UTR of the mRNA can lead to mRNA 
stabilization, by, for instance, avoiding exoribonuclease activity (Figure 1.4, right panel, A). An 
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example of this can be found in the regulation of the Fst toxin by the RNAII sRNA (Greenfield et al., 
2000). Indeed, RNAII binding to the Fst mRNA leads to translation inhibition due to the sequestration 
of the translation start codon, but at the same time, it promotes Fst mRNA stabilization (reviewed in 
Brantl and Jahn, 2015). Another mRNA stabilization example is found in the regulation of the gadXW 
mRNA (operon) by the stationary phase-induced sRNA GadY. It has been shown that GadY base 
pairing to the gadXW mRNA leads to the cleavage of the duplex between the gadX and gadW genes by 
RNase III and GadX mRNA stabilization (Opdyke et al., 2004; Tramonti et al., 2008). Alternatively, 
sRNA binding, if leading to the formation of an extended RNA duplex, could target the mRNA for 
degradation by the double-stranded-specific ribonuclease RNase III (Figure 1.4, right panel, B).  
Further, sRNA binding to the 3’ UTR can also repress mRNA expression, by, for instance, 
inhibiting translation by promoting the formation of stable RBS sequester structures that do not exist in 
the original mRNA folding (Figure 1.4, right panel C). An example of this regulatory mechanism is 
found in the case of the Fst mRNA regulation by the RNAII sRNA (as above-mentioned), as well as in 
the regulation of the BsrG toxin mRNA by the SR4 antitoxin sRNA. Indeed, SR4 does not directly 
interact with the RBS, but rather generates an extended intramolecular SD sequestration (4 bp in the free 
BsrG mRNA is extended to 8 bp upon SR4 binding) (Jahn and Brantl, 2013; Jahn et al., 2012). 
Alternatively, sRNA binding to the 3’ UTR can lead to the disruption of an SD-occluding structure, and 
thus, to the de-repression of the mRNA expression. Further discussion in the regulation of toxin 
mRNAs by antitoxin sRNAs can be found in Masachis and Darfeuille, (2018) in the section 1.4.1 of this 
Chapter. 
 
 
 
Figure 1.4. Mechanisms of action of cis-encoded sRNAs. Cis-encoded sRNAs can overlap the 5’UTR of 
the mRNA (left panel), the Open Reading Frame (ORF, central panel), or the 3’ UTR of the mRNA (right 
panel). 5’UTR overlapping sRNAs can regulate gene expression by occluding the Shine-Dalgarno (SD) or 
sRNA sRNA sRNA
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Ribosome Binding Site (RBS) in general (left panel, A) or by inducing the formation of terminator 
structures that lead to the premature transcription termination of the mRNA and thus to transcription 
attenuation (left panel, B). Disruption of an anti-terminator structure can also be possible, leading to a 
positive regulation (not shown). ORF-overlapping sRNAs can impede translation elongation, leading to 
ribosome recycling (central panel, A), and/or promote mRNA degradation by cellular ribonucleases 
(central panel, B). 3’UTR overlapping sRNAs can have a positive regulatory effect by increasing mRNA 
stability through the protection from exonuclease degradation (impeded by stable double-stranded structures) 
(right panel, A). However, they can also repress mRNA expression by increasing mRNA decay mediated by 
endonucleases (right panel, B) and/or inhibit translation by prompting the formation of SD sequester 
structures that are not present in the absence of sRNA binding (right panel, C). Alternatively, sRNA to the 
3’UTR can also disrupt an SD-occluding structure, leading to a de-repression of the mRNA translation. 
 
 
Trans-encoded sRNAs 
 
Contrary to the cis-encoded sRNAs, trans-encoded sRNAs are encoded elsewhere in the genome and 
share limited complementarity with their target mRNA, interacting by short and imperfect base-pairing. 
Nevertheless, this gives them interaction flexibility, and consequently, trans-encoded sRNAs can 
typically target multiple mRNAs and are often found as global modulators of physiological responses 
(review in Masse et al., 2005; Massé et al., 2007; Valentin-Hansen et al., 2007). A major consequence 
of the limited contact (~10-25 nucleotides, in discontinuous patches (e.g., the only 4 nt required for 
interaction of the SgrS sRNA with the PtsG mRNA out of the possible 23 bp, Kawamoto et al., 2006)) 
between trans-encoded sRNA and their targets is that, in most cases, the RNA chaperone Hfq is 
required to facilitate the interaction. This is true for all characterized trans-encoded sRNA in E. coli, 
however, there are some exceptions, such as the repression of OmpA expression by the VrrA sRNA in 
Vibrio cholerae, which do not require Hfq activity thanks to the presence of an exceptionally long 
interaction region (Song et al., 2008). Interestingly, Hfq has been proposed to act as a platform for RNA 
binding, increasing the local concentrations of sRNAs and mRNAs (diminishing the impact of molecule 
diffusion) (Aiba, 2007), and has been exploited as a tool for the identification of sRNAs in E. coli 
(Zhang et al., 2003) and S. typhimurium (Chao et al., 2012). 
 Most of the trans-encoded sRNA regulation characterized so far is negative, and mainly 
achieved by the direct occlusion of the RBS on the target mRNA (Figure 1.5, left panel A) (Gottesman, 
2005). However, sRNAs can also target far up- or downstream regions from the canonical RBS and start 
codon of their target mRNA. For instance, the GcvB sRNA in Salmonella is able to inhibit translation of 
the gltI mRNA by binding to a C/A-rich translation enhancer element located at -57 to -45 upstream the 
translation start codon (Sharma et al., 2007). On the other side, sRNA binding to a region other than the 
RBS can also lead to mRNA degradation, directly (i.e., RNA duplex degradation by RNase III), or 
indirectly (i.e., caused by the lack of translating ribosomes (Deana and Belasco, 2005; Iost and Dreyfus, 
1995)) (Figure 1.5, left panel B). This is the case for the MicC sRNA in S. typhimurium, which targets 
the coding sequence of the ompD mRNA (via £12 bp with the 23-26 codons) and triggers ompD mRNA 
degradation by RNase E (Pfeiffer et al., 2009). In this case, the mRNA destabilization effect is indirect, 
due to the lack of translating ribosomes. Other sRNAs, such as SgrS and RyhB, promote degradation of 
their target mRNAs by exposing otherwise hidden RNase E cleavage sites (Morita et al., 2005). 
Interestingly, some sRNA can have a positive effect in the expression of their target genes, by, 
for instance, increasing the stability and/or translation of their target mRNAs (Figure 1.5 central and 
right panels). An example of sRNA increasing the stability of its target mRNA is the FasX sRNA of 
Streptococcus. The FasX sRNA basepairs with the 5’ end of the secreted virulence factor streptokinase 
ska mRNA and thereby prevent its degradation, which ultimately results in an increased overall 
translation of the Ska protein (Liu et al., 2012). Similarly, in Salmonella, the RydC sRNA selectively 
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activates the longer of two isoforms of the cfa mRNA (coding for a cyclopropane fatty acid synthase) by 
binding to its 5’ end and directly interfering with RNase E-mediated decay (Fröhlich et al., 2013) 
(Figure 1.5, central panel A and B). Additionally, and similarly to some cis-encoded sRNAs, a set of 
trans-encoded sRNAs activate the expression of their target mRNAs by disrupting SD-occluding 
structures, directly (i.e., binding to the RBS region), or indirectly (i.e., binding up-or downstream the 
RBS region but inducing a conformational change on it) (Figure 1.5, right panel A). Importantly, 
despite most sRNAs act through a predominant regulatory mechanism, different target mRNAs may be 
regulated through different pathways; i.e., having positive or negative effects, and mediated by any of 
the above-mentioned mechanisms (i.e., the Qrr 1-4 sRNAs, central regulators of quorum-sensing 
pathways (Feng et al., 2015; Papenfort and Bassler, 2016; Shao et al., 2013)). 
 
 
 
 
Figure 1.5. Mechanisms of action of trans-encoded sRNAs. Trans-encoded sRNAs do not overlap their 
target gene. They can negatively regulate gene expression by binding to ribosome binding site region or the 
Shine-Dalgarno (SD) sequence, inhibiting translation (left panel A), or by promoting mRNA degradation, 
directly (i.e., exposing otherwise hidden cleavage sites) or indirectly (i.e., through the deprotection of the 
mRNA due to the lack of translating ribosomes) (left panel B). Alternatively, they can positively regulate 
their targets, by impeding mRNA degradation (e.g., blocking the priming of exonucleases) (central panel 
A), which can ultimately lead to an overall increased mRNA translation (central panel B), or by disrupting 
an SD-occluding structure present in the free-state mRNA, which will also result in increased levels of 
mRNA translation (right panel A). 
 
 
 
 
 
 
 
 
Target ORF sRNA
Non-overlapping
Trans-encoded sRNAs
3’5’
SD
5’3’
A
3’5’
5’3’
B
3’5’
5’3’
5’ 3’
SD
B
A
A
CHAPTER 1. Introduction 
 34 
1.3.3.3. Small regulatory RNAs in H. pylori 
During a long period of time, due to its small genome size, the apparent lack of the RNA chaperone 
Hfq, and the conservation of very few transcriptional regulators and housekeeping RNAs (i.e., only the 
SRP RNA, the M1 RNA, and tmRNA are conserved (Sharma et al., 2010)), H. pylori was thought to 
lack riboregulation. Only recently, with the development of a differential RNA sequencing approach 
(sRNA-seq) that specifically selects for the 5’ end of primary transcripts, a global map of transcriptional 
start sites and operons was defined and revealed a complex yet compact H. pylori transcriptome 
structure (Sharma et al., 2010). Importantly, this study also uncovered the existence of massive 
antisense transcription as well as an unanticipated high number of sRNAs (< 60). Such sRNAs represent 
potential regulators of cis-and trans-encoded mRNA targets and suggest the existence of a rich and 
unexplored transcriptional riboregulation in H. pylori (for a review see, Pernitzsch and Sharma, 2012). 
To date, due to their relatively recent discovery, very few regulatory sRNAs (two trans- and two 
cis-encoded sRNAs) have been characterized in H. plyori. The first trans-encoded sRNA to be 
characterized was the RepG sRNA (HPnc5490), which can post-transcriptionally mediate both, the 
activation and the repression, of the TlpB chemotaxis receptor through a novel mechanism involving the 
interaction with a variable homopolymeric G-repeat (hypermutable simple sequence repeat, SSR) in the 
TlpB mRNA (Pernitzsch et al., 2014). Soon after, a second trans-encoded sRNA, named CncRI 
(HPnc2630), was characterized. The CncRI sRNA is encoded in the Cag-PAI and binds to the fliK 
mRNA (encoding for a flagellar checkpoint protein) to negatively regulate motility and adhesion to host 
cells. Interestingly, the observed phenotypic effects are indirect and linked to the regulation of s(54)-
dependent genes (Vannini et al., 2016). Among the cis-encoded sRNAs, the first one to be characterized 
was the 5’ ureB sRNA, which downregulates ureAB (part of the urease gene cluster) expression by 
enhancing transcription termination 5’ of ureB (Wen et al., 2013). The second cis-encoded sRNA, 
IsoA1, was recently characterized and identified as an RNA antitoxin in a type I TA system (Arnion et 
al., 2017, see appendix 8.3 in Chapter 8). Indeed, we recently reported on the existence of a family of 
type I TA systems, namely, aapA/IsoA (standing for antisense associated peptide family A/ Inhibitor of 
small ORF family A) in H. pylori, representing the first family of type I TA systems characterized in 
epsilonproteobacteria. A member of this family will be the focus of this thesis, thus, in the next sections 
of this Chapter, type I TA systems and their regulation will be further discussed.  
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 1.4. Type I Toxin-antitoxin systems 
1.4.1. Paper I: Type I toxin-antitoxin systems: regulating toxin expression via 
Shine-Dalgarno sequence sequestration and small RNA binding 
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1.4.2. Biological role of type I TA systems 
The biological role of TA systems is strongly linked to the mode of toxin expression (e.g., constitutive 
or inducible) as well as to the molecular effects of it (e.g., cellular target; reversible or irreversible 
effect). For instance, toxins of plasmid-encoded TAs are usually constitutively expressed as highly 
stable mRNAs. Plasmid loss during cell division rapidly leads to the depletion of the pool of unstable 
antitoxin RNA, and subsequently to cell death of the daughter cell having lost the TA-encoding 
plasmid (PSK mechanism). Thus, plasmid-encoded type I TAs are able to act as plasmid stabilizer 
elements as shown for the hok/Sok of the plasmid R1 (Gerdes et al., 1986), the srnB’/SrnC-RNA of 
the plasmid F and the pndA/PndB-RNA of the R483 plasmid (Nielsen et al., 1991) in E. coli, and for 
the fst/RNAII of the pAD1 plasmid in E. faecalis (Greenfield and Weaver, 2000). Many of the TA 
systems found if plasmids are also found in bacterial chromosomes, however, the function of 
chromosomally-encoded type I TA systems is enigmatic.  
The SymE antitoxin (SOS-inducible yjiW gene with similarities with the MazE type II toxin) 
from E. coli has been suggested to recycle damaged mRNAs upon SOS response and to act as a 
defense mechanism against infection by RNA phages (Kawano, 2012). Some type I TAs in B. subtilis 
(e.g., BsrG, YonT and TxpA) are located on prophages and have been proposed to act as stabilizer 
elements in a reminiscent way to PSK (Durand et al., 2012). Other toxin-encoding mRNAs, such as 
BrsG, BsrE, and BsrH possess a putative ResD (ResD/ResE two-component systems involved in 
global aerobic and anaerobic responses in B. subtilis) binding site upstream their promoters, and have 
been suggested to be induced under oxidative stress conditions, which role could be to cause 
bacteriostasis to limit oxygen composition (Durand et al., 2012). In a similar way, the toxins TxpA, 
BsrG, BsrE, BsrH, and YonT have been reported to be induced upon glucose starvation, which could 
be beneficial if they cause bacteriostasis and reduce glucose consumption (Jahn et al., 2012; Nicolas et 
al., 2012). Other chromosomally-encoded type I TAs play a role in persister cell formation, by 
forming pores in the cell membrane that lead to membrane depolarization, ATP depletion, and 
subsequently, to a decrease of macromolecular synthesis rates and entry into a persister state, as 
demonstrated for the SOS-inducible tisb/IstR (Berghoff et al., 2017; Dörr et al., 2010; Gurnev et al., 
2012; Vogel et al., 2004) and the hok/Sok (Pedersen and Gerdes, 1999; Verstraeten et al., 2015; 
Wilmaerts et al., 2018) systems in E. coli. However, the role of TAs in persister cell formation is 
currently highly controversial, as a recent study has highlighted that previous observations of the role 
of 10 chromosomally-encoded type II TAs in persistence and antibiotic resistance (retracted) was an 
artifact caused by a F80 bacteriophage infection (Goormaghtigh et al., 2018; Harms et al., 2017). 
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CHAPTER 2. Aims of this thesis 
 
2.1. Research background: a new family of type I TA systems in H. pylori 
In 2010, a transcriptome-wide screen for sRNAs revealed the existence of massive antisense 
transcription and >60 new sRNAs in H. pylori (Sharma et al., 2010). To date, only four of them are 
characterized and are presented in the section 1.3.3.3 of Chapter 1. Among the sRNAs with the highest 
levels of expression, there was a family of six homologous cis-encoded antisense RNAs (named IsoA1 
to IsoA6, standing for inhibitor of small ORF family A, locus 1 to 6) expressed in the opposite DNA 
strand to a novel class of small mRNAs (named AapA1 to AapA6, standing for antisense associated 
peptide family A) (Sharma et al., 2010). Both, the AapA mRNA and the IsoA sRNA are constitutively 
transcribed, representing small expression modules repeated at six chromosomal loci (Figure 2.1). 
Additionally, in vitro translation assays showed that each AapA small mRNA codes for a small 
protein of 30 amino acids, which translation is repressed by the IsoA sRNAs in a loci-specific manner 
(no cross-regulation). Considering their operon organization, these loci were hypothesized to be 
chromosomally-encoded type I TA systems. Further characterization confirmed this hypothesis, 
making the aapA/IsoA family the first family of type I TAs identified in epsilon proteobacteria 
(Arnion et al., 2017; Sharma et al., 2010). 
 
Figure 2.1. Location of the aapA/IsoA modules in the H. pylori chromosome. The aapA/IsoA modules 
are present at six different chromosomal loci in the H. pylori chromosome (loci I to VI). 
 
 In our recent work (Arnion et al., 2017, see Appendix 8.3 in Chapter 8), the module present at 
the locus I (aapA1/IsoA1) of the H. pylori was characterized. We showed that the aapA1 gene codes 
for a small protein whose expression is toxic for H. pylori, and revealed several layers of post-
transcriptional regulation that act in concert with the antitoxin to prevent toxin expression (as shown in 
Figure 2.2). The transcription of the aapA1 gene generates a full-length mRNA of 250 nt denoted 
aapA1-FL (full-length) that is translationally inactive thanks to a long-distance interaction between the 
5’ and the 3’ ends of the mRNA. This inactive message is highly stable and is slowly processed at its 
3’ end to generate a truncated transcript of 225 nt that becomes translatable. This active transcript, 
denoted aapA1-Tr (truncated), base-pairs with the IsoA1 asRNA to form an extended RNA 
heteroduplex that is rapidly degraded by the RNase III. In absence of IsoA1, the AapA1 toxin is 
ori
H.	pylori chromosome
(1.67	Mb)
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(i.e., the Mok and LdrX leader peptides required for Hok and Ldr translation, respectively) (Kawano et 
al., 2002; Thisted and Gerdes, 1992). Another major difference with other TA systems relies on the 
fact that the IsoA1 antitoxin is directly targeting the translation initiation region of the toxin gene. This 
specificity is due to its genomic organization, as it is fully complementary to the 5’ UTR of the toxin-
encoding mRNA, similarly to what was previously shown for the symE/SymR system in E. coli 
(Kawano et al., 2007). Finally, our bioinformatics analysis revealed that this TA locus belongs to a 
large family of type I TA systems (named aapA/IsoA) that is not only present on chromosome but also 
associated with mobile genetic elements (MGEs). This is an interesting observation, as the aapA/IsoA 
module may comply most of the characteristics (e.g., constitutive transcription, stable toxin-encoding 
mRNA and unstable antitoxin, and killing activity) present in TA systems acting as plasmid-stabilizer 
elements, suggesting a possible MGE-stabilizing function following a PSK-like mechanism.  
Additionally, our group has recently characterized the AapA1 peptide (Korkut et al., in 
preparation). Similar to most type I toxins (with the exception of SymE and RalA) (Brantl and Jahn, 
2015; Fozo et al., 2008; Wen and Fozo, 2014), the aapA1gene codes for a small hydrophobic protein 
that contains an alpha-helical transmembrane domain (TM). Indeed many type I toxins (as shown for 
the Hok (Verstraeten et al., 2015), DinQ (Weel-Sneve et al., 2013), Fst (Göbl et al., 2010), Ibs (Mok et 
al., 2010) and TisB (Unoson and Wagner, 2008)) act by altering membrane integrity (Brielle et al., 
2016), as described in the section 1.4.2 in Chapter 1. To date, only a few of such TM domains have 
been experimentally validated (e.g., TisB and Ibs in E. coli (Grage et al., 2016; Mok et al., 2010; 
Steinbrecher et al., 2012), Fst in E. faecalis (Göbl et al., 2010), and SprA1 in S. aureus (Sayed et al., 
2012)). We showed that the AapA1 peptide, despite having a small hydrophobicity index, has a strong 
affinity to the prokaryotic membrane and it is able to localize a soluble tag at the inner membrane of 
the bacterium. Plasmon Waveguide Resonance (PWR), solid-state Nuclear Magnetic Resonance 
(NMR) and molecular dynamics simulations, revealed that despite being a small protein (30 amino 
acids), the AapA1 is organized in three domains: 1) a disordered, positively charged N-terminal 
domain (8 amino acids), 2) a single alpha-helix domain spanning the membrane (~19 amino acids), 
and 3) a short and basic C-terminal domain (Figure 2.3). Furthermore, an alanine-scanning of AapA1 
peptide in E. coli, revealed that the N-terminal domain is not required for toxicity, and these results are 
supported by phylogenetic studies showing that this region is the less conserved part of the AapA1 
ORF. 
 
Figure 2.3. The AapA1 peptide is organized in three domains. This Figure has been adapted from 
Korkut et al., in preparation. See text for details. 
 
2.2. Understanding the regulation and biological role of type I TAs in H. pylori 
The work carried out in the lab before the start of this thesis have raised several questions: 
 
Q1) AapA1 toxicity was only tested using inducible systems, whether its endogenous 
expression is constitutive or not was unknown. Indeed, to date, most TA systems are studied using 
synthetic expression vectors and heterologous organisms (Fozo et al., 2008; Jahn and Brantl, 2013; 
Unoson and Wagner, 2008). However, this can lead to misinterpretations of the physiological effects 
of toxin expression (which would never be that high levels under endogenous conditions). 
N-ter C-ter
AapA1
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strain (StrS/ErmR), on which the TA locus of interest has been replaced by the counterselection marker 
rpslCj-erm in a streptomycin-resistant genetic background (rpsl K43R), as described by (Dailidiene et al., 
2006; Pernitzsch et al., 2014). Unmarked transformants (having replaced the rpslCj-erm cassette by the TA-
PCR products) are selected in the presence of streptomycin, pooled, and genomic DNA is extracted and 
used to amplify the TA locus. PCR products are used sequenced by Illumina paired-end sequencing 
approach and sequence datasets are analyzed using a differential analysis approach (e.g., DESeq2). 
Sequence analysis reveals with nucleotide resolution toxicity suppressor mutations, that represent gene 
expression and functionality determinants. 
 
2) Apply FASTBAC-Seq to study the aapA/IsoA module present in the H. pylori chromosomal locus 
III (the aapA3/IsoA3 module). Such deep characterization aims to uncover the molecular 
underpinnings behind the regulation of the AapA3 toxin expression, beyond antitoxin RNA binding 
(e.g., transcription, mRNA decay, translation, and protein function). Thus, aiming to gain insights into 
the research questions presented above (Q1 to 4, section 2.2 in Chapter 2). 
 
3) Understanding how this type I TA system is regulated under endogenous conditions may shed light 
into more challenging questions, such as what is its biological role (if any), or how can it be exploited 
with biotechnological (e.g., boost protein production) or biomedical (e.g., alternative antimicrobial 
strategies) purposes. 
 
 
 
CHAPTER 3. Thesis map 
 42 
CHAPTER 3. Thesis map 
 
3.1. Organization 
This thesis is organized into eight Chapters. In Chapter 1, the biological background of gene 
expression regulation in bacteria is reviewed, with the main focus on the study of post-transcriptional 
gene regulation and type I toxin-antitoxin (TA) systems in the RNase E and Hfq-lacking bacterium H. 
pylori. Additionally, a review document discussing the underlying mechanisms of type I TA systems 
regulation is presented (Paper I). In Chapter 2, the main objectives of this work are presented and 
justified. The organization of the thesis and the main scientific outputs as well as work contributed by 
others and collaborations is shown in Chapter 3.  
Results are presented in Chapter 4, which is composed of three sections, corresponding to the three 
main publications fruit of this work. In section 4.1, the Paper II is presented. On it, we respond to the 
lack of tools to study chromosomally-encoded type I TA systems under endogenous conditions. A 
detailed protocol of the here developed approach (FASTBAC-Seq) for the identification of gene 
expression determinants on toxin-encoding genes belonging to type I TA systems (revealed in the 
form of genetic toxicity suppressors) is presented. The sections 4.2 and 4.3, correspond to the Papers 
III and IV, respectively. On them, we exploit the results obtained from the FASTBAC-Seq analysis of 
the aapA3/IsoA3 type I TA locus, hosted in the chromosome of H. pylori. More specifically, in 
section 4.2, we describe how the study of suppressor mutations in the aapA3 toxin-encoding gene 
uncovered the existence of functional metastable RNA structures that are essential to impede the co-
transcriptional translation of the toxin-encoding mRNA. In sections 4.3 and 4.4, we focus on the 
understanding of the enigmatic role of RNA processing in the regulation of the aapA3/IsoA3 system, 
and how this is determined by the RNA secondary structure. 
In Chapter 5, the work is globally discussed and concluding remarks are presented. Additionally, 
remaining open questions and future perspectives are discussed. A description of the general methods 
used throughout the study as well as Paper-specific methods sections are described in Chapter 6. 
References are listed in Chapter 7. And finally, supplementary information of the Paper III and IV, 
as well as a copy of two studies that are closely related to this work (related papers I and II), is 
provided in Chapter 8. 
 
3.2. Main scientific outputs 
 
1. Manuscripts published 
The review document introducing to type I TA systems regulation presented in Chapter 1 section 1.4.1 
was recently published elsewhere as:  
Paper I   Masachis S. and Darfeuille F.* (2018) Type I toxin-antitoxin systems: regulating 
expression with small antisense RNAs. Microbiol Spectr. 2018 Jul;6(4). doi: 
10.1128/microbiolspec.RWR-0030-2018. 
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The method to characterize chromosomally-encoded type I TA systems presented in Chapter 4 section 
4.1 has been recently published elsewhere as:  
Paper II  Masachis S., Tourasse N., Chabas S., Bouchez O. and Darfeuille F.* (2018) 
FASTBAC-Seq: Functional AnalysiS of Toxin-antitoxin systems in BACteria by deep-Sequencing. 
Methods in Enzymology: High- Density Sequencing Applications in Microbial Molecular Genetics, 
Vol. 612. Edited by A.J. Carpoussis. https://doi.org/10.1016/bs.mie.2018.08.033 
 
2. Manuscripts in preparation  
 
The work described in Chapter 4 sections 4.2 and 4.3 are in preparation for publication as: 
Paper III  Masachis S., Tourasse N., Lays C., Faucher M., Chabas S., Iost I., and Darfeuille F.*. 
Chromosomal inactivation of antitoxin RNA uncovers metastable structures embedded in a toxin-
encoding mRNA.  
 
Paper IV  Masachis S., Arnion H., Boissier F., Chabas S. and Darfeuille F.*. When mRNA 
folding rules decay: lessons from a type I toxin-antitoxin system. 
 
 
3. Additional work related to this thesis in a more indirect way can be found in Chapter 8 section 8.3 
(related paper)  
Related Paper   Arnion H., Korkut D.N., Masachis Gelo S., Chabas S., Reignier J., Iost I. and 
Darfeuille F.* (2017) Mechanistic insights into type I toxin antitoxin systems in Helicobacter pylori. 
NAR, 45(8):4782-4795 
 
 
3.3. Contribution by others 
 
The work presented on this thesis was performed under the supervision of the Dr. Fabien Darfeuille at 
the ARNA Laboratory, INSERM (Institute National de la Santé et Recherche Médicale) Unit 1212, 
Bordeaux, France. Parts of the work that have been contributed or performed in collaboration with 
others are presented below. 
 
1. Chapter 4 section 4.1 (Paper II) 
Work contributed by others before my arrival to the group: 
• The rpslCj-erm cassette was a generous gift from the Dr. Berg DE (Department of Molecular 
Microbiology, University Medical School, St. Louis, USA) and cloned into pSC-60 by the group 
of Cynthia Sharma (University of Würzburg, Germany). 
• Development of the rpslCj-erm cassette-mediated deletion method in H. pylori was done by the 
engineer Sandrine Chabas (Darfeuille’s Lab). 
Work performed by collaborators: 
• DNA Illumina sequencing was performed by Olivier Bouchez (Plateformed GeT-PlaGe- Genotoul, 
Centre INRA, BP52627, 31326 Castanet Tolosan). 
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• NGS data statistical analysis was performed by the Dr. Nicolas Jacques Tourasse (ARNA 
laboratory, INSERM U1212). 
 
 
2. Chapter 4 section 4.2 (Paper III) 
Work contributed by others before my arrival to the group: 
• Preliminary studies on the aapA3/IsoA3 locus were carried out by the Postdoc Claire Lays 
(Darfeuille’s lab). 
• AapA3 RNA in vitro structure probing shown in Figure 4.2.2 was previously done by the Master 
student Marion Faucher under supervision of Fabien Darfeuille. 
• RNase III deletion in the B128 H. pylori strain was previously done by the Dr. Isabelle Iost 
(Darfeuille’s lab). 
• Protocol for H. pylori polysome fractionation was developed by the Dr. Isabelle Iost. 
 
 
3. Chapter 4 section 4.3 (Paper IV) 
Work contributed by others before my arrival to the group: 
• Preliminary PNPase deletion mutant and study of its role on wild type aapA3 mRNA maturation 
was performed by the engineer Hélène Arnion (Darfeuille’s lab). 
• PNPase deletion strain in rpsl K43R genetic background was generated by the engineer Sandrine 
Chabas. 
Work performed by others: 
• RNase J protein purification was performed by the engineers Fanny Boissier and Snadrine Chabas 
(Darfeuille’s lab). 
• RNase J in vitro cleavage assay shown in Figure 4.3.6D was performed by the engineer Fanny 
Boissier.
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CHAPTER 4. Results and discussion 
4.1.  Paper II: FASTBAC-Seq: Functional AnalysiS of Toxin-antitoxin 
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4.2.  Paper III: A genetic selection reveals functional metastable structures 
embedded in a toxin-encoding mRNA. 
 
 
In Chapter 4 section 4.1 (Paper II), we stated the need for tools allowing the study of chromosomally-
encoded type I TA systems under endogenous conditions and described the protocol of the 
FASTBAC-Seq approach (Masachis et al., 2018). The first part of this Chapter will present a global 
view of the main results obtained from the characterization of the aapA3/IsoA3 type I TA system 
using FASTBAC-Seq. Secondly, we will focus on the study of some of the identified toxicity 
suppressor mutations. FASTBAC-Seq revealed unanticipated regulatory elements embedded in the 
AapA3 toxin-encoding mRNA. Despite most suppressors located in the AapA3 ORF (and are 
described in Chapter 4 section 4.1), one-third mapped to non-coding regions of the toxin mRNA. 
Some of such mutations, targeted well-known regulatory elements (e.g., SD sequence), however, 
others did not and their existence struck us.  
Translation initiation is assumed to be the rate-limiting step of protein synthesis in bacteria 
(Duval et al., 2015; Kozak, 2005; Milón and Rodnina, 2012; Nakagawa et al., 2017; Simonetti et al., 
2009). The canonical translation initiation mechanism involves the base-pairing interaction between 
the Shine-Dalgarno (SD) sequence in the mRNA and the anti-SD sequence in the 16S rRNA 
embedded in the 30S ribosomal subunit (Shine and Dalgarno, 1974; Steitz and Jakes, 1975). Together 
with the Initiation Factor 2 (IF-2) that kinetically assists the specific interaction between an anticodon 
present in the fMet-tRNAfMet and an optimally-spaced (Chen et al., 1994) start codon (AUG or 
UUG/GUG), they form the so-called translation initiation complex. Several studies have previously 
highlighted the importance of SD accessibility for translation initiation (Bhattacharyya et al., 2018; 
Espah Borujeni et al., 2014; Kozak, 2005). In this Chapter, we will present a special set of suppressor 
mutations laying within the non-coding region of the AapA3 toxin-encoding mRNA. Such mutations, 
act as energetic traps, freezing the mRNA in translationally inert conformations. The study of these 
mutations revealed the existence of transient (metastable) functional RNA hairpins containing a CU-
rich sequence motif. Through this motif, they co-transcriptionally mask the SD sequence and impede 
the toxin translation initiation during the mRNA synthesis. Our work highlights the importance of co-
transcriptional folding to impede the premature toxin translation and allow the presence of these toxic 
genes in bacterial chromosomes. 
4.2.1. Results 
4.2.1.1. The small antisense RNA IsoA3 is essential to prevent AapA3 translation 
We previously identified a new family of type I TA loci on the chromosome of H. pylori, the 
aapA/IsoA family (Arnion et al., 2017, see appendix 8.3 in Chapter 8). Here, we studied the 
aapA3/IsoA3 module (Figure 4.2.1A; for sequence details see Figure 8.1.1B in the Appendix). As 
other TAs of this family, the aapA3/IsoA3 locus codes for an antisense RNA, IsoA3 (80 nucleotides), 
encoded in the cis-overlapping orientation to a small ORF, AapA3 (30 amino acids). The AapA3 
peptide shares 60% sequence homology with the AapA1 peptide, whose ectopic expression is toxic in 
H. pylori (Arnion et al. 2017). However, in contrast to AapA1, cloning of AapA3 peptide under an 
IPTG-inducible promoter is not viable. Therefore, we decided to ask whether AapA3 expression from 
the chromosome was also toxic. To do so, we inactivated the antitoxin promoter by introducing two 
point mutations (Figure 4.2.1B, pIsoA3* in all figures), as previously described (Arnion et al., 2017). 
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increasing concentrations of IsoA3 cold RNA (0-100 nM) was performed. Untreated RNA (lanes 1 and 15, 
denoted C) and partially alkali digested RNA (denoted OH, lane 2) served as control and ladder, 
respectively. Positions of all G residues revealed upon T1 digestion under denaturing conditions are 
indicated relative to the transcription start site of the aapA3 gene. Cleaved fragments were analyzed on an 
8% denaturing PAA gel. 2D structure predictions were generated with the RNAfold Web Server (Gruber et 
al., 2008) and VARNA RNA (Darty et al., 2009) was used to perform the drawing. The region involved in 
RNA duplex formation between IsoA3 and aapA3-Tr mRNA is indicated with a blue line; internal and 
apical loops are represented by IL and AL, respectively; AapA3 start codon is highlighted in green; AapA3 
stop codon is highlighted in red; AapA3 SD sequence is highlighted in turquoise. 
 
Furthermore, the accumulation of aapA3-Tr in an RNase III knockout strain pointed at a 
double-strand-specific mRNA decay pathway. In vitro structure probing of the different AapA3 
mRNA forms in presence or absence of IsoA3 (Figure 4.2.2) confirmed that IsoA3 RNA only interacts 
with the aapA3-Tr mRNA (Figure 4.2.2, lanes 4 to 8). Base pairing between the aapA3-Tr mRNA and 
IsoA3 RNA creates an extended RNA heteroduplex of 80 base pairs (Figure 4.2.2, lane 4). This 
IsoA3/aapA3-Tr RNA duplex is translationally inert, as shown by in vitro translation assays (Figure 
4.2.1D, lanes 6, 7 and 8) and by the viability of an RNase III deleted strain on which the accumulation 
of aapA3-Tr reflects the stabilization of this RNA duplex (Figure 5.1C, lanes 14 and 15), consistently 
with previous observations (Arnion et al. 2017). 
Taken together, we demonstrate that IsoA3 small RNA continuously represses aapA3 
constitutive expression at the translational level by forming a stable RNA heteroduplex. This RNA 
duplex is then targeted by the double-strand-specific ribonuclease RNase III, leading to a rapid, but 
not essential, turnover of the translationally active toxin-encoding mRNA. 
 
4.2.1.2. Decoding AapA3 toxicity determinants with nucleotide resolution  
To study AapA3 toxicity in a quantitative manner, we generated four PCR constructs carrying a wild 
type or mutated version of each of the TA components as described in Figure 4.2.3A. We next 
introduced them into a H. pylori strain on which the aapA3/IsoA3 locus had been previously replaced 
by the rpslCj-erm counter-selection marker (ΔaapA3/IsoA3::rpslCj-erm/K43R) (Dailidiene et al., 2006; 
Pernitzsch et al., 2014). Markless transformants having undergone homologous recombination were 
then selected on streptomycin-containing plates. For each transformation, the exact number of 
streptomycin-resistant colonies was determined and normalized to the total number of colony forming 
units (Figure 4.2.3B). As expected, when no-DNA was used for transformation (H2O) only phenotypic 
revertants having mutated the rpslCj gene present on the rpslCj-erm cassette were selected (data not 
shown). In line with previous results, the lack of IsoA3 expression led to a strong reduction (1.83 log-
fold) in the number of transformed strains compared to WT or the double mutant constructs (Figure 
4.2.3B). These results confirmed that chromosomal expression of AapA3 is toxic and hampers the 
creation of recombinant strains lacking antitoxin expression. However, the number of transformants 
obtained in absence of antitoxin was significantly higher than the one obtained when no DNA was 
used for transformation (5-fold) (Figure 4.2.3B). This reflects the development of so-called 
suppressors strains. AapA3/IsoA3 locus sequencing of 100 of such strains revealed that all of them 
contained mutations in the AapA3 ORF (mainly missense and nonsense, data not shown).  
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Figure 4.2.3. Unveiling local toxicity determinants with nucleotide resolution. (A) Four different 
aapA3/IsoA3 locus constructs were generated by PCR: wild-type, WT; IsoA3 promoter inactivated by the 
point mutations A87C and A90G, pIsoA3*; AapA3 start codon inactivated by the point mutation G54A, 
start; and AapA3 start codon and IsoA3 promoter inactivated, start/pIsoA3* (left panel). PCR products 
were used for H. pylori natural transformation. Homologous recombination allowed the replacement of the 
counter selection cassette rpslCj-erm (StrS/ErmR) by the PCR-generated constructs in an H. pylori 26695 
rpsl mutated genetic background (rpsl K43R, StrR). Recombinant strains were selected in presence of 
streptomycin (right panel). (B) Number of StrR upon transformation was calculated. Error bars represent 
s.d; n=3 biological replicates (**P<0.0001; *P<0.0005 values according to unpaired t-test). (C) Number of 
reads containing 0 to 10 substitutions. Error bars represent s.d; n=3 biological replicates. (D) Positional 
analysis of single-nucleotide substitutions on the aapA3/IsoA3 locus. Bar plot shows the log2 of the fold 
change (pIsoA3*/WT) for the 70 positions whose adjusted p-value (padj) was lower than 0.05. Bars are 
drawn in different shades of grey according to the p-value. 5’ and 3’ UTR, 5’ and 3’ untranslated regions; 
red box, aapA3 -10 box; black arrow with “+1”, aapA3 +1 Transcription Start Site (TSS); turquoise box, 
aapA3 Shine-Dalgarno sequence (SD); grey arrow, AapA3 Open Reading Frame (ORF); black arrow with 
“+1” inside aapA3 ORF, IsoA3 TSS; blue box inside aapA3 ORF, IsoA3 -10 box. 
 
To explore the complete landscape of suppressors we next scaled-up the transformation assay. 
The WT or inactivated antitoxin promoter (pIsoA3*) PCR products were used as DNA substrates for 
transformation as described previously, and we performed the assay in three independent biological 
replicates for each construct. Approximately 60,000 strains selected upon transformation with each of 
the constructs were collected, genomic DNA was extracted, and an amplicon of 426 nt was sequenced 
by the Illumina paired-end approach. Consistently with preliminary results, deep-sequencing data 
analysis showed that 97.7% of the strains transformed with the inactivated antitoxin promoter PCR 
product contained mutations (pIsoA3*, Figure 4.2.3C). A strong mutation rate was also observed 
when the WT PCR product was used (51.2%) (WT, Figure 4.2.3C). This demonstrates that mutations 
come from the Taq DNA polymerase error rate during the PCR. The strong biases can be explained by 
pIsoA3*
WT
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an unanticipated technical artifact linked to the combined use of a low-fidelity Taq DNA polymerase 
and PCR assembly, which led to a strong mutation rate in the overlapping region used for PCR 
assembly (nucleotides 80, 81 and 82 from aapA3 +1 site). This artifact strongly reduced sequencing 
depth and made it impossible to interpret the possible co-variation of double and triple mutations. 
Nevertheless, it did not alter the interpretation of single point mutations. Consequently, on this 
manuscript, we will focus on single nucleotide mutations having been significantly enriched (adjusted 
False Discovery Rate padj ≤ 0.05) in absence of antitoxin relative to WT (Figure 4.2.3D).  
Analysis of the number of mutations per read in the complete sequencing dataset (all 
replicates combined) showed that more than half of the strains transformed with the pIsoA3* PCR 
product (51.8% out of ~5.1 million) were mutated at a single nucleotide position (Figure 4.3.3C). This 
result demonstrates that single point mutations are sufficient to abolish AapA3 toxin activity and/or 
expression. A reduced number of pIsoA3* strains (2.1%) had a wild-type locus sequence (Figure 
4.2.3C, pIsoA3* zero mutations), which could be explained by sequencing error rates (around 1.5%) 
and/or suppressor mutations lying in regions outside the loci (not sequenced). Single nucleotide 
mutations were overwhelmingly substitutions, favored by PCR biases. Only 4% were insertions and 
deletions (indels). Hierarchical clustering analysis revealed that the location and frequency of single 
substitutions were highly similar in the three biological replicates, indicating that locus coverage was 
close to optimum (Figure 8.1.2A in the Appendix). Single nucleotide indels were almost exclusively 
present in AapA3 ORF, where they would lead to the generation of truncated or longer forms of the 
peptide. Contrary to substitutions, indels were rarely found in non-coding regions, and when they 
were, they were not present in all three replicates. This reflects insufficient sequencing depth coming 
from their under-representation in the PCR products (Figure 8.1.2B and 8.1.2C in the Appendix). 
Importantly, depending on the type of statistical analysis, “position-specific” or “nucleotide-specific” 
(see Material and Methods for details), there were statistically enriched substitutions in absence of 
antitoxin (padj ≤ 0.05) at 70 or 72 positions within the aapA3/IsoA3 locus, respectively (65 positions 
in common between the two analyses). Positions appearing in just one of the analyses include (relative 
to aapA3 +1 site): 1) in the 5’ non-coding DNA, positions -26 and -7; 2) in the 5’ UTR, position +28; 
3) in AapA3 ORF, positions +64 and +97; and 4) in the 3’UTR, positions +146 and +177. Such 
positions have generally a close-to cut-off padj value, but not in all cases as for instance, position +28 
(that will be extensively studied here) had a highly significant padj value of 7.2x10-6.  
Expectedly, the highest mutation densities (obtained by dividing the number of mutated 
nucleotides by the total number of nucleotides in the regions of interest) located in the AapA3 ORF 
(53%) (grey arrow, Figure 4.2.3D), as well as in well-known regulatory regions such the -10 box of 
the toxin mRNA (66.7%) (Figure 8.1.3 in the Appendix) and the SD sequence (42.8%) (Figure 
4.2.5A). In the aapA3 -10 box, out of the six potential targets (5’-TAGGAT-3’), suppressors mostly 
appeared on the two first nucleotides at the 5’ end and the last nucleotide at the 3’ end (Figure 8.1.3 in 
the Appendix). This allowed us to identify the minimal functional aapA3 -10 box motif 5’-TANNNT-
3’, which is in agreement with previous studies (Sharma et al., 2010).  This result also confirmed that 
the arbitrary chosen False Discovery Rate cut-off (padj ≤ 0.05) was stringent enough to avoid false 
positives but permissive enough to allow the identification of suppressors. Interestingly, a mutation 
upstream of the aapA3 -10 box was significantly enriched (position -26 from the +1 site, Figure 8.1.3 
in the Appendix). The existence of such suppressor is intriguing, and if confirmed, could suggest a 
potential transcriptional regulation of the aapA3 gene. Remarkably, seventeen mutations were 
unveiled in the 5’ and 3’ untranslated regions lying outside the already-known regulatory elements 
(Figure 4.2.3D). In the present work, we will focus on the study of three of them. 
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4.2.1.3. A single nucleotide substitution is sufficient to inhibit AapA3 toxin translation 
The genetic selection of suppressors allowed us to characterize the toxin SD sequence with nucleotide 
resolution (Figure 4.2.4A). Among the seven mutable positions (5’-AAAGGAG-3’), the two central 
guanine nucleotides (at position +42 and +43 from aapA3 +1) were the most abundantly enriched in 
absence of antitoxin. As expected from PCR biases, the transition G>A was preferentially enriched in 
both cases. The efficient SD sequence inactivation by one of these mutations (G at position +43 into 
A) was further validated in vivo (G43A, Figure 4.2.4B). Interestingly, the single-nucleotide 
transversion A to T at position +40 from aapA3 +1 (A40T, Figure 4.2.4) within the SD sequence 
appeared as being underrepresented in the read count. The selection of a transversion despite their 
underrepresentation in the PCR product used for transformation (due to PCR biases), together with its 
‘isolated’ character (none of the flanking adenine residues have been selected) was striking and drove 
us to study this suppressor in more depth. Moreover, an additional mutation in close proximity to the 
SD sequence was identified, the single-nucleotide transversion A to C at position +28 from aapA3 +1 
(A28C, Figure 4.2.4). We generated these two mutant strains for further study.  
Due to their proximity to the SD sequence, we first tested if they could interfere with AapA3 
translation. We assessed AapA3 translation by polysome fractionation coupled to Northern Blot 
analysis. A suppressor strain mutated in the AapA3 ORF at the residue 19 (Phe 19 to Ser achieved by 
the single nucleotide substitution T +107 to C from aapA3 +1) was used as positive translation control 
(T107C, Figure 4.2.4B). Polysome fractionation of this strain provided the first in vivo prove that the 
toxin full-length mRNA (aapA3-FL) is translationally inert (only 3.5% located in translating fractions; 
T107C panel in Figure 4.2.4B, lanes 10 to 14) contrary to the 3’ end-truncated isoform (aapA3-Tr), 
which appears strongly associated with monosome and disome fractions (72.9% located in fractions 
10 to 14; T107C panel in Figure 4.2.4B). Its poor presence in polysomic fractions reflects on the ORF, 
length since a ribosome occupies a region of approximately 90 nucleotides, it seems coherent that it 
can accommodate a maximum of two ribosomes. Similar polysome fractionation experiments were 
performed on the previously generated start/pIsoA3* and G43A strains, both used as negative 
translation controls (start and G43A panels, Figure 4.2.4B). Strikingly, we observed high levels of 
AapA3 mRNA degradation that were not observed before in standard total RNA samples. The 
extended time of sample collection and treatment prior to RNA extraction that exists in the polysome 
fractionation protocol but not in the standard total RNA extraction could explain this effect. This 
increased degradation was especially evident in strains producing a non-translatable AapA3 mRNA 
(i.e. start and G43A), as previously observed for other mRNAs (Iost and Dreyfus, 1995). 
Unfortunately, this effect impeded the quantification of aapA3-Tr band intensities on the start strain 
(shown in red as not-detectable (n.d.), start, Figure 4.2.4B). The fraction of aapA3-Tr mRNA on 
translating fractions on the SD suppressor strain was strongly reduced (4.2%) (G43A panel, Figure 
4.2.4B, fractions 10 to 14) compared to the WT strain (9.1%) (fractions 10 to 14, Figure 8.1.4A in the 
Appendix) and suggests that a certain amount of AapA3 peptide may be synthesized despite the lack 
of a canonical AUG translational start codon. Remarkably, a very strong translation reduction was 
observed in the A28C and the A40T suppressors. The mutation A40T had the strongest effect with 
only 6.7% of aapA3-Tr associated with translating ribosomes (Figure 4.2.4B, A40T panel, lanes 10 to 
14) compared to the 18.9% of the A28C strain (Figure 4.24B, A28C panel, lanes 10 to 14) (see Figure 
8.1.7 quantification graphs in the Appendix). Likewise, in vitro translation assays confirmed the 
results observed in vivo (Figure 8.1.4C in the Appendix), demonstrating that the A28C and the A40T 
suppressors act by reducing AapA3 translation efficiency in vivo.  
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Figure 4.2.4. Single-point mutations in the aapA3 5’ UTR inhibit its translation in absence of IsoA3. 
(A) Nucleotide substitutions significantly enriched (pajd≤0.05, “nucleotide-specific” analysis) in pIsoA3* 
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compared to WT sequences within the aapA3 Shine-Dalgarno (SD) region. Asterisks (*) above bars 
indicate transversion mutations. The A28C (adenine at position +28 from the aapA3 TSS mutated to 
cytosine), A40T (adenine at position +40 from the aapA3 TSS mutated to thymine), and G43A (guanine at 
position +43 from the aapA3 TSS changed to adenine) mutations are highlighted in orange, purple and 
turquoise, respectively. (B) Cell lysate of the indicated aapA3 mutant strains (T107C, Phe19Ser; start, 
AapA3 start codon mutated; G43A; A28C; and A40T) was subjected to ultracentrifugation through a 
sucrose gradient under polysome stabilization conditions (+ Chloramphenicol). A profile at OD254 was 
recorded. Peaks of the free 30S and 50S subunits, 70S ribosomes (free and translating) and polysomes are 
indicated. RNA was extracted from each fraction and equal volumes of each extract were subjected to 
Northern Blot analysis. The same membrane was successively probed for the aapA3, IsoA3, and 5S rRNA 
transcripts. The different transcripts are annotated as: aapA3-FL, aapA3-Tr, and 5S rRNA (loading 
control). M, monosomes; D, disomes. 
 
Together, these results demonstrate that it is possible to overcome antitoxin absence by 
reducing, even if not to abolishment, toxin translation efficiency. Remarkably, this translation 
inhibition can be achieved by a single nucleotide substitution in the 5’ UTR of the toxin-encoding 
mRNA. 
 
4.2.1.4. The suppressors A28C and A40T inhibit toxin translation by stabilizing a metastable 
SD-sequester hairpin 
Because the suppressor A40T locates within the AapA3 mRNA SD sequence, we next tested 
if it could act by SD sequence inactivation. To do so, we studied its location on the AapA3 mRNA 
secondary structure. In wild-type context, the SD sequence on the active toxin mRNA is accessible for 
interaction with both, ribosomes (Figure 4.2.1D) and IsoA3 RNA (Figure 4.2.2, lanes 4 to 8). 
RNAfold (Gruber et al., 2008) secondary structure predictions suggested that A40T could stabilize the 
mRNA in an SD-sequestered state by extending a pre-existing anti-SD sequence embedded on a 
metastable hairpin by one base-pair (anti-SD sequence 1 (aSD1), Figure 4.2.5A). To investigate 
whether this SD-sequestering hairpin exists in vivo, we next performed a transformation assay. Three 
constructs were used: 1) the suppressor A40T; 2) a double mutant carrying a mutation in the opposite 
hairpin strand, expected to restore WT stem stability by disrupting the extra base-pair created by the 
suppressor (A33T / A40T); and 3) because the double mutation was expected to be toxic, a strain 
containing an additional mutation on the AapA3 start codon was generated (A33T / A40T / start, 
Figure 4.2.5C). Transformation assay was performed as previously described (see Material and 
Methods section).  
As expected, the suppressor A40T was not toxic (A40T, Figure 4.2.5D). However, a 
significant reduction (2 log-fold) in the number of StrR/CFU was observed with the A33T / A40T 
construct (A33T / A40T, Figure 4.2.5C). This effect disappeared when the toxin start codon was 
mutated (A33T / A40T /start, Figure 4.2.5C) demonstrating that toxicity comes from AapA3 peptide 
synthesis. Unfortunately, this approach could not be used for the study of the A28C suppressor since 
the compensatory mutation would locate within the SD sequence. Thus, we tested its SD accessibility 
by performing an RNase H/oligonucleotide accessibility assay (Figure 4.2.5B, see gels in Figure 8.1.5 
and nucleotide list in Table 8.1.4 in the Appendix). The A40T and A40T / A33T suppressors were 
included in the study for comparison with a translation inhibitor mutation located outside the SD 
sequence. Reduced oligonucleotide accessibility was observed on A28C and A40T aapA3-Tr RNAs 
when compared to WT, demonstrating that, the A28C mutation as the in vivo validated A40T, inhibit 
toxin expression by reducing SD accessibility to ribosomes. The double mutant A33T / A40T showed 
WT accessibility. These results demonstrate that the suppressor A40T, despite being located on the SD 
sequence, acts by stabilizing SD sequestration by the addition of one base pair in a pre-existing hairpin 
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containing an anti-SD sequence. Thus, it acts at the mRNA structure level instead of at the sequence 
level. 
 
Figure 4.2.5. Single nucleotide substitutions in the AapA3 5’UTR stabilize SD occlusion by an 
upstream to SD aSD sequence. (A) Secondary structure prediction of the +28 to +45 region of the AapA3 
mRNA. Shine-Dalgarno (SD) sequence is highlighted in turquoise. A CU-rich sequence element located 
upstream and able to mask the SD sequence creating an RNA hairpin is highlighted in yellow (anti-SD1, 
aSD1). The A28C and A40T suppressor mutations stabilizing this SD-occluding hairpin are shown in 
orange and purple, respectively. The A40T compensatory mutation A33T is shown in red. RNAfold 
(Gruber et al., 2008) was used for secondary structure and energy predictions, VARNA (Darty et al., 2009) 
was used for drawing. (B) Secondary structure prediction of the +1 to +45 region of the AapA3 mRNA. A 
black arrow represents the binding site of the DNA oligonucleotide used in the RNase H1 assays (left 
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panel). 30 fmol of internally labeled aapA3-Tr RNA (wild type or containing the indicated mutations) were 
incubated in presence of 0 to 10 µM DNA oligonucleotide (FA644 for WT and A40T; FA651 for 
A33T/A40T; and FA652 for A28C, see Table S4) and subjected or not to digestion by E. coli RNase H1 
(right panel). Digestion products were analyzed in an 8% PAA denaturing gel. Substrate consumption was 
quantified as relative band intensity (peak area). Error bars represent the s.d; n=2 independent experiments. 
(C) PCR constructs used to assess the SD-sequestering structure involving the A40T mutation by 
transformation assay are shown. (D) Number of StrR upon transformation with the indicated PCR 
constructs was calculated. Error bars represent s.d; n=3 biological replicates. (***P<0.0001; *P=0.001 
according to unpaired t-test). 
 
4.2.1.5. A second metastable SD-sequester hairpin is embedded in the aapA3 ORF 
A synonymous mutation converting the AapA3 serine codon at position 9 from TCT to TCC (T to C 
transition at position +78 from aapA3 +1, T78C in all figures) was selected in our suppressor screen. 
Located at 33 nt distance from the SD and apparently far from any other mRNA regulatory element, 
the existence of this mutation was intriguing. We generated the strain for further study. Northern Blot 
analysis showed that the T78C strain has wild-type expression and mRNA stability patterns (Figure 
8.1.4B in the Appendix). We next tested its translatability in vivo by performing polysome 
fractionation coupled to Northern Blot analysis. A reduced AapA3 translatability was observed 
(Figure 4.2.6A, lanes 10 to 14) when compared to the positive control strain (Figure 4.2.4B, T107C 
panel, lanes 10 to 14). However, with 34.3% of the active toxin mRNA located in the monosome and 
disome fractions, the T78C mutation showed the smaller translation inhibitory effect when compared 
to the two previously studied suppressors (A28C and A40T, Figure 4.2.4B) (see Figure 8.1.7 in the 
Appendix for band intensity quantification). In vitro translation assays confirmed these results (Figure 
8.1.4C in the Appendix) demonstrating that the T78C suppressor acts by inhibiting Aapa3 translation. 
Interestingly, these results also indicate that a relatively high amount of peptide synthesis is tolerated 
by the cells, suggesting that toxicity is strongly dependent on the concentration of peptide in the cell, 
which could be diluted during cell division.  
We next performed RNase H/ oligonucleotide protection assays to address SD accessibility on 
the T78C RNA. In this case, RNAfold (Gruber et al., 2008) secondary structure prediction revealed 
the putative stabilization of a second metastable SD-sequestering hairpin involving a second aSD 
(aSD2) sequence embedded on AapA3 ORF, and on which the suppressor T78C is located (Figure 
4.2.6B). In order to reveal the accessibility to this region, a new oligonucleotide targeting the predicted 
stabilized hairpin was designed (FA633, see Table 8.1.4 in the Appendix). Remarkably, a strong 
reduction in SD accessibility was observed in the T78C RNA when compared to WT (≈58X more 
non-digested substrate with the maximal oligonucleotide concentration tested, Figure 8.1.5 in the 
Appendix). Notably, this single-nucleotide transition converts a wobble base-pair G-U into a G-C pair, 
allowing survival by addition of one hydrogen bond. Importantly, despite being located on AapA3 
coding region, the T78C suppressor acts at the mRNA folding level.  
 Sequence conservation analysis of the AapA3 coding-region in 49 H. pylori strains (Figure 
8.1.6 in the Appendix) revealed that the serine residue at position 9 (where T78C is located) is one of 
the most highly conserved residues in the peptide. Among all the analyzed strains, only the UM066 
strain (highlighted in pink in Figure 8.1.6 in the Appendix) possesses a mutation on this codon. This 
mutation converts the TCT (Ser) codon into CCT (Pro) and probably abolishes peptide toxicity by 
disrupting the alpha-helix structure. Nevertheless, a possible conservation for an anti-SD strengthening 
sequence enhancing SD sequestration on an alternative secondary structure cannot be discarded. 
Likewise, the nucleotides corresponding to -10 box of IsoA3 small RNA (-10 IsoA3, in Figure 8.1.6 in 
the Appendix) are among the most highly conserved ones. This reflects the high selection pressure the 
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system is subjected to for avoiding premature toxin expression during transcription, and the 
essentiality of IsoA3 antitoxin for survival, respectively. Additionally, it is interesting to note that 
thirteen UC-rich motifs with potential anti-SD activity are embedded in the aapA3 mRNA (Figure 
8.1.8 in the Appendix). However, our results have clearly demonstrated that, unexpectedly, only three 
of them (two co- and one post-transcriptionally) are functional. 
Altogether, we demonstrate that AapA3 translation can be inhibited by a single-nucleotide 
substitution located not only in the 5’ UTR as described above but also in the coding region. Through 
the study of these translation inhibitor suppressors we uncovered the existence of two metastable 
(MeSt) SD-sequestering hairpins embedded in the AapA3 mRNA (MeSt1, involving the aSD1 
sequence; and MeSt2, involving the aSD2 sequence, Figure 4.2.7) and highlighted the importance of 
such co-transcriptional folding for survival as it prevents premature toxin expression during 
transcription.  
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Figure 4.2.6. A synonymous single-point mutation within a downstream to SD aSD sequence motif 
stabilizes SD occlusion and hampers AapA3 translation. (A) Cell lysate of the T78C (thymine at 
position +78 from the aapA3 TSS mutated to cytosine) strain was subjected to ultracentrifugation through a 
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sucrose gradient under polysome stabilization conditions (+ Chloramphenicol). A profile at OD254 was 
recorded. Peaks of the free 30S and 50S subunits, 70S ribosomes (free and translating) and polysomes are 
indicated. RNA was extracted from each fraction and equal volumes of each extract were subjected to 
Northern Blot analysis. The same membrane was successively probed for the aapA3, IsoA3, and 5S rRNA 
transcripts. The different transcripts are annotated as: aapA3-FL, aapA3-Tr, and 5S rRNA (loading 
control). M, monosomes; D, disomes. (B) RNAfold (Gruber et al., 2008) was used for secondary structure 
and energy predictions and VARNA (Darty et al., 2009) for drawing. A black arrow represents the binding 
site of the DNA oligonucleotide used for the RNase H1 assays. The T78C mutation is shown in blue; 
Shine-Dalgarno sequence (SD) is shown in turquoise; anti-Shine-Dalgarno motifs (from the 5’ end, aSD1 
and aSD2) are shown in yellow; start codon is shown in green. (C) 30 fmol of internally labeled aapA3-FL 
and aapA3-Tr RNA (WT or T78C) were incubated in presence of 0 to 10 µM DNA oligonucleotide 
(FA633) and subjected or not to digestion by E. coli RNase H1. (D) Substrate consumption was quantified 
as the relative band intensity (peak area). Error bars represent the s.d; n=2 independent experiments. 
 
 
4.2.2. Discussion 
How bacteria modulate gene expression via RNA structure has been a fascinating topic for the last 30 
years. This post-transcriptional regulation is often achieved at the translation initiation step through 
the sequestration of the SD sequence in stable RNA hairpins that prevent ribosome binding to the 
translation initiation region (TIR) of the mRNA (Duval et al., 2013, 2015; Meyer, 2017). Although 
translation efficiency strongly correlates with the mRNA structure around the TIR (Mustoe et al., 
2018), little is known about the influence of co-transcriptional folding. Bacteria could, in principle, 
reduce or delay the translation of a specific mRNA by playing with its secondary structure while the 
mRNA is being made (Lai et al., 2013; Zhu and Meyer, 2015). In this article, we identified two 
functional RNA hairpins within a type I toxin-encoding mRNA for which a tight control of translation 
is essential. The study of such RNA structures reflected the importance of co-transcriptional folding 
and the existence metastable RNA hairpins able to sequentially occlude SD accessibility during 
mRNA synthesis. 
 
4.2.2.1. FASTBAC-Seq uses lethality to identify suppressor mutations  
The initial aim of this work was to study the chromosomal expression of the AapA3 small toxic 
protein, which belongs to a new family of type I TA system recently discovered on the chromosome of 
the major human gastric pathogen H. pylori (Arnion et al., 2017). To date, most of TA systems 
studies, including our previous work (Arnion et al., 2017), made use of artificial expression systems to 
characterize the effects of toxin expression. The use of such overexpression vectors is often a source 
of misinterpretations, as toxin proteins would rarely be found at such high concentrations under 
endogenous conditions. To detect the AapA3 toxin expression at the chromosomal level, we 
inactivated the antitoxin promoter by introducing of two synonymous mutations, as previously 
described (Arnion et al., 2017). However, despite several attempts, we were unable to obtain a viable 
strain without having suppressor mutations in the toxin-encoding gene. Suppressor mutations have 
been previously reported in B. subtilis when two chromosomally-encoded type I toxins with killer-
activity were expressed (the txpA/RatA (Silvaggi et al., 2005) and the bsrG/SR4 (Jahn et al., 2012)). 
But strikingly, such lethality has never been observed before in chromosomally-encoded TAs in 
Gram-negative bacteria. Indeed, the killer activity observed in the plasmid-encoded hok/Sok TA 
system was even believed not to be conserved in the chromosomally-encoded homologs (Pedersen and 
Gerdes, 1999). In the K12 reference strain, most of these homologs (hokA, C and E) have been 
inactivated by the insertion elements IS150 or IS186, located close to the toxin-encoding reading 
frames (Pedersen and Gerdes, 1999). These observations, together with studies reporting on the 
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differential expression of several TA systems in response to various stresses (e.g., temperature shift, 
oxidative stress, starvation), suggested that chromosomally-encoded TAs may not be involved in a 
killer activity, but rather, in a reversible growth arrest in response to a specific stress. On the contrary, 
our results clearly demonstrated that the chromosomal expression of the AapA3 toxin is constitutive 
and lethal in the absence of the IsoA3 antitoxin. Consequently, we took advantage of this lethality, and 
coupled the genetic selection of suppressors to Next-Generation sequencing (FASTBAC-Seq, see 
section 4.1 in Chapter 4), allowing the fast identification of hundreds of intragenic suppressors 
mutations with nucleotide resolution (Masachis et al., 2018).  
 
4.2.2.2. A single nucleotide substitution is sufficient to abolish toxin translation  
FASTBAC-Seq revealed a wide range of unanticipated cis-encoded toxicity determinants, affecting 
the toxin protein, or its expression. Among the mutations affecting the toxin mRNA expression, we 
identified five single nucleotide substitutions able to inhibit the AapA3 translation without affecting its 
stability. Three of such mutations were located in the SD sequence. Two of them, were highly 
enriched, substituting the guanines at positions 43 and 44 from the AapA3 TSS (G43 and G44) by 
either an adenine, a cytosine, or a uridine. This revealed the 5’ AGG 3’ and the 5’ GGA 3’ as the 
minimal functional SD sequences allowing AapA3 translation, in agreement with the previously 
identified H. pylori SD consensus sequence (5’ AAGGA 3’) (Sharma et al., 2010). The third mutation 
(A40T), was much less enriched, and remarkably, at that position, only the transversion mutation 
adenine to thymine was selected. Another transversion mutation was selected 14 nucleotides upstream 
the SD sequence. The fact that only transversion mutations were selected at these two positions 
indicated that, in this case, the nature of the substituted nucleotide was important, and the effect of 
these mutations may not directly play at the sequence level, but rather at the structure level. Our 
results demonstrated that these mutations create, one (for A28C) or two (for A40T), additional base 
pair(s) within a stem-loop structure formed between the SD sequence and an upstream complementary 
anti-SD (aSD) sequence (aSD1, 5’ UCCU 3’). Thus, the A40T mutation, despite being located within 
the SD sequence, remarkably acts at the mRNA structural level and not at the sequence level.  
Interestingly, the T78C mutation revealed the existence of a second aSD sequence (aSD2) 
located downstream the SD sequence, within the toxin coding region. This synonymous substitution 
(UCUàUCC, Ser codon at position 9, Ser9), creates a perfect aSD sequence (5’ CUCCU 3’). Despite 
having no impact in the protein sequence, synonymous mutations can influence gene expression 
(Kudla et al., 2009). The stability of the mRNA folding close to the TIR can explain more than half of 
the variation in protein levels. Indeed, a strong codon bias to avoid mRNA structure close to the TIR 
region is often observed within the first 15 codons (Bentele et al., 2014; Bhattacharyya et al., 2018). A 
similar aSD sequence (5’ UCCU 3’) has been observed in the coding sequence of the gnd gene in E. 
coli (Carter-Muenchau and Wolf, 1989). However, it is encoded far downstream (codon 66-71), 
having only a moderate effect on translation that is highly dependent on ribosome concentration. 
Interestingly, when this aSD sequence is placed at the codon 13, it is able to fully inhibit translation. In 
line with this work, we show that despite the presence of up to thirteen CU-rich sequences in the 
AapA3 mRNA, only three of them are able to act as aSD sequences, reflecting a strong context-
dependent functionality of these translation regulatory elements.  
  
4.2.2.4. Suppressor mutations reveal functional metastable structures acting co-transcriptionally 
to impede premature toxin translation 
The three here-studied mutations (A78C, A40T, and T78C) act within a pre-existing sequence context. 
Indeed, they locate within and stabilize, SD-sequester hairpin structures that were previously predicted 
to be formed in the co-transcriptional folding pathway of several AapA mRNAs (Arnion et al., 2017). 
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Importantly, despite stabilizing such structures, they do not interfere with the folding pathway of the 
full-length mRNA, neither affecting its transcription, stability, or 3’ end maturation, and indicating 
that they exclusively act on the active AapA3 mRNA form (Figure 4.2.7). The selection of such 
stabilizing mutations, suggests that the thermodynamic stability of such SD-sequestering stem-loops in 
the wild-type context is not sufficient as to avoid the translation of the active AapA3 mRNA form 
(Figure 4.2.7).  
 
 
Figure 4.2.7. Working model of the aapA3 co- and post-transcriptional translational SD-accessibility 
regulation. Co-transcriptional folding of the AapA3 mRNA leads to the sequential generation of two 
transient RNA hairpins (metastable structures 1 and 2, MeSt1 and MeSt2) that mask the Shine-Dalgarno 
(SD) sequence using CU-rich sequence elements called anti-SD sequences (aSD, aSD1 and aSD2, 
successively), temporally impeding ribosome accessibility. Upon transcription, the aapA3 full-length 
transcript (aapA3-FL) is kept translationally inert through the SD occlusion by a third aSD sequence 
(aSD3) mediated by a 5’-3’ long-distance interaction between both mRNA ends. Only upon a 3’-end 
nucleolytic truncation that leads to the loss of the aSD3, the toxin mRNA becomes translationally 
competent (aapA3-Tr) and can potentially lead to cell death if translated. Our results show that, in the 
absence of antitoxin, a single nucleotide substitution can hamper the translation of this active toxin mRNA 
form (aapA3-Tr) by stabilizing one of the two SD-occluding RNA hairpins predicted to be co-
transcriptionally formed (MeSt1 using the aSD1 in the case of the A28C and the A40T mutants; MeSt2 
using the aSD2 in the case of the T78C mutant). The selection of these hairpin-stabilizing suppressor 
mutations reflects on the existence of the two-above-mentioned functional metastable structures. 
 
Instead, our results suggest that in the wild-type situation, such SD-sequestering structures are 
transiently formed to co-transcriptionally impede the premature toxin translation (metastable structures 
1 and 2, MeSt1 and 2, Figure 4.2.7). This transient character is essential to ensure the proper 
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transcription termination and folding of the full-length mRNA, and it is achieved by hierarchically-
increasing thermodynamic stabilities (see energy of wild-type metastable structures 1 and 2, Figure 
4.2.8). Importantly, the suppressor mutations do not provide enough stabilization as to impede the 
formation of the next most stable structure (i.e., the A40T mutated metastable structure 1 has an 
energy of -20.90 kcal/mol, while the metastable structure 2 has an energy of -29.30 kcal/mol, Figure 
4.2.8). This may explain why the SD-sequester mutations are able to impede the translation of the 
active mRNA form without interfering with its co-transcriptional folding pathway. 
 
Figure 4.2.8. The two successive AapA3 mRNA metastable structures have increasing stability and 
are stabilized by the A40T and the T78C suppressors. The two metastable structures (1, ~45 nt long, 
upper panel; and 2, ~80 nt long, lower panel) successively formed during the AapA3 mRNA transcription 
are shown. Shine-Dalgarno (SD) sequence is highlighted in turquoise, anti-SD (aSD) sequences (aSD1 and 
aSD2) are highlighted in yellow, suppressor mutation stabilizing SD sequestration by the aSD1 in the 
metastable structure 1 is highlighted in purple (A40T), the suppressor stabilizing the SD sequestration by 
the aSD2 in the metastable structure 2 is highlighted in blue (T78C). RNAfold (Gruber et al., 2008) was 
used for secondary structure and minimum free energy predictions, and VARNA RNA (Darty et al., 2009) 
for drawing. 
 
Another proof of the existence of such metastable RNA structures in the AapA3 mRNA is the 
strict conservation of the UCU Serine codon at position 9. As our results have shown, a UCC codon at 
that position (T78C mutation) would have render the AapA3 toxin expression inefficient, what would 
have rapidly led to the TA locus sequence degeneration and lost. The formation of metastable RNA 
structures has been reported in several RNA-mediated regulatory pathways, including the viral RNA 
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by boxes with different red intensities depending on the strength of the sequence to mask the SD, as 
indicated at the top right. aSD sequences sequentially masking the SD at the different stages of the 
regulatory pathway are represented by the numbers 1, 2 or 3, written within the aSD boxes. The 
translationally inert (full-length, -FL) and active (truncated, -Tr) toxin mRNA forms are indicated. The 
sequence context involved in the SD sequestration by the most stable aSD interaction is represented by a 
red line. Sok and IsoA3 sRNA antitoxins are shown in green. Ribosomes are represented in yellow. In the 
hok/Sok regulation, tac (translational activator), fbi (‘fold-back-inhibition’ element). 
 
In our work, we provide in vivo evidences for the existence of functional metastable hairpins 
that impede the co-transcriptional toxin translation. This temporal control of gene expression is 
achieved through the sequential formation of two functional transient RNA structures that mask the 
SD sequence via CU-rich elements and that are replaced by a more stable one involving a long-
distance-interaction between both mRNA ends in the full-length mRNA (Figure 4.2.9B). Similar to 
the hok mRNA, this final mRNA structure is so stable that its translational activation requires the 
removal of a third aSD sequence (aSD3, located within the 3’ end of the mRNA), by an exonucleolytic 
activity (see section 4.3 of Chapter 4). The highly stable structure of the aapA3-FL mRNA is also 
similar to the cloverleaf-like structure found in the 5’ UTR of the maturation (A) gene of the MS2 
RNA coliphage (Groeneveld et al., 1995). Interestingly, it has been shown that in the case of the 
maturation (A) gene, it may take up to several minutes for the mRNA to be synthetized and properly 
folded (van Meerten et al., 2001), explaining the existence of functional transient structural 
intermediates preventing premature gene expression. 
Overall, in the case of the Hok mRNA, the first aSD sequence masking the SD is the most 
stable one (represented by an intense-red box named 1, Figure 4.2.9A). On the contrary, in the case of 
the Aapa3 toxin mRNA, three increasingly-stable aSD sequences (boxes termed 1, 2 and 3, in 
increasingly-intense red color, Figure 4.2.9B) transiently occlude ribosome binding until reaching the 
most stable conformation (full-length) on which the SD is masked by the aSD3 (represented by an 
intense-red box named 3, Figure 4.2.9B). This is a crucial difference in the co- and post-transcriptional 
regulation of these systems, as mechanistically, the tightness of the co-transcriptional SD 
sequestration, as well as the dynamic time-window of gene expression, are drastically different (which 
may have functional consequences, e.g., ability or no of ribosome concentration sensing and 
regulation by sRNA binding). Our study represents the first in vivo evidence of the existence of 
sequential metastable structures, directly but transiently, avoiding the co-transcriptional translation of 
a toxin-encoding mRNA. 
 
4.2.2.5. Conclusion 
To conclude, our work revealed the existence of CU-rich sequence elements that act co-
transcriptionally to either transiently or stably occlude ribosome binding to the toxin-encoding mRNA. 
Due to the co-transcriptional translation that occurs in bacteria, these RNA hairpin structures are 
essential to uncouple the transcription and translation processes, and allow the presence of type I toxin 
antitoxin systems on bacterial chromosomes. To date, only four families of functional transient RNA 
structures have been described, including the Trp operon leader, the 5’ UTR of the Levivirus (MS2 
phage), the HDV ribozyme, and the SAM riboswitch (Zhu and Meyer, 2015). Our work is closer to the 
previous studies on the 5’ UTR of the MS2 phage (van Meerten et al., 2001), except that in that case, 
the transient structure is formed to allow translation initiation to occur before the cloverleaf-like 
structure is formed. In both cases, a transient RNA structure is formed to exert a temporal control of 
translation, either negatively or positively. Although transient RNA structures can be predicted in 
silico (Meyer, 2017), their in vivo visualization remains challenging. Several methods have been 
recently reported to analyze the co-transcriptional folding of regulatory RNA, both in vitro (Uhm et 
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al., 2018; Watters et al., 2016) and in vivo (Incarnato et al., 2017). It would be really interesting to use 
these complementary techniques to analyze the formation of these metastable hairpins in real-time.  
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4.3. Paper IV: When mRNA folding rules decay: lessons from a type I toxin-
antitoxin system  
 
 
In the previous section (Paper III), we described how the AapA3 toxin-encoding mRNA is silenced 
via RNA-based regulatory mechanisms throughout its synthesis. How untranslated RNAs avoid 
degradation (and Rho-dependent termination) is a major question in the prokaryotic field that arises 
from the observation that many mRNAs, including type I toxin-encoding mRNAs (Masachis and 
Darfeuille, 2018), escape to transcription/translation coupling. In this paper, we aimed at exploring the 
mRNA stability determinants of the AapA3 toxin-encoding mRNA, and at understanding how they 
influence its activation pathway and the regulation of the system. 
The stability of a specific RNA is strongly dependent on its secondary structure, as most 
exonucleases (and some endonucleases) are, to a lesser or greater extent, inhibited by them. For 
instance, it has been shown that PNPase, the major 3’-5’-exonuclease present in H. pylori, degrades 
the 3’ end of RNA until encountering an energetically stable enough stem-loop structure (shown in E. 
coli, Spickler and Mackie, 2000). This property has even been exploited in some studies for the in 
vitro secondary structure analysis of RNAs (Chen et al., 1991). Similarly, a strong sensitivity to 
secondary structure has been shown for the only so far identified H. pylori 5’-3’-exonuclease, the 
RNase J (in H. pylori (Redko et al., 2013) and in E. coli, Even et al., 2005)), whose activity has also 
been used for RNA structure in vitro studies (Daou-Chabo and Condon, 2009). The key role of 5’ and 
3’ end stem-loop structures in mRNA decay was discovered long ago (Chen et al., 1991; Emory et al., 
1992; Mott et al., 1985). With the recent development of the Term-Seq approach (Dar et al., 2016), a 
massive existence of such protective hairpins in the E. coli transcriptome has been reported (Dar and 
Sorek, 2018). 
 FASTBAC-Seq revealed several suppressor mutations able to trigger the degradation of the 
AapA3 toxin mRNA. Such mutations locate within highly-stable hairpins that are present at both ends 
of the 3’ end processed species. Remarkably, these mutations lead to a strong destabilization of the 
hairpins by disrupting only one base pair in their stem. Our work demonstrated that the stem-loop 
present at the 3’ end functions as a thermodynamic roadblock, impeding the 3’-exonuclease activity of 
the PNPase. Furthermore, this protective hairpin is essential for the proper maturation of the AapA3 
mRNA, as its translational activation is achieved through a 3’-exonucleolytic processing pathway led 
by the PNPase. On the other hand, the hairpin present at the 5’ end blocks 5’-processing activities, 
such as RNase J. Importantly, both termini protective hairpins act in coordination, and the strict 
presence of both of them is essential to ensure that the AapA3 mRNA is stable enough as to be 
efficiently translated (i.e., functional stability). Overall, this work highlights the key role of secondary 
mRNA structure for the stability and nucleolytic activation of the AapA3 toxin-encoding mRNA. 
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4.3.1. Results 
4.3.1.1. Ribonucleolytic processing activates the aapA3 mRNA  
We recently reported on the existence of a truncated AapA3 mRNA species that accumulates in the 
absence of antitoxin as well as in absence of RNase III and is the only translationally active Aapa3 
mRNA form (see Chapter 4 section 4.2). Based on RNA-Seq data (Sharma et al., 2010), by 
reminiscence to the AapA1 mRNA (Arnion et al., 2017), and considering that the RNA antitoxin 
targets the 5’ end of the toxin mRNA, we hypothesized that this active mRNA species is the product 
of a 3’ end ribonucleolytic activation process. However, the molecular underpinnings of this activation 
were unknown.  
In the present study, we first aimed to confirm that the observed truncated AapA3 mRNA was 
the product of a nucleolytic activity and not that of transcription termination. To that aim, we 
performed RNA decay studies using rifampicin. Northern Blot analysis of the wild-type 26695 H. 
pylori strain revealed the presence of a transcript with longer size (aapA3 full-full length, aapA3-FFL, 
≈ 280 nt) than the so far considered to be the full-length (aapA3-FL, ≈ 225 nt) (Figure 4.3.1A). This 
aapA3-FFL species appears to be generated by transcription termination and be highly stable. The 
constant levels of aapA3-FFL mRNA indicate that the so far considered to be the AapA3 primary 
transcript and the most abundant AapA3 mRNA form found in vivo, the aapA3 full-length (aapA3-FL, 
≈ 225 nt), is generated by an independent transcription termination mechanism rather than by 
nucleolytic cleavage of the aapA3-FFL species. Furthermore, the lack of correlation between the 
levels of aapA3-FLL and aapA3-FL forms with those of the IsoA3 RNA (IsoA3, ≈ 80 nt), is in line 
with previous results and demonstrates that IsoA3 RNA targets none of them.  
 
 
 
Figure 4.3.1. Rifampicin treatment reveals an exonucleolytic activation pathway of the aapA3 mRNA 
led by PNPase. After rifampicin addition (at OD600 = 1.7), aliquots of H. pylori 26695 WT (+ pnp) (A), or 
ΔPNPase (- pnp) (B), cultures were collected at several time points (as indicated on top of the gel). RNA 
was extracted and subjected to Northern blot analysis. The membrane was successively probed with 32P-
FD38 labeled oligonucleotide and IsoA3 riboprobe to detect aapA3 and IsoA3 transcripts, respectively. The 
different transcripts are annotated as: aapA3-FFL (full-full-length, » 280 nt), aapA3-FL (full-length, » 225 
nt), aapA3-i (intermediate, » 200 nt), aapA3-Tr (truncated, » 190 nt), IsoA3-p (» 95 nt) and IsoA3 (» 80 
nt). A labeled DNA marker (25 bp intervals, lane M) was used for size estimation. Proper loading was 
assessed by the level of 5S rRNA using the labeled oligo probe FD35.  
 
Surprisingly, a band of an intermediate size between the aapA3-FL and the aapA3-Tr species 
was revealed (aapA3-i, ≈ 200 nt, Figure 4.3.1A). This intermediate form appears before the aapA3-Tr 
can be observed, accumulates in a time- and IsoA3-independent manner, and has a relatively long 
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half-life. This reflects a slow and IsoA3-independent decay, pointing out that aapA3-i, as the two 
longer species (aapA3-FFL and aapA3-FL), is inert for interaction with the IsoA3 RNA. Remarkably, 
the aapA3-i levels decrease when those of the aapA3-Tr increase, demonstrating that it is a nucleolytic 
intermediate on the aapA3 mRNA activation pathway. Rifampicin assays demonstrated that the 
AapA3 truncated form (aapA3-Tr, ≈ 190 nt) is a ribonucleolytic product that accumulates only once 
the IsoA3 RNA pool has been fully degraded (Figure 4.3.1A). This result is in line with previous 
observations and demonstrates that aapA3-Tr is rapidly targeted by IsoA3 RNA and that the duplex is 
degraded by the double-strand-specific RNase III, as previously shown in vivo (see Chapter 4 section 
4.2). Taken together, our results demonstrate that aapA3 mRNA translational activation occurs by 
ribonucleolytic degradation of a long (and inert) primary transcript in an IsoA3-independent manner. 
4.3.1.2. AapA3 mRNA translational activation is led by the 3’-exonucleolytic activity of PNPase 
To uncover the molecular underpinnings of the aapA3 mRNA nucleolytic activation process, and 
given that H. pylori lacks RNase II, we tested AapA3 mRNA expression and decay in different genetic 
backgrounds deleted for one/or both of the two major H. pylori 3’-5’ exonucleases, the ribonuclease R 
(RNase R, HP1248) (- rnr) and the polynucleotide phosphorylase (PNPase, HP1213) (- pnp). No 
changes in the relative abundance or length of the different AapA3 mRNA species were observed in 
the absence of RNase R (data not shown). However, an abundant steady-state presence of the aapA3-i 
species was observed in the pnp deleted background (Figure 4.3.1B). The absence of aapA3-i/IsoA3 
linked-decay despite the high steady-state levels of aapA3-i in the pnp deleted background confirmed 
that the IsoA3 RNA antitoxin does not target the aapA3-i species. As previously observed (Figure 
4.3.1A), the levels of aapA3-i decreased when those of aapA3-Tr increased (Figure 4.3.1B), 
demonstrating that PNPase is involved in the 3’ end processing of the aapA3-i species to generate the 
active aapA3-Tr mRNA. However, the observation of the aapA3-Tr species despite PNPase absence 
reflects the existence of a so far unidentified redundant activity able to counteract the lack of PNPase.  
In order to identify the PNPase redundant activity responsible of the generation of the aapA3-
Tr species in H. pylori, we generated a deletion strain of the endoribonuclease RNase Y (HP0760) 
(Drny::aphA3, Table 8.2.3 in the Appendix) as well as a double deletion strain lacking both, PNPase 
and RNase Y activities (Drny::aphA3/Dpnp::catCG, Table 8.2.3 in the Appendix). Rifampicin assays 
on the - rny strain revealed decreased levels of aapA3-Tr, and close to wild type aapA3-i levels 
(Figure 8.2.1A in the Appendix). When comparing the aapA3 mRNA decay profile in the double - 
rny/- pnp mutant with that of the wild type strain (Figure 8.2.1B in the Appendix), a slight decreased 
on aapA3-i levels can still be observed, indicating that RNase Y is involved in the generation of 
aapA3-i from the aapA3-FL species. However, in the double - rny/- pnp mutant, the levels of aapA3-
Tr were strongly reduced when compared to those of the simple - pnp mutant (Figure 8.2.1C in the 
Appendix). This strong reduction cannot be fully explained by the decreased aapA3-i levels, and 
indicates that RNase Y is also involved in the generation of the active aapA3 mRNA species (aapA3-
Tr) from the aapA3-i form. Nevertheless, despite the lack of RNase Y and PNPase activities, the 
aapA3-Tr species is still produced, therefore, the identity of the redundant activity remains enigmatic.  
 
4.3.1.3. 3’ RACE reveals a heterogeneous population of AapA3 mRNA species 
So far, we had estimated the size of the different AapA3 mRNAs based on RNA-Seq data (Sharma et 
al., 2010) and size markers in Northern Blot analyses. Protocols for the identification of 5’ ends have 
been well established for several years (Argaman et al., 2001; Thomason et al., 2015; Urban and 
Vogel, 2007), however, the identification of 3’ ends in bacterial mRNAs has proved to be more 
challenging due to the lack of poly-U tails in most mRNAs. Nevertheless, recently, Dar and colleagues 
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(aapA3 +1). Heterogeneous sequence populations of the aapA3 full-length (aapA3-FL), intermediate 
(aapA3-i) and truncated (aapA3-Tr) species are shown. (C) Schematic representation of the different aapA3 
mRNA species. The two longer forms (aapA3-FFL, » 280 nt and aapA3-FL, » 225 nt) generate from 
transcription termination. The generation of aapA3-FL from aapA3-FFL is unlikely but not discarded (grey 
arrow). 3’ end processing led by the 3’-5’-exonuclease activity of the PNPase (represented by a purple Pac-
man) successively generates the aapA3-i (intermediate, » 200 nt) species with a 5’ stem-loop, and the 
aapA3-Tr (» 190 nt) with both a 5’ and a 3’ stem-loops. 
 
Subsequently, PCR products were cloned and sequenced. As shown in Figure 4.3.2B, 3’ 
RACE sequencing revealed highly heterogeneous populations of the three main AapA3 mRNA 
species (unfortunately, due to its low abundance in the PCR, the aapA3-FFL species got lost in the 
cloning process). The observation of such landscape of 3’ ends is highly significant and reflects the 
mechanism of action of the actors in the AapA3 mRNA activation pathway (3’-exonucleases). If we 
now make RNA secondary structure predictions using the newly identified aapA3-FL (≈ 229-218 nt), 
aapA3-i (≈ 202-198 nt) and aapA3-Tr (≈ 192-188 nt) 3’ ends, we can observe that the 3’ends are not 
arbitrary, but rather defined by energetic roadblocks for 3’-exonucleases (Figure 8.2.2 in the 
Appendix). Indeed, in the secondary structure of the last AapA3 mRNA activation product (aapA3-
Tr), two highly stable stem-loop structures can be observed at both, the 5’ (with five consecutive GC 
pairs) and the 3’ (with three consecutive CG pairs) ends. The 5’ stem-loop is expected to be co-
transcriptionally formed to avoid the premature mRNA degradation by cellular 5’-3’-exonucleases and 
to re-appear after the cleavage of the first 3’end nucleotides in the full-length transcript (weakening 
the 5’-3’ long-distance interaction). On the contrary, the 3’ stem-loop is unlikely formed during 
transcription, as the 5’-3’ long-distance interaction needs to be efficiently formed to avoid both, 
ribosomes and IsoA3 binding to the nascent mRNA. Thus, the 3’ stem-loop is a unique feature of the 
final AapA3 mRNA activation state, the aapA3-Tr species (Figure 4.3.2C and Figure 8.2.2 in the 
Appendix).  
 
4.3.1.4. The active AapA3 mRNA harbors a 3’ end protective stem-loop structure 
During the analysis of the toxicity suppressor mutations previously identified by FASTBAC-Seq (see 
Chapter 4 section 4.1), two groups of mutations struck us. Such mutations where located in the 5’ and 
3’ non-coding regions (untranslated regions, UTRs) of the AapA3 mRNA laying outside any known 
regulatory element (e.g. Shine-Dalgarno). Interestingly, mapping the mutations to the secondary 
structure of the active AapA3 mRNA species (aapA3-Tr), we observed that they symmetrically cluster 
at both sides of the stems, in both, the 5’ and 3’ termini stem-loops which now we know, are 
characteristic of this AapA3 mRNA species (mutations shown in orange and purple, respectively, 
Figure 8.2.3 in the Appendix). To understand how these single point mutations were able to counteract 
the absence of the IsoA3 sRNA antitoxin, we selected one mutation on each stem-loop for deeper 
mechanistic characterization. The single point substitution G183A (guanine at position 183 from 
AapA3 TSS mutated to adenine) located in the 3’ stem-loop was surgically introduced into the H. 
pylori chromosome together with two point mutations inactivating the IsoA3 antitoxin promoter, as 
described in Chapter 4 sections 4.1 and 4.2. Total RNA was extracted and subjected to Northern Blot 
analysis. Strikingly, the active AapA3 mRNA species (aapA3-Tr) was missing in the G183A strain 
despite IsoA3 absence (compare lanes 5 and 6, Figure 4.3.3A). This result was unexpected and could 
be explained by two events: 1) the mutation was blocking the 3’ end maturation process, or 2) the 
mutation was prompting aapA3-Tr mRNA degradation by 3’-exonucleases.  
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Because we already identified the 3’-5’-exonuclease PNPase as one of the actors involved in 
the AapA3 mRNA maturation process and the G183A mutation was disrupting two hydrogen bonds in 
the 3’ stem-loop (predicted to reduce the stem-loop stability by 5.1 kcal/mol), we decided to test the 
second hypothesis first and asked whether the G183A suppressor was still able to avoid toxicity in 
absence of PNPase activity. To that aim, the G183A/pIsoA3* PCR construct was used to perform H. 
pylori transformation assay in wild-type or -pnp strains (Figure 4.3.3B). Because the G183A mutation 
was expected to be toxic in a – pnp background, a second mutated PCR construct carrying an 
additional mutation inactivating the AapA3 translation start codon (start G183A/pIsoA3*) was 
included in the study (Figure 4.3.3B). As shown in Figure 4.3.3C, H. pylori transformation with the 
G183A/pIsoA3* PCR construct was lethal in the PNPase deleted background (- pnp), obtaining ≈ 1.4 
log-fold fewer transformants than in wild type background (+ pnp). Additionally, this number was 
significantly higher (≈ 1.4 log fold) than that obtained in the no-DNA transformation control (H2O, 
Figure 4.3.3C), reflecting the (expected) emergence of suppressor strains. In line with these results, 
northern blot analysis revealed the recovery of the aapA3-Tr mRNA species in the start 
G183A/pIsoA3* mutant in –pnp background (lane 10, Figure 4.3.3A), explaining its toxicity in the 
transformation assay (Figure 4.3.3C). These results clearly pointed at a destabilization effect of the 
G183A mutation in the 3’ stem-loop of the aapA3-Tr mRNA species causing the full mRNA 
degradation mediated by 3’-exonucleases. Interestingly, the observation of the apaA3-Tr mRNA 
species in the start G183A/pIsoA3*/-pnp strain was possible thanks to the existence of the, previously 
noticed and unidentified, PNPase redundant activity. Thus, thanks to the study of the G183A 
suppressor, we were able to differentiate between both activities, as the PNPase redundant activity was 
proven to be more sensitive to mRNA secondary structure (not being able to degrade the aapA3-Tr 
mRNA despite the presence of the G183A destabilizer mutation, lane 10, Figure 4.3.3A). 
To get a more precise idea of the amplitude of the destabilizing effect that the G183A 
mutation has in the 3’ stem-loop, we performed UV-melting experiments using chemically 
synthesized wild-type or G183A 3’ RNA stem-loops as template. Interestingly, during RNA 
purification, we observed a strong migration delay on the wild-type RNA when compared to the G24A 
RNA, indicative of a lack of denaturation despite migrating on a denaturing PAA gel (Figure 8.2.4 in 
the Appendix). As shown in Figure 4.3.3D, a dramatic melting temperature (Tm) reduction (~10°C) 
was observed in the G183A stem-loop when compared to that of the wild-type, in line with the 5.1 
kcal/mol destabilization effect predicted using RNAfold Web Server (Gruber et al., 2008). 
Interestingly, a decrease in the G183A curve slope when compared to wild-type can be observed 
(Figure 4.3.3D), reflecting a loss of cooperativity in the helix, and explaining how a single point 
mutation can have such a strong impact in the stability of a 24 nt-long stem-loop structure. Together, 
these results demonstrate that the AapA3 mRNA possess a 3’ end terminal protective structure that 
impede the degradation by 3’-5’-exonucleases. 
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4.3.4B). Secondary structure and stability predictions suggested a 5.5 kcal/mol destabilization effect 
caused by the G24A mutation (shown in orange in Figure 4.3.4A). UV-melting experiments confirmed 
this prediction and demonstrated that similarly to the G183A mutation, the G24A mutation leads to a ~ 
10°C decreased in the melting temperature of the stem-loop (Figure 4.3.4E). By similarity to the 
previously studied G183A mutation, we hypothesized that the G24A mutation was able to counteract 
IsoA3 absence by promoting the degradation of the active aapA3-Tr species by, in this case, 5’-3’-
exonucleases.  
The major H. pylori 5’-3’-exonuclease is RNase J, however, unlike the PNPase, the rnj gene is 
essential for H. pylori. Thus, we decided to first test the role of the 5’ stem-loop stability in vivo by 
performing H. pylori transformation assays. To this aim, we generated a PCR construct carrying the 
G24A mutation together with the C4T mutation (cytosine at position 4 from the Aapa3 TSS mutated 
to thymine) and the antitoxin promoter inactivated (allowing toxicity assessment). The C4T mutation 
locates in the stem in front of the G24A mutation and is predicted to partially restore the stem-loop 
stability (see predicted kcal/mol values under the structures in Figure 4.3.4A). This restoration could 
only be partial as we are converting a GC pair (two hydrogen bonds) into an AT pair (one hydrogen 
bond). Because the C4T mutation was expected to be toxic if the G24A mutation was acting as a 5’ 
stem-loop destabilizer, a third PCR construct carrying an additional point mutation in the AapA3 
translation start codon (start) was introduced to the study. As shown in Figure 4.3.4C, when the C4T 
G24A PCR construct was used for transformation, a strong reduction (~ 1.5 log-fold) in the number of 
transformants obtained was observed when compared to when the PCR carrying the G24A suppressor 
mutation was used. Additionally, and as expected, this number was significantly higher (~ 1.5 log-
fold) than the one obtained when no DNA was used for transformation (H2O, Figure 4.3.4C), 
reflecting the apparition of suppressor strains. Further, Northern Blot analysis confirmed the recovery 
of the active AapA3 mRNA species in the C4T G24A start/pIsoA3* strain (Figure 4.3.4B), explaining 
the toxicity observed in the transformation assays when the PCR carrying the C4T G24A mutations 
was used. Together, these results demonstrate that the G24A suppressor destabilizes the 5’ stem-loop 
and promotes the degradation of the aapA3-Tr mRNA by 5’-exonucleases (i.e. RNase J). 
To investigate the role of the RNase J, H. pylori RNase J was expressed, purified in E. coli 
cells, and used to perform in vitro cleavage assays. Uniformly 32-P labeled 5’ monophosphate in vitro 
synthesized RNA corresponding to the aapA3-Tr 5’ stem-loop with wild-type or carrying the G24A 
mutation was used as substrate. As shown in Figure 4.3.4D, a strong increase in the accumulation of 
labeled mononucleotides (UMP, exonuclease activity product) over time was observed when the 
G24A mutated RNA was used as substrate. This reflects a facilitated RNase J activity due to the 
destabilization of the stem-loop and strongly points at RNase J as the responsible of the apaA3-Tr 
disappearance in the G24A suppressor strain.  
The here identified suppressor mutants in the 5’ stem-loop offered us a unique opportunity to 
study 5’ end-mediated mRNA decay in vivo. Although in bacteria lacking RNase E, as is the case of 
H. pylori, the existence of an RNA degradosome remains enigmatic, the presence of a ‘minimal RNA 
degradosome’ composed by RNase J and the helicase RhpA (HP0249) has been proposed in H. pylori 
(Redko et al., 2013). To test whether the observed 5’-exonucleolytic degradation of the G24A aapA3-
Tr mRNA was dependent on the helicase activity, we generated a rhpA deletion strain and used it as 
genetic background to introduce the G24A mutation. If RhpA was required for RNase J activity on the 
G24A aapA3-Tr mRNA, such suppressor is expected to be lethal in absence of RhpA activity. As 
shown in Figure 8.2.5A in the Appendix, the G24A suppressor was still viable in absence of RhpA 
and no changes in aapA3 expression or processing pattern were observed. A significant growth defect 
was observed in absence of RhpA, but this was independent on the presence of the G24A mutation 
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melting experiments were performed on chemically synthesized RNA consisting on the 5’stem loop (5’-SL, 
25 nucleotides).  
 
Another key factor of 5’ end-mediated mRNA decay is the 5’ phosphorylation state as 
observed for the IsoA3 sRNA here studied as well as in several previous studies (Mackie, 1998, 2000; 
Xu and Cohen, 1995). To determine whether the 5’-exonucleolytic degradation observed in the G24A 
aapA3-Tr mRNA was dependent in the 5’ phosphorylation state, we used the RppH deletion strain as 
genetic background to introduce the G24A suppressor as well as an independent suppressor also 
located in the 5’ stem-loop, the C4G mutation (cytosine at position 4 for the AapA3 TSS mutated to 
guanine). As shown in Figure 8.2.6A in the Appendix, the suppressors were not lethal in absence of 
RppH activity and no changes in the expression or processing profile were observed. These results 
demonstrate that, as shown in Figure 8.2.6B, the destabilizer effect of the 5’ stem-loop suppressors is 
so dramatic that 5’-exonucleases (i.e., RNase J) are able to cleave independently of the 5’ 
phosphorylation state. At the same time, and interestingly, the results highlight that in wild-type 
conditions, the stability of the 5’ stem-loop is so high that 5’-exonucleases (i.e., RNase J) are not able 
to act despite the presence of a 5’ monophosphate. Indeed, in vitro cleavage assays using 5’32-P 
aapA3-Tr RNA as substrate showed an almost complete absence of RNase J exonuclease activity, 
being only a few endonucleolytic cleavages in single-stranded regions visible (Figure 8.2.7 in the 
Appendix). 
 
4.3.2. Discussion 
Studying how toxin-encoding mRNAs are co- and post-transcriptionally regulated is key for the 
comprehensive understanding of type I toxin-antitoxin (TA) regulation as genetic systems. Here, we 
present the first insights into the characterization of the activation and decay pathways of the AapA3 
toxin-encoding mRNA, belonging to the aapA3/IsoA3 type I TA locus present in the H. pylori 
chromosome. To explore the molecular underpinnings of such pathways, we made use of traditional 
rifampicin treatment assays, chromosome engineering, 3’ RACE (Rapid Amplification of cDNA 
Ends), biophysics and computational predictions, and the newly developed high-throughput selection 
of suppressors, FASTBAC-Seq (Masachis et al., 2018).  
 
4.3.2.1. Behind the scenes of a 2D-structure-based 3’ end maturation of a toxin-encoding mRNA 
In previous work, we identified the aapA3/IsoA3 type I TA module (Sharma et al., 2010) and 
characterized its regulation at the chromosomal level (see Chapter 4 sections 4.1 and 4.2). Considering 
that the AapA3 mRNA encodes a constitutively expressed toxin with self-targeting activity, it is 
intuitive to think that it must be optimally regulated co- and post-transcriptionally by means that 
complement the blind-spots of the IsoA3 sRNA antitoxin activity (for a review see (Masachis and 
Darfeuille, 2018) in Chapter 1, section 1.4.1). We recently reported on the existence of a truncated 
AapA3 mRNA species that accumulates in the absence of IsoA3 or RNase III. Indeed, this species is 
the only translationally active one and the IsoA3 sRNA competes with the ribosome to bind to it. Once 
the IsoA3 RNA is bound to its target, the RNA heteroduplex is rapidly degraded by RNase III, 
explaining its accumulation in the absence of this two elements (see Chapter 4 section 4.2). At that 
point, we hypothesized, based on RNA-Seq data (Sharma et al., 2010) and by the fact that the IsoA3 
RNA targets the 5’ end of the toxin mRNA, that this truncated species is the product of a 3’ end 
processing. However, the molecular underpinnings of this process were unknown.  
Here, we demonstrate that the translationally inert AapA3 primary transcript undergoes a 3’ 
end exonucleolytic activation process (as previously observed for the AapA1 mRNA (Arnion et al., 
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2017, see appendix 8.3 in Chapter 8)) led by 3’-5’-exonuclease PNPase. The endonuclease RNase Y, 
as well as, one or more, unidentified redundant activity(ies) are also involved. An interaction between 
PNPase and RNase Y has been previously described in B. subtilis (Salvo et al., 2016), but further 
investigation will be required to decipher its role in H. pylori. A similar 3’ end processing has been 
described for the Hok mRNA, belonging to the hok/Sok type I TA system in E. coli (Thisted et al., 
1994). Remarkably, in the case of the Hok mRNA, the actors of its activation could be fully 
unmasked, being the PNPase and the RNase II. The fact that the AapA3 and the Hok mRNAs share 
such similar activation pathways despite having no sequence homology is striking. Indeed, as 
discussed in Masachis and Darfeuille (2018) (Chapter 1 section 1.4.1), a major hallmark of the 
regulation of type I TA systems is that toxin-encoding mRNAs possess their SD sequence occluded 
and must undergo a nucleolytic activation step to be translated. How this activation occurs is not 
random and strongly depends on the operon organization of the TA system. In systems where the 
antitoxin is encoded overlapping the 5’ end of the toxin mRNA (e.g., AapA1 (Arnion et al., 2017) and 
Hok (Thisted et al., 1994) mRNAs), SD occlusion is achieved by a long-distance interaction between 
the 5’ and 3’ mRNA ends, and activation occurs by 3’-trimming. On the opposite, in systems whose 
antitoxin is encoded in no-overlapping fashion, SD occlusion occurs within stem-loops and activation 
by 5’ processing. However, as in the case of 3’ processed mRNAs, despite several 5’ ends have been 
mapped for some mRNAs such as the TisB (Darfeuille et al., 2007), DinQ (Weel-Sneve et al., 2013), 
ShoB (Kawano et al., 2005) and ZorO (Wen et al., 2014), the activities responsible for this activation 
remain enigmatic.  
Defining mRNA termini is an essential step for the mechanistic understanding of any given 
mRNA. However, despite protocols for the identification of 5’ ends have been well set up for years 
(Argaman et al., 2001; Thomason et al., 2015; Urban and Vogel, 2007), defining 3’ mRNA ends in 
bacteria is challenging due to the lack of poly-U tails in most transcripts. Nevertheless, a recent study 
by Dar and colleagues., (2016) described a new genome-wide 3’ end mapping strategy based on an 
improved 3’RACE protocol. We used this protocol with slight modifications (see Methods section) to 
study in more detail the AapA3 mRNA 3’ end activation pathway. Remarkably, 3’RACE revealed that 
the three main AapA3 mRNA species, previously observed by Northern Blot analysis, are in fact 
heterogeneous populations of sequentially 3’ processed mRNA species, in line with the here proposed 
3’-exonucleolytic activation pathway. Furthermore, the different 3’ ends are not defined arbitrarily but 
by energetic roadblocks for 3’-exonuclease activity. This result, was of high informative value and 
revealed a major hallmark of the active AapA3 mRNA species that was later on exploited as a tool to 
study mRNA decay: it possesses highly stable 5’- and a 3’- termini stem-loop structures. 
 Indeed, it can be striking to see the PNPase enzyme involved in an activation pathway instead 
of leading to mRNA decay (as originally described for the RNA I, antisense inhibitor of ColEI-type 
plasmids (Xu and Cohen, 1995)). However, by studying the AapA3 mRNA, we understood that this is 
possible thanks to the formation of a highly stable 3’ stem-loop that acts as an energetic shield 
impeding the PNPase 3’-exonucleolytic activity at the right place, by limiting its degradation to the 
only »35 last nucleotides to get rid of the aSD sequence that occludes ribosome accessibility to the SD 
sequence. Thus, the in vivo 3’ end of the active AapA3 mRNA is derived from the 3’-5’-
exonucleolytic processing of the primary transcript back to the 3’ terminal protective hairpin. 
Importantly, these results demonstrated that although some highly stable 3’ end stem-loop structures 
are often automatically thought to act as Rho-independent terminators, in the case of the AapA3 
mRNA, this structure has both, protective and ‘activating’ functions instead.  
A similar case has been previously reported in E. coli. The tryptophan operon mRNA 
undergoes a 3’-exonucleolytic maturation mediated by PNPase and RNase II. This processing stops at 
a 3’ stabilizer hairpin structure that was previously assumed to act as an intrinsic terminator (Mott et 
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al., 1985). The observation of such similar maturation patterns in these two distant mRNAs is 
interesting, and invites to the carful study of 3’end stem-loop structures thought to act as Rho-
dependent terminators to search for hidden mRNA stability-related functions. 
 
4.3.2.2. Termini protective stem-loops ensure functional stability of the AapA3 mRNA 
3’RACE highlighted that the active AapA3 mRNA possesses two highly stable termini stem-loop 
structures. FASTBAC-Seq identified two sets of mutations symmetrically clustering at both termini 
structures. As shown in Table 8.2.1 in the Appendix, the 5’ stem-loop is highly stable, having a 
predicted Minimum Free Energy of -13.30 kcal/mol. From the four selected mutations in the 5’ stem-
loop, two of them, C4G (cytosine at position 4 from the AapA3 TSS mutated to guanine) and G24A 
(guanine at position 24 from the Aapa3 TSS mutated to adenine), were predicted to have a strong 
destabilization effect of 5.6 kcal/mol and 5.5 kcal/mol, respectively. The other two, G3C (guanine at 
position 3 from the AapA3 TSS mutated to cytosine) and C4T (cytosine at position 4 from the AapA3 
TSS mutated to thymine), were predicted to have a lower destabilization effect of 3 kcal/mol and 2.7 
kcal/mol, respectively. Interestingly, the amplitude of the predicted destabilization effect correlated 
with the padj value that each mutation had in the statistical analysis of the deep-sequencing datasets, 
suggesting that low destabilization effects may lead to more dynamic or less stable toxicity avoidance 
phenotypes (Table 8.2.1 in the Appendix). However, this correlation was not so clear with the selected 
mutations in the 3’ stem-loop, as the G183A here studied suppressor has the lowest padj value 
(2.24x10-40) but is not predicted to have the strongest stem-loop destabilization effect (Table 8.2.2 in 
the Appendix).  
We choose to study one mutation on each stem-loop, having a padj value above our cut-off 
(padj<0.05), to test whether this arbitrarily-selected statistical threshold was able to discriminate false-
positives. As shown in Table 8.2.1 and Table 8.2.2 in the Appendix, a good correlation between the 
padj values and viability (or not) of the strains was observed. Thus, our statistical analysis efficiently 
identified as false-positives the C4T mutation in the 5’ stem-loop (padj=0.64 and lethal, Table 8.2.1 in 
the Appendix) and the G176 mutation in the 3’ stem-loop (padj=0.2083 and lethal, Table 8.2.2 in the 
Appendix). However, the discriminative power of our statistical analysis is not infallible. Some 
mutations may display intermediate toxicity phenotypes, as is the case of the G3C mutation, which we 
were able to obtain but not in a reproducible nor stable manner. Thus, the G3C mutation appears in 
our statistical analysis as a ‘real’ suppressor mutation (padj=0.0039) despite not having a stable 
suppressor phenotype (Table 8.2.1 in the Appendix). This limitation may be linked to the way the 
suppressors are selected, as upon 3 only days growth, the genotypic stability of a suppressor strain 
linked to the different toxicity levels cannot be fully assessed. Nevertheless, we estimate the number 
of cases following the G3C situation to be strongly limited and therefore having a minimum 
deleterious impact in the FASTBAC-Seq analysis.  
Northern Blot analysis of the G24A in the 5’ stem-loop, and the G183A in the 3’ stem-loop 
revealed the absence of the aapA3-Tr mRNA species despite the lack of IsoA3. We further 
demonstrated that the G183A mutation is a PNPase-dependent suppressor, as in a deleted background 
for pnp the G183A mutation is lethal due to the presence of the active AapA3 mRNA species. 
Importantly, this observation could only be made thanks to the presence of the, so far unidentified, 
PNPase redundant activity, as otherwise the aapA3-Tr mRNA would not be generated. Moreover, the 
G183A mutation allowed us to discriminate between the PNPase and the redundant activity, as the 
latter one has proven to be more sensitive to RNA secondary structure. It is not surprising to observe 
this strong sensitivity to secondary RNA structure in 3’-exonucleases. Previous studies in E. coli have 
reported a strong inhibition of the 3’-5’-exonucleases RNase II and PNPase by secondary structure 
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(Spickler and Mackie, 2000). Nevertheless, some 3’-5’-exonucleases such as RNase R, possess an 
intrinsic helicase activity and can easily degrade highly structure RNA molecules (Hossain et al., 
2016).  
In a similar manner, we were able to demonstrate that the G24A mutation located in the 5’ 
stem-loop is a 5’-exonuclease-dependent suppressor. Many examples have previously reported mRNA 
stabilization mediated by the presence of a 5’ stem-loop structure (Bouvet and Belasco, 1992; Emory 
et al., 1992; Matsunaga et al., 1996). However, the viability of the G24A mutation in a rppH deleted 
background, demonstrate that the destabilization effect of the G24A mutation in the 5’ stem-loop is 
independent of the 5’ phosphate state. Indeed, 5’-exonucleases (i.e., RNase J) are able to degrade the 
mutated mRNA albeit the presence of a 5’ triphosphate. On the other hand, these results reflect that 
the stability of the wild-type 5’ stem-loop is so high that 5’-exonucleases cannot act despite the 
presence of a 5’ monophosphate. These results are surprising as RNase J it is known to be sensitive to 
the 5’ phosphate state, as shown in the case of the IsoA3 (see Chapter 4 section 4.4), as well as in 
several previous studies (Daou-Chabo and Condon, 2009; Even et al., 2005; Mackie, 1998, 2000; Xu 
and Cohen, 1995). Going further, these results reflect to which extend the toxin mRNA is has evolved 
to be strictly regulated (having to undergo a 3’ nucleolytic activation processing) but at the same time, 
remarkably highly stable, having an estimated half-life similar to the H. pylori doubling time. The 
biological relevance of this phenomenon is mysterious, however, we could hypothesize that 
synchronizing the half-life of a toxin-encoding mRNA with the doubling time opens the possibility to 
the vertical transmission of the mRNA, following an innovative variation of the previously described 
mechanism of Post-Segregational Killing (PSK) (Franch et al., 1997; Gerdes and Wagner, 2007; 
Gerdes et al., 1986; Greenfield et al., 2000, 2001; Nielsen et al., 1991; Weaver, 2012). Considering the 
short half-life of the antitoxin sRNA, it could represent a time-window on which the toxin mRNA can 
be expressed, which may be favorable in some specific situations (e.g., to increase phenotypic 
heterogeneity under stress conditions). 
 
 
Figure 4.3.5. Functional AapA3 mRNA stability is ensured by two termini protective stem-loop 
structures. In wild-type conditions, the aapA3-FL species is protected from degradation (and from IsoA3 
and ribosomes binding) via a 5’-3’ long-distance interaction. 3’ end processing by a, so far unidentified 
enzyme (?), generates an intermediate species (aapA3-i) that is further processed by PNPase together with a 
redundant activity to generate the active aapA3-Tr mRNA. This species has highly stable 5’- and 3’ stem-
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loops that act as structural shields against exonucleolytic degradation. A single point mutation on the 5’- or 
3’- stem-loop can lead to the full degradation of the active aapA3 mRNA, mainly mediated by the 5’-3’-
exonuclease RNase J or the 3’-5’-exonuclease PNPase, respectively. 
 
 
Figure 4.3.5 summarizes the knowledge on the role secondary RNA structure for the stability 
and activation of the AapA3 toxin-encoded mRNA that was revealed by the study of the 5’ and 3’ 
stem-loop suppressors. In the wild-type situation (WT), the translationally inert AapA3 primary 
transcript (aapA3-FL) undergoes a 3’ exonucleolytic activation process mediated by PNPase and one 
or more, so far, unidentified redundant activity(ies). The active AapA3 mRNA (aapA3-Tr) possess 
two highly stable termini step-loops that act as energetic shields against exonuclease activity (despite 
5’ monophosphate state) and ensure its functional stability. In the context of a 5’ stem-loop (5’ SL) 
destabilizer suppressor, 5’-exonucleases degrade the aapA3-i and/or -Tr mRNA species, independently 
of the 5’ phosphate state. Importantly, such mutations do not lead to aapA3-FL degradation, indicating 
that the co-transcriptional mRNA folding is fast enough as to reach the stable 5’-3’ long-distance 
interaction conformation before 5’-exonucleases can act. In a similar manner, 3’ stem-loop (3’SL) 
destabilizer mutations, trigger the degradation of the aapA3-i and/or -Tr mRNA species by 3’-
exonucleases, including the PNPase. 
 
4.3.3. Conclusion 
The existence of 5’ and 3’ protective RNA structures is increasingly recognized as a major 
determinant of mRNA decay in bacteria (e.g., being involved in the differential operon decay, Dar and 
Sorek, 2018) (Dar et al., 2016; Emory et al., 1992; (Mott et al., 1985). As described in the section 4.2 
of this Chapter (Paper III), the AapA3 mRNA must be kept untranslated, co- and post-
transcriptionally, to avoid cell death. Untranslated RNAs can rapidly become unstable. The results of 
this work showed that termini protective stem-loop structures need to be present at both ends of the 
AapA3 toxin-encoding mRNA to ensure its functional stability. In the absence of one of such 
protective hairpins, the translation efficiency at the population level is strongly reduced, leading to 
toxin production levels that lie below the lethality threshold. Hence, even though translation initiation 
is assumed to be the rate-limiting step of protein production in bacteria, our work shows that, in the 
case of the Aapa3 mRNA, mRNA stability is the limiting factor. Furthermore, this work highlighted 
the key role of such protective structures, not only in the AapA3 mRNA stability, but also for its 
proper 3’-exonucleolytic activation. Indeed, this work revealed that the 3’ stem-loop of the AapA3 
mRNA does not act as an intrinsic terminator, but instead, it determines the position until which the 
maturation process occurs and generate and active mRNA.  
As discussed in our recent review (see section 1.4.1 in Chapter 1, Masachis and Darfeuille, 
2018), understanding how the activation of type I toxin-encoding mRNAs occurs is key for 
comprehension of the regulation of these systems. However, even though the existence of such 
activation mechanism has been reported in a few cases, including the 3’ end activation of the Hok 
toxin mRNA (Franch et al., 1997), and the 5’ end activation of the TisB (Darfeuille et al., 2007), DinQ 
(Weel-Sneve et al., 2013), ShoB (Kawano et al., 2005) and ZorO (Wen et al., 2017) toxin mRNAs, in 
most cases the identity of the activities involved remain enigmatic. The future development of tools 
such as FASTBAC-Seq (Masachis et al., 2018), may help revisit the post-transcriptional regulatory 
mechanisms of previously-identified type I TA systems, and shed light into the molecular 
underpinnings behind the strict regulation of type I toxin-encoding mRNAs expression. 
CHAPTER 4. Results and discussion 
 80 
4.4. On the decay of a sRNA antitoxin  
 
 
In the previous section (Paper IV), the role of mRNA structure in the high stability of an untranslated 
toxin-encoding mRNA was studied. However, the expression output of a toxin belonging to a type I 
TA system, do not only depend on its self, but in the molecular ratio between the toxin mRNA and the 
RNA antitoxin counterpart. The levels of RNA antitoxins can be post-transcriptionally adjusted by 
RNA degradation. In our recent studies, we have shown that IsoA1 sRNA, as well as IsoA3 sRNA, are 
degraded by the RNase III when forming an RNA heteroduplex with their toxin-encoding mRNA 
counterparts (see section 4.3 Chapter 4, and Arnion et al., (2017), section 8.3 in Chapter 8). However, 
the functional pools of sRNA antitoxins are, firstly and strongly, dependent on the stability of the 
sRNAs themselves (i.e., in ‘free-state’). The activities involved in this process vary depending on the 
bacterial species. For instance, RNase E is involved in the functional inactivation of the Sok RNA in 
E. coli (Dam Mikkelsen and Gerdes, 1997), meanwhile RNase Y and PNPase control several sRNAs 
in B. subtilis (e.g., SR4 and RatA RNA antitoxins, Durand et al., 2012; Jahn and Brantl, 2013; 
Silvaggi et al., 2005).  
Interestingly, an RNA-sequencing study of a H. pylori RNase J depleted strain, recently 
suggested that between the several targets of RNase J, there was the IsoA3 sRNA antitoxin (Redko et 
al., 2016). Additionally, another recent global RNA-seq study, demonstrated that the IsoA3 sRNA is 
stabilized in a H. pylori strain deleted for the RppH (Bischler et al., 2017). The H. pylori RppH 
(HP1228, HpRppH) is an RNA pyrophosphohydrolase from the Nudix family of enzymes, that 
convers 5’ triphosphates and diphosphates to monophosphates, triggering 5’ end exonucleolytic RNA 
degradation. Because RNase J activity has been previously shown to be sensitive to the RNA 5’ end 
phosphorylation state (Mathy et al., 2007; Richards et al., 2011), the observations shown in the two-
above-mentioned studies were consistent, and motivated a deeper characterization of the molecular 
activities underlying the IsoA3 sRNA antitoxin decay mechanism. 
 
 
4.4.1. Results 
4.4.1.1. PNPase is involved in the maturation of the IsoA3 sRNA antitoxin 
During the study of the AapA3 mRNA activation pathway, Northern Blot analysis of rifampicin 
assays in a H. pylori PNPase deleted strain revealed a strong accumulation of a long IsoA3 transcript 
(IsoA3 precursor, IsoA3-p, ≈ 95 nt) (see Figure 4.3.1B in the section 4.3.1 of this Chapter). This result 
indicated that, as shown for other type I antitoxin sRNAs (Durand et al., 2012), the 3’-exonuclease 
PNPase is involved in the processing of IsoA3 in vivo. Additionally, relatively high levels of IsoA3-p 
can be observed even upon the apparition of the aapA3-Tr mRNA (higher levels than the mature 
IsoA3 RNA (≈ 80 nt)), indicating that IsoA3-p is totally or partially impaired to interact with the 
aapA3-Tr mRNA, and suggesting that PNPase processes 3’end of IsoA3-p to generate the mature 
IsoA3 sRNA form. Importantly, the observation of the mature IsoA3 RNA species despite the lack of 
PNPase activity reflects the existence of a redundant activity able to partially compensate its absence, 
and generate enough (although in lower levels than in wild-type conditions) mature IsoA3 RNA as to 
avoid AapA3 toxicity (as shown in Figure 4.3.1B in the section 4.3.1 of this Chapter). Whether this 
redundant activity is the same as the one acting on aapA3-i mRNA remains unknown, nevertheless, 
some clues came from the study of IsoA3 expression in E. coli cells. 
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When the H. pylori aapA3/IsoA3 module is expressed in E. coli cells (from its endogenous 
promoter), a strong accumulation of a long IsoA3 species is observed (IsoA3-p*, ≈ 125 nt, lanes 6, 7 
and 9, Figure 4.4.1). Strikingly, although a full-length AapA3 mRNA of a similar size to the one 
observed in H. pylori can be observed in E. coli cells, the mature IsoA3 sRNA (≈ 80 nt) is absent. This 
result strongly suggests that the E. coli PNPase activity is not able to maturate the IsoA3 sRNA. 
Furthermore, the full lack of mature IsoA3 sRNA indicates that E. coli may lack the PNPase 
redundant activity previously observed in H. pylori (or it may as well be inactive on this sRNA). In 
line with these results, the active aapA3-Tr mRNA is absent in E. coli, despite the inactivation of 
IsoA3 expression (compare the lanes 2-4 and 6- 8, Figure 4.4.1). Together, these results strongly point 
at the lack of a 3’-exonuclease activity able to process the AapA3 or IsoA3 RNAs in E. coli, 
highlighting the importance of the use of endogenous conditions when studying post-transcriptional 
gene expression regulation. Nevertheless, the non-viability of an E. coli strain harboring a wild type 
AapA3 peptide and lacking IsoA3 expression (data not-shown), demonstrated that despite not 
processing the AapA3 mRNA, toxin expression could be achieved from the aapA3-FL species. This 
phenomenon is probably due to the coupling of transcription and translation processes that may take 
place in the fast-growing E. coli but not in the slow grower H. pylori.  
 
Figure 4.4.1. E. coli PNPase activity on the AapA3 and IsoA3 RNAs is strongly impaired. 10 µg total 
RNA from the wild-type or the indicated aapA3/IsoA3 mutated versions H. pylori 26695 strains, and E. 
coli TOP10 strain harboring a pGEM-T vector carrying the different indicated aapA3/IsoA3 locus versions 
was subjected to Northern Blot. Membrane was successively probed for IsoA3 and 5S rRNA transcripts as 
described in. Transcripts are annotated as: aapA3-FFL (full-full-length, » 280 nt), aapA3-FL (full-length, » 
225 nt), aapA3-Tr (truncated, » 190 nt), IsoA3-p* (E. coli, ≈ 125 nt) and IsoA3 (H. pylori, ≈ 80 nt). Start, 
AapA3 translation start codon mutated (ATGàATT by the single point mutation G54T, from AapA3 
TSS). pIsoA3*, IsoA3 -10 box inactivated (5’ TATAAT 3’à5’ TACAAG 3’, by the point mutations A87C 
A90G, from AapA3 TSS). DpA3, AapA3 -10 box inactivated (5’ TAGGAT 3’à 5’ TAGGAC 3’, by the 
single point mutation T-7C, from AapA3 TSS). 
Although these results demonstrate that PNPase plays a major role in the maturation of the 
IsoA3 sRNA, rifampicin assays in a H. pylori 26695 RNase Y and RNase Y/PNPase deletion strains 
revealed decreased levels of both, the IsoA3-p and the IsoA3 RNAs (Figure 8.2.1 in the Appendix). 
This result is sticking and suggest that RNase Y is involved in the generation not only of IsoA3 (≈ 80 
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nt), but also of the IsoA3-p (≈ 95 nt). Nevertheless, and similarly to what was observed for the AapA3 
mRNA maturation, the presence of the mature IsoA3 species despite the lack of RNase Y and PNPase 
activity reflects the existence of, so far enigmatic, additional actors on its maturation pathway. 
 
4.4.1.2. RNase J is involved in the IsoA3 sRNA decay and senses its 5’ phosphate in vivo  
To investigate the actors of IsoA3 decay, we studied the role of the major H. pylori 5’-3’-exonuclease 
and endonuclease RNase J, recently suggested to be involved in IsoA3 degradation by RNA-seq 
studies (Redko et al., 2016). Because the rnj (HP1430) is an essential gene for H. pylori, the H. pylori 
RNase J protein was expressed and purified in Rossetta2 E. coli cells. On a first test, 5’ end 32-P 
labeled IsoA3 RNA was used as substrate to differentiate and map the potential exo- and endonuclease 
activities of RNase J. As shown in Figure 4.4.2A, three major endonucleolytic cleavages appear within 
the first 10 seconds of incubation and their intensity increase over time. After 300 seconds (s), two 
more cleavage products become visible. Interestingly, if we map the cleavages in the IsoA3 RNA 
secondary structure prediction, we observe that they are in single-stranded regions, and mainly, in the 
so-called IsoA3 linker (LK, Figure 4.4.2A). The LK region, stands between the two IsoA3 stem-loop 
structures (annotated as L1 and L2 in Figure 4.4.2A), and may be involved in the locus-specific 
AapA3 mRNA recognition. From the cleavages that lay outside the LK region, on is located in the L1, 
and the second one, which appears only upon 300 s of incubation, correspond to released labeled 
mononucleotides product of exonuclease activity (indicated by a red arrow next to the gel; from this 
gel, it could have also been an endonucleolytic cleavage close to the nucleotide at position 10, but the 
experiment in Figure 4.4.2B further evidence that they are labeled mononucleotides product of 
exonucleolytic activity).  
Numerous studies point to the importance of the 5’ end in the regulation of mRNA decay in 
bacteria (Mackie, 1998, 2000; Xu and Cohen, 1995). We next investigated whether the observed 
IsoA3 processing events were dependent on the 5’ phosphorylation state (as recently proposed by 
RNA-seq studies (Bischler et al., 2017)). To that aim, uniformly 32-P-labeled triphosphorylated and 
monophosphorylated IsoA3 RNAs were used as substrates. As shown in Figure 4.4.2B, RNase J 
activity was strongly reduced in the presence of a 5’ triphosphate end (red arrow next to the gel 
indicates labeled mononucleotide product of 5’ exonucleolytic activity). This result demonstrates that 
similarly to other mRNA targets (e.g,. mRNAs from the T-box family, Even et al., (2005)), RNase J 
activity on IsoA3 sRNA is sensitive to the 5’ phosphorylation state.  
We next sought to investigate the effect of the IsoA3 sRNA 5’ end state in vivo. To that aim, 
we generated a H. pylori 26695 deletion strain for the pyrophosphohydrolase gene rppH (HP1228) and 
studied IsoA3 expression by Northern Blot. As shown in Figure 4.4.2D, there is a mild stabilization 
effect of IsoA3 in the absence of RppH (- rppH), as previously reported by Bischler et al., (2017). 
However, a shorter IsoA3 RNA species accumulates in - rppH background (IsoA3-s, ≈ 50 nt, Figure 
4.4.2C). Strikingly, the size of this species corresponds to the most abundantly observed 
endonucleolytic cleavage products (cleavage in the LK region). This result allowed us to identify in 
vivo an endonucleolytic cleavage in the IsoA3 LK sequence, and demonstrate that RNase J senses the 
5’ phosphorylation state as part of the decay pathway of the IsoA3 sRNA.  
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assessed by the level of 5S rRNA using the labeled oligo probe FD35.Transcripts are annotated as: aapA3-
FFL (full-full-length, » 280 nt), aapA3-FL (full-length, » 225 nt), IsoA3 (» 80 nt) and IsoA3-p (» 50 nt).  
(D) A mild IsoA3 stabilization observed in absence of RppH activity reveals the presence of a short species 
(IsoA3-s, » 50 nt). Lower exposition image of the membrane shown in (C). 
 
4.4.2. Discussion 
We have previously demonstrated that IsoA3 is an essential sRNA for H. pylori (see Chapter 4 section 
4.2). Considering this, it is expected that the post-transcriptional regulation of this sRNA is tightly 
controlled. Indeed, the levels of sRNA antitoxins are often post-transcriptionally controlled by RNA 
decay, as shown for the Sok sRNA, controlled by the 5’ end state sensitive RNase E in E. coli (Gerdes, 
2016), as well as for the RatA sRNA controlled by RNase Y and RNase J1 in B. subtilis (Durand et 
al., 2012). Interestingly, a stabilization effect of the IsoA3 sRNA in a H. pylori deletion strain for the 
phyrophosphohydrolase rpph gene was previously observed (Bischler et al., 2017), indicating the 
existence of a 5’-exonuclease-mediated RNA decay pathway. Here, we were able to show that the 
IsoA3 sRNA decay is mediated by the 5’-3’ exonuclease and endonuclease activity of RNase J in a 5’ 
phosphate state-sensitive manner. These results highlight the importance of the 5’ end state in mRNA 
decay, as previously shown, for instance, in E.coli for RNase E activity (Mackie, 1998) and in B. 
subtilis for RNase J1/J2 activity on mRNAs from the T-box family (Even et al., 2005).  
 Interestingly, we observed that RNase J endonucleolytic activity on IsoA3 RNA was stronger 
than the 5’-3’-exonucleolytic activity, even when the 5’ end was monophosphate. More specifically, it 
was mainly directed to a single-stranded region named IsoA3 linker region (LK) (as previously 
described for the IsoA1 sRNA, Arnion et al., (2017)). These results reflect a strong sensitivity of the 
RNase J to secondary RNA structure, line with previous studies (Even et al., 2005; Mackie, 1998), and 
support the possible exploitation of RNase J for RNA structure in vitro studies, as the one performed 
by Daou-Chabo and Condon (2009). 
Strikingly, the IsoA3 LK region is involved in the binding to the AapA3 mRNA and may also 
be important for the locus-specificity interaction between the different IsoA sRNAs and their toxin 
mRNA counterparts in the aapA/IsoA family of type I TA systems in H. pylori. Thus, we propose that 
RNase J endonucleolytic cleavage of IsoA3 leads to its direct functional inactivation. This kind of 
antitoxin inactivation mechanism has previously been reported for the Sok sRNA, mediated in this 
case, by the RNase E in E. coli (Dam Mikkelsen and Gerdes, 1997). The similarities of these 
mechanisms are intriguing, and, considering the pattern building tendency of nature, it may reflect the 
existence of such regulatory events in many other type I TA systems. 
Most Gram-negative bacteria possess a so-called RNA degradosome, a multiprotein complex 
involved in mRNA degradation. This complex is principally composed by the 3’-5’-exonuclease 
PNPase, the RNA helicase RhlB, and an enolase, all assembled on RNase E ((Miczak et al., 1996; Py 
et al., 1996), for a review see (Carpousis, 2007)). However, the existence of an RNA degradosome in 
bacteria species lacking RNase E (e.g., H. pylori) remains an open question. A recent study pointed at 
the existence of a minimal RNA degradosome in H. pylori composed by RNase J and the helicase 
RhpA (Redko et al., 2013). However, we did not observe any effect on AapA3 or IsoA3 RNA decay 
in a RhpA deletion strain (Figure 8.2.5 in the Appendix), indicating that the AapA3 mRNA 3’-
exonucleolytic activation pathway, as well as the IsoA3 sRNA 5’-exonucleolytic decay, do not require 
helicase activity. 
Interestingly, we show that PNPase takes part in the IsoA3 sRNA antitoxin maturation 
pathway, in a similar manner as previously shown for the AapA3 mRNA 3’ end exonucleolytic 
activation. The adoption of this kind of parallel strategies is intriguing, and may represent a 
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biologically relevant mechanism helping to balance the pools of functional toxin mRNA and antitoxin 
sRNA in the cell. Furthermore, the observation of a PNPase-mediated IsoA3 maturation is interesting, 
as PNPase has been previously associated to the degradation of sRNAs that do not interact with Hfq, 
and which decay occurs in a target- and RNase III- independent manner (e.g., MicA, GlmY, RyhB and 
SgrS, Andrade et al., 2012), and this is the case for the IsoA3 sRNA, which aapA3-Tr-dependent 
RNase III-mediated degradation has little impact on its global levels (see Chapter 4 section 4.2). 
Nevertheless, other studies have reported a protective effect of PNPase on a Hfq-dependent manner 
against other RNases such as RNase E (De Lay and Gottesman, 2011), or even further, pointed to a 
reprogrammable PNPase activity, having a protective role when forming a ternary complex together 
with the RNA chaperone Hfq and degradative in absence of Hfq (Bandyra et al., 2016). Thus, it is 
possible that part of the reduction on the mature IsoA3 RNA levels in the absence of PNPase comes 
from the de-protection from other RNases, notably RNase J, which we know is involved in IsoA3 
turn-over (see the next discussion section). Nevertheless, although the latter hypothesis cannot be 
discarded, the observation of the accumulation of a longer IsoA3 form (IsoA3-p) in absence of 
PNPase, clearly demonstrates that the major reason for the reduced levels of mature IsoA3 RNA in 
absence of PNPase is that PNPase is involved on its maturation. And even further, H. pylori lacking 
Hfq, as well as any other characterized RNA chaperone, it remains an open question whether a 
protective activity of PNPase could be observed independently of any ternary partner. 
Figure 4.4.3 summarizes the here obtained information about IsoA3 sRNA decay. Through the 
study of the deletion strain for the pnp gene, we uncovered the accumulation of a long IsoA3 species 
(IsoA3-p), which demonstrated that PNPase is involved in the 3’ end maturation of the IsoA3 sRNA 
(Figure 4.4.3A). Secondary structure analysis of the IsoA3 RNA reflected the existence of a highly 
stable stem-loop on its 3’ end. The fact that the PNPase stops degrading at that position indicates that 
the 3’ stem-loop is a roadblock, acting as an energetic shield for the 3’-exonuclease activity of PNPase 
(Figure 4.4.3B). Additionally, in vitro RNase J cleavage assays revealed that the linker region (LK), 
located between the 5’ and the 3’ termini stem-loops of the IsoA3 sRNA, represents the major target 
for the RNase J endonucleolytic activity (Figure 4.4.3B). Furthermore, Northern Blot analysis of a 
rpph deletion strain revealed the accumulation of a ~50 nt-long IsoA3 cleavage product, 
corresponding to the major IsoA3 RNase J endonucleolytic product (cleaved in the LK). This result 
allowed us to demonstrate that RNase J senses the 5’ phosphorylation state as part of the regulation of 
the IsoA3 decay pathway (Figure 4.4.3C). 
Nevertheless, although the two stem-loop structures present in the IsoA3 sRNA may be 
reminiscent to the 5’ and 3’ protective stem-loops observed in the AapA3 mRNA, it is important to 
note that the IsoA3 sRNA half-life is about 15 minutes, while that of the AapA3 mRNA is around 10 
times longer. This difference may be the result of several factors. However, taking a closer look to the 
stability of the termini stem-loops in both RNAs, while the 3’ end stem-loops on both RNAs have 
similar stabilities (-13.80 kcal/mol and -13.70 kcal/mol, 3’ stem-loop in the IsoA3 and Aapa3 RNAs, 
respectively), the 5’ stem-loop in the IsoA3 sRNA is more unstable (44 nt, -10.80 kcal/mol) than that 
of the active Aapa3 mRNA (25 nt, -13.30 kcal/mol). Hence, it is tempting to think that this difference 
in the stability of the 5’ end stem-loop may be behind the stronger RNase J activity in the IsoA3 
sRNA. Nevertheless, the results of this work also indicate that IsoA3 decay is strongly determined by 
the RNase J endonucleolytic activity. Indeed, the observation of the IsoA3-p in the H. pylori -pnp 
strain and the IsoA3-p* in E. coli (having an inactive PNPase against IsoA3 substrate), demonstrates 
that these long IsoA3 species are highly protected against RNase J endonuclease activity thanks to the 
occlusion of the LK region within the double-stranded region of the stem-loop (see LK in Figure 
4.4.3A). 
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loop structures protect IsoA3 RNA from RNase J 5’-3’ exonucleolytic activity, the LK sequence is the 
major target of RNase J endonucleolytic activity on IsoA3 RNA and key on its decay pathway. 
Importantly, the LK sequence in the IsoA3-p species is protected within the structure (see A). (C) In the 
absence of RppH activity, a short IsoA3 form (IsoA3-s, » 50 nt) is observed. Its size corresponds to the 
RNase J most abundant endonucleolytic product, demonstrating that RNaseJ 5’-exonuclease activity on 
IsoA3 substrate requires a monophosphorylated 5’ end. RNAfold (Gruber et al., 2008) was used for 
secondary structure prediction and VARNA RNA (Darty et al., 2009) for drawing. 
 
Additionally, as in the case of the AapA3 mRNA, the 3’ end stem-loop structure does not act 
as a Rho-independent (i.e., intrinsic) transcription terminator in the IsoA3 sRNA. However, a closer 
look at the 3’ end sequence of the IsoA3-p sRNA revealed a potential Rho-binding site (C-rich 
sequence highlighted in orange, Figure 4.4.4), which is phylogenetically highly conserved between H. 
pylori strains (data not-shown). Rho is a homohexameric protein with RNA-dependent ATPase and 
helicase activities (Dombroski and Platt, 1988). Rho binds to poorly-structures C-rich sequences on 
ribosome-free RNAs, occupying a region of 70-80 nt (Richardson and Richardson, 1996; Zhu and von 
Hippel, 1998). Further experiments will be required to confirm or discard the role of Rho in IsoA3 
transcription termination, and to understand the possible mechanistic consequences of it in the 
regulation of the aapa3/IsoA3 system. Interestingly, Rho has been proposed to be essential in H. 
pylori (Castillo et al., 2007). This phenomenon will make the experimental validation challenging, but, 
at the same time, it opens the exciting question of whether its essentiality could be linked to the proper 
transcription termination of the essential sRNA antitoxin IsoA3, or of any other of the highly 
conserved IsoA sRNAs in H. pylori. 
 
 
Figure 4.4.4. Putative single-stranded Rho-binding sites on the IsoA3-p sRNA. RNAfold (Gruber et al., 
2008) was used for secondary structure prediction and VARNA RNA (Darty et al., 2009) for drawing. 
Putative Rho-binding sites (C-rich sequences) are highlighted in orange. 
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CHAPTER 5. Conclusion and outlook 
 
5.1. Conclusion  
The work presented in this thesis provided unpredictable insights into the regulation of the aapA/IsoA 
family of chromosomally-encoded type I TA systems in H. pylori. We developed a new approach, 
called FASTBAC-Seq, that uses lethality as selection pressure to identify loss-of-function mutations 
(toxicity) in toxin-encoding genes belonging to type I TA systems. Furthermore, as lethality is 
achieved by antitoxin promoter inactivation, FASTBAC-Seq allows the identification of gene 
expression determinants of the toxin gene component that are beyond their ‘primary regulator’, the 
RNA antitoxin. The coupling of such genetic selection of suppressors to Next-Generation Sequencing 
provides a high-throughput dimension to the approach, and allows the identification with nucleotide 
resolution of a great number suppressors, mainly limited by the homologous recombination rate of the 
bacterium. Thanks to the high selection pressure that lethality imposes, the use of mutagenesis 
techniques is not necessary for the highly-recombinant bacterium H. pylori. Indeed, this work 
demonstrated that the error rate of the DNA polymerase used to generate the PCR products for 
transformation provides sufficient mutations as to obtain a good coverage of the TA locus if 
recombination is not a limiting factor.  
The use of FASTBAC-Seq to characterize the aapA3/IsoA3 system revealed a myriad of cis-
encoded gene expression determinants in the AapA3 toxin-encoding mRNA. This study highlighted 
that type I RNA antitoxins do not act alone to regulate toxin expression. Instead, they act in 
coordination with a battery of regulatory elements embedded in the toxin-encoding mRNA. This 
observation makes sense, as contrary to the other antitoxin types (with the exception of type III), type I 
antitoxins can only act at the post-transcriptional level. There are several blind-spots for type I 
antitoxin action (e.g., co-transcriptional translation and degradation, mRNA decay and diffusion rates 
determining mRNA translation) that are covered by cis-acting regulatory elements embedded in the 
toxin-encoding mRNA (e.g., co-transcriptional folding, 5’ and 3’ end stabilizer structures and inert 
folding of primary transcript). The study of suppressor mutations in the AapA3 toxin-encoding mRNA 
showed that mRNA folding plays a central role in the regulation of the Aapa3 toxin expression. 
Indeed, mRNA folding rules both, AapA3 translation and mRNA decay, two major determinants of 
gene expression in bacteria.  
This thesis has highlighted the role of co-transcriptional folding to avoid both, co-transcriptional 
mRNA translation and degradation, in the context of absence of compartmentalization found in 
bacteria. AapA3 co-transcriptional translation is impeded by the formation of so-called metastable 
structures, which are transient SD-occluding hairpins that are essential to avoid premature toxin 
translation, and probably also premature antitoxin binding.  
Moreover, the results of this work demonstrated that a functional mRNA stability is the major 
gene expression determinant of the AapA3 mRNA, as suppressors destabilizing the mRNA impede the 
achievement of enough AapA3 translation efficiency as to reach the threshold of toxicity. The active 
Aapa3 mRNA possesses two highly stable termini stem-loop structures that act as energetic-shields 
against exonuclease activity and ensures its functional stability. The study of the destabilizing 
mutations located in such protective stem-loops shed light on the actors of mRNA decay in H. pylori, 
and how RNA secondary structure affects their activities. We demonstrated that the AapA3 
translational activation is achieved by 3’-5’-exonucleases. Indeed, the 3’ protective stem-loop, 
previously thought to act as an intrinsic terminator, is instead essential for the 3’ end maturation of the 
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AapA3 mRNA. This work has demonstrated that the AapA3 mRNA is transcribed passed the 3’ stem-
loop, and it is then processively degraded from its 3’ end back to the 3’ stem-loop roadblock. We 
show that the 3’-5’-exonuclease PNPase is the major actor in the AapA3 activation pathway. 
However, the mRNA activation can also be achieved by one or more, so far unidentified, PNPase 
redundant activity(ies) (see section 5.2.3 of this Chapter for further discussion).  
Importantly, spotting RNA folding in the focus of how this TA system is regulated, allowed 
the identification of similar regulatory mechanisms in other previously studied systems, reflecting the 
evolution of somehow similar strategies to overcome the high selection pressure of toxicity. Such 
mechanisms, although strongly dependent in the TA operon organization, follow clear patterns, that 
may help the future characterization of de novo-identified type I TA systems (see Masachis and 
Darfeuille (2018) in the section 1.4.1 of Chapter 1). TA systems appear to move horizontally and 
vertically. Type I TAs are believed to be inherited vertically by gene duplication in specific lineages, 
while type II and III are thought to move by horizontal gene transfer (HGT) (Fozo et al., 2010). A 
recent study showed that type I TAs seem to be represented in a narrower phylogenetic range than 
type II (i.e., all toxins being represented in only one phylum, expect SymE, which is in four) (Coray 
and Wheeler, 2017). The fact that the only type I TA having a larger representation is the only one 
using an antitoxin that is a not a sRNA (the DNase RalA was not included in the study), is very 
informative and reflects the difficulty to computationally identify sRNAs, and by extension, type I 
TAs (see review (Coray and Wheeler, 2017)). Similarly, although both, type II and III are thought to 
be prone to HGT, type III present a much narrower distribution (i.e., mainly found in Firmicutes and 
Fusobacteria) (Coray and Wheeler, 2017). This is probably not a coincidence since, as type I, type III 
TAs use RNA antitoxins. The results of this thesis may provide hints for the future optimization of 
computational prediction tools for type I TAs in bacterial genomes, by incorporating RNA folding 
constraitns (e.g., SD sequestration, double-stranded ends, etc.) in addition to the already used protein 
folding and conservation. Indeed, our group has recently developed a new type I TA database 
(T1tadb), using RNA structure based predictions that revealed the existence of an unanticipated 
massive number of type I TAs in several bacteria species, including H. pylori (visit our database in 
https://d-lab.arna.cnrs.fr/t1tadb).  
Furthermore, this study has shown that a single point mutation in the AapA3 toxin-encoding 
gene is able to abolish toxicity. However, phylogenetic studies demonstrate that it happens very rarely, 
and when it does, the whole TA locus appears degenerated (data not-shown). These results, highlight 
the importance of the co-evolution of genes composing TA systems. Indeed, it seems intuitive to think 
that the existence (and conservation) of toxin genes rely on that of their antitoxin counterparts, as its 
loss would lead to cell death. However, it is just as important (though less intuitive) to understand that 
the conservation of antitoxin genes strongly depends on that of their toxin counterparts, as the loss of 
the toxin gene would immediately result in the loss of the selection pressure to maintain the antitoxin 
functionality. Thus, both genes are under an ‘interdependent-existence’ selection pressure.  
Several studies have explored the use of TA systems as alternative antimicrobial strategies 
(due to their self-killing activity and their wide distribution in bacterial genomes) (Williams and 
Hergenrother, 2012). However, most of them target the toxin-antitoxin interaction or the antitoxin 
levels to induce the toxin production. The here identified cis-acting mRNA structural regulatory 
elements may represent new targets for the future development of alternative antimicrobial strategies. 
For instance, identifying small molecules able to impede the formation of the metastable SD-sequester 
structures in the toxin-encoding mRNA, would lead to premature toxin synthesis and cell death, in an 
antitoxin independent manner. Additionally, some of the traits of the toxin-encoding mRNA could be 
exploited with biotechnological purposes. For instance, the highly stable termini stem-loop structures 
could be used as portable mRNA stabilizing elements to enhance protein production, as recently 
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proposed upon the screening of a library of 5’UTRs based on the OmpA mRNA (Viegas et al., 2018) 
and six randomized 5’UTR libraries aiming at gene product synthesis optimization (Kang et al., 2018). 
5.2. Open questions  
5.2.1. Transcriptional regulation of the IsoA3 sRNA? 
The results presented in Chapter 4 section 4.2 (Paper III), demonstrated that the endogenous AapA3 
toxin expression is constitutive and lethal in H. pylori. Thus, the IsoA3 RNA antitoxin is expected to 
constitutively repress its translation under normal conditions. However, a recent genome-wide 
characterization of DNA-binding sites of the essential orphan response regulator HP1043 (Pelliciari et 
al., 2017), revealed a binding motif in the IsoA3 promoter region (Figure 5.1A).  
The HP1043 regulator belongs to the OmpR family and has a highly degenerated receiver 
sequence that cannot be phosphorylated. To date, only three HP1043 genomic binding sites have been 
characterized, 1) its own promoter, 2) the promoter region of the tlpB chemotaxis protein-encoding 
gene, and 3) the promoter region of the CncR1 sRNA, encoded within the Cag-PAI (Delany et al., 
2002; Vannini et al., 2016). The characterization of the role of HP1043 is challenging as the gene has 
been proven to be essential (Delany et al., 2002). However, some studies relate it to cell cycle 
regulation (Delany et al., 2002) and homeostatic (Bauer et al., 2013) or oxidative stress control 
(Olekhnovich et al., 2014). To investigate whether HP1043 was playing a role in the transcriptional 
regulation of IsoA3, we generated mutant strains on which one or both of the HP1043 binding motifs 
were mutated (playing with the genetic code to conserve the AapA3 ORF) (B1 and B2, Figure 5.1A). 
If HP1043 was a transcriptional activator of IsoA3, the mutation of the HP1043 binding sites on IsoA3 
promoter region was expected to be lethal, as IsoA3 RNA would no-longer be produced to counteract 
AapA3 toxicity.  
As shown in Figure 5.1B, the mutation of neither one or both HP1043 binding motifs on 
IsoA3 promoter region was lethal unless the -10 box was also inactivated (pIsoA3*, as described in 
Chapter 4 section 4.1 and 4.2), and no suppressor mutations in the TA locus were observed in any of 
the several sequenced strains. This result indicated that HP1043 is not a transcriptional activator of 
IsoA3 expression, however, Northern Blot analysis revealed something puzzling. As shown in Figure 
5.1C, IsoA3 RNA is absent in the strain mutated for both HP1043 binding motifs on IsoA3 promoter 
region (single mutants were not analyzed). Furthermore, the strain presents an OD-dependent 
accumulation of the translationally active aapA3-Tr mRNA species which, we know, is only present in 
absence of IsoA3 (as shown in Chapter 4 section 4.2), strongly suggesting that HP1043 is a 
transcriptional activator of the IsoA3 sRNA. However, this result was unexpected, and the reason 
behind the viability of the strain despite accumulating a translationally active toxin-encoding mRNA 
remains a mystery. One possibility could be the apparition of spontaneous suppressor mutations 
somewhere else in the genome, a future genome-wide sequencing of several of these HP1043 B1B2* 
isolated strains will provide some answers. Another option could be that the HP1043 also acts as a 
transcriptional activator of one of the components on the AapA3 toxicity pathway. A future RNA-seq 
or proteomic comparative analysis could provide an answer, potentially shedding light into the 
molecular underpinnings of AapA3 toxicity. 
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indicated. The different transcripts are annotated as: IsoA3 (~80 nt), IsoA3-s (~50 nt), and 5S rRNA as 
loading control (5S rRNA). 
 
The fact that a sRNA has multiple targets is not surprising. Indeed, several recent studies have 
placed sRNAs as central regulators of diverse physiological and adaptive responses (e.g., bacterial 
communication, carbon metabolism or even phage-defense (Altuvia et al., 2018; Papenfort and Vogel, 
2014; Svenningsen, 2018)). However, to date, it has never been reported in the case of type I 
antitoxins. Although an in vivo approach for the identification of IsoA3 sRNA targets (e.g., RIL-Seq 
(Melamed et al., 2016), GRIL-Seq (Han et al., 2016), Ribo-Seq (Wang et al., 2015), MAPS (Lalaouna 
and Massé, 2015)) will have to be performed in the future, an in silico approach (TargetRNA2 
software) predicted some potentially new IsoA3 targets. For instance, it is predicted to bind to the start 
codon region of a type I restriction enzyme M protein (hsdM) mRNA as well as to that of the glycyl-
tRNA ligase subunit alpha (glyQ) mRNA. Other targets are components of the central metabolism and 
ammonia assimilation pathways, such as the acetyl-CoA synthetase (acsA, HP1045) and the aspartate 
ammonia-lyase (aspA, HP0649), predicted to be targeted by IsoA3 at the Shine-Dalgarno (SD) region 
(Figure 5.3, see Figure 5.5 for location of interaction region in IsoA3 sRNA). The identification of the 
two latter targets is intriguing. A reduced acetyl-CoA activity would lead to reduced levels of fumarate 
coming from the TCA (tricarboxylic acid) cycle. At the same time, reduced AspA activity would also 
result in reduced levels of fumarate coming from the ammonia assimilation pathways. Fumarate is an 
endogenous substrate for accepting electrons from NADH in the H. pylori anaerobic fumarate- 
respiration pathway and it is been proposed to reduce H2O2 production from NADH (Chen et al., 
1999). H. pylori possess a functional NADH-fumarate reductase (FRD), which has been shown to be 
essential for colonization of the mouse stomach (Ge et al., 2000) and proposed as a therapeutic target 
to treat H. pylori infections (Ge, 2002). In this context, if confirmed, IsoA3 interaction with the acetyl-
CoA and AspA mRNAs would result in increased oxidative stress, reduced activity of the respiratory 
chain and reduced colonization potential.  
 
 
Figure 5.3. IsoA3 in silico predicted interaction with the aspA and acsA mRNAs. (A) Predicted 
interaction between the IsoA3 and the aspA and acsA mRNAs is shown. TargetRNA2 tool was used for 
prediction. AspA and AcsA Shine-Dalgarno (SD) region is underlined. Positions in the mRNAs are relative 
to the translation start codon. 
 
Another IsoA3 predicted target is the HP0893 gene. As shown in Figure 5.4A, the translation 
initiation region (TIR) of the HP0893 mRNA was predicted to be a binding site for the IsoA3 RNA 
(see Figure 5.5 for a location of the interaction region in the IsoA3 sRNA). The HP0893 gene belongs 
to a type II TA system of H. pylori. To date, only four type II TA systems have been characterized in 
the H. pylori 26695 strain: HP0315 (VapD-homologue)-HP0316 (Kwon et al., 2012), HP0894 (YafQ-
homologue)-HP0895 (Pathak et al., 2013), HP0967-HP0968 (Cárdenas-Mondragón et al., 2016) and 
HP0892-HP0893 (Han et al., 2013; Im et al., 2014). All of them belong to the Vap (virulence-
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associated protein) family, which is widely found in Bacteria and Archaea (Makarova et al., 2006). 
Interestingly, the HP0892-HP0893 TA module is found in close proximity (50 nucleotides 
downstream) to the HP0894-HP0895 module (Figure 5.4B), and the antitoxin transcription of both TA 
modules (HP0893 and HP0895) was shown to be induced upon interaction with the human gastric 
mucosa during infection (Graham et al., 2002; Han et al., 2011). Furthermore, the HP0892-HP0893 
module is considered a marker of virulent strains, as its absence is associated with cag-PAI-negative 
strains (Terry et al., 2005).  
 
 
Figure 5.4. IsoA3 in silico predicted interaction with the HP0893 mRNA. (A) Predicted interaction 
between the IsoA3 and the HP0893 mRNA is shown. TargetRNA2 tool was used for prediction. HP0893 
translation start codon is underlined. Positions in the HP0893 are relative to the translation start codon. (B) 
Schematic representation of the chromosomal organization of the HP0892-HP0893 and HP0894-HP0895 
type II TYA loci of the H. pylori 26695 strain. IsoA3 predicted binding region in the HP0893 mRNA is 
indicated by a blue dotted line. The antitoxin promoter of both TA modules have been described to be 
activated upon interaction with the human gastric mucosa (Graham et al., 2002; Han et al., 2011). 
 
The binding of IsoA3 to the TIR region of the HP0893 antitoxin gene would result in 
translation inhibition. Considering the constitutive IsoA3 expression, this would imply a constitutive 
repression of the HP0893 antitoxin. Although the constitutive inhibition of an antitoxin seem as a 
counterintuitive and unlikely role, regulation could be complex, involving, for instance, ternary actors 
(e.g., chaperons) or specific conditions that modulate the ratio of IsoA3::HP0893 RNA molecules 
(e.g., stress conditions found during infection). If confirmed, the role of IsoA3 as a translation 
inhibitor of the HP0893 antitoxin could be of allowing HP0892 ribonuclease activity during infection 
(when higher HP0893 transcription levels are expected (Graham et al., 2002; Han et al., 2011)), which 
might be directly or indirectly linked with H. pylori virulence. The IsoA3-mediated inhibition of the 
HP0893 translation could also serve to uncouple the action of the HP0894 and the HP0892 toxins 
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during infection. Additionally, if confirmed, it would represent the first example of TA ‘cross-type’ 
non-cognate interaction. 
Interestingly, the predicted regions involved in the IsoA3 binding to the three potentially new 
IsoA3 targets are located in close proximity to each other, having overlapping regions mainly 
corresponding to the anti-start codon and the anti-SD sequences. (Figure 5.5). The binding region to 
the aspA mRNA is fully overlapping with that of the acsA mRNA (which has 58% overlap with that of 
the aspA mRNA). This is intriguing as it may represent a mechanism of competition between both 
mRNAs to bind to IsoA3, which may balance or keep IsoA3 inhibition effects within specific 
biologically relevant limits.  
 
 
 
Figure 5.5. Regions of IsoA3 sRNA interaction with its in silico predicted targets. RNAfold (Gruber et 
al., 2008) was used for secondary structure prediction and VARNA RNA (Darty et al., 2009) for drawing.. 
Region involved in IsoA3 binding to the HP0893, acsA and aspA mRNAs are indicated by a red, an orange 
and a purple line, respectively. 
 
Nevertheless, it is important to keep in my that these are only computational predictions and 
they can be vague and misleading when studying such highly-structured RNAs. For instance, the 
TargetRNA2 also predicts binding of the IsoA3 RNA to the TIR region of the AapA3 homolog 
encoded at the locus V (AapA5 toxin-encoding mRNA) (Figure 5.6). However, as this work has 
shown, the interaction of IsoA3 with the AapA3 mRNA is highly specific and strongly dependent on 
RNA structure, being even able to discriminate between the different mRNA species and exclusively 
target the 3’ end processed form. More importantly, and in line with previous studies (Sharma et al., 
2010), this thesis has demonstrated that despite the presence of six IsoA homologs in the H. pylori 
chromosome, none of them is able to avoid AapA3 lethality in the absence of IsoA3, reflecting a 
complete lack of cross-interaction between modules (see Chapter 4 section 4.2). Therefore, even 
though the interaction with the AapA5 mRNA is predicted, it does not occur in vivo. One possible hint 
can come from the observation of where the predicted interaction region locates in the IsoA3 RNA 
secondary structure. For instance, the interaction with the AapA3 mRNA comprises a large single-
stranded region (the linker region), whereas that of the AapA5 mRNA mostly locates within a double-
stranded region (stem-loop). Such intramolecular interaction (stem-loop) masking the binding 
sequence, would be unlikely replaced by the interaction with the AapA5 mRNA in trans. Considering 
this, the above-described predicted interactions, especially the one with the HP0893 antitoxin and the 
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aspA mRNAs are highly unlikely to take place in vivo and will need to be considered carefully and 
experimentally validated. 
 
 
Figure 5.6. IsoA3 predicted interaction with the AapA3 and AapA5 mRNAs. Predicted interaction 
regions between IsoA3 and the AapA3 (A) and AapA5 (B) mRNAs is shown. TargetRNA2 tool was used 
for prediction. Translation start codon of AapA5 and Shine-Dalgarno sequences are underlined. Positions 
in the mRNAs are relative to the translation start codon. (C) Regions of interaction in the IsoA3 secondary 
structure prediction are shown. RNAfold (Gruber et al., 2008) structure prediction and VARNA RNA 
(Darty et al., 2009) for drawing. Region involved in the IsoA3 binding to the AapA3 and AapA5 mRNAs 
are indicated by a dark blue and a grey line, respectively. 
 
5.2.3. Missing actors in the AapA3 mRNA activation? 
In Chapter 4 section 4.3 (paper IV), a 3’ end nucleolytic activation of the AapA3 toxin-encoding 
mRNA was described. Our results demonstrated that the 3’-5’-exonuclease PNPase (HP1213) plays a 
major role, together with the endonuclease RNase Y (HP0760), and one or more, so far unidentified, 
redundant activities. We also demonstrated that this activation pathway is independent on the RhpA 
(HP0249) helicase activity as well as on the 5’ end phosphorylation state. In our attempts to identify 
the redundant activities, we analysed AapA3 mRNA expression in different deletion backgrounds. 
Thereby, we discarded a potential role of the 3’-5’-exonuclease RNase R (HP1242) as well as of the 
membrane-associated nuclease NucT (HP0323) (data not-shown). An in-silico prediction using the 
STRING online tool revealed a possible interaction between the PNPase and the protein component of 
the endonuclease RNase P (rnpA, HP1448). The RNase P catalyzes the removal of the 5’-leader 
sequence from the pre-tRNA to produce the mature 5’-terminus (Li and Altman, 2003). Interestingly, 
it has been shown that either PNPase or RNase P is able to remove the Rho-independent transcription 
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strain. Connection lines thickness indicates confidence as indicated at the bottom right. The following 
proteins are represented: RNase P protein component (rnpA, HP1448), RNase III (rnc, HP0662), integral 
membrane protein (lptG, HP1498), RNase J (rnj, HP1430), PNPase (pnp, HP1213), RNase R (rnr, 
HP1248), poly(A)polymerase (HP0640), DNA polymerase III subunit epsilon (HP1387), RNase Y (rny, 
HP0760), polysialic acid capsule expression protein (kpsF, HP1429), inosine 5’-monophosphate 
dehydrogenase (guaB, HP0829). 
 
 
5.2.4. Start codon accessibility, one more regulatory layer? 
In Chapter 4 section 4.2 (paper III), the role of the co- and post-transcriptional Shine-Dalgarno (SD) 
sequence accessibility in translation initiation of the AapA3 toxin-encoding mRNA was discussed. 
Intriguingly, while studying the aapA1/IsoA1 system (aapA/IsoA module encoded in the 
chromosomal locus I of the H. pylori 26695 strain), we observed that, when trying to inactivate the 
Aapa1 translation start codon as previously done for the AapA3 peptide (G to T single point mutation 
at the third codon position, AUG to AUU), it would still be toxic in absence of IsoA1. As shown in 
Figure 5.8A, the AapA1 translation start codon is fully base-paired within a highly stable stem-loop 
structure (energy = -8.90 kcal/mol). Interestingly, the start codon inactivation by the point mutation 
G53T (guanine at position 53 from the AapA1 TSS mutated to thymine) is predicted to cause a 
dramatic destabilization of such stem-loop structure (energy = -4.60 kcal/mol, Figure 5.8B). 
Furthermore, the analysis of suppressor strains able to compensate the toxicity of the start codon 
mutated AapA1, revealed the existence of a suppressor mutation, T49C (thymine at position 49 from 
AapA1 TSS mutated to cytosine; changing a GU Wobble pair into a GC pair), partially restoring the 
stem-loop stability (-7.30 kcal/mol, Figure 5.8C). These results are striking as they strongly suggest 
that the increased accessibility to the start codon thermodynamically prompts the efficient recognition 
of the AUU non-canonical start codon by the fMet-tRNAfMet despite the pairing of only 2/3 codon 
positions. This recognition triggers the subsequent 50S ribosomal subunit assembly to the 30S subunit 
and leads to translation initiation and the generation of a wild-type peptide (Figure 5.8B). 
Nevertheless, although these results were surprising, several studies have highlighted that 
translation from non-canonical codons occurs more often than previously anticipated (Hecht et al., 
2017; Romero and García, 1991), in many cases having important regulatory roles. For instance, the 
tufA (coding for the EF-TuA) and the hupB (coding for the EF-TuB) are among the most highly 
expressed genes in E. coli (one cell is estimated to contain 74,981 EF-TuA and 87,672 EF-TuB 
molecules) despite the EF-TuA being translated from a non-canonical GUG initiation codon (Lu et al., 
2007). Another example is the infC gene (coding for the IF3), which is translated from the non-
canonical AUU or AUC initiation codons and is also expressed at fairly high levels (5,488 
molecules/cell) in E. coli (Lu et al., 2007). Indeed, it has been demonstrated that infC translation from 
AUU or AUC initiation codons represents an essential cis-acting element in the autogenous 
translational control of translation initiation by the initiation factor IF3 (Brombach and Pon, 1987; 
Butler et al., 1987; Sacerdot et al., 1996). The second example of chromosomal translation initiated at 
AUU is the E. coli pcnB gene, coding for the poly (A) polymerase (PAPI), which is toxic when 
overproduced. Interestingly, it has been shown that initiation at AUU is a mechanism to limit the 
translation of the potentially toxic pcnB gene product (Binns and Masters, 2002). In line with this 
observation, a further example can be found within a type I TA system, as is the case of the YonT 
toxin-encoding mRNA. Surprisingly, the SD sequence is not sequestered in the YonT mRNA, but 
instead, it uses the non-canonical GUG initiation codon to strongly limit the translation initiation rate 
(Durand et al., 2012; Reif et al., 2018). 
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does not efficiently avoid AapA1 peptide synthesis, probably due to the stop codon recognition by a 
Glutamine tRNA through a GU Wobble base pair. (B) When a stop codon is introduced at the 7th AapA1 
codon position, the stability of the stem-loop is not strongly affected (energy = -6.60 kcal/mol) and thus, 
possible stop codon misreading events are not reflected as toxicity in absence of antitoxin. Shine-
Dalgargno (SD) sequence is highlighted in turquoise, translation start codon is highlighted in green, the 
newly introduced stop codon is highlighted in red. Ribosome is represented in yellow. Gln-tRNAGln is 
represented in purple. RNAfold Web Server (Gruber et al., 2008) was used to predict the structures and 
minimum free energy values, VARNA RNA (Darty et al., 2009) for drawing. 
 
Altogether, these results suggest that the AapA1 start codon-sequestering stem-loop structure 
is one more layer of regulation ensuring a limited AapA1 transaltion. From a physilogical point of 
view, the use of start codon accessibility to dictate the transaltion efficiency of a toxic gene could 
represent a sensor mechanism. For instance, it could provide a fast response (lethality) to changes in 
ribosome concentration or temperature (as shown for other RNA thermometers, Kortmann and 
Narberhaus, 2012)). Apart from the toxicity observed in the transformation assays, we confirmed by in 
vitro translation assays and toeprint experiments the translation of the AUU mutant and the limited 
translation of the T49C suppressor. Additionally, polysome fractionation assays showed a slight 
increase of translation of the AUU mutant compared to that of the double mutant AUU T49C in vivo 
(unpublished data). However, in the future, more quantitative approaches such as ribosome profiling 
or proteomics will allow the further characterization of this exciting hypothesis. 
 
 
5.2.5. A 3’ end standby site in a AapA3 mRNA species? 
In the Chapter 4 section 4.3, we described how Northern Blot analysis revealed the existence of a 
AapA3 transcript having a 3’ extension of approximately 55 nt compared to the full-length species, the 
so-called aapA3 full-full length (aapA3-FFL, ≈ 280 nt). Interestingly, this longer transcript appears to 
be more abundant in a suppressor strain carrying a mutation in the AapA3 ORF, the Val26Ala (Valine 
at position 26 mutated to Alanine, previously identified by FASTBAC-Seq, see Chapter 4 section 4.1) 
strain, allowing us to study this mRNA species in more depth. In previous studies (see Chapter 4 
section 4.2), we showed that the only translationally active AapA3 mRNA species is the aap3-Tr (≈ 
190 nt). However, with the discovery of the aapA3-FFL, we asked whether it could be translated. To 
test aapA3-FFL translation in vivo, we performed polysome fractionation in sucrose gradient coupled 
to Northern Blot analysis of the isolated fractions (as described in Chapter 4 section 4.2). As controls 
(apart of the 5S rRNA location), we used the aapA3-FL species (≈ 225 nt)., which is located in the 
first fractions of the gradient, indicative of being in ‘free state’ (non-translated), and the aapA3-Tr 
species (≈ 190 nt), which is located in monosome and disomes fractions reflecting that it is being 
translated in vivo, as described in our recent paper (see Chapter 4 section 4.2). Strikingly, polysome 
fractionation analysis showed that the aapA3-FFL species mainly locates in the fractions 
corresponding to the 30S ribosomal subunit (Figure 5.11A, upper panel), and surprisingly, RNA 
secondary structure prediction revealed the presence of a putative ribosome standby site located on the 
3’ end of this mRNA species (within the 55 nt 3’ end extension, underlined in yellow, left panel, 
Figure 5.11C).  
Standby sites, originally discovered in the MS2 phage coat protein, are nucleotide unspecific 
single-stranded regions that allow translation of mRNAs on which the Shine-Dalgarno (SD) sequence 
is sequestered (de Smit and van Duin, 1990, 2003; Sterk et al., 2018). They have previously been 
identified at the 5’ end of other type I TA toxin-encoding mRNAS such as the TisB (Darfeuille et al., 
2007) and ZorO (Wen et al., 2017). However, the standby site of the aapA3-FFL mRNA would 
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represent the first identified case of a 3’ end standby site. To test whether the aapA3-FFL presence in 
30S fractions was due to the predicted 3’ standby site, we introduced a mutation inactivating the SD 
sequence (the single point mutation guanine at position 43 from AapA3 TSS to adenine, G43A, 
suppressor mutation identified by FASTBAC-Seq, see Chapter 4 section 4.1) into the Val26Ala 
genetic background, generating the strain Val26Ala SD* (Val26Ala/G43A/pIsoA3*).  
As shown in Figure 5.11A (lower panel), the aapA3-FFL mRNA species in this SD 
inactivated strain is no longer in the 30S fractions but on the ‘free RNA’ ones, together with the 
aapA3-FL mRNA. This result clearly demonstrated that the aapA3-FFL mRNA species was able to 
interact with 30S ribosomal subunits by using a standby site mechanism. However, the low presence 
of the aapA3-FFL species in the 70S fractions was sticking, as usually standby sites allow the 
translation of the mRNAs they are harbored in. To better understand this phenomenon, we performed 
in vitro translation assays using E. coli 30S extracts. The aapA3-FFL RNA, in line with the polysome 
fractionation results, was proved to be non-translatable (Figure 5.11B), obtaining a slightly higher 
translation than when the aapA3-FL RNA was used as substrate (-FL lane, Figure 5.11B), but being 
very close to background levels obtained in absence of exogenous RNA (control lane ‘C’, Figure 
5.11B). Furthermore, a so far unobserved band of approximately 300 nt-long (aapA3-FFL*) appeared 
in the ‘free RNA’ fractions. Interestingly, RNA secondary structure predictions of the aapA3-FFL* 
mRNA located the standby site regions stably sequestered within stems (underlined in yellow, right 
panel, Figure 5.11C). This situation is in conformation with the polysome fractionation results (lower 
panel, Figure 5.11A) and explains the absence of the aapA3-FF* mRNA in 30S fractions in contrast to 
the aapA3-FFL where the standby site regions are not sequestered. Put together, these results 
demonstrated that the aapA3-FFL mRNA is able to interact with 30S ribosomal subunits by using the 
single-stranded standby site region. However, due to the stable sequestration of the SD sequence 
within the long-distance interaction between the 5’ and the 3’ ends of the mRNA, the 50S ribosomal 
subunit cannot be assembled, explaining the low presence of the aapA3-FFL in the 70S fractions 
(upper panel, Figure 5.11A). Nevertheless, although the use of polysome fractionation was useful for 
us the future, the performance of in vitro toe-prints assays would be interesting and may reveal further 
mechanistic details. 
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(truncated, »190 nt) and 5S rRNA as loading control (5S rRNA). (B) In vitro translation assays were run 
with 0.5 µg aapA3 RNAs using [35S]-Met for labeling. Control lane (C) shows the translation background 
obtained in absence of exogenous RNA. Band corresponding to AapA3 peptide production is indicated 
(AapA3). (C) Secondary structure folding or the aapA3-FFL (full-length, » 225 nt) species reveal a single-
stranded region that serves as standby site for 30S ribosomal subunits. However, due to the tight Shine-
Dalgarno (SD) sequestration, assembly of the 50S ribosomal subunit cannot take place. On the opposite, in 
the longer form, aapA3-FFL* (full-full-length*, » 300 nt), the standby site is trapped within secondary 
structures, rendering it non-functional. RNAfold Web Server (Gruber et al., 2008) was used to predict the 
aapA3-FFL* and the aapA3-FFL (full-length, » 225 nt) structures and VARNA RNA (Darty et al., 2009) 
was used for drawing. SD sequence is shown in green, 30S and 50S ribosomal subunits and 70S ribosomes 
are represented in yellow, standby site regions are underlined in yellow. 
 
Interestingly, a recent study has highlighted the role of AU-CA-repeats (Sterk et al., 2018), 
known to enhance translation of highly structured mRNAs (Komarova et al., 2005; Sharma et al., 
2007; Yang et al., 2014), and be potentially recognized by the S1/S2 ribosomal proteins (as recently 
described for the lpp mRNA (Andreeva et al., 2018)), as enhancers of the standby site  mechanism. As 
shown in Figure 5.12, several AU-CA rich motifs can be observed in the aapA3 mRNA. Strikingly, 
the distribution of the AU-CA rich motifs in the AapA3 mRNA is not random. Despite being seemly 
homogeneously decorated with AU-CA rich motifs, none of them is located in the 3’ processed region 
that differentiates the primary transcript (aapA3-FL) from the active message (aapA3-Tr) (region 
indicated by a red line in Figure 5.12). This observation is intriguing and suggests that the AU-CA rich 
motifs in the aapA3 mRNA may be functional and enhance the translation efficiency of this unusually 
highly structured mRNA. Furthermore, the AU-CA rich motifs re-appear in the 3’ extended region 
that is unique to the aapA3-FFL species (indicated by a green line in Figure 5.12). This suggests that 
the aapA3-FFL species may be translationally active, however, further studies (e.g., point-mutation 
analysis, toeprints in presence or absence of S1 ribosomal protein, etc.) will be required to confirm and 
understand this mystery. The biological relevance for the generation of such a long (and energetically 
costly) transcript is enigmatic. However, one can think that it may provide a biological benefit under 
circumstances where a low toxin production is advantageous (e.g., stress conditions). Or even further, 
it may act as a sensor of intracellular ribosome concentration (i.e., high ribosome density would 
kinetically compensate the tight SD sequestration) and for instance, promote growth arrest or death of 
cells overproducing ribosomes (which may have deleterious effects, e.g., increased aberrant 
translation, or TA system lost due to increased cell division rates).  
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Figure 5.12. Distribution of AU-CA-rich motifs in the aapA3 mRNA. RNAfold Web Server (Gruber et 
al., 2008) was used to predict the structures and VARNA RNA (Darty et al., 2009) for drawing. Translation 
start and stop codons are shown in green and red, respectively; Shine-Dalgarno (SD) sequence is 
highlighted in green; AU-CA-rich motifs are highlighted in purple; the 3’processed region in the mature 
aapA3 mRNA species is indicated by a red line. The 3’ extended region that is unique to the aapA3-FFL is 
indicated by a green line. 
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5.2.6. The inner membrane, the AapA3 target?  
In Chapter 4 section 4.2 (paper III), we identified and characterized toxicity suppressor mutations able 
to inhibit the translation of the toxin-encoding AapA3 mRNA. Between them, there was the 
synonymous mutation T78C, which acts as an energetic trap stabilizing the active AapA3 mRNA 
species into a translationally inert conformation. Because this suppressor strain still codes for a wild-
type AapA3 peptide, possible growth defects were studied. Interestingly, although no significant 
doubling time defects were observed (just a very slight growth retardation, unpublished data), 
microscopic observation of the cell morphology revealed something striking. H. pylori is known for 
being a ‘chameleonic’ bacteria, which undergoes several cell shape changes under different growth 
phases and environmental conditions, having a great impact in the colonization and virulence 
processes. During the exponential growth phase, H. pylori cells have helicoidal shape, are actively 
dividing, and are motile, being able to rapidly colonize the host. Towards the stationary phase, cells 
progressively become coccoïdal, stop dividing, and loss the motility, playing key roles in biofilm 
formation (see section 1.1.1.1 in Chapter 1, Bonis et al., 2010; Carron et al., 2006; García et al., 2014; 
Sycuro et al., 2012).  
As shown in Figure 5.13, an unexpectedly high proportion of cells in the T78C/pisoA3* strain 
present signs of transitioning to coccoïd shape, even at early exponential growth phases (OD ~0.7). 
Interestingly, we were able to identify all of the previously described growth phase-dependent 
transition stages (see Figure 1.1 in Chapter 1) (Cellini, 2014; Keshavarz et al., 1999), in one sole time-
point in the T78C/pisoA3* strain, and built a ‘coccoïd score (CS)’ ranging from 0 (helicoidal shape) to 
6 (coccoïd shape) (Figure 5.13A). As shown in Figure 5.13B and C, meanwhile the CS in the wild-
type strain is, as expected, growth phase-dependent (0±0 at OD 0.7 and 9.5±4.5 at OD 1.4, n=3 images 
per OD, with ~180 cells each), the CS observed in the T78C/pisoA3* strain seems to remain stable 
over growth (22.8±2.6 at OD 0.7, and 40.6±22.6, n=3 images per OD, with ~180 cells each), and is in 
all cases significantly higher than the one found in the wild-type strain. Because despite stabilizing the 
AapA3 mRNA into a conformation on which the SD sequence is sequestered, mRNA folding is 
dynamic, it is likely that the observed phenotype in the T78C/pisoA3* strain is produced by the 
leaking AapA3 expression. Thus, this result suggests that the AapA3 peptide can directly or indirectly 
promote cell transition to coccoïd shape. 
To date, how H. pylori cells become coccoïd is still enigmatic. Electron microscopy and 
proteomic studies have pointed out that there are two types of coccoïd cells: 1) viable, having intact 
cytoplasm (e.g., unchanged protein and DNA content) and membrane structure, and 2) non-viable, 
having degenerated organelles and cell membrane and usually bigger than the viable ones (Bumann et 
al., 2004; Hua and Ho, 1996; Sisto et al., 2000; Young et al., 2001). In our case, and in line with the 
no-lytic phenotype observed during AapA3 peptide overexpression in E. coli (unpublished data), 
FM4-64 staining showed apparently intact membranes in the coccoïd cells, suggesting that they are 
viable (Figure 5.13).  
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Interestingly, previous studies on the AapA1 toxic protein of H. pylori have demonstrated that 
it targets the cell membrane (Korkut et al., in preparation). Traditionally, the highly specific 
bacteriophage T7 polymerase has been used for protein overexpression in E. coli. However, the 
overexpression of membrane proteins is often challenging. A study aiming at the optimization of 
membrane protein production from a phage T7 polymerase expression system in E. coli led to the 
selection of the mutant strain C43 (DE3). Notably, in the C43 (DE3) strain the toxic effects associated 
with overexpression are strongly reduced (Miroux and Walker, 1996). Another strategy that has been 
developed to reduce the overexpression-associated toxicity is the co-transformation of the plasmid 
containing the protein of interest with a plasmid containing the phage T7 lysozyme (Studier et al., 
1990). The T7 lysozyme is a protein of 150 amino acids (~17 kDa) (Dunn and Studier, 1983) with N-
acetylmuramyl-L-alanine amidase activity able to cut the peptidoglycan (PG) layer of the E. coli cell 
wall (Inouye et al., 1973). However, the reason behind the use of the T7 lysozyme for the expression 
of toxic proteins is its ability to bind to the T7 RNA polymerase and inhibit transcription (Moffatt and 
Studier, 1987).  
Preliminary attempts to clone the AapA3 ORF into an inducible vector repeatedly failed, 
leading to the apparitions of spontaneous mutations even under non-induced conditions. Considering 
this, we tested the use of the BL21 C43 (DE) strain and the pLysS plasmid containing the T7 
lysozyme to express the AapA3 peptide from a phage T7 promoter (pET-MCN vector). In this case, 
the cloning of the AapA3 ORF was successful, and we were able to observe toxicity (bacteriostatic 
effect) upon induction (data not shown). However, once again, the microscopic analysis of the cells 
upon AapA3 protein induction revealed something striking. As shown in Figure 5.14, when AapA3 
expression from the pET-MCN T7-derived expression vector in the C43 (DE3) E. coli strain co-
transformed with the pLysS vector (containing the T7 lysozyme) was induced, strikingly round cells 
appeared visible (compare Figure 5.14E and K for detail). Furthermore, such round cells showed 
increased permeability to DAPI staining, suggesting an increased inner membrane permeability 
(compare Figure 5.14E and K for detail).  
Interestingly, previous studies performed by C. Sharma soon after the identification of the 
aapA/IsoA family of type I TA systems in H. pylori (Sharma et al., 2010), demonstrated that it is 
possible to clone the AapA3 peptide into an overexpression vector (the arabinose-inducible pCSN16-
8), and in a standard E. coli strain (e.g., MG1655), if it is in the context of the whole locus (C. Sharma, 
unpublished). Now, with the results generated in this thesis, we can understand the absence of leaking-
toxicity in this case, as the AapA3 mRNA folding (involving the 5’ and 3’ UTRs, absent in the ORF-
cloning strategy) is a key regulator of the AapA3 expression. Furthermore, in this case, the IsoA3 
sRNA was also cloned, thus, it may also contribute to the lack of leaking AapA3 expression, and its 
presence does not represent a problem to study AapA3 toxicity as its low production from its 
endogenous promoter cannot compete with the high AapA3 expression levels obtained upon 
induction. Surprisingly, microscopy analysis of the MG1655/pCSN16-8 cells upon AapA3 induction 
showed no round phenotype (Figure 5.15, compare E and K for detail). Thus, these results 
demonstrated that the round phenotype observed in the BL21 C43 (DE3)/pLysS cells (Figure 5.14) 
was not a direct effect of AapA3 expression.  
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Comparing the context of AapA3 expression in both strains, we spotted the pLysS (encoding 
the phage T7 lysozyme) as the responsible of the round phenotype. Remarkably, the presence of the 
phage T7 lysozyme turned out to be an excellent reporter of the AapA3 activity. Indeed, due to its 
high molecular weight (~17 kDa), the phage T7 lysozyme alone is incapable of crossing the E. coli 
inner membrane (lysis requires the action of several phage proteins (Bartel et al., 1996; Rajaure et al., 
2015)). In our experiments, the T7 lysozyme could access and degrade the PG layer, leading to a 
round phenotype, only when the AapA3 peptide was produced. Therefore, these results suggest that 
the AapA3 peptide may interact with the inner membrane (IM) in a way that allows the T7 lysozyme 
to cross (e.g., behaving in a holing-like way, forming pores, as previously described allowing 
endolysin action (Wang et al., 2000; Young, 2014), or as described for the type I toxins TisB 
(Berghoff et al., 2017; Gurnev et al., 2012; Steinbrecher et al., 2012) and Hok (Wilmaerts et al., 2018) 
in E. coli).  
Going a step further, in H. pylori, a similar mechanism involving H. pylori lysozyme-like 
autolytic enzymes (such as lys (Marsich et al., 2002)), may be responsible for the transition to coccoïd 
shape observed in the T78C/pIsoA3* strain, or even in general matters. Importantly, we do not 
observe cell lysis or membrane fusion. This phenotype is reminiscent to the one found in the spanin 
(phage-encoded proteins that connect the IM with the OM during phage lysis) mutants (Rajaure et al., 
2015), indicating that the outer membrane (OM) remains intact (and can be observed by FM4-64 
staining, see Figures 5.13 and 5.14). Overall, the phage T7 lysozyme turned out to be an unexpectedly 
efficient in vivo reporter system of the AapA3 expression and activity in the inner membrane, which 
could likely be expanded to the study of other toxic membrane proteins. Interestingly, these results 
strongly suggest that the AapA3 peptide may act by forming pores in the IM of the bacterium and 
promote the formation of coccoid cells. As described in the section 1.1.1.1 of Chapter 1, H. pylori 
coccoïd cells are often associated with biofilm formation and persistent infections. Pore formation is 
often linked to the entry to the so-called persister state (see section 1.4.2. in Chapter 1). Thus, these 
results suggest that coccoïd cells may represent a variant of the persister cells previously described in 
other bacteria, suggesting a role of AapA3 in H. pylori virulence.  
However, further characterization will be required to confirm AapA3 peptide location at the 
IM (as previously described for the AapA1 toxin, Korkut et al., in preparation) and pore formation. 
Additionally, further studies analyzing the role of pore formation in the transition to coccoïd cells 
(e.g., direct or indirect effect) will be necessary. Importantly, the confirmation of the reversibility of 
the coccoïd phenotype and the restoration of growth, will be a key factor to confirm or discard a 
possible role of coccoïd cells in persistence. Finally, the role of AapA3 in H. pylori biofilm formation 
and virulence will need to be assessed, e.g., under which conditions AapA3 peptide is produced at the 
sufficient levels as to induce cell shape transition? Does IsoA3 transcriptional regulation play a role? 
If not, may stochastic expression of AapA3 increase population heterogeneity, as a mechanism of 
ensuring the presence of some coccoïd cells (which may be advantageous to respond to stress 
conditions, e.g., during infection)? 
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CHAPTER 6. Material and Methods 
6.1. Material 
6.1.1. Equipment 
 
Equipment and instrument Manufacturer 
Anaerobic jar system Oxoid 
Analytical balances, Sartorius 
Anoxomat® Mark II Advanced Instruments 
Benchtop centrifuge  Eppendorf 
Cell culture hood,  Thermo Scientific 
Cell density meter Amersham Biosciences 
Gel dryer  Biorad 
Heating block  GRANT 
Horizontal electrophoresis systems Emoi-Tec 
Hybridization oven TECHNE 
Imaging plate cassettes Biorad 
Incubator for bacterial plates Thermo Scientific 
Incubator shaker (Innova®44) New Brunswick Scientific 
K-screen, gel documentation system Biorad 
Microvolume UV-Vis spectophotometer Denovix 
Orbital Shaker (Thermoshake) Gerhardt 
Pharos FX phosphorimager Biorad 
Precellys homogenizer Bertin 
Screen-K eraser  Biorad 
SW41 Ti Swinging-Bucket rotor  Beckman Coulter 
Swing-out rotor, refrigerated centrifuge  Heraeus 
Thermocycler Sensoquest 
Trans-Blot®Cell Biorad 
UA-6 detector ISCO 
Ultracentrifuge Beckman Coulter 
UV-Crosslinker, UVP 
Vertical electrophoresis systems APELEX 
Vertical sequencing gel system CBS SG-400-20 C.B.S. Scientific 
Water-bath (polystat®) Bioblock Scientific 
 
6.1.2. Labware 
 
Labware Manufacturer 
Autoradiography films GE Healthcare 
Cell culture flasks 25 cm3 Thermo Scientific 
Cell culture flasks 75 cm3 Thermo Scientific 
Cover slips KNITTEL GALSS 
Erlenmeyer glass flasks 250 ml DURAN, SIMAX 
Falcon tubes (plastic) 25 ml, 50 ml SARSTEDT 
Glass beads (2.85-3.35 mm) for plating of CFU/ml SARSTEDT 
Glass bottles VWR 
Inoculating loops (plastic) 1, 10 µl VWR 
Membrane for nucleic acid transfer, HybondTM-N GE Healthcare  
MicroSpinTM G-25 columns GE Healthcare  
Objective slides KNITTEL GALSS 
Petri dishes SARSTEDT 
Phase Lock Gel (PLG)-tubes, 2 ml 5PRIME 
Pipet tips SARSTEDT 
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Pipets 10 µl, 20 µl, 200 µl, 1000 µl GILSON 
Q-tips (CLASSIQSwabsTM) COPAN 
Safe-lock tubes 0.2 ml, 1.5 ml, 2 ml SARSTEDT 
Serological pipets (plastic) 5 ml, 10 ml, 25 ml, 50 ml SARSTEDT 
Spectrophotometer cuvettes SARSTEDT 
Sterile filters (0.20 µm pore size) SARSTEDT 
Syringes (plastic) 10 ml, 50 ml Terumo 
 
6.1.3. Reagents and chemicals 
 
Product Manufacturer 
1X alkaline hydrolysis buffer Ambion 
10X RNA structure buffer Ambion 
2-mercaptoethanol Sigma 
20X SSC (saline sodium citrate buffer) Sigma 
Acetic acid (100 %) VWR 
Acetone VWR 
Acrylamide EUROMEDEX 
Agarose Thermo Scientific 
Ammonium acetate Sigma 
Ampicillin sodium salt Merk 
Bacteriological agar Thermo Scientific, Oxoid 
Chloramphenicol Sigma 
Chloroform:isoamylalcohol (24:1) Fluka 
Dimethyl sulfoxide (DMSO) EUROMEDEX 
Dithiothreitol (DTT) Sigma 
ddNTPs/dNTPs Sigma 
DPBS (1X) GIBCO 
Erythromycin Sigma 
Ethanol VWR 
Ethanol absolute VWR 
Ethidium Bormide Sigma 
Ethylenediaminetetraacetic acid disodium salt 
dehydrate (EDTA) 
Sigma 
Formaldehyde VWR 
Formamide (99.5 %) Sigma 
Glycerol (99 %) Sigma 
Hydrochloric acid (HCl, 32 %) Sigma 
Isopropanol Sigma 
Kanamycin sulfate Sigma 
Lead (II)-acetate Fluka 
Magnesium chloride Fluka 
Methanol VWR 
Methylene Blue Sigma 
Molecular Biology Water Eurobio 
PEG4000 (50 %) Thermo Scientific 
Phenol Sigma 
Potassium chloride Sigma 
Rifampicin Sigma 
Sephadex G25  GE Healthcare 
Sodium acetate Sigma 
Sodium chloride Sigma 
Sodium dodecyl sulphate (SDS) Bisolve-Prolabo 
Streptomycin Sigma 
Sucrose Sigma 
TRIS-Base EUROMEDEX 
TRIS-Glycine Buffer 10X EUROMEDEX 
Triton-X100 Sigma 
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Tween20 Amresco 
Urea Life-technologies 
Yeast tRNA Ambion 
α-32P-UTP (32P; 250 µCi (9.25 MBq)) Perkin-Elmer 
β-35S-Met (35S; 1 mCi (37 MBq)) Perkin-Elmer 
γ-32P-ATP (32P; 250 µCi (9.25 MBq)) Perkin-Elmer 
 
6.1.4. Enzymes and size markers 
 
Product Manufacturer 
Calf Intestinal Phosphatase (CIP, 10 u / µl) New England Biolabs 
Deoxyribonuclease I (DNase I, 1 u / µl) Thermo Scientific 
DpnI (20 u / µl) Promega 
DreamTaq DNA polymerase  (5 u / µl) Thermo Scientific 
Gene Ruler 1 kb plus DNA ladder Thermo Scientific 
Low-Range Rainbow molecular weight marker GE Healthcare 
Pfu Ultra High Fidelity DNA polymerase  Agilent 
Phusion High-Fidelity DNA polymerase (2 u / µl) Thermo Scientific 
Restriction enzymes Promega/ Thermo Scientific 
Ribonuclease A (RNase A) Clinisciences 
Ribonuclease H1 (RNase H1, 2 u / µl) Ambion 
Ribonuclease III (RNase III, 2 u / µl) New England Biolabs 
Ribonuclease T1 (RNase T1 0.01 u / µl) Ambion 
RNaseOUT™ Recombinant Ribonuclease Inhibitor Thermo Scientific 
RNasin® Ribonuclease Inhibitor Promega 
Shrimp Alkaline Phosphatase (SAP, 1 u / µl) Thermo Scientific 
SuperScriptII Reverse Transcriptase Invitrogen 
SuperScriptIII Reverse Transcriptase Invitrogen 
T4 DNA Ligase  Promega 
T4 Polynucleotide Kinase (PNK) New England Biolabs 
T4 RNA Ligase Thermo Scientific 
 
6.1.5. Commercially available systems 
 
System Manufacturer 
2X Gel Loading Buffer II (RNA) Ambion 
6X Sample Loading Buffer (DNA) Fermentas 
Cell Lysing Kit (2 ml tubes) Precellys 
E. coli S30 Extract System for Linear Templates Kit Promega 
GlycoBlueTM Ambion 
High Purity Plasmid Miniprep Kit Neo Biothech 
HiTrapTM Heparin HP affinity columns GE Healthcare 
MAXIscript T7 in vitro transcription Ambion 
MEGAscript T7 in vitro transcription Ambion 
PCR and DNA fragment purification Kit Neo Biothech 
pGEM®-T vector system Promega 
Quick Bacteria Genomic DNA extraction Kit Neo Biothech 
Spin-X®-centrifuge tubes filter Sigma 
Stains-All Sigma-Aldrich 
Tricine Sample Buffer Biorad 
 
6.1.6. Strains, oligonucleotides and plasmids 
Helicobacter pylori strains used in this study are compiled in the Tables 8.1.1 and 8.2.3 in the 
Appendix. Plasmids are listed in the Tables 8.1.2 and 8.2.5 in the Appendix. Oligonucleotides are 
listed in the Tables 8.1.4 and 8.2.6 in the Appendix. 
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6.1.7. Media and supplements 
H. pylori-specific media: 
BHI medium (Oxoid)   
36 g  Brain Heart Infusion: 0.5% (w/v) beef heart, 1.25% (w/v) calf   brains, 0.25% (w/v) 
disodium hydrogen phosphate, 0.2% (w/v) D (+)-glucose, 1% (w/v) peptone  
ad 900 ml  H2O 
add after autoclaving: 
10% (w/v)  heat-inactivated fetal bovine serum 
 
CAB medium (Oxoid)   
36 g  Columbia Blood Agar Base (CAB): 0.5% (w/v) enzymatic digest of casein, 0.8%     
(w/v) enzymatic digest of animal tissue, 1% (w/v) yeast enriched peptone, 
0.1%  (w/v) corn starch, 85.6 mM           sodium chloride, 1.4% (w/v) agar 	
ad 900 ml H2O 
add after autoclaving: 
7% (w/v) Laked Horse Blood (Thermo Scientific) 
2 vials               H. pylori selective supplement (Dent, Oxoid, Basingstoke, UK)  
 
E. coli-specific media: 
Lennox Broth (LB) liquid medium (Oxoid) 
1% (w/v) peptone 140  
0.5% (w/v) yeast extract 
85.6 mM sodium chloride  
 
LB agar plate  
LB medium (see above) 
1.2 % agar  
 
SOC medium (Oxoid) 
2% (w/v) tryptone 
0.5% yeast extract 
85.6 mM NaCl 
2.5 mM KCl 
10 mM MgCl2 
20 mM glucose 
 
Terrific broth (Sigma) 
1.2% (w/v) tryptone 
2.4% (w/v) yeast extract 
0.94% (w/v) K2HPO4 
0.22% (w/v) KH2PO4 
 
6.1.8. Buffers 
2X Gel Loading buffer II (RNA): 
95%    formamide 
18 mM   EDTA, pH 8.0 
0.025% (w/v)  each of SDS, Xylene Cyanol, and Bromophenol Blue  
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Caco-buffer (pH 7.3 at 20°C): 
20 mM   sodium cacodylate 
20 mM   NaCl 
140 mM  KCl 
1 mM    MgCl2 
 
Buffer A:  
10 mM   Tris-HCl, pH 7.5 
60 mM   potasium chloride 
10 mM   magnesium chloride 
 
Grad-buffer:  
10 mM   Tris-HCl, pH 7.5 
50 mM   ammonium chloride 
10 mM   magnesium chloride 
1 mM   DTT 
 
Lysis buffer:  
20 mM   sodium acetate, pH 4.2 
0.5% (w/v)  SDS 
1 mM   EDTA 
 
Modified Church buffer:  
1 mM   EDTA 
0.5 mM  sodium phosphate, pH 7.2 
7 % (w/v)  SDS 
 
Phosphate buffered Saline (10X):  
80 g   sodium chloride 
2 g   potassium chloride 
17.7 g   disodiumhydrogen phosphate 
800 ml   H2O 
adjust to pH 7.4 
add H2O to a final volume of 1 l  
 
RNA elution buffer: 
0.1 M   sodium acetate, pH 5.2 
0.1% (w/v)  SDS 
1 mM    EDTA 
 
RNA elution buffer-NH4Ac: 
0.3 M   ammonium acetate 
0.1% (w/v)  SDS 
1 mM    EDTA 
 
RNase J-exo reaction buffer (5X) 
100 mM   Tris-HCl pH 7.0 
40 mM   MgCl2 
500 mM  NH4Cl 
0.5 mM  DTT 
RNA structure buffer (1X): 
10 mM   Tris-HCl, pH 7.0 
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10 mM   magnesium chloride 
100 mM  potassium chloride 
 
RNase J-endo reaction buffer (5X) 
100 mM   Tris-HCl pH 8.0 
40 mM   MgCl2 
500 mM   NaCl 
 
Sequencing buffer (1X): 
20 mM   sodium citrate, pH 5.0 
7 M   Urea 
1 mM   EDTA 
 
SSC (saline-sodium citrate) buffer (20X stock solution): 
173.5 g   sodium chloride 
88.2 g   sodium citrate 
800 ml   H2O 
adjust to pH 7.0 (using HCl) 
add H2O to a final volume of 1 l  
 
Stains-All: 
30 ml   Stains-All stock 
90 ml   formamide 
add H2O to a final volume of 200 ml  
 
Stains-All stock: 
0.03 g dissolved in 30 ml formamide 
 
Stop Solution: 
95 % (v/v)  ethanol 
5 % (v/v)  phenol 
 
TBE buffer (10X stock): 
108 g   Tris base 
55 g   boric acid 
40 ml   0.5 M EDTA, pH 8.0 
add H2O to a final volume of 1 l  
 
TE buffer (1X): 
100 mM  Tris-HCl, pH 8.0 
10 mM   EDTA, pH 8.0 
 
Tris-HCl/SDS buffer (3M Tris-Cl, 0.3% SDS, pH 8.45): 
18.2 g    Tris-Base (TRIZMA base) 
ad    300 ml H2O 
adjust to pH 8.45 
add 7.5 ml   20 % SDS 
add H2O to a final volume of 500 ml  
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Washing-buffer (1X): 
25 mM   Tris-HCl, pH 8.0 
300 mM   NaCl 
 
1X cathode buffer (0.1 M Tris, 0.1M tricine, 0.1% SDS, pH ≈8.3, do not adjust): 
12.11 g   Tris-Base (TRIZMA base) 
17.92    Tricine 
5 ml    20 % SDS 
add H2O to a final volume of 1 l  
 
5X anode buffer (0.2 M Tris, pH 8.9): 
121.1 g   Tris-Base (TRIZMA base) 
add H2O to a final volume of 500 ml  
adjust to pH 8.9 with HCl 10 N 
 
6.1.9. Sterilization 
Media solutions were sterilized before use by autoclaving at 120°C and 1 bar for 20 min. Thermo-
labile solutions were filtered-sterilized. 
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6.2. General Methods 
This section describes general methods that were routinely used throughout the study. For a detailed 
protocol of the FASTBAC-Seq method see Chapter 4 section 4.1 (paper II, (Masachis et al., 2018)). 
 
6.2.1. E. coli growth conditions and strain generation 
E. coli strains were grown at 37°C and normal aeration conditions. Cultures were inoculated either 
from overnight grown single-colonies or freshly grown single-colony 5 ml LB cultures diluted 1/100 
and incubated at 37°C and 200 rpm. 
For inducible PLac or PBAD promoters, cultures were supplemented with 0.25 mM or 13.3 mM IPTG or 
L-(+)-arabinose, respectively. 
When needed, antibiotics were used as follows: 
Kanamycin: 50 µg/ml 
Ampicillin: 100 µg/ml 
Chloramphenicol: 25 or 30 µg/ml for low- or high-copy plasmids, respectively 
6.2.1.1. Transformation of E. coli chemically competent cells 
50 µl of homemade chemically competent TOP10 cells (Invitrogen) were mixed with 1 µl ligation 
product or 0.5-2 µl plasmid (concentration 10-150 ng/µl). After 5 min pre-incubation on ice, cells were 
subjected to a heat-shock for 45 seconds at 42°C. Next, cells were chilled on ice for 1 min and 
resuspended in 500 µl SOC medium. Recovery was carried out for 30 or 60 min for cells carrying 
ampicillin or chloramphenicol resistance markers, respectively. Cells were pelleted by centrifugation 
at 3000 rpm for 5 min and resuspended in 50 µl SOC medium before being plate on LB-agar plates 
supplemented with the appropriate antibiotics. 
 
6.2.2. H. pylori growth conditions and strain generation 
The H. pylori strains used in this study were 26695 (Tomb et al., 1997), B128 (Farnbacher et al., 2010; 
McClain et al., 2009) and X47-2AL (Ermak et al., 1998). Strains were grown on Columbia agar plates 
supplemented with 7% horse blood and Dent selective supplement for 24 h to 48 h depending on the 
strain. Liquid cultures were performed in Brain-Heart Infusion (BHI) medium supplemented with 10% 
fetal bovine serum (FBS) and Dent. H. pylori plates and liquid cultures were incubated at 37°C under 
microaerobic conditions (10% CO2, 6% O2; 84% N2) using an Anoxomat atmosphere generator. For 
liquid cultures, bacteria harvested from plates were inoculated at an optical density at 600 nm of 0.02 
(OD600 = 0.02) into tubes containing 10 mL BHI medium supplemented with 10% FBS and Dent 
supplement and incubated at 37°C and 200 rpm shacking. After 8 h, pre-cultures were diluted to the 
desired OD600 into 25 mL flasks and incubated at 37°C and 120 rpm shaking.  
 
For H. pylori mutant selection and culture, antibiotics were used at the following final concentrations: 
Kanamycin: 20 µg/ml 
Chloramphenicol: 8 µg/ml  
Streptomycin: 10 µg/ml  
Erythromycin: 10 µg/ml  
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6.2.2.1. H. pylori chromosomal manipulation techniques 
All mutant H. pylori strains listed in the Tables 8.1.1 and 8.2.3 in the Appendix were generated by 
chromosomal homologous recombination of PCR-generated constructs, introduced by natural 
transformation, as previously described (Bury-Moné et al., 2001). In all cases, constructs contained ≈ 
400 nt of the up- and downstream regions of the target gene of the chromosome, flanking the DNA 
fragment to be introduced (i.e., antibiotic resistance marker to generate deletions or a wild type copy 
of the target gene for complementation). DNA fragments of interest previously cloned in E. coli 
vectors to avoid H. pylori wild type genomic DNA (gDNA) contamination. Constructs were generated 
by PCR assembly of PCR products amplified from the plasmids shown in Tables 8.1.2 and 8.2.5 in the 
Appendix with the oligonucleotides shown in Tables 8.1.4 and 8.2.6 in the Appendix. Prior to 
transformation, H. pylori strains were grown from -80°C stocks for two passages, then resuspended in 
1 ml BHI and non-selective CAB plates were inoculated (by making a small circle) with the volume 
equivalent to 1 OD600. After 4 hours incubation at 37°C under microaerobic conditions, 1 µg of PCR 
assembly product was added to the cells and plates were incubated for another 16 hours. Transformed 
cells were then passed into plates supplemented with the appropriate antibiotics for the selection of 
recombinant cells and incubated for 4-6 days until isolated colonies appeared. Genomic DNA from 
potential clones was purified using the Quick Bacteria Genomic DNA extraction Kit and subjected to 
PCR and Sanger sequencing for mutant validation. 
6.2.2.2. Generation of an H. pylori 26695 streptomycin resistant strain 
The use of traditional drug resistance selection markers for the generation of mutant strains in H. 
pylori is possible, however, it can rapidly become limiting (e.g., if several genes need to be deleted, if 
resistance determinant affects cellular metabolism, or if alleles with small differences need to be 
compared). The use of a recipient strain containing a counterselectable marker at the locus of interest 
can overcome such limitations. In this study, the rpslCj-erm counterselectable marker conferring 
streptomycin sensitivity (rpslCj) and erythromycin resistance (erm) was used as described by 
Dailidiene and collegues (Dailidiene et al., 2006) and (Pernitzsch et al., 2014). This allows the 
selection of unmarked transformants by the loss of this rpslCj-erm marker, avoiding the use of 
traditional resistance determinants in the donor DNA. However, the use of this counterselectable 
marker requires the prior generation of a streptomycin resistant strain. To that aim, a PCR fragment 
containing the H. pylori 26695 rpsl gene carrying a mutation in the Lysine at position 43 to Arginine 
(rpslK43R), was used to transform a wild type H. pylori 26695 strain as described in the General 
Methods section in subheading 8.2.2.1 generating the strain rpslK43R (Table 8.1.1 in Appendix). This 
mutation in the rpsl gene, coding for the protein S12, has been previously demonstrated to confer 
streptomycin resistance by prompting S12 mutated binding to the same 16S rRNA loops that are 
specifically targeted by streptomycin (Gregory et al., 2001; Torii et al., 2003), thereby avoiding its 
action. 
6.2.2.3. Deletion of the H. pylori 26695 aapA3/IsoA3 locus using the rpslCj-erm cassette 
The method here developed for the analysis of toxicity determinants on toxin-encoding genes 
belonging to type I TA systems (FASTBAC-Seq, Chapter 4 section 4.1) required the previous 
generation of a strain on which the TA locus of interest have been replaced with the counterselection 
cassette rpslCj-erm on a streptomycin resistant background (rpsl K43R), as described by (Dailidiene et 
al., 2006). To this aim, 1) a fragment upstream of the locus was amplified with the primer pair 
FA406/FA407 (Table 8.1.4 in Appendix), representing a 415 nt homology region, 2) a second 
fragment downstream of the locus was amplified with the primer pair FA408/FA409 (Table 8.1.4 in 
Appendix), representing a 418 nt homology region. Note, the internal primers (FA407 and FA408) 
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were used to introduce a 3’- and 5’- rpslCj-erm cassette homology tails, respectively, that will allow 
subsequent PCR assembly. The rpslCj-erm cassette was amplified from the pSP60-2 plasmid (Table 
8.1.3 in the Appendix) using the primer pair FA110/FA111 (Table 8.1.4 in Appendix). The upstream 
and downstream fragments were then assembled with the rpslCj-erm cassette by PCR assembly using 
the external primers (FA406/FA409). This construct was used to transform the H. pylori 26695 strain 
as described in the General Methods section subheading 6.2.2.1. This process generated the strain that 
was posteriorly used as recipient strain in all our transformation experiments, the 
ΔaapA3/IsoA3::rpslCj-erm/rpslK43R strain (Table 8.1.1 in the Appendix). 
6.2.2.4. AapA3/IsoA3 locus sub-cloning in E. coli 
Because H. pylori has a highly active homologous recombination machinery, a cloning step of the 
aapA3/IsoA3 locus in an E. coli vector was essential to avoid contamination with WT H. pylori gDNA 
of the PCR products used in the transformation assays. To this end, the aapA3/IsoA3 locus was split 
into two fragments amplified with the Phusion High-Fidelity Hot Start DNA Polymerase and the 
primer pairs FA406/FA386 (fragment “Up”, of 638 nt containing 415 nt of homology region, the 
aapA3 promoter and the first 10 amino acids residues of AapA3 peptide, see Figure 8.1.1A in the 
Appendix) and FA409/FA387 (fragment “Down”, of 680 nt containing IsoA3 promoter, the rest of 
aapA3 mRNA and 418 nt of homology region, Figure 8.1.1A1A in the Appendix). Note that the 
FA386 and FA387 primers have 25 nucleotides overlap to allow PCR assembly. Each fragment was 
cloned in a separate pGEM®-T plasmid (Table 8.1.3 in the Appendix) and transformed into One Shot 
TOP10 chemically competent E. coli cells. 
6.2.2.5. Mutant generation by Site-Directed mutagenesis PCR  
Plasmids generated in the General Methods subheading 8.2.2.4. were isolated. Custom designed 
overlapping oligonucleotides containing the desired mutations were used to perform Site-Directed 
mutagenesis PCR. To inactivate the IsoA3 –10 box two synonymous point mutations (at position +87 
and +90 from the AapA3 TSS) were introduced using the primer pair FA283/FA284 (Table 8.1.4 in 
the Appendix, see Figure 4.2.1 for details). This strategy preserves the toxin coding sequence while 
completely abolishing the transcription of the antitoxin. To inactivate the toxin start codon, a single 
point mutation in the third codon position was introduced using the primer pair FA281/FA282 (Table 
8.1.4 in the Appendix, see Figure 4.2.1 for details). Wild-type or mutated fragments were amplified 
from the previously-generated and isolated plasmids using 35 amplification cycles, the Phusion High-
Fidelity Hot Start DNA Polymerase, and the same primer pairs as those used for insert amplification 
prior to cloning. PCR assembly with 35 amplification cycles, the Phusion High-Fidelity Hot Start 
DNA Polymerase and the external primers FA406/FA409 was performed to construct the 
aapA3/IsoA3 locus variants (1294 nt amplicon) posteriorly used as DNA substrates for H. pylori 
transformation. For the in vivo ‘clean’ validation of all the mutants here studied, this same protocol 
was used adapting the DNA oligonucleotides used for Site-Directed mutagenesis PCR. 
 
6.2.2.6. Determining H. pylori transformation efficiency  
H. pylori transformation was performed as described in General Methods subheading 6.2.2.1. The 
transformation assays aimed at the determination of the transformation efficiency as an indirect prove 
of the toxicity produced by the expression of a PCR construct. For this purpose, transformation 
patches (after 16 hours growth upon DNA addition) were recovered and resuspended in 1 ml BHI. 
Ten-fold serial dilutions adapted to each transformation case (10-7, 10-6 and 10-5 for non-selective 
media; and 10-4, 10-3, 10-2 for selective media upon transformation with water or a toxic construct; and 
10-5, 10-4, 10-3 for selective media upon transformation with non-toxic constructs) were performed. 
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Allelic replacement events were selected by the use of streptomycin-containing plates (selection of 
loss of the rpslCj-erm cassette, StrR). The number of StrR CFU/total CFU was calculated, plotted on 
base-10 logarithmic scale and statistically analyzed by unpaired t-test (GraphPad Prism software 
version 7).  
6.2.2.7. H. pylori transformation assay to identify toxicity suppressors by Illumina 
sequencing 
Transformation assays aiming at the identification to toxicity suppressors by Illumina sequencing were 
performed in three biological replicates, using the wild-type (WT) or antitoxin promoter inactivated 
PRC-generated constructs (pIsoA3*). Upon transformation, all bacteria were recovered and serially 
diluted. Colonies were isolated on streptomycin-containing plates by using optimized dilutions (9 
plates/replicate of 10-1 dilution for pIsoA3* and 3 plates/replicate of 10-3 dilution for WT). Three days 
after transformation, isolated colonies were pooled (approximately 60,000 colonies per 
transformation) and genomic DNA was extracted. Next, a 426 nt-long amplicon corresponding to the 
aapA3/IsoA3 locus was amplified with the primer pair FA395/FA396 (introducing the DNA adapters 
for Illumina paired-end sequencing, Table 8.1.4 in the Appendix). Importantly, to avoid amplification 
from rpslCj revertant strains (mutated rpslCj gene), the FA395 and FA396 primers are nested to the 
ones used for locus deletion (FA407 and FA408), thus, binding to deleted regions that are re-
introduced only upon recombination. For this PCR, the Phusion High-Fidelity Hot Start DNA 
polymerase and 35 amplification cycles were used. Finally, the samples were sent for sequencing at 
the Platforme GeT-PlaGe-, Genotoul Centre INRA, Toulouse. Sequencing was done on an Illumina 
MiSeq instrument in paired-end mode 2 x 250 nt (overlapping reads). 
 
6.2.3. Nucleic acid techniques 
Molecular biology experiments were performed according to standard procedures and the supplier 
recommendations. High Purity Plasmid Miniprep Kit and Quick Bacteria Genomic DNA extraction 
Kit were used for plasmid preparations and H. pylori genomic DNA extractions, respectively. PCR 
were performed either with Dream Taq DNA polymerase, or with Phusion High-Fidelity Hot Start 
DNA polymerase when the product required high fidelity polymerase. Site directed mutagenesis PCR 
was performed with the PfuUltra High-Fidelity DNA Polymerase. 
6.2.3.1. Agarose gel electrophoresis 
DNA fragments were separated in agarose gels. For preparation 0.8 to 2% (w/v) agarose was dissolved 
in 1X TBE buffer. At a gel solution temperature of ≈55°C, ethidium bromide was added to a final 
concentration of ≈50 µg/100 ml. Samples were mixed with five volumes of 6X Sample Loading 
Buffer, loaded and run in 1X TBE buffer at 120 V for 20-40 min (depending on the fragment size). 
6.2.3.2. Polyacrylamide gel electrophoresis 
RNA fragments were separated in polyacrylamide (PAA) gels.  
 
Denaturing PAGE: denaturing gels (native structure of RNA molecules is destroyed) were 
supplemented with urea to a final concentration of 7 M. 
 
Prior to use, all equipment was carefully cleaned with 70% ethanol. Polymerization was initiated by 
adding 1/100 volume of ammonium persulfate (APS) and 1/1000 volume of N,N,N',N'-
tetramethylethane-1,2-diamine (TEMED). RNA samples were mixed with one volume of 2X Gel 
Loading Buffer II, denatured for 5 min at 90°C and loaded. Gel runs were performed in 1 x TBE at 
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18W for 1 to 4 hours (according to the size of the RNA species to be analyzed). When needed (i.e., 
sequencing gels), gels were dried for 45 min at 80°C, and revealed using a Pharos FX 
phosphorimager. 
6.2.3.3. Total RNA preparation with hot phenol 
Bacterial growth was stopped at the desired OD600 by addition of 650 µl Stop Solution (pre-chilled at -
20°C) to 5 mL of culture and rapidly placed on ice. Cells were then centrifuged for 10 min at 3,500 
rpm and 4°C and the pellets were stored at -80°C. Cell pellets were resuspended in 600 µl Lysis 
Solution and added to 600 µl hot phenol pH 5.2. After incubation for 10 min at 65°C, the mixture was 
centrifuged for 10 min at 13,000 rpm and room temperature. The aqueous phase was transferred to a 
phase-locked gel tube with an equal volume of chloroform and centrifuged for 10 min at 13,000 rpm 
and room temperature. Total RNA was precipitated from the aqueous phase by adding 2.5 volumes of 
EtOH 100% and 1/10 volumes 3 M NaOAc pH 5.2. After centrifugation for 30 min at 13,000 rpm and 
4°C, the supernatant was discarded and the pellet was washed with 75% EtOH. Finally, the 
supernatant was discarded and the RNA pellet air-dried and resuspended in H2O. For RNA half-life 
determinations, rifampicin (prepared at 34 mg/ml in methanol) was added to the culture at a final 
concentration of 80 µg/ml and cells were harvested at the desired time points. A culture where 
rifampicin was replaced by the same volume of methanol served as a non-treated control. 
6.2.3.4. DNase I digestion 
RNA samples resuspended in H2O denatured at 65°C for 5 min and subsequently cooled down on ice 
for other 5 min. Then, 1 µl of DNase I per µg of RNA was added and samples were incubated for 30 
min at 37°C. After DNase I treatment RNA was isolated by phenol:chloroform:isoamylalcohol (P:C:I) 
extraction. RNA was mixed with one volume of P:C:I (25:24:1 v/v) by vortexing for 10 s. Samples 
were centrifuged for 10 min at 13,000 rpm and 4°C. The aqueous phase (upper) was mixed with 2.5 
volumes of 30:1 (v/v) EtOH:3M NaOAc pH 5.2 and RNA was precipitated overnight at -20°C. 
6.2.3.5. Radioactive labeling of DNA oligonucleotides for RNA detection 
For DNA oligonucleotide labeling 10 pmol of the oligonucleotide was incubated in a 10 µl reaction 
volume with 25 µCi of 32P-γ-ATP in the presence of 1 u T4 polynucleotide kinase (PNK) for 30 min at 
37°C. MicroSpinTM G-25 columns were used to get rid of unincorporated nucleotides. 
6.2.3.6. Northern Blot 
For Northern blot analysis, 1 to 10 µg RNA were separated on an 8% polyacrylamide (PAA), 7M urea, 
1x Tris-Borate-EDTA (TBE) gel. RNA was transferred to a HybondTM-N nylon membrane by 
electroblotting in TBE 1X at 8V and 4°C overnight. Then, RNA was cross-linked to the membrane by 
UV irradiation (302 nm) for 2 min in a UV-crosslinker. After pre-hybridization for 1 h in 15 ml 
modified Church Buffer at 42°C or 65°C for DNA or RNA probes, respectively, the radioactive 
labeled probe (2-5 pmol) was added. After a hybridization period of 3-18 h at 42°C or 65°C for DNA 
or RNA probes, respectively, the Membranes were washed two times 5 minutes in 2X SSC, 0.1% 
SDS, and revealed using a Pharos FX phosphorimager. For the detection of aapA3 mRNA species the 
labeled primer FD38 was used (Table 8.1.4 in the Appendix). IsoA3 small RNA was detected with a 
riboprobe corresponding to the aapA3-Tr RNA species transcribed from a PCR fragment containing 
the T7 promoter amplified with the primer pair FA170/FA173 (Table 8.1.4 in the Appendix). 
6.2.3.7. Polysome fractionation in sucrose gradients 
H. pylori strains were grown as previously described. At an early exponential phase (OD600<0.9), 
chloramphenicol (100 µg/ml) was added to the culture to stabilize translating ribosomes. After 5 min 
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incubation at 37°C, cultures were quickly cooled by transferring them into pre-chilled flasks 
immerged in a dry ice/ethanol bath. Cultures were then centrifuged for 10 min at 3,500 rpm and 4°C 
and pellets were washed with Buffer A and frozen at -80°C. Then, pellets were resuspended in 500 µl 
of Buffer A containing RNasin® Ribonuclease Inhibitor and cells were lyzed with glass beads in a 
Precellys homogenizer. Lysates were recovered and immediately frozen in liquid nitrogen. About 10 
OD260 units of lysate were layered onto 10% - 40% sucrose gradients in Grad-Buffer and centrifuged 
at 35,000 rpm for 3.75 h at 4°C in a SW41 Ti rotor. Gradients were analyzed with an ISCO UA-6 
detector with continuous monitoring at 254 nm. Fractions of 500 µl were collected and RNA was 
precipitated by adding 1 volume of ethanol containing 150 mM of sodium acetate pH 5.2 and stored at 
-20°C. RNA was extracted as described above and subjected to Northern Blot analysis following the 
above-described protocol.  
6.2.3.8. Cold and hot in vitro transcription 
For cold in vitro synthesis of the aapA3 and IsoA3 RNAs, DNA templates were amplified from H. 
pylori 26695 genomic DNA using primer pairs: FA170/FA175 (aapA3-FL), FA170/FA173 (aapA3-
Tr), FD11/FD17 (IsoA3), each forward primer carrying a T7 promoter sequence (see primer list in 
Table 8.1.4 in Appendix). In vitro transcription was carried out using the MEGAscript® T7 
Transcription Kit according to the manufacturer’s protocol. After P:C:I (25:24:1 v/v) extraction 
followed by overnight isopropanol precipitation at -20°C and 30 min centrifugation at 13,000 rpm and 
4°C, the RNA pellets were resuspended in H2O. Samples were desalted and unincorporated 
nucleotides were removed by gel filtration using a Sephadex G-25 1 ml column. RNA integrity was 
checked on PAA denaturing gel and visualized by Stains-All. Hot in vitro transcription, was 
performed as described above but in the presence of 50 µCi of 32P-α-UTP and 1 mM cold UTP 
(instead of 10 mM used for all dNTPs during cold in vitro transcription). To generate 5’-
monophosphate internally labelled RNAs, 30 mM GMP (8-fold excess of guanosine monophosphate 
over guanosine triphosphate to obtain uniformly labeled RNA that has a 5’-monophosphorylated end) 
was added to the hot in vitro transcription reaction. Unincorporated nucleotides were removed using a 
MicroSpinTM G-25 column and labeled RNA was purified on an 8% PAA containing 7 M urea 1X 
TBE gel. Upon visualization of the labeled RNA on an autoradiography film, the band corresponding 
to the RNA species of interest was cut from the gel and eluted overnight at 4°C under shaking in 750 
µl RNA elution buffer. RNA was extracted by P:C:I (25:24:1 v/v), desalted and concentrated by 
ethanol precipitation, pellets were resuspended in 100 µl H2O and stored at -20°C. 
Sequences of the T7 RNAs used in Chapter 4 sections 4.2 and 4.3 are shown in Table 6.3.2 and Table 
6.4.2, respectively, in this Chapter.  
6.2.3.9. 5’ end labeling of RNA 
20 pmol RNA was dephosphorylated with 10 u of calf alkaline phosphatase (CIP) in a 20 µl reaction at 
37°C for 1 h. RNA was isolated by phenol extraction and precipitated overnight at -20°C in the 
presence of 30:1 EtOH: NaOAc pH 5.2 and 20 µg GlycoBlueTM. The dephosphorylated RNA was then 
5’ end-labeled with 10 pmol 32P-γ -ATP using the T4 polynucleotide kinase (PNK) for 30 min at 37°C 
in a 20 µl reaction. Labeled RNA was gel purified as described in the subheading 6.2.3.8. of the 
General Methods section, resuspended in 50 µl H2O and stored at -20°C. 
 
CHAPTER 6. Materials and Methods 
 126 
6.2.4. Protein techniques 
6.2.4.1. One-dimensional SDS PAGE 
Denaturing separation of protein samples was performed in 15% SDS-PAGE gels. Preparation was 
performed as follows: 
 
PAA gel for 15 % resolving gel (Vf =30 ml) 
40% PAA solution (29:1 acrylamide/bisacrylamide)   11.25 ml 
Tris-HCl 3M pH 8.45, 0.3% SDS     10 ml 
100% Glycerol        3.2 ml 
H2O         5.5 ml 
10% APS        100 µl 
TEMED        30 µl 
 
PAA gel for 6 % stacking gel (Vf =15 ml) 
40% PAA solution (29:1 acrylamide/bisacrylamide)   2.25 ml 
Tris-HCl 3M pH 8.45, 0.3% SDS     3.75 ml 
100% Glycerol        3.2 ml 
H2O         9 ml 
10% APS        60 µl 
TEMED        37.5 µl 
 
Gels were run for 1h at 80 V (stacking gel) and for 2 h at 120 V on 1X cathode (upper tank) and 1X 
anode (lower tank) buffers. 
 
6.2.4.2. In vitro translation assays 
In vitro translation assays were performed as described in (Sharma et al., 2010) with minor 
modifications. For in vitro translation of the aapA3-FL and aapA3-Tr mRNAs, 0.5 µg (≈7 pmol 
aapA3-Tr, 8 pmol aapA3-FL) of cold in vitro transcribed RNA was added to the E. coli S30 Extract 
System for Linear Templates Kit in 25 µl reactions containing 0.2 mM [35S]-methionine (1175 
Ci/nmol; Perkin-Elmer), 7.5 µl S30 extract, 10 µl S30 premix without amino acids, and 0.1 mM of 
each amino acid minus methionine. Reactions were incubated for 1 h at 73°C, stopped with 100 µl 
NaOH and precipitated with 1 ml of TCA (25%). After 30 min centrifugation at 13,000 rpm, pellets 
were washed twice with acetone, then resuspended in 20 µl of 1X Tricine Sample Buffer, heat-
denatured for 5 min at 90°C and separated in 16.5% Tris-tricine gels using Low-Range Rainbow 
molecular weight marker as size standard. Gels were run at 120V for 1h at 80 V (stacking gel) and for 
2 h at 120 V, dried at 80°C for 2 h and revealed using a Pharos FX phosphorimager. 
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6.3. Methods Paper III 
6.3.1. Bacterial strains and oligonucleotides 
H. pylori strains used in Chapter 4 section 4.2 (Paper III) are listed in Table 8.1.1 in the Appendix. H. 
pylori chromosome manipulations and mutant strain generation were performed as described in the 
General Methods section. Selection of toxicity suppressor mutations and analysis by Illumina 
sequencing was performed as described in the General Methods section and in more detail in Chapter 
4 section 4.1 (Paper II). 
For the in vivo validation of suppressor mutants, single nucleotide mutations of interest were 
introduced by Site-Directed mutagenesis PCR using the pA3-Up and pA3-Down plasmids (Table 
8.1.2 in the Appendix, see Table 6.3.1 for sequences details) as DNA templates and the DNA 
oligonucleotides listed in in the Table 8.1.4 in the Appendix. 
 
6.3.2. In vitro structure probing 
Structure probing analyses were performed as described previously (Darfeuille et al., 2007; Sharma et 
al., 2007, 2010), using 0.1 pmol of 5’ end-labeled RNA. Before use, each in vitro transcribed RNA 
was denatured by incubation at 90°C for 2 min in the absence of magnesium and salt, then chilled on 
ice for 1 min, followed by a renaturation step at room temperature for 15 min in 1X Structure Buffer. 
To determine the secondary structure of RNA, 0.01 u RNase T1 was added to the labeled RNA and 
incubated in 1X Sequencing Buffer for 5 min at 37°C. Lead acetate (5 mM final concentration) 
digestions of both aapA3-Tr and aapA3-FL were done in the absence or in the presence of 2-10 fold 
excess IsoA3 cold RNA. All the reactions were stopped by adding 10 µl of 2X Gel Loading Buffer II 
and stored at -20°C. Cleaved fragments were then analyzed on an 8% denaturing PAA gel containing 
7M urea and 1X TBE. Gels were dried 45 min at 80°C, and revealed using a Pharos FX 
phosphorimager. 
 
6.3.3. RNase H1/oligonucleotide accessibility assays 
Before use, each in vitro transcribed RNA and DNA oligonucleotides were denatured by incubation at 
90°C for 2 min in the absence of magnesium and salt, then chilled on ice for 1 min. RNA followed a 
renaturation step at 37°C for 5 min in 1X Structure Buffer. Next, DNA oligonucleotides 
complementary to the region around the SD sequence (FA633 for WT and T78C (aSD2) mRNA; 
FA644 for A40T mRNA (aSD1); FA651 for the double mutant 33A>T/A40T mRNA (aSD1); and 
FA652 for A28C mRNA; sequences listed in Table 8.1.4 in the Appendix) were added to a final 
concentration of 0 to 10 µM. Reactions were adjusted to a final volume of 10 µl with RNase free H2O 
and incubated for 30 min at 30°C in the presence or absence (control) of 0.25 u E. coli RNase H1. 
Reactions were then stopped by addition of 10 µl of 2X Gel Loading Buffer and stored at -20°C. 
Cleaved fragments were analyzed on an 8% denaturing PAA gel containing 7M urea and 1X TBE.  
Gels were dried 45 min at 80°C, and revealed using a Pharos FX phosphorimager. 
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Table 6.3.1. Inserts of rpslCj-erm and aapA3/IsoA3 plasmids used in Paper III. 
Restriction enzymes sites are highlighted in blue; promoters are highlighted in yellow; Transcriptional Start 
Site (TSS) is highlighted in yellow and in bold; aapA3-FL mRNA 3’ end is highlighted in yellow and bold; 
Shine-Dalgarno sequences are highlighted in green; ORFs are shown in red; translation start and stop sites 
are highlighted in bold; mutations are underlined. Cloning primers determine the borders of the insert, and 
add when need it the restriction sites to allow cloning. SDS primers are the ones used for Site-Directed 
mutagenesis PCR. All nucleotide positions (mutations) are relative to Aapa3 TSS. A3 refers to the 
aapA3/IsoA3 chromosomal locus of the H. pylori 26695 strain.  
Name Plasmid/
Origin/ 
Marker 
Insert (nt) Cloning 
primers  
SDM 
primers 
pSP60-
2 
(rpslCj-
erm) 
pSP60/ 
pSC101* / 
AmpR 
GGATCCTGCTTTATAACTATGGATTAAACACTTTTTTAGTAAT
TTCTTAAAATCAATTTTGGAATTTTTCATTTTGTCTAAAATGA
GTAAGATTATTTTTATAAGTAAAACAATAATTAAAAATTAGT
TTATGTTTTATAAATATTAATGTAAATTATGTAGGTTTATTTT
ATAAAAATTTTTAAAAGCATTTAAATTATTTCTAGTTTATATT
TTTGTAAGTAAATTTTAGATATCATCCAAAGTTTATTACATTT
TTAAAGAAAGGAATTATTGTGCCTACCATAAATCAATTGGTT
AGAAAAGAGCGCAAAAAAGTTTTAGAAAAATCTAAATCTCC
AGCGCTTAAAAATTGTCCACAAAGAAGGGGAGTTTGCACTA
GGGTTTATACTACAACACCTAAAAAACCAAACTCAGCGTTA
AGAAAAGTTGCCAAAGTAAGACTTACTAGTGGCTTTGAAGT
GATCAGCTATATCGGCGGTGAAGGTCATAACTTGCAAGAAC
ACAGCATTGTTTTAGTGCGTGGTGGTAGGGTAAAAGACTTAC
CAGGGGTTAAATATCACATCGTTCGTGGTGCTCTTGATACAG
CAGGTGTTGCAAAAAGAACAGTTTCTCGTTCTAAATATGGTG
CTAAACGTCCTGAAGCAGGCGCTGCAAAATAATCATTCATAC
AGACAAATCCGTTAGACCAATAATCGCATCAGATTGCAGTAT
AAATTAACGATCACTCATCATGTCATATTATCAGAGCTCGTG
CTATAATTATACTAATTTTATAAGGAGGGAAAAATAAAGAG
GGTTATAATGAACGAGAAAAATATAAAACACAGTCAAAACT
TTATTACTTCAAAACATAATATAGATAAAATAATGACAAATA
TAAGATTAAATGAACATGATAATATCTTTGAAATCGGCTCAG
GAAAAGGGCATTTTACCCTTGAATTAGTACAGAGGTGTAATT
TCGTAACTGCCATTGAAATAGACCATAAATTATGCAAAACTA
CAGAAAATAAACTTGTTGATCACGATAATTTCCAAGTTTTAA
ACAAGGATATATTGCAGTTTAAATTTCCTAAAAACCAATCCT
ATAAAATATTTGGTAATATACCTTATAACATAAGTACGGATA
TAATGCGCAAAATTGTTTTTGATAGTATAGCTGATGAGATTT
ATTTAATCGTGGAATACGGGTTTGCTAAAAGATTATTAAATA
TAAAACGCTCATCGGCATTATTTTTAATGGCAGAAGTTGATA
TTTCTATATTAAGTATGGTCCCAAGAGAATATTTTCATCCTA
AACCTAAAGTGAATAGCTCACTTATCAGATTAAATAGAAAA
AAATCAAGAATATCACACAAAGATAAACAGAAGTATAATTA
TTTCGTTATGAAATGGGTTAACAAAGAATACAAGAAAATATT
TACAAAAAATCAATTTAACAATTCCTTAAAACATGCAGGAAT
TGACGATTTAAACAATATTAGCTTTGAACAATTCTTATCTCTT
TTCAATAGCTATAAATTATTTAATAAAGTAAGAATTC (1545) 
(Pernitzsch 
et al., 
2014) 
- 
pA3-
Up WT 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAAAT
CCTATGTCAAAAGGAGCATGCCATGAAACACAAAAGTGGCA
AACGCTCTTGG (638) 
FA406/ 
FA386 
- 
pA3-
Down 
WT 
pGEM-T/ 
CoEl1/ 
AmpR 
CACAAAAGTGGCAAACGCTCTTGGAAAACATTATACTTTGA
GTTTGCTTTTTTGGGGCTTAAAGTGATCGTTTCTGTGAAACGC
TGATTTTTCTAAGAGCGTTCCCTTAAGCTTTTAAGCTTAGGG
GTTTCCTTATGAAGCGGGTTTGTCCTTGACTTTTGGGGCGTTG
GTCATTTTGTTGTAAAACTTATTTTCTTTAGGGGATAGAAAT
AATTCTCCCCTCTATAAAACTAAATCCCCTCATAGAGTGCTT
FA387/ 
FA409 
- 
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TTAAAAAATACCGCTTGCTCTAGCTTTTTGATTATTTGTCTTA
AAAATCACTCCCTTAAAAACCCGTATTCATAGACTTTAGGCT
GTATTTCTTTGGCGAGATCTTTTAGGGCGTCTTGCAAATTAG
CGTAAAGCTGTTTGTAATATTCATCTTTAGCTTTAGCGGGTA
AATTTAATTTGCCTTGCTTGTTACGGCCTTGAAAAAATTCTTT
GATGTCATAAAGGCTTGCGTTAGCGTTATAGGGGCGGTTTGT
GAAATCTTGTGTGTGGTAATAGCGATAAACCTCTCTGCTAGC
GTCAAACACCTTTGAAGCGCTCGGGCTGAATTTCAGGGGCTT
GTTTTCTTTTTTGGCACTTAAAAAGAGGCTATCGTTCTCTTTA
AGTTCTTTGATTTCGCCTTTTAAAAACTCTAATAGAGCGTGG
CTAG (680) 
pA3-
Up 
start  
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAAAT
CCTATGTCAAAAGGAGCATGCCATTAAACACAAAAGTGGCA
AACGCTCTTGG (638) 
FA406/ 
FA386 
FA281/ 
FA282 
pA3-
Down  
pIsoA3
* 
pGEM-T/ 
CoEl1/ 
AmpR 
CACAAAAGTGGCAAACGCTCTTGGAAAACGTTCTACTTTGAG
TTTGCTTTTTTGGGGCTTAAAGTGATCGTTTCTGTGAAACGCT
GATTTTTCTAAGAGCGTTCCCTTAAGCTTTTAAGCTTAGGGG
TTTCCTTATGAAGCGGGTTTGTCCTTGACTTTTGGGGCGTTGG
TCATTTTGTTGTAAAACTTATTTTCTTTAGGGGATAGAAATA
ATTCTCCCCTCTATAAAACTAAATCCCCTCATAGAGTGCTTTT
AAAAAATACCGCTTGCTCTAGCTTTTTGATTATTTGTCTTAAA
AATCACTCCCTTAAAAACCCGTATTCATAGACTTTAGGCTGT
ATTTCTTTGGCGAGATCTTTTAGGGCGTCTTGCAAATTAGCG
TAAAGCTGTTTGTAATATTCATCTTTAGCTTTAGCGGGTAAA
TTTAATTTGCCTTGCTTGTTACGGCCTTGAAAAAATTCTTTGA
TGTCATAAAGGCTTGCGTTAGCGTTATAGGGGCGGTTTGTGA
AATCTTGTGTGTGGTAATAGCGATAAACCTCTCTGCTAGCGT
CAAACACCTTTGAAGCGCTCGGGCTGAATTTCAGGGGCTTGT
TTTCTTTTTTGGCACTTAAAAAGAGGCTATCGTTCTCTTTAAG
TTCTTTGATTTCGCCTTTTAAAAACTCTAATAGAGCGTGGCTA
G (680) 
FA387/ 
FA409 
FA283/ 
FA284 
pA3-
Up 
A28C 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAACT
CCTATGTCAAAAGGAGCATGCCATGAAACACAAAAGTGGCA
AACGCTCTTGG (638) 
FA406/ 
FA386 
FA465/ 
FA466 
pA3-
Up 
A33T 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAAAT
CCTTTGTCAAAAGGAGCATGCCATGAAACACAAAAGTGGCA
FA406/ 
FA386 
FA546/ 
FA547 
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AACGCTCTTGG (638) 
pA3-
Up 
A40T 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAAAT
CCTATGTCAATAGGAGCATGCCATGAAACACAAAAGTGGCA
AACGCTCTTGG (638) 
FA406/ 
FA386 
FA467/ 
FA468 
pA3-
Up 
A33T 
A40T 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAAAT
CCTTTGTCAATAGGAGCATGCCATGAAACACAAAAGTGGCA
AACGCTCTTGG (638) 
FA406/ 
FA386 
FA548/ 
FA549 
pA3-
Up 
T78C  
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAAAT
CCTATGTCAAAAGGAGCATGCCATGAAACACAAAAGTGGCA
AACGCTCCTGG (638) 
FA406/ 
FA386 
FA511/ 
FA512 
pA3-
Down  
T78C 
pGEM-T/ 
CoEl1/ 
AmpR 
CACAAAAGTGGCAAACGCTCCTGGAAAACATTATACTTTGA
GTTTGCTTTTTTGGGGCTTAAAGTGATCGTTTCTGTGAAACGC
TGATTTTTCTAAGAGCGTTCCCTTAAGCTTTTAAGCTTAGGG
GTTTCCTTATGAAGCGGGTTTGTCCTTGACTTTTGGGGCGTTG
GTCATTTTGTTGTAAAACTTATTTTCTTTAGGGGATAGAAAT
AATTCTCCCCTCTATAAAACTAAATCCCCTCATAGAGTGCTT
TTAAAAAATACCGCTTGCTCTAGCTTTTTGATTATTTGTCTTA
AAAATCACTCCCTTAAAAACCCGTATTCATAGACTTTAGGCT
GTATTTCTTTGGCGAGATCTTTTAGGGCGTCTTGCAAATTAG
CGTAAAGCTGTTTGTAATATTCATCTTTAGCTTTAGCGGGTA
AATTTAATTTGCCTTGCTTGTTACGGCCTTGAAAAAATTCTTT
GATGTCATAAAGGCTTGCGTTAGCGTTATAGGGGCGGTTTGT
GAAATCTTGTGTGTGGTAATAGCGATAAACCTCTCTGCTAGC
GTCAAACACCTTTGAAGCGCTCGGGCTGAATTTCAGGGGCTT
GTTTTCTTTTTTGGCACTTAAAAAGAGGCTATCGTTCTCTTTA
AGTTCTTTGATTTCGCCTTTTAAAAACTCTAATAGAGCGTGG
CTAG (680) 
FA387/ 
FA409 
FA511/ 
FA512 
pA3-
Down  
T78C/p
IsoA3* 
pGEM-T/ 
CoEl1/ 
AmpR 
CACAAAAGTGGCAAACGCTCCTGGAAAACGTTCTACTTTGA
GTTTGCTTTTTTGGGGCTTAAAGTGATCGTTTCTGTGAAACGC
TGATTTTTCTAAGAGCGTTCCCTTAAGCTTTTAAGCTTAGGG
GTTTCCTTATGAAGCGGGTTTGTCCTTGACTTTTGGGGCGTTG
GTCATTTTGTTGTAAAACTTATTTTCTTTAGGGGATAGAAAT
AATTCTCCCCTCTATAAAACTAAATCCCCTCATAGAGTGCTT
TTAAAAAATACCGCTTGCTCTAGCTTTTTGATTATTTGTCTTA
AAAATCACTCCCTTAAAAACCCGTATTCATAGACTTTAGGCT
GTATTTCTTTGGCGAGATCTTTTAGGGCGTCTTGCAAATTAG
FA387/ 
FA409 
FA511/ 
FA512 
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CGTAAAGCTGTTTGTAATATTCATCTTTAGCTTTAGCGGGTA
AATTTAATTTGCCTTGCTTGTTACGGCCTTGAAAAAATTCTTT
GATGTCATAAAGGCTTGCGTTAGCGTTATAGGGGCGGTTTGT
GAAATCTTGTGTGTGGTAATAGCGATAAACCTCTCTGCTAGC
GTCAAACACCTTTGAAGCGCTCGGGCTGAATTTCAGGGGCTT
GTTTTCTTTTTTGGCACTTAAAAAGAGGCTATCGTTCTCTTTA
AGTTCTTTGATTTCGCCTTTTAAAAACTCTAATAGAGCGTGG
CTAG (680) 
pA3-
Up 
G43A 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTAAA
TTTCAATTAAAGGAGTCATCATGGCACACCATGAACAACAA
CAGCAACAACAGGCTAACAGCCAACACCACCACCATCACCA
TGCGCACCACCACCATTACTACGGTGGCGAACACCATCACCA
TAATGCGCAACAACACGCCGAACAACAAGCAGAGCAACAAG
CTCAGCAACAGCAACAACAACAAGCACACCAACAACAACAA
CAAAAAGCGCAACAACAAAACCAACAATATTGATTGGGGCG
TTTGTGGGGGCGGCCTTAGGGCTACTCCTAGCTTTTAACTCTT
TCTTTTAATCTAGTAAATTTATCCATTTAAACTAACTTTTTTA
ACTCCGTTAGATTTTTAAACTTTTAAAATCCCTCTTTTTGATG
CTTGTCAAATGGCTCTGTTTTCTATCCAATAAAGATAAGCCT
TATTAATTGAGTGGTCGTAATGGGGTGTAAAAACTTTGTCTT
GCGTATTTGATGCGGTCTAGGGGTGTTTTAAGGGGGTTTGTT
GTAGGATTTCATCACGCCCCATAGTTGCAATATGGGGCAAAT
CCTATGTCAAAAGAAGCATGCCATGAAACACAAAAGTGGCA
AACGCTCTTGG (638) 
FA406/ 
FA386 
FA535/ 
FA536 
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Table 6.3.2. Sequence of T7 RNAs used for in vitro studies in Paper III. 
Lower-case letter indicated the T7 promoter used. Red letters indicate ORFs. Translation start and stop 
codons are shown in bold. Mutated positions are underlined. nt* indicates the length in nucleotides of the 
RNA (excluding the T7 promoter sequence). 
T7 RNA Sequence (5’à3’) (nt*) Primer pair Template 
aapA3-FL WT gaaattaatacgactcactataggACGCCCCATAGTTGCAA
TATGGGGCAAATCCTATGTCAAAAGGAGCAT
GCCATGAAACACAAAAGTGGCAAACGCTCTT
GGAAAACATTATACTTTGAGTTTGCTTTTTTG
GGGCTTAAAGTGATCGTTTCTGTGAAACGCT
GATTTTTCTAAGAGCGTTCCCTTAAGCTTTTA
AGCTTAGGGGTTTCCTTATGAAGCGGGTTTGT
CCTTGACTTTTGGGGCGTTGGTC (229) 
FA170/FA175 gDNA H. pylori 
26695 WT 
aapA3-Tr WT gaaattaatacgactcactataggACGCCCCATAGTTGCAA
TATGGGGCAAATCCTATGTCAAAAGGAGCAT
GCCATGAAACACAAAAGTGGCAAACGCTCTT
GGAAAACATTATACTTTGAGTTTGCTTTTTTG
GGGCTTAAAGTGATCGTTTCTGTGAAACGCT
GATTTTTCTAAGAGCGTTCCCTTAAGCTTTTA
AGCTTAGGGGTTTCCT (190) 
FA170/FA173 gDNA H. pylori 
26695 WT 
aapA3-Tr  A28C gaaattaatacgactcactataggACGCCCCATAGTTGCAA
TATGGGGCAACTCCTATGTCAAAAGGAGCAT
GCCATGAAACACAAAAGTGGCAAACGCTCTT
GGAAAACATTATACTTTGAGTTTGCTTTTTTG
GGGCTTAAAGTGATCGTTTCTGTGAAACGCT
GATTTTTCTAAGAGCGTTCCCTTAAGCTTTTA
AGCTTAGGGGTTTCCT (190) 
FA170/FA173 gDNA H. pylori 
26695 aapA3 
A28C/ pIsoA3* 
aapA3-Tr A40T gaaattaatacgactcactataggACGCCCCATAGTTGCAA
TATGGGGCAAATCCTATGTCAATAGGAGCAT
GCCATGAAACACAAAAGTGGCAAACGCTCTT
GGAAAACATTATACTTTGAGTTTGCTTTTTTG
GGGCTTAAAGTGATCGTTTCTGTGAAACGCT
GATTTTTCTAAGAGCGTTCCCTTAAGCTTTTA
AGCTTAGGGGTTTCCT (190) 
FA170/FA173 gDNA H. pylori 
26695 aapA3 
A40T/ pIsoA3* 
aapA3-Tr A33T A40T gaaattaatacgactcactataggACGCCCCATAGTTGCAA
TATGGGGCAAATCCTTTGTCAATAGGAGCAT
GCCATGAAACACAAAAGTGGCAAACGCTCTT
GGAAAACATTATACTTTGAGTTTGCTTTTTTG
GGGCTTAAAGTGATCGTTTCTGTGAAACGCT
GATTTTTCTAAGAGCGTTCCCTTAAGCTTTTA
AGCTTAGGGGTTTCCT (190) 
FA170/FA173 gDNA H. pylori 
26695 aapA3 
A33T A40T/ 
pIsoA3* 
aapA3-Tr T78C gaaattaatacgactcactataggACGCCCCATAGTTGCAA
TATGGGGCAAATCCTATGTCAAAAGGAGCAT
GCCATGAAACACAAAAGTGGCAAACGCTCCT
GGAAAACATTATACTTTGAGTTTGCTTTTTTG
GGGCTTAAAGTGATCGTTTCTGTGAAACGCT
GATTTTTCTAAGAGCGTTCCCTTAAGCTTTTA
AGCTTAGGGGTTTCCT (190) 
FA170/FA173 gDNA H. pylori 
26695 aapA3 
T78C/pIsoA3* 
IsoA3 WT CAAGAGCGTTTGCCACTTTTGTGTTTCATGGC
ATGCTCCTTTTGACATAGGATTTGCCCCATAT
TGCAACTATGGGGCGT (80) 
FD110/FD17 gDNA H. pylori 
26695 WT 
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6.6. Methods Paper IV 
6.4.1. Bacterial strains and oligonucleotides 
Bacterial strains and oligonucleotides used in the Chapter 4 section 4.3 (paper IV) are listed in the 
Table 8.2.3 and 8.2.6 in the Appendix, respectively. Sequences of the pGEM-T cloned inserts of the 
aapa3/IsoA3 locus mutated variants are shown in Table 6.4.1 in this Chapter. 
 
Generation of the H. pylori PNPase and PNPase/aapA3/IsoA3 deleted strains 
To generate the pnp deletion in the H. pylori 26995/rpslK43R strain, the PNPase residues 1-658 were 
replaced by the counterselection marker rpslCj-erm in a rpslK43R genetic background as described by 
(Dailidiene et al., 2006). PCR-construction was performed as described in the General Methods. In 
detail, the primer pairs FD699/FA109 and FA112/FD702 (Table 8.2.6 in the Appendix) were used to 
amplify the upstream and downstream to pnp deletion regions and introduce the rpslCj-erm homology 
tails to allow the subsequent PCR assembly. The rpslCj-erm cassette was amplified from the pSP60-2 
plasmid (Table 8.2.5 in the Appendix) with the primer pair FA110/FA111. Fragments were assembled 
by PCR using the primer pair FD699/FD702.  This PCR-construct was then used to perform natural 
transformation of the H. pylori 26995/rpslK43R strain and generate the Δpnp::rpslCj-erm/rpslK43R 
strain (Table 8.2.3 in the Appendix). The rpslCj-erm cassette was excised from the pnp locus by 
transforming the H. pylori 26995 Δpnp::rpslCj-erm/rpslK43R strain with a PCR fragment generated 
with the primer pair DD699/FA113. This lead to the generation of a ‘clean’ pnp deleted strain (lacking 
the residues 1-658), the Δpnp/rpslK43R strain (Table 8.2.3 in the Appendix). The Δpnp/rpslK43R 
strain was used as background to generate the double deletion strain by deleting the aapA3/IsoA3 
strain using the rpslCj-erm cassette as described in the General Methods section subheading 6.2.2.3. 
 
Generation of the H. pylori RNase Y, RhpA and RppH deletion strains 
To generate the H. pylori 26695 RNase Y deleted strain, the primer pairs FD631/FD632 and 
FD633/FD634 (Table 8.2.6 in the Appendix) were used to amplify the up- and downstream to rny 
deletion regions and introduce the aphA3 homology tails to allow the subsequent PCR assembly. The 
aphA3 cassette was amplified from the pUCK18K2 plasmid (Table 8.2.5 in the Appendix) with the 
primer pair FD70/FD255 (Table 8.2.6 in the Appendix). Fragments were assembled by PCR using the 
primer pair FD631/FD634 and the product was used to transform the H. pylori 26695 strain generating 
the Drny::aphA3 strain (Table 8.2.3 in the Appendix). To obtain the double RNase Y/PNPase deletion 
mutant (Drny::aphA3/(Dpnp::catCG, Table 8.2.3 in Appendix), the pnp gene was replaced by the 
catCG gene (amplified from pILL2150, Table 8.2.5 in Appendix) in the Drny::aphA3 genetic 
background. The H. pylori 26695 RhpA and RppH deletion strains were generated by replacing the 
rhpA or the rppH genes by the aphA3 gene or the rpsl-erm cassette, respectively, using standard PCR 
assembly (primers listed in Table 8.2.6 in Appendix) and natural transformation protocols. 
 
Expression of the aapA3/IsoA3 locus in E. coli 
To express the H. pylori 26995 aapA3/IsoA3 locus in E. coli cells, a PCR fragment containing the full 
locus sequence (1294 nt-long amplicon) was amplified with the primer pair FA406/FA409 (Table 
8.2.6 in the Appendix) using the Dream Taq DNA polymerase, which adds 3’ adenine overhangs and 
cloned into pGEM-T vector allowing T-A cloning strategy (aapA3/IsoA3 locus expression occurs 
from H. pylori endogenous promoters). The ligation product was then used to transform TOP10 
chemocompetent cells and the strains were stored in glycerol -80°C stocks upon Sanger sequencing 
verification of the inserts. 
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In vivo validation of mRNA decay-related suppressors 
The Δpnp/ΔaapA3/IsoA3::rpslCj-erm/rpslK43R strain was used as genetic background to assess the 
effect of the selected mutations in the 3’-terminal hairpin of the aapA3 mRNA. In detail, the 
aapA3/IsoA3 locus (1294 nt-long amplicon) containing the G183A mutation was amplified from 
gDNA of an isolated G183A suppressor strain using the primer pair FA406/FA409 (Table 8.2.6 in 
Appendix). This PCR-product was used substrate for natural H. pylori transformation in both +pnp 
and –pnp genetic backgrounds, achieving the allelic replacement of the rpslCj-erm cassette present in 
the aapA3/IsoA3 locus. As the G183A mutation was expected to be toxic in the absence of PNPase, a 
mutation in the AapA3 start codon (G54T) was introduced. To that aim, the G54T mutation was 
introduced by Site-Directed mutagenesis PCR in a previously isolated pA3-Up plasmid (Table 8.2.5 in 
Appendix). PCR assembly using the primer pair FA406/FA409 (Table 8.2.6 in Appendix) was used to 
construct the aapA3G183A G54A/pIsoA3* fragment used for H. pylori +pnp and –pnp genetic 
background transformation. This same protocol was used to perform chromosomal targeted 
mutagenesis to introduce the different point mutations here studied. Note that the T128C –Val26Ala- 
mutant was an isolated suppressor therefore it was directly split-cloned in pGEM-T as described above 
(with no need of Site-Directed mutagenesis PCR). 
 
6.4.2. Rapid amplification of cDNA 3’ ends (3’RACE) 
Mapping of mRNA 3’ends by 3’RACE was performed following the protocol for Term-seq library 
preparation described in Dar et al., (2016) with minor modifications. In bacteria, contrary to the 5’-
triphosphate end of primary transcripts, the 3’ end carries a 3’hydroxyl group that can be directly 
ligated to the 5’monophosphate of a DNA oligonucleotide (3’ adapter). In detail, 5 µg DNase I treated 
total RNA was subjected to 3’end specific ligation by mixing with 1.5 µl of 100 µM adapter solution 
(FA609, see Table 8.2.6 in Appendix), 2.5 µl 10X T4 RNA ligase buffer (containing 10 mM ATP), 2 
µl DMSO, 9.5 µl 50% PEG4000 and 2.5 µl T4 RNA ligase enzyme in a final volume reaction of 25 µl. 
The reaction was incubated at 23°C for 2.5 h. Then, the DNA-RNA hybrid was extracted by P:C:I 
(25:24:1 v/v) followed by overnight precipitation at -20°C in the presence of 2.5 volumes of 30:1 (v/v) 
EtOH:3M NaOAc pH 5.2 and resuspended in 10 µl H20. For cDNA synthesis, 10 µl ligation product 
was mixed with 0.5 µl of 100 µM FA120 deoxyoligonucleotide (50 pmol) (Table 8.2.6 in Appendix), 
2 µl of 10 mM dNTPs solution and incubated at 65°C for 5 min then chilled on ice for 2 min. Next, 4 
µl of 5X First Strand buffer, 1 µl of 100 mM DTT, 1 µl RNaseOUTTM (10 u) and 2 µl of SuperScriptII 
enzyme (20 u) were added to the mix. Reaction was incubated for 30 min at 37°C. Subsequently, 3.25 
µl of the cDNA samples were used as DNA template in standard DreamTaq DNA polymerase reaction 
using the FA120 reverse primer that anneals with the adapter sequence and the FD49 gene specific 
forward primer. Following visualization in 2% agarose gel, PCR products were cloned into pGEM®-T 
E. coli vectors and Sanger-sequenced.  
 
6.4.3. RNA chemical synthesis and purification 
The AapA3 5’- wild type and G24A mutant, and the 3’-wild type and G183A mutant terminal stem-
loops were synthesized in RNA chemistry using 1 µmol synthesis scale by Brune Vialet at the 
University of Bordeaux, France. Samples were mixed with one volume of Gel Loading Buffer II, 
denatured at 90°C for 1 min and loaded on a 10 % PAA gel containing 8 M urea and 1X TBE. Gel run 
for 2 h at 17W in 0.5X TBE. After identifying the RNA species of interest by UV shadowing (254 
nm), the RNA was cut from the gel and passively eluted overnight at 4°C in 1 ml RNA elution-buffer-
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NH4Ac. Gel pieces were removed by using Spin-X®-centrifuge tubes filter. Then RNA was 
precipitated overnight in the presence of 2.5 volumes of EtOH 100 %. After centrifugation at 13,000 
rpm and 4°C for 30 min, RNA pellets were washed with 75 % EtOH and resuspended in 50 µl of H2O. 
RNA integrity was checked on PAA denaturing gel, visualized by Stains-All and 20 µM were used for 
mass-spectrometry confirmation. Sequences of the chemically synthesized RNAs are shown in the 
Table 6.4.3. 
 
6.4.4. UV melting experiments 
Thermal denaturation of aapA3 5’- and 3’-terminal hairpins was performed as described in (Ducongé 
et al., 2000) with slight modifications. 1 µM final concentration of chemically synthesized, gel 
purified RNA was denatured for 1 min at 90°C and chilled on ice for 10 min. Then, the RNA was 
mixed with Caco-buffer pH 7.3 (20 mM sodium cacodylate, 140 mM KCl, 20 mM NaCl, 1 mM 
MgCl2) in a final volume reaction of 250 µl. Denaturation of the samples was achieved by increasing 
the temperature at 0.4°C/min from 5°C to 90°C. Melting temperatures were determined as the 
maximum of the first derivate of the UV melting curves. 
 
6.4.5. RNase J overexpression and purification 
For the rnj gene cloning, a fragment containing the full-length RNase J ORF (residues 1-693) was 
amplified by PCR using the primer pair FA369/FA370 (Table 8.2.6 in Appendix) and genomic DNA 
from the H. pylori B128 strain as template. Ligation of sequentially NdeI and BlpI digested PCR 
products, purified with the PCR and DNA fragment purification Kit, with sequentially NdeI and BlpI 
digested pET-15b plasmid was performed using the T4 DNA ligase following the manufacturer 
instructions. This plasmid allows the expression of a fusion protein containing a hexa-histidine tag and 
thrombine cleavage site at the N-terminus of RNase J. The ligation product (named pRNaseJ, Table 
8.2.5 in Appendix) was subcloned into E. coli TOP10 cells. For overexpression of the recombinant 
RNase J, E. coli BL21 (DE3) Rosetta2 cells carrying the pET-15b-RNaseJ plasmid were grown in 
Terrific Broth supplemented 100 µg/ml ampicillin and 25 µg/ml chloramphenicol at 37°C and 200 rpm 
shaking. Induction of protein expression was initiated by addition of 1 mM IPTG at an OD600 ≈ 1.5–2 
and expression continued for 3 h at 37°C and 200 rpm shaking. Cells were harvested by centrifugation 
at 4,000 g for 15 min, and the cell pellet was frozen at −20°C overnight. Cell pellets were then lysed 
by sonication and centrifuged at 20,000 g for 45 min at 4°C. The supernatant was applied to a nickel-
affinity gel for 1 h at 4°C. After extensive washes with Washing-buffer (25 mM Tris,pH 8.0 and 300 
mM NaCl), the protein was eluted with a gradient of imidazole (0–500 mM). Elution fractions 
corresponding to the protein were then pooled. A second chromatography step was performed using a 
heparin HiTrap Heparin-HP affinity column with a linear gradient of 300 mM-1 M NaCl.  
 
6.4.6. RNase J in vitro cleavage assays 
For RNase J-6XHist-Nter exonucleolytic activity assays, 1 µg PCR product (amplified with the primer 
pair FA170/FA624, Table 8.2.6 in Appendix) containing the aapA3 mRNA 5’-terminal stem-loop 
(5’SL, 47 nt) with wild type or G24A mutated sequence and carrying the T7 promoter was used as 
template for hot in vitro transcription in the presence of 50 µCi of 32P-α-UTP and 30 mM UMP as 
described in the 8.2.3.6 subheading of the General Methods section. Kinetics reactions were 
performed in 10 µl reaction volume using uniformly 32-P labeled 5’monophosphate RNA and 28 µM 
H. pylori RNase J, purified as described in this section subheading 6.4.6. Reactions were incubated at 
37°C during 0-30 min and time points were taken every 5 min. Labeled RNA was denatured at 90°C 
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for 1 min in the absence of salt and magnesium, then chilled on ice for 1 min, followed by the addition 
of 2.2 µl 5X RNase J reaction buffer and an excess of cold 5’SL RNA (47 nt). Reactions were stopped 
by the addition of 10 µl 2X Gel Loading Buffer II, run on a 20% denaturing PAA gel and analyzed 
using a Pharos FX phosphorimager.  
 
6.4.7. Mapping of RNase J and RNase III endonucleolytic cleavages 
20 pmol IsoA3 or aapA3-Tr in vitro transcribed RNA was dephosphorylated with 10 u of calf alkaline 
phosphatase (CIP) in a 20 µl reaction at 37°C for 1 h. RNA was isolated by phenol extraction and 
precipitated overnight at -20°C in the presence of 30:1 EtOH: NaOAc pH 5.2 and 20 µg GlycoBlueTM. 
The dephosphorylated RNA was then 5’ end-labeled with 10 pmol 32P-γ -ATP using the T4 
polynucleotide kinase (PNK) for 30 min at 37°C in a 20 µl reaction. Labeled RNA was gel purified, 
resuspended in 50 µl H2O and stored at -20°C. Before use, 0.1 pmol of 5’ end-labeled RNA was 
denatured by incubation at 90°C for 2 min in the absence of magnesium and salt, then chilled on ice 
for 1 min, followed by a renaturation step at 37°C for 5 min. For RNase J cleavage assays, RNA was 
incubated at 37°C in the presence of 1µg Yeast RNA and 28 µM H. pylori RNase J in 1X RNase J-
endo reaction buffer. For RNase III assays, reactions were incubated at 37°C for 5 min in the presence 
of 0.1, 0.01, or 0.001 u RNase III in 1X Structure Buffer. Reactions were stopped by the addition of 10 
µl 2X Gel Loading Buffer II at the indicated time points. Cleavage products were run on a 6% 
denaturing PAA gel and analysed using a Pharos FX phosphorimager. 
 
Table 6.4.1. Inserts of aapA3/IsoA3 mutant plasmids used in Paper IV. 
Promoters are highlighted in yellow; Transcriptional Start Site (TSS) is highlighted in yellow and bold; 
aapA3-FL mRNA 3’ end is highlighted in yellow and bold; Shine-Dalgarno sequences are highlighted in 
green; ORFs are shown in red; translation start and stop sites are highlighted in bold; mutations are 
underlined. Cloning primers determine the borders of the insert, and add when need it the restriction sites to 
allow cloning. SDS primers are the ones used for Site-Directed mutagenesis PCR. All nucleotide positions 
(mutations) in the aapA3/IsoA3 constructs are relative to Aapa3 TSS. A3 refers to the aapA3/IsoA3 
chromosomal locus of the H. pylori 26695 strain. 
Name Plasmid/
Origin/ 
Marker 
Insert (nt) Cloning 
primers  
SDM 
primers 
pA3-Up 
G3C 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTA
AATTTCAATTAAAGGAGTCATCATGGCACACCATGAACAA
CAACAGCAACAACAGGCTAACAGCCAACACCACCACCATC
ACCATGCGCACCACCACCATTACTACGGTGGCGAACACCA
TCACCATAATGCGCAACAACACGCCGAACAACAAGCAGAG
CAACAAGCTCAGCAACAGCAACAACAACAAGCACACCAA
CAACAACAACAAAAAGCGCAACAACAAAACCAACAATAT
TGATTGGGGCGTTTGTGGGGGCGGCCTTAGGGCTACTCCTA
GCTTTTAACTCTTTCTTTTAATCTAGTAAATTTATCCATTTA
AACTAACTTTTTTAACTCCGTTAGATTTTTAAACTTTTAAA
ATCCCTCTTTTTGATGCTTGTCAAATGGCTCTGTTTTCTATC
CAATAAAGATAAGCCTTATTAATTGAGTGGTCGTAATGGG
GTGTAAAAACTTTGTCTTGCGTATTTGATGCGGTCTAGGGG
TGTTTTAAGGGGGTTTGTTGTAGGATTTCATCACCCCCCAT
AGTTGCAATATGGGGCAAATCCTATGTCAAAAGGAGCATG
CCATGAAACACAAAAGTGGCAAACGCTCTTGG (638) 
FA406/ 
FA386 
FA540/ 
FA541 
pA3-Up 
C4T 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTA
AATTTCAATTAAAGGAGTCATCATGGCACACCATGAACAA
CAACAGCAACAACAGGCTAACAGCCAACACCACCACCATC
ACCATGCGCACCACCACCATTACTACGGTGGCGAACACCA
TCACCATAATGCGCAACAACACGCCGAACAACAAGCAGAG
CAACAAGCTCAGCAACAGCAACAACAACAAGCACACCAA
CAACAACAACAAAAAGCGCAACAACAAAACCAACAATAT
TGATTGGGGCGTTTGTGGGGGCGGCCTTAGGGCTACTCCTA
GCTTTTAACTCTTTCTTTTAATCTAGTAAATTTATCCATTTA
AACTAACTTTTTTAACTCCGTTAGATTTTTAAACTTTTAAA
FA406/ 
FA386 
FA515/ 
FA516 
                       6.4. Methods Paper IV 
 137 
ATCCCTCTTTTTGATGCTTGTCAAATGGCTCTGTTTTCTATC
CAATAAAGATAAGCCTTATTAATTGAGTGGTCGTAATGGG
GTGTAAAAACTTTGTCTTGCGTATTTGATGCGGTCTAGGGG
TGTTTTAAGGGGGTTTGTTGTAGGATTTCATCACGTCCCAT
AGTTGCAATATGGGGCAAATCCTATGTCAAAAGGAGCATG
CCATGAAACACAAAAGTGGCAAACGCTCTTGG (638) 
pA3-Up 
G24A 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTA
AATTTCAATTAAAGGAGTCATCATGGCACACCATGAACAA
CAACAGCAACAACAGGCTAACAGCCAACACCACCACCATC
ACCATGCGCACCACCACCATTACTACGGTGGCGAACACCA
TCACCATAATGCGCAACAACACGCCGAACAACAAGCAGAG
CAACAAGCTCAGCAACAGCAACAACAACAAGCACACCAA
CAACAACAACAAAAAGCGCAACAACAAAACCAACAATAT
TGATTGGGGCGTTTGTGGGGGCGGCCTTAGGGCTACTCCTA
GCTTTTAACTCTTTCTTTTAATCTAGTAAATTTATCCATTTA
AACTAACTTTTTTAACTCCGTTAGATTTTTAAACTTTTAAA
ATCCCTCTTTTTGATGCTTGTCAAATGGCTCTGTTTTCTATC
CAATAAAGATAAGCCTTATTAATTGAGTGGTCGTAATGGG
GTGTAAAAACTTTGTCTTGCGTATTTGATGCGGTCTAGGGG
TGTTTTAAGGGGGTTTGTTGTAGGATTTCATCACGCCCCAT
AGTTGCAATATGGGACAAATCCTATGTCAAAAGGAGCATG
CCATGAAACACAAAAGTGGCAAACGCTCTTGG (638) 
FA406/ 
FA386 
FA463/ 
FA464 
pA3-Up 
C4T 
G24A 
pGEM-T/ 
CoEl1/ 
AmpR 
GCATTATAAAATGAAATCCTAGCTAATGAGCTAGAATTTA
AATTTCAATTAAAGGAGTCATCATGGCACACCATGAACAA
CAACAGCAACAACAGGCTAACAGCCAACACCACCACCATC
ACCATGCGCACCACCACCATTACTACGGTGGCGAACACCA
TCACCATAATGCGCAACAACACGCCGAACAACAAGCAGAG
CAACAAGCTCAGCAACAGCAACAACAACAAGCACACCAA
CAACAACAACAAAAAGCGCAACAACAAAACCAACAATAT
TGATTGGGGCGTTTGTGGGGGCGGCCTTAGGGCTACTCCTA
GCTTTTAACTCTTTCTTTTAATCTAGTAAATTTATCCATTTA
AACTAACTTTTTTAACTCCGTTAGATTTTTAAACTTTTAAA
ATCCCTCTTTTTGATGCTTGTCAAATGGCTCTGTTTTCTATC
CAATAAAGATAAGCCTTATTAATTGAGTGGTCGTAATGGG
GTGTAAAAACTTTGTCTTGCGTATTTGATGCGGTCTAGGGG
TGTTTTAAGGGGGTTTGTTGTAGGATTTCATCACGTCCCAT
AGTTGCAATATGGGACAAATCCTATGTCAAAAGGAGCATG
CCATGAAACACAAAAGTGGCAAACGCTCTTGG (638) 
FA406/ 
FA386 
FA461/ 
FA462 
pA3-
Down  
G168A 
pIsoA3* 
pGEM-T/ 
CoEl1/ 
AmpR 
CACAAAAGTGGCAAACGCTCTTGGAAAACGTTCTACTTTG
AGTTTGCTTTTTTGGGGCTTAAAGTGATCGTTTCTGTGAAA
CGCTGATTTTTCTAAGAGCGTTCCCTTAAACTTTTAAGCTT
AGGGGTTTCCTTATGAAGCGGGTTTGTCCTTGACTTTTGGG
GCGTTGGTCATTTTGTTGTAAAACTTATTTTCTTTAGGGGA
TAGAAATAATTCTCCCCTCTATAAAACTAAATCCCCTCATA
GAGTGCTTTTAAAAAATACCGCTTGCTCTAGCTTTTTGATT
ATTTGTCTTAAAAATCACTCCCTTAAAAACCCGTATTCATA
GACTTTAGGCTGTATTTCTTTGGCGAGATCTTTTAGGGCGT
CTTGCAAATTAGCGTAAAGCTGTTTGTAATATTCATCTTTA
GCTTTAGCGGGTAAATTTAATTTGCCTTGCTTGTTACGGCC
TTGAAAAAATTCTTTGATGTCATAAAGGCTTGCGTTAGCGT
TATAGGGGCGGTTTGTGAAATCTTGTGTGTGGTAATAGCG
ATAAACCTCTCTGCTAGCGTCAAACACCTTTGAAGCGCTCG
GGCTGAATTTCAGGGGCTTGTTTTCTTTTTTGGCACTTAAA
AAGAGGCTATCGTTCTCTTTAAGTTCTTTGATTTCGCCTTTT
AAAAACTCTAATAGAGCGTGGCTAG (680) 
FA387/ 
FA409 
FA559/ 
FA560 
pA3-
Down  
G176A 
pIsoA3* 
pGEM-T/ 
CoEl1/ 
AmpR 
CACAAAAGTGGCAAACGCTCTTGGAAAACGTTCTACTTTG
AGTTTGCTTTTTTGGGGCTTAAAGTGATCGTTTCTGTGAAA
CGCTGATTTTTCTAAGAGCGTTCCCTTAAGCTTTTAAACTT
AGGGGTTTCCTTATGAAGCGGGTTTGTCCTTGACTTTTGGG
GCGTTGGTCATTTTGTTGTAAAACTTATTTTCTTTAGGGGA
TAGAAATAATTCTCCCCTCTATAAAACTAAATCCCCTCATA
GAGTGCTTTTAAAAAATACCGCTTGCTCTAGCTTTTTGATT
ATTTGTCTTAAAAATCACTCCCTTAAAAACCCGTATTCATA
GACTTTAGGCTGTATTTCTTTGGCGAGATCTTTTAGGGCGT
CTTGCAAATTAGCGTAAAGCTGTTTGTAATATTCATCTTTA
GCTTTAGCGGGTAAATTTAATTTGCCTTGCTTGTTACGGCC
TTGAAAAAATTCTTTGATGTCATAAAGGCTTGCGTTAGCGT
TATAGGGGCGGTTTGTGAAATCTTGTGTGTGGTAATAGCG
ATAAACCTCTCTGCTAGCGTCAAACACCTTTGAAGCGCTCG
GGCTGAATTTCAGGGGCTTGTTTTCTTTTTTGGCACTTAAA
AAGAGGCTATCGTTCTCTTTAAGTTCTTTGATTTCGCCTTTT
AAAAACTCTAATAGAGCGTGGCTAG (680) 
FA387/ 
FA409 
FA471/ 
FA472 
pA3-
Down  
pGEM-T/ 
CoEl1/ 
CACAAAAGTGGCAAACGCTCTTGGAAAACGTTCTACTTTG
AGTTTGCTTTTTTGGGGCTTAAAGTGATCGTTTCTGTGAAA
CGCTGATTTTTCTAAGAGCGTTCCCTTAAGCTTTTAAGCTT
FA387/ 
FA409 
- (isolated 
suppressor 
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G183A 
pIsoA3* 
AmpR AGGAGTTTCCTTATGAAGCGGGTTTGTCCTTGACTTTTGGG
GCGTTGGTCATTTTGTTGTAAAACTTATTTTCTTTAGGGGA
TAGAAATAATTCTCCCCTCTATAAAACTAAATCCCCTCATA
GAGTGCTTTTAAAAAATACCGCTTGCTCTAGCTTTTTGATT
ATTTGTCTTAAAAATCACTCCCTTAAAAACCCGTATTCATA
GACTTTAGGCTGTATTTCTTTGGCGAGATCTTTTAGGGCGT
CTTGCAAATTAGCGTAAAGCTGTTTGTAATATTCATCTTTA
GCTTTAGCGGGTAAATTTAATTTGCCTTGCTTGTTACGGCC
TTGAAAAAATTCTTTGATGTCATAAAGGCTTGCGTTAGCGT
TATAGGGGCGGTTTGTGAAATCTTGTGTGTGGTAATAGCG
ATAAACCTCTCTGCTAGCGTCAAACACCTTTGAAGCGCTCG
GGCTGAATTTCAGGGGCTTGTTTTCTTTTTTGGCACTTAAA
AAGAGGCTATCGTTCTCTTTAAGTTCTTTGATTTCGCCTTTT
AAAAACTCTAATAGAGCGTGGCTAG (680) 
strain) 
Note: the pSP60-2, pA3-Up, pA3-UP start and pA3-Down pIsoA3* plasmids shown in Table 8.1.2 in 
the Appendix. 
 
 
Table 6.4.2. Sequence of T7 RNAs used for in vitro studies in Paper IV. 
Lower-case letter indicated the T7 promoter used. Mutated positions are underlined. Nt* indicates the 
length in nucleotides of the RNA (excluding the T7 promoter sequence). The wild type aapA3 full-length 
and truncated isoforms as well as the IsoA3 RNA used in this study were already described in the Table 
6.3.2. 
T7 RNA Sequence (5’à3’) (nt*) Primer pair  Template 
aapA3-5’SL WT gaaattaatacgactcactataggACGCCCCATAGTTGC
AATATGGGGCAAATCCTATGTCAAAAGGA
GCA (47) 
FA170/FA624 gDNA H. pylori 
26695 WT 
aapA3-5’SL 
G24A 
gaaattaatacgactcactataggACGCCCCATAGTTGC
AATATGGGACAAATCCTATGTCAAAAGGA
GCA (47) 
FA170/FA624 gDNA H. pylori 
26695 aapA3 
G24A/pIsoA3* 
 
 
Table 6.4.3. Sequence of chemically synthesized RNAs used in Paper IV. 
Mutated positions are underlined. 
RNA Sequence  (5’à3’) (nt*) 
aapA3-5’SL25 WT ACGCCCCATAGTTGCAATATGGGGC (25) 
aapA3-5’SL25 G24A ACGCCCCATAGTTGCAATATGGGAC (25) 
aapA3-3’SL24 WT CCCTTAAGCTTTTAAGCTTAGGGG (24) 
aapA3-3’SL24 G183A CCCTTAAGCTTTTAAGCTTAGGAG (24) 
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Figure 8.1.2. Comparison of the distribution and relative frequency of single-nucleotide suppressors 
in the WT and pIsoaA3* aapA3/IsoA3 modules. Heatmap of the location and relative abundance of 
single-nucleotide substitutions (A), deletions (B), and insertions (C), in WT (aapA3/IsoA3) and pIsoA3* 
(aapA3/pIsoA3*) samples coming from Miseq Ilumina deep-sequencing. For a given position, all 
sequences showing a single-nucleotide substitution (A), deletion (B), or insertion (C) at that position were 
counted irrespective of the nucleotide identity (“positional” analysis). Sequence counts were converted to 
TMM-normalized median-centered, and log2-transformed FPKM values were hierarchically clustered 
according to biological replicate sample (see Methods section for details). The color key gives the log2 
value scale (negative and positive values represent relative frequencies below and above the median, 
respectively). Positions are numbered relative to the aapA3 transcriptional start site (TSS, +1). Colored 
arrows and boxes on the right-hand side of each heatmap indicate the locations of relevant sequence 
elements on the aapA3/IsoA3 locus: -10 box, aapA3 promoter -10 box; -10 box IsoA3, IsoA3 promoter -10 
box; +1 (5’ end), aapA3 transcription start site; SD, Shine-Dalgarno; ORF, open reading frame; 5’ and 3’ 
ends delimit the UTRs (untranslated regions) on the aapA3 mRNA; the “10 nt” scale bar at the bottom of 
panel (A) is used to measure intervals of 10 nucleotides alongside the map. 
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Figure 8.1.4. The A28C, A40T and T78C suppressors inhibit aapA3-Tr mRNA translation. (A) Only 
the 3’ end truncated aapA3 mRNA form is translated in vivo. Cell lysate of the H. pylori 26695 wild-type 
(WT) strain was subjected to ultracentrifugation through a sucrose gradient under polysome stabilization 
conditions (+ Chloramphenicol). A profile at OD254 was recorded. RNA was extracted from each fraction 
and equal volumes of each extract were subjected to Northern Blot analysis. Fractions corresponding to the 
free 30S and 50S subunits, 70S ribosomes (free and translating) and polysomes are indicated. The different 
transcripts are annotated as: aapA3-FL (full length, 225 nt), aapA3-Tr (3’ end truncated, 190 nt), and 5S 
rRNA as loading control (5S rRNA). M, monosomes; D, disomes. (B) Gene expression analysis of the 
indicated strains was analyzed by Northern Blot. Transcripts aapA3-FL (full length), aapA3-Tr (3’ end 
truncated), and IsoA3 full-length and processed transcripts are shown. Proper loading was assessed by the 
level of 5S rRNA. The T78C* construct contains a WT IsoA3. (C) Relative peptide production upon in 
vitro translation of aapA3-FL, aapA3-Tr and the aapA3-Tr form of the three independent suppressor 
B
C W
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Figure 8.1.7. Quantification of the relative aapA3 mRNA band intensity from polysome fractionation 
Northern Blots shown in Figure 4. Relative band intensity was determined using the ImageLab software. 
Percentage of band intensity located on 70S fractions was calculated for each aapA3 transcript (full-length, 
-FL or truncated, -Tr) by dividing the band intensity in 70S fractions by the total band intensity (addition of 
intensity values in all fractions). Each panel shows the data for a given WT or mutant transcript. M, 
monosomes; D, disomes. In the case of the G54T strain, the quantification of the aapA3-Tr form present on 
the M+D fractions was not possible due to a strong mRNA degradation (n.d= non-detectable). 
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Figure 8.1.8. Only three out of the thirteen potential aSD sequenced embedded in aapA3 mRNA are 
functional. 2D structure predictions were generated with the RNAfold Web Server (Gruber et al., 2008) 
and VARNA RNA (Darty et al., 2009) was used to perform the drawing. Potential, but not used, anti-
Shine-Dalgarno (aSD) sequences (UC-rich motifs) are highlighted in red. The three functional aSD 
sequences (aSD1, aSD2, aSD3) are shown in gold. Shine-Dalgarno (SD) sequence is shown in turquoise. 
Translation start and stop codons are shown in green and red, respectively. 
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Supplementary Tables 
Table 8.1.1. Helicobacter pylori strains used in Paper III. 
Name Strain 
number 
Description Plasmid Resistance Reference 
B128 B050(H1) Wild-type B128 strain none - (Farnbacher 
et al., 2010; 
McClain et 
al., 2009) 
B128 Δrnc H54 
(IHP18) 
B128 rnc::aphA-3 none KanR (Anion et 
al., 2017) 
26695 JR34 (H5) Wild type 26695 strain, Institut 
Pasteur collection 
none - (Tomb et 
al., 1997b) 
26695 
rpslK43R  
H158 rpsl gene mutated on the Lys at 
position 43 to Arg (K43R) 
none StrR this study 
26695 
ΔaapA3/IsoA3 
H204 ΔaapA3/IsoA3::rpslCj-
erm/rpslK43R 
none ErmR this study 
26695 
Complemented 
aapA3/IsoA3  
H170 ΔaapA3/IsoA3 + aapA3/IsoA3 none StrR this study 
26695 aapA3 
start 
H171 aapA3 start codon mutated to 
ATT by the single point mutation 
G54T  
none StrR this study 
 
26695 aapA3 
ΔT109 
H172 aapA3 carrying a -1 frameshift 
mutation (deletion of T at position 
109) generating a 23 amino acids-
long peptide 
none StrR this study 
 
26695 aapA3 
start/pIsoA3* 
H173 aapA3 G54T and IsoA3 promoter 
inactivated  by the double point 
mutation A87C/A90G  
none StrR this study 
 
26695 aapA3 
G43A/ pIsoA3* 
H247 aapA3 SD inactivated by the 
G43A mutation and IsoA3 
promoter A87C/A90G  
none StrR this study 
 
26695 aapA3 
T107C/ 
pIsoA3* 
H278 aapA3 ORF suppressor T107C 
(Phe 19 Ser) and IsoA3 promoter 
A87C/A90G  
none StrR this study 
26695 aapA3 
A28C/ pIsoA3* 
H224 aapA3 A28C suppressor mutation 
and IsoA3 promoter  A87C/A90G  
none StrR this study 
26695 aapA3 
A40T/ pIsoA3* 
H225 aapA3 A40T and IsoA3 promoter 
A87C/A90G  
none StrR this study 
 
26695 aapA3 
A33T/ 
A40T/G54T/ 
pIsoA3* 
H257 aapA3 A40T/A33T/G54T and 
IsoA3 promoter A87C/A90G  
none StrR this study 
 
26695 aapA3 
T78C/ pIsoA3* 
H240 aapA3 T78C and IsoA3 promoter 
A87C/A90G  
none StrR this study 
 
26695 aapA3 
T78C 
H226 aapA3 T78C with wild-type 
IsoA3 expression 
none StrR this study 
 
* All nucleotide positions are indicated relative to the AapA3 transcriptional start site (TSS, +1). 
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Table 8.1.2. Plasmids used in Paper III. 
Name Description Origin/ 
Marker 
Reference 
pSP60 -2 pSP60 carrying the counter selection cassette rpsl-erm pSC101*
/ 
AmpR 
(Dailidiene, 
D. et al., 
2006) 
(Pernitzsch 
et al., 2014) 
pA3-Up WT pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus amplified with the FA406/FA386 
primer pair  
ColE1/ 
AmpR 
this study 
pA3-Down WT pGEM-T carrying the downstream fragment of the 
aapA3/IsoA3 locus amplified with the FA409/FA387 
primer pair 
ColE1/ 
AmpR 
this study 
pA3-Down pIsoA3* pGEM-T carrying the downstream fragment of the 
aapA3/IsoA3 locus containing IsoA3 -10 box 
inactivated (A87C/A90G)  
ColE1/ 
AmpR 
this study 
pA3-Up start pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus containing the AapA3 start codon 
mutation G54T  
ColE1/ 
AmpR 
this study 
pA3-Up A28C pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus containing the suppressor A28C  
ColE1/ 
AmpR 
this study 
pA3-Up A33T pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus containing the A33T mutation  
ColE1/ 
AmpR 
this study 
pA3-Up A40T pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus containing the suppressor A40T  
ColE1/ 
AmpR 
this study 
pA3-Up A40T/A33T pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus containing the A40T and the 
compensatory mutation A33T  
ColE1/ 
AmpR 
this study 
pA3-Up T78C pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus containing the suppressor T78C  
ColE1/ 
AmpR 
this study 
pA3-Down T78C pGEM-T carrying the downstream fragment of the 
aapA3/IsoA3 locus containing the suppressor T78C  
ColE1/ 
AmpR 
this study 
pA3-Down T78C/ 
pIsoA3* 
pGEM-T carrying the downstream fragment of the 
aapA3/IsoA3 locus containing the suppressor T78C 
and IsoA3 -10 box inactivated (A87C/A90G)  
ColE1/ 
AmpR 
this study 
pA3-Up G43A pGEM-T carrying the upstream fragment of the 
aapA3/IsoA3 locus containing the SD suppressor 
G43A  
ColE1/ 
AmpR 
this study 
* All nucleotide positions are indicated relative to the AapA3 transcriptional start site (TSS, +1). 
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Table 8.1.3. Escherichia coli strains used in Paper III. 
Name Description/ genotype Plasmid Resistance Reference 
TOP10 mcrA ∆(mrr-hsdRMS-
mcrBC) Φ80lacZ∆M15 
∆lacX74 deoR recA1 
araD139 ∆(ara-leu)7697 
galU galK rpsL endA1 
nupG  
none none Invitrogene 
A3-Up WT TOP10 pA3-Up WT AmpR this study 
A3-Down WT TOP10 pA3-Do WT AmpR this study 
A3-Down pIsoA3* TOP10 pA3-Do pIsoA3* AmpR this study 
A3-Up start TOP10 pA3-Up start AmpR this study 
A3-Up A28C TOP10 pA3-Up A28C AmpR this study 
A3-Up A33T TOP10 pA3-Up A33T AmpR this study 
A3-Up A40T TOP10 pA3-Up A40T AmpR this study 
A3-Up A40T/A33T TOP10 pA3-Up 
A40T/A33T 
AmpR this study 
A3-Up T78C TOP10 pA3-Up T78C AmpR this study 
A3-Down T78C TOP10 pA3-Do T78C AmpR this study 
A3-Down T78C/ pIsoA3* TOP10 pA3-Do T78C/ 
pIsoA3* 
AmpR this study 
A3-Up G43A TOP10 pA3-Up G43A AmpR this study 
* All nucleotide positions are indicated relative to the AapA3 transcriptional start site (TSS, +1). 
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Table 8.1.4. Oligonucleotides used in Paper III. 
 Sequence (5’à3’ direction) Used for 
FD11 GAAATTAATACGACTCACTATAGCAAG
AGCGTTTGCCACTT 
Reverse primers carrying a T7 promoter 
for IsoA3 amplification for in vitro 
transcription 
FD17 ACGCCCCATAGTTGCAATAT 
 
Forward primer for IsoA3 amplification 
for in vitro transcription 
FD35 TCGGAATGGTTAACTGGGTAGTTCCT 
 
Reverse primer for 5S rRNA mRNA 
detection by Northern Blot 
FD38 GCTCCTTTTGACATAGGATT 
 
Reverse primer for aapA3 mRNA 
detection by Northern Blot 
FA110 TGCTTTATAACTATGGATTAAAC 
 
Forward primer for rpsl-erm cassette 
amplification from pSP60 
FA111 TTACTTATTAAATAATTTATAGC 
 
Revese primer for rpsl-erm cassette 
amplification from pSP60 
FA170 GAAATTAATACGACTCACTATAGGACG
CCCCATAGTTGCAATAT 
Forward primer carrying a T7 promoter for 
aapA3 in vitro transcription 
FA173 AGGAAACCCCTAAGCTTAAAAGC Reverse primer for aapA3-Tr amplification 
FA175 GACCAACGCCCCAAAAGTC Reverse primer for aapA3 full-length 
amplification 
FA281 AGCATGCCATTAAACACAAA Forward primer for mutagenesis of aapA3 
26695 start codon (G54A)  
FA282 TTTGTGTTTAATGGCATGCT Reverse primer for mutagenesis of aapA3 
26695 start codon (G54A)  
FA283 TGGAAAACCTTGTACTTTGAGT 
 
Forward primer for mutagenesis of IsoA3 -
10 box: mutations A87C/A90G  
FA284 ACTCAAAGTACAAGGTTTTCCA 
 
Reverse primer for mutagenesis of IsoA3 -
10 box: mutations A87C/A90G  
FA386 CCAAGAGCGTTTGCCACTTTTG Reverse primer for aapA3/IsoA3 locus 
split cloning in pGEM®T (upstream 
fragment) 
FA387 CACAAAAGTGGCAAACGCTC Forward primer for aapA3/IsoA3 locus 
split cloning in pGEM®T (downstream 
fragment) 
FA395 
 
CTTTCCCTACACGACGCTCTTCCGATCT
CTATCCAATAAAGATAAGC 
Forward primer for aapA3 26695 
amplification for Illumina paired-end 
sequencing 
FA396 
 
GGAGTTCAGACGTGTGCTCTTCCGATCT
GCACTCTATGAGGGGATTTAG 
Reverse primer for aapA3 26695 
amplification for Illumina paired-end 
sequencing 
FA406 GCATTATAAAATGAAATCC 
 
Forward primer for the amplification of 
aapA3 26695 fragment Up from hpn-like  
FA407 GTTTAATCCATAGTTATAAAGCACAA
AAAGAGGGATTTTAAAAG 
Reverse primer for the amplification of 
aapA3 26695 Up fragment to generate the 
aapA3/IsoA3 locus deletion designed for 
deep-seq  
FA408 GCTATAAATTATTTAATAAGTAACCGC
TTGCTCTAGCTTTTTG 
Forward for the amplification of aapA3 
26695 Down fragment to generate the 
aapA3/IsoA3 locus deletion designed for 
deep-seq  
FA409 CTAGCCACGCTCTATTAGAG 
 
Reverse for the amplification of aapA3 
26695 Down fragment to generate the 
aapA3/IsoA3 locus deletion designed for 
deep-seq  
FA465 CAATATGGGGCAAcTCCTATGTC Forward primer for the introduction of the 
suppressor A28C 
FA466 
 
GACATAGGAgTTGCCCCATATTG 
 
Reverse primer for the introduction of the 
suppressor A28C 
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FA467 
 
CCTATGTCAAtAGGAGCATG 
 
Forward primer for the introduction of the 
suppressor A40T 
FA468 
 
CATGCTCCTaTTGACATAGG 
 
Reverse primer for the introduction of the 
suppressor A40T 
FA511 
 
CAAAAGTGGCAAACGCTCcTGGAAAACc
TTgTACTTTGAGTTTG 
Forward primer for the introduction of the 
suppressor T78C 
FA512 
 
GTTTTCCAgGAGCGTTTGCCACTTTTG 
 
Reverse primer for the introduction of the 
suppressor T78C  
FA535 
 
CCTATGTCAAAAGaAGCATGCCATGAAA
CAC 
 
Forward primer for the introduction of the 
SD mutation G43A 
FA536 
 
GTGTTTCATGGCATGCTtCTTTTGACATA
GG 
 
Reverse primer for the introduction of the 
SD mutation G43A 
FA546 
 
GTTGCAATATGGGGCAAATCCTtTGTCA
AAAGGAGCATGCC 
 
Forward primer for the introduction of 
A33T mutation (complementation of A40T 
suppressor)  
FA547 
 
GGCATGCTCCTTTTGACAaAGGATTTGC
CCCATATTGCAAC 
 
Reverse primer for the introduction of 
A33T mutation (complementation of A40T 
suppressor)  
FA548 
 
GTTGCAATATGGGGCAAATCCTtTGTCA
AtAGGAGCATGCC 
 
Forward primer for the introduction of 
A33T mutation in aapA3 A40T mutant 
background  
FA549 
 
GGCATGCTCCTaTTGACAaAGGATTTGC
CCCATATTGCAAC 
Reverse primer for the introduction of 
A33T mutation in aapA3 A40T mutant 
background 
FA633 CATGGCATGCTCCTTT  RNaseH/oligonucleotide accessibility 
assay on WT-FL, WT-Tr and T78C-Tr 
aapA3 mRNAs 
FA644 CATAGGATTTGCCCCA  RNaseH/oligonucleotide accessibility 
assay on A40T-Tr aapA3 mRNA 
FA651 CAAAGGATTTGCCCCA  RNaseH/oligonucleotide accessibility 
assay on A33T/A40T-Tr aapA3 mRNA 
FA652 CATAGGAGTTGCCCCA  RNaseH/oligonucleotide accessibility 
assay on A28C-Tr aapA3 mRNA 
* All nucleotide positions are indicated relative to the AapA3 transcriptional start site (TSS, +1). 
** Sequences highlighted in bold correspond to rpslCj-erm 5’-overhang tails used for assembly PCR during the 
construction of the aapA3/IsoA3 deleted strain.  
*** Underlined sequences correspond to the DNA adaptors used for Illumina paired-end sequencing approach. 
**** Nucleotides in lowercase correspond to the mutations to be introduced by site-directed mutagenesis PCR.
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Figure 8.2.2. 3’RACE on aapA3 mRNA revealed a 3’ end activation pathway lead 3’-5’-exonucleases 
and roadblocks. The aapA3 primary transcript (aapA3-FL, 229-218 nt) gets processed by its 3’end until 
reaching a first roadblock for 3’-exonucleases (double stranded region) leading to the generation of an 
intermediate species (aapA3-i, 202-198 nt). Further 3’end processing takes place until reaching a second 
roadblock for 3’-exonucleases and generates the translationally active aapA3 mRNA species (aapA3-Tr, 
192-188 nt). This species is protected from 5’- and 3’-exonucleases by two highly stable terminal stem-
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loops (highlighted in bold). 2D structure predictions were generated with the RNAfold Web Server (Gruber 
et al., 2008) and VARNA RNA (Darty et al., 2009) was used for drawing. Shine-Dalgarno (SD) sequence 
is highlighted in bold-grey; translation start codons is highlighted in bold-green. 
 
 
Figure 8.2.3. Toxicity suppressor mutations cluster symmetrically in the termini stem-loops of the 
active aapA3 mRNA. Single nucleotide substitutions significantly enriched (padj £0.05; DESeq2 
‘nucleotide-specific’ analysis, Masachis et al., in preparation) in absence antitoxin and located close to 
aapA3 5’ and 3’ mRNA ends are shown. aapA3-Tr 2D structure predictions were generated with the 
RNAfold Web Server (Gruber et al., 2008) and VARNA RNA (Darty et al., 2009 was used for drawing. 
Location of the suppressor mutations in the aapA3-Tr mRNA is illustrated. Shine-Dalgarno (SD) sequence 
is shown in bold-grey; start codon is shown in bold-green; stop codon is shown in bold-red; suppressor 
mutations located in the 5’-terminal stem-loop are highlighted in orange; suppressor mutations located in 
the 3’-terminal tem-loop are highlighted in purple. The two single point mutations used to inactivate IsoA3 
expression (A87C and A90G) are highlighted in light blue. Most abundant nucleotide substitutions are 
indicated next to its position. 
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Supplementary Tables 
Table 8.2.1. Minimum Free Energy and padj of the here studied single nucleotide substitutions in the 
aapA3 5’-terminal stem-loop. Minimum Free Energy values (kcal/mol) were calculated using the 
RNAfold Web Server (Gruber et al., 2008). Padj values were obtained by nucleotide specific Deseq2 
analysis of single nucleotide substitutions appearing in wild type and pIsoA3* samples in our previously 
generated Illumina sequencing datasets (Masachis et al., in preparation, see Paper III in Chapter 4 section 
4.2). 
 
5’SL (+25) Minimum Free Energy 
(Kcal/mol) 
Padj 
WT -13.30 - 
G3C -10.30 0.0039 (*) 
C4G -7.70 2.75x10-36 
G24A -7.80 6.87x10-150 
C4T -10.60 0.64 (Toxic) 
 
 
 
Table 8.2.2. Minimum Free Energy and padj of the here studied tested single nucleotide substitutions 
in the aapA3 3’-terminal stem-loop. Minimum Free Energy values (kcal/mol) were calculated using the 
RNAfold Web Server (Gruber et al., 2008). Padj values were obtained by nucleotide specific Deseq2 
analysis of single nucleotide substitutions appearing in wild type and pIsoA3* samples in our previously 
generated Illumina sequencing datasets (Masachis et al., in preparation, see Paper III in Chapter 4 section 
4.2). 
 
3’SL (+16-+184) Minimum Free Energy (Kcal/mol) padj 
WT -13.70 - 
G183A -8.60 2.24x10-40 
G168A -7.00 0.0334 (Toxic) 
G176A -9.20 0.2083 (Toxic) 
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Table 8.2.3. Helicobacter pylori strains used in Paper IV 
Name Strain 
number 
Description Plasmid Resistance Reference 
26695 JR34(H5) Wild-type strain, Institut Pasteur 
collection 
none - (Tomb et al., 
1997) 
26695 rpslK43R  H158 rpsl gene coding for the 
ribosomal protein S12 mutated 
on the amino acid K43 to R 
conferring resistance to 
streptomycin 
none StrR This study 
26695 ΔaapA3/
ΔIsoA3::rpsl-erm 
H204 Strain deleted for the 
aapA3/IsoA3 locus using the 
rpsl-erm cassette (in rpsl K43R 
background) 
none ErmR This study 
26695 
pAapA3*/IsoA3 
H214 aapA3 -10 box inactivated by 
the single nucleotide mutation 
T-7C (TAGGAT to TAGGAC) 
(in rpsl K43R background) 
none StrR This study 
 
26695 aapA3 
start 
H171 aapA3 start codon mutated by 
the single nucleotide 
substitution G54T (from aapA3 
+1) (in rpsl K43R background) 
none StrR This study 
26695 aapA3 
start/pIsoA3* 
H173 aapA3 start codon mutated by 
G54T, and IsoA3 promoter 
inactivated (double mutation; 
A87C/A90G from aapA3 +1) 
(in rpsl K43R background) 
none StrR This study 
26695 
ΔrhpA::aphA3 
H287 Strain deleted for the rhpA gene 
(-rhpA) using the aphA3 ORF 
none KanR This study 
26695 
ΔrppH::rpsl-erm 
H237 Strain deleted for the rppH gene 
(-rppH) using the rpsl-erm 
cassette (in rpsl K43R 
background) 
none ErmR This study 
26695 
Δpnp::rpsl-erm 
H160 Strain deleted for the pnp gene 
(-pnp) using the rpsl-erm 
cassette (in rpsl K43R 
background) 
none ErmR This study 
26695 Δpnp H161 Strain deleted for the pnp gene 
(-pnp) in rpsl K43R background 
(rpsl-erm cassette excised) 
none StrR This study 
26695 
Δrny::aphA3 
H46 Strain deleted for the rny gene (-
rny) using the aphA3 ORF 
none KanR This study 
26695 
Δrny::aphA3/ 
Δpnp::catCG/ 
H213 Strain where rny gene is 
replaced by the aphA3 ORF and 
the pnp gene by the catCG ORF 
none KanR CmR This study 
26695 
Δpnp/ΔaapA3/ΔI
soA3::rpsl-erm 
H206 Strain deleted for the pnp gene 
and the aapA3/IsoA3 locus 
using the rpsl::erm cassette (in 
rpsl K43R background) 
none ErmR This study 
26695 Δpnp/ 
aapA3 start 
H207 Δpnp /aapA3 start codon 
mutated (start, G54T) (in rpsl 
K43R background) 
none StrR This study 
26695 Δpnp/ 
aapA3 start/ 
pIsoA3* 
H208 Δpnp/ aapA3 start codon 
mutated (start, G54T) and IsoA3 
-10 box inactivated 
(A87C/A90G from aapA3 +1) 
(in rpsl K43R background) 
none StrR This study 
26695 aapA3 
G183A 
H209 Suppressor strain carrying the 
single nucleotide substitution 
none StrR This study 
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G182A (in rpsl K43R 
background) 
26695 
Δpnp/aapA3 start 
G183A/ pIsoA3* 
H210 Δpnp/ aapA3 start codon 
mutated (start, G54T), 
suppressor mutation G182A and 
IsoA3 -10 box inactivated 
(A87C/A90G from aapA3 +1) 
(in rpsl K43R background)  
none StrR This study 
26695 aapA3 
start G183A/ 
pIsoA3* 
H211 aapA3 start codon mutated 
(start, G54T), suppressor 
mutation G182A and IsoA3 -10 
box inactivated (A87C/A90G 
from aapA3 +1) (in rpsl K43R 
background) 
none StrR This study 
26695 aapA3 
G24A/ pIsoA3* 
H212 Suppressor mutation G24A and 
IsoA3 -10 box inactivated 
(A87C/A90G from aapA3 +1) 
(in rpsl K43R background) 
none StrR This study 
26695 aapA3 
C4G/ pIsoA3* 
H241 Suppressor mutation C4G and 
IsoA3 -10 box inactivated 
(A87C/A90G from aapA3 +1) 
(in rpsl K43R background) 
none StrR This study 
26695 aapA3 
start C4T G24A 
/pIsoA3* 
H242 Suppressor mutation G24A, 
compensatory mutation C4T 
and start codon mutated (start, 
G54T) and IsoA3 -10 box 
inactivated (A87C/A90G from 
aapA3 +1) (in rpsl K43R 
background) 
none StrR This study 
26695 aapA3 
G3C/ pIsoA3* 
H259 Suppressor mutation G3C and 
IsoA3 -10 box inactivated 
(A87C/A90G from aapA3 +1) 
(in rpsl K43R background) 
none StrR This study 
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Table 8.2.4. Escherichia coli strains used in Paper IV. 
Name Description Plasmid Resistance Reference 
TOP10 E. coli strain used for genetic 
manipulation of plasmids 
none none Invitrogene 
A3-Up WT TOP10 pGEMT-A3-Up WT AmpR This study 
A3-Down WT TOP10 pGEMT-A3-Down WT AmpR This study 
A3-Up start TOP10 pGEMT-A3-Up start AmpR This study 
A3-Down 
pIsoA3* 
TOP10 pGEMT-A3-Down 
pIsoA3* 
AmpR This study 
A3-Up G3C TOP10 pGEMT-A3-Up G3C AmpR This study 
A3-Up C4G TOP10 pGEMT-A3-Up C4G AmpR This study 
A3-Up C4T TOP10 pGEMT-A3-Up C4T AmpR This study 
A3-Up G24A TOP10 pGEMT-A3-Up G24A AmpR This study 
A3-Up G168A TOP10 pGEMT-A3-Up 
G168A 
AmpR This study 
A3-Up G176A TOP10 pGEMT-A3-Up 
G176A 
AmpR This study 
A3-Up G183A TOP10 pGEMT-A3-Up 
G183A 
AmpR This study 
 
  
CHAPTER 8 Appendices 
 180 
Table 8.2.5. Plasmids used in Paper IV. 
Name Description Resistance Reference 
pSP60  pSP60 carrying the cassette rpsl-erm AmpR (Dailidiene, D. 
et al., 2006)  
(Pernitzsch et 
al., 2014) 
pUC18K2 pUC18 carrying the aphA3 gene KanR (Skouloubris et 
al., 1998) 
pILL2150 carrying the catCG gene CmR (Boneca et al., 
2008) 
pA3-Up WT pGEM-T carrying the upstream fragment of 
aapA3/IsoA3 locus (see Figure S2 for upstream 
references) 
AmpR This study 
pA3-Up start pGEM-T carrying the upstream fragment of 
aapA3/IsoA3 locus mutated in the AapA3 start 
codon (G54A from AapA3 TSS) (see Figure S2 
for upstream references) 
AmpR (This study 
pA3-Down WT pGEM-T carrying the downstream fragment of 
aapA3/IsoA3 locus (see Figure S2 for upstream 
references) 
AmpR This study 
pA3-Down 
pIsoA3* 
pGEM-T carrying the downstream fragment of 
aapA3/IsoA3 locus (see Figure S2 for upstream 
references) with the IsoA3 -10 box inactivated 
(A87C/A90G from aapA3 +1) 
AmpR This study 
pA3-Up G3C pGEM-T carrying the upstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor G3C from aapA3 +1  
AmpR This study 
pA3-Up C4G pGEM-T carrying the upstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor C4G from aapA3 +1  
AmpR This study 
pA3-Up C4T pGEM-T carrying the upstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor C4T from aapA3 +1  
AmpR This study 
pA3-Up G24A pGEM-T carrying the upstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor G24A from aapA3 +1  
AmpR This study 
pA3-Up 
C4T/G24A 
pGEM-T carrying the upstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor C4T/G24A from aapA3 +1  
AmpR This study 
pA3-Down 
G168A/ 
pIsoA3* 
pGEM-T carrying the downstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor G168A from aapA3 +1 and 
the IsoA3 -10 box inactivated (A87C/A90G from 
aapA3 +1) 
AmpR This study 
pA3-Down 
G176A/ 
pIsoA3* 
pGEM-T carrying the downstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor G176A from aapA3 +1 and 
the IsoA3 -10 box inactivated (A87C/A90G from 
aapA3 +1) 
AmpR This study 
pA3- Down 
G183A/ 
pIsoA3* 
pGEM-T carrying the downstream fragment of 
aapA3/IsoA3 locus containing the single 
nucleotide suppressor G182A from aapA3 +1 and 
the IsoA3 -10 box inactivated (A87C/A90G from 
aapA3 +1) 
AmpR This study 
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Table 8.2.6. Oligonucleotides used in Paper IV. 
Name Sequence 5’à3’ Description 
FD70 GTACCCGGGTGACTAACTAGG 
 
Forward primer for the amplification 
of the aphA3 gene from pUC18K2  
FD255 CAGGTACTAAAACAATTCATCC 
 
Reverse primer for the amplification 
of the aphA3 gene from pUC18K2 
FA75 ATGGAGAAAAAAATCACTGGA Forward primer for the amplification 
of the catCG gene from pILL2150 
FD271 GAGAAAAAAATCACTGGATATAC 
 
Reverse primer for the amplification 
of the catCG gene from pILL2150 
FD701 TGAGTGGCAGGGCGGGGCGTAACATGGA
CAAGTGTCAAGTGGT 
 
Forward primer the amplification of 
the H. pylori 26695 pnp gene for 
gene deletion using the catCG 
cassette 
FD700 TATATCCAGTGATTTTTTTCTCCATATTTA
ATGTTCCTTTTTT  
 
Reverse primer the amplification of 
the H. pylori 26695 pnp gene for 
gene deletion using the catCG 
cassette 
FA562 GATTTAATATCATCTGCAGAG 
 
Forward primer for the amplification 
of H. pylori 26695 rhpA gene ‘Do’ 
fragment  
FA608 GTCAAACCCCTACTATCCATCA 
 
Reverse primer for the amplification 
of H. pylori 26695 rhpA gene ‘Up’ 
fragment 
FA610 CCGGTGATATTCTCATTTTAGCCATGGGA
GATTCATACCTC 
 
Reverse primer the amplification of 
the H. pylori 26695 rhpA gene 
‘Down’ fragment for gene deletion 
using the aphA3 cassette 
FA611 TTTTACTGGATGAATTGTTTTAGAATATTT
AAAAAGGAAATTCATG 
 
Forward primer the amplification of 
the H. pylori 26695 rhpA gene ‘Up’ 
fragment for gene deletion using the 
aphA3 cassette 
FA484 GAATTGAAAGCGCAATAGCCG 
 
Forward primer for the amplification 
of H. pylori 26695 rppH gene ‘Up’ 
fragment 
FA485 GTTTAATCCATAGTTATAAAGCAGTATAC
TAGCTTTAAGAATGCC 
 
Reverse primer the amplification of 
the H. pylori 26695 rppH gene ‘Up’ 
fragment for gene deletion using the 
rpsl-erm cassette 
FA486 GCTATAAATTATTTAATAAGTAAGATTTG
AACAAGCACACGCC 
 
Forward primer the amplification of 
the H. pylori 26695 rppH gene 
‘Down’ fragment for gene deletion 
using the rpsl-erm cassette 
FA487 CAATGGATTGGATCACGGCG 
 
Reverse primer for the amplification 
of H. pylori 26695 rppH gene 
‘Downstream’ fragment 
FD699 GCTCTGTATTTAGCTCACGCT 
 
Forward primer for the amplification 
of H. pylori 26695 pnp gene ‘Up’ 
fragment 
FA109 GTTTAATCCATAGTTATAAAGCAATTTAA
TGTTCCTTTTTTAAA 
 
Reverse primer the amplification of 
the H. pylori 26695 pnp gene ‘Up’ 
fragment for gene deletion using the 
rpsl-erm cassette 
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FA112 GCTATAAATTATTTAATAAGTAAACAAGT
GTCAAGTGGTTTTAAAAG 
 
Forward primer the amplification of 
the H. pylori 26695 pnp gene ‘Down’ 
fragment for gene deletion using the 
rpsl-erm cassette 
FA113 CTTTTAAAACCACTTGACACTTGTATTTA
ATGTTCCTTTTTTAAA 
 
Reverse primer the amplification of 
the H. pylori 26695 pnp gene ‘Up’ 
fragment for rpsl-erm cassette 
excision 
FA114 ACAAGTGTCAAGTGGTTTTAAAAG 
 
Forward primer the amplification of 
the H. pylori 26695 pnp gene ‘Do’ 
fragment for rpsl-erm cassette 
excision 
FD702 ACCAATTCCACCACCAGTGCT 
 
Reverse primer for the amplification 
of H. pylori 26695 pnp gene 
‘Downstream’ fragment 
FD700 TATATCCAGTGATTTTTTTCTCCATATTTA
ATGTTCCTTTTTT  
 
Reverse primer the amplification of 
the H. pylori 26695 pnp gene ‘Up’ 
fragment for gene deletion using the 
catCG cassette 
FD701 TGAGTGGCAGGGCGGGGCGTAACATGGA
CAAGTGTCAAGTGGT 
 
Forward primer the amplification of 
the H. pylori 26695 pnp gene ‘Down’ 
fragment for gene deletion using the 
catCG cassette 
FD631 CGTGTGGTTGCCTAAAAGC 
 
Forward primer for the amplification 
of H. pylori 26695 rny gene ‘Up’ 
fragment 
FD632  CTAGTTAGTCACCCGGGTACCCCTCTAGC
GTAATAGATC 
 
Reverse primer the amplification of 
the H. pylori 26695 rny gene ‘Up’ 
fragment for gene deletion using the 
aphA3 cassette 
FD633 GGATGAATTGTTTTAGTACCTGCAAGCTT
TAGAAGAGATCGCG 
 
Forward primer the amplification of 
the H. pylori 26695 rny gene ‘Down’ 
fragment for gene deletion using the 
aphA3 cassette 
FD634 TGTGGGCCTCTCTCAAGC 
 
Reverse primer for the amplification 
of H. pylori 26695 rny gene 
‘Downstream’ fragment 
FD11 GAAATTAATACGACTCACTATAGCAAGAGC
GTTTGCCACTT 
Reverse primer carrying a T7 
promoter for amplification for IsoA3 
in vitro transcription 
FD17 ACGCCCCATAGTTGCAATAT 
 
Forward primer for IsoA3 
amplification for in vitro 
transcription 
FD35 TCGGAATGGTTAACTGGGTAGTTCCT Reverse primer for H. pylori 5S 
rRNA mRNA detection by Northern 
Blot 
FD211 TACGGCGTTTCACTTCTGAGTT 
 
Reverse primer for E. coli 5S rRNA 
mRNA detection by Northern Blot 
FD38 GCTCCTTTTGACATAGGATT Reverse primer for aapA3 mRNA 
detection by Northern Blot 
FA110 TGCTTTATAACTATGGATTAAAC 
 
Forward primer for rpsl-erm cassette 
amplification from pSP60 
FA111 TTACTTATTAAATAATTTATAGC 
 
Reverse primer for rpsl-erm cassette 
amplification from pSP60 
FA170 GAAATTAATACGACTCACTATAGGACGCCC
CATAGTTGCAATAT 
 
Forward primer carrying a T7 
promoter for aapA3 in vitro 
transcription 
FA173 AGGAAACCCCTAAGCTTAAAAGC 
 
Reverse primer for aapA3 truncated 
amplification for in vitro 
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transcription 
FA175 GACCAACGCCCCAAAAGTC 
 
Reverse primer for aapA3 full-length 
amplification for in vitro 
transcription 
FA622 GGGGAGAATTATTTCTATCCCCTAAAGAAA
ATAAGTTTTAC 
 
Reverse primer for aapA3 full-full-
length amplification for in vitro 
transcription 
FA281 AGCATGCCATTAAACACAAA Forward primer for mutagenesis of 
aapA3 26695 start codon (G54A)  
FA282 TTTGTGTTTAATGGCATGCT Reverse primer for mutagenesis of 
aapA3 26695 start codon (G54A)  
FA283 TGGAAAACCTTGTACTTTGAGT 
 
Forward primer for mutagenesis of 
IsoA3 -10 box: mutations 
A87C/A90G  
FA284 ACTCAAAGTACAAGGTTTTCCA 
 
Reverse primer for mutagenesis of 
IsoA3 -10 box: mutations 
A87C/A90G  
FA386 CCAAGAGCGTTTGCCACTTTTG Reverse primer for aapA3/IsoA3 
locus split cloning in pGEM®T 
(upstream fragment) 
FA387 CACAAAAGTGGCAAACGCTC Forward primer for aapA3/IsoA3 
locus split cloning in pGEM®T 
(downstream fragment) 
FA406 GCATTATAAAATGAAATCC 
 
Forward primer for the amplification 
of aapA3 26695 fragment ‘Up’ from 
hpn-like  
FA407 GTTTAATCCATAGTTATAAAGCACAAAAA
GAGGGATTTTAAAAG 
Reverse primer for the amplification 
of aapA3 26695 Up fragment to 
generate the aapA3/IsoA3 locus 
deletion designed for deep-seq  
FA408 GCTATAAATTATTTAATAAGTAACCGCTT
GCTCTAGCTTTTTG 
Forward for the amplification of 
aapA3 26695 ‘Down’ fragment to 
generate the aapA3/IsoA3 locus 
deletion  
FA409 CTAGCCACGCTCTATTAGAG 
 
Reverse for the amplification of 
aapA3 26695 ‘Down’ fragment to 
generate the aapA3/IsoA3 locus 
deletion  
FA461 GATTTCATCACGtCCCATAGTTG Forward primer for C4T site-directed 
mutagenesis PCR 
FA462 CAACTATGGGaCGTGATGAAATC Reverse primer for C4T site-directed 
mutagenesis PCR 
FA463 GCAATATGGGaCAAATCCTATG Forward primer for G24A site-
directed mutagenesis PCR 
FA464 CATAGGATTTGtCCCATATTGC Reverse primer for G24A site-
directed mutagenesis PCR 
FA515 GATTTCATCACGgCCCATAGTTG Forward primer for C4G site-directed 
mutagenesis PCR 
FA516 CAACTATGGGcCGTGATGAAATC Reverse primer for C4G site-directed 
mutagenesis PCR 
FA540 GTTGTAGGATTTCATCACcCCCCATAGTTGC
AATATGGGGC 
Forward primer for G3C site-directed 
mutagenesis PCR 
FA541 GCCCCATATTGCAACTATGGGGgGTGATGA
AATCCTACAAC 
Reverse primer for G3C site-directed 
mutagenesis PCR 
FA559 CTAAGAGCGTTCCCTTAAaCTTTTAAGCTTA
GGGGTTTCC 
Forward primer for G168A site-
directed mutagenesis PCR 
FA560 GGAAACCCCTAAGCTTAAAAGtTTAAGGGA
ACGCTCTTAG 
Reverse primer for G168A site-
directed mutagenesis PCR 
FA471 GCTTTTAAaCTTAGGGGTTTCC Forward primer for G176A site-
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 directed mutagenesis PCR 
FA472 GGAAACCCCTAAGtTTAAAAGC Reverse primer for G176A site-
directed mutagenesis PCR 
FA609 [PHO]NNNNNNTTCACTGTTCTTAGCGGCCG
CATGCTC[AmC6] 
3' DNA adapter for 3'RACE PCR 
(5'P and 3'NH2 in C6) 
FA624 TGCTCCTTTTGACATAGGATTTG Reverse primer for aapA3 5’-terminal 
47 nt amplification for in vitro 
transcription 
FA680  AGGAAACtCCTAAGCTTAAAAGC Reverse primer for the amplification 
of aapA3-Tr G183A for in vitro 
transcription 
* Nucleotides in lowercase correspond to the mutations to be introduced by site-directed mutagenesis PCR. 
** Sequences highlighted in bold correspond to rpsl-erm, aphA3 or catCG 5’-overhang tails used for assembly 
PCR during the construction of the different deletion strains. 
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ABSTRACT
Type I toxin-antitoxin (TA) systems have been identi-
fied in a wide range of bacterial genomes. Here, we
report the characterization of a new type I TA sys-
tem present on the chromosome of the major hu-
man gastric pathogen, Helicobacter pylori. We show
that the aapA1 gene encodes a 30 amino acid pep-
tide whose artificial expression in H. pylori induces
cell death. The synthesis of this toxin is prevented
by the transcription of an antitoxin RNA, named
IsoA1, expressed on the opposite strand of the toxin
gene. We further reveal additional layers of post-
transcriptional regulation that control toxin expres-
sion: (i) transcription of the aapA1 gene generates
a full-length transcript whose folding impedes trans-
lation (ii) a 3′ end processing of this message gen-
erates a shorter transcript that, after a structural re-
arrangement, becomes translatable (iii) but this rear-
rangement also leads to the formation of two stem-
loop structures allowing formation of an extended
duplex with IsoA1 via kissing-loop interactions. This
interaction ensures both the translation inhibition of
the AapA1 active message and its rapid degradation
by RNase III, thus preventing toxin synthesis under
normal growth conditions. Finally, a search for ho-
mologous mRNA structures identifies similar TA sys-
tems in a large number of Helicobacter and Campy-
lobacter genomes.
INTRODUCTION
The bacterial pathogen Helicobacter pylori is the etiologic
agent of chronic gastritis and peptic ulcers and plays a ma-
jor role in the genesis of gastric cancer (1). About half of
the human population is infected by this bacterium, which
is responsible for about 700 000 deaths worldwide every year
(2). To chronically survive and multiply in the human stom-
ach, H. pylori has developed original strategies to modu-
late its gene expression in response to various stresses. Ri-
boregulation, which has emerged as a major level of reg-
ulation in bacteria, was also proposed to play an impor-
tant role in the adaptive response ofH. pylori (3). However
apart from housekeeping RNAs, transfer-messenger RNA,
signal recognition particle RNA, 6S RNA and M1 RNA
(RNase P), none of the enterobacterial small non-coding
RNAs (sRNAs) are conserved in this bacterium. A combi-
nation of bioinformatics and genome wide RNA-seq anal-
ysis allowed us to characterize the H. pylori transcriptome
and to reveal the existence of more than 60 new sRNAs in
H. pylori strain 26695 (4). Regulator of polymeric G repeats
(RepG) was identiied as the irst example of a trans-acting
sRNA in H. pylori, repressing the expression of TlpB, a
chemotaxis receptor (5). Although several of the RNA-seq-
identiied sRNAs in H. pylori are putative regulators, their
mechanisms and functions are still unknown.
Among the sRNA with the highest level of expression in
H. pylori strain 26695 was an intriguing family of six ho-
mologous cis-encoded antisense RNAs (named IsoA1 to
IsoA6) that are expressed on the opposite strand of a novel
class of small mRNAs (4). Using in vitro translation, we
previously showed that each of the small mRNA of the A
family expresses a short peptide (30 amino acids), desig-
nated AapA (Antisense-associated peptide family A). We
also showed that the AapA and IsoA transcripts are both
constitutively expressed in vivo during exponential growth,
deining a small expression module, repeated many times at
six different chromosomal loci (I–VI) (4). In vitro transla-
tion of AapA1 and AapA3 mRNAs was speciically inhib-
ited by their cognate IsoA1 and IsoA3 antisense RNA, re-
spectively. Due to the gene organization of these loci, it was
hypothesized that these expression modules might consti-
tute a new family of chromosomally encoded type I toxin-
antitoxin (TA) systems. The TAs systems are categorized
into six types based on their genetic organization and the
*To whom correspondence should be addressed. Tel: +33 557574565; Email: fabien.darfeuille@inserm.fr
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nature of the antitoxin (6,7). In the type I, the toxin is down-
regulated by base-pairing of the antitoxin sRNA with the
stable mRNA of the toxin (8). These systems were initially
discovered on plasmids, where they play a key role in their
stabilization during bacterial cell division, a phenomenon
also known as post-segregational killing (9). When present
on the chromosome, the identiication of their function is
less intuitive. A few of them have been reported to play im-
portant roles in adaptive responses to stress, including phe-
nomena such as bacterial persistence (10).
In the present study, we characterize the aapA1/IsoA1
locus of H. pylori and demonstrate that it belongs to a new
family of type I TA system. By using an artiicial expression
system, we show that the aapA1 gene encodes a small pep-
tide whose expression leads to toxicity. The synthesis of the
toxin is prevented by IsoA1 sRNA which thus acts as an
antitoxin. Surprisingly, the use of rifampicin during RNA
decay measurements reveals the existence of a transcript
generated from a 3′ processing of the highly stable AapA1
full-length (FL) mRNA. By using in vitro translation assays
and footprinting experiments, we further demonstrate that,
in contrast to the FL mRNA, the processed AapA1mRNA
can be translated due to a structural rearrangement of the 5′
untranslated region (UTR). This truncated transcript binds
IsoA1, creating an extended duplex that prevents ribosome
binding and that is targeted for degradation by RNase III.
This degradation prevents the accumulation of the active
message, and, together with the particular folding of the
FL mRNA allow H. pylori growth despite the presence of
a toxic gene in its genome. Finally, we take advantage of
the strong conservation of the mRNA folding properties
of this new TA system to identify many homologs in other
Helicobacter and Campylobacter species. Interestingly, they
are not only present on the chromosome but also associ-
ated with mobile genetic elements (MGE) such as plasmids,
prophages and integrative and conjugative elements (ICE).
MATERIALS AND METHODS
Molecular techniques
Molecular biology experiments were performed according
to standard procedures and the supplier (NEB) recommen-
dations. QIAprep SpinMiniprep Kit (Qiagen), PureLink®
HiPure Plasmid Maxiprep Kit (Thermo Fisher Scientiic)
and QIAamp DNA Mini Kit (Qiagen) were used for plas-
mids preparations andH. pylori genomic DNA extractions,
respectively. PCR were performed either with Taq Core
DNA polymerase (MP Biomedicals), or with Phusion Hot
Start DNA polymerase (Finnzymes) when the product re-
quired high idelity polymerase.
H. pylori strains and culture conditions
The H. pylori strains used in this study (Supplementary
Table S1) were 26 695 (11) B128 (12,13) and X47-2AL
(14). Strains were grown on Columbia agar plates supple-
mented with 7% horse blood andDent selective supplement
(Oxoid, Basingstoke, UK) for 24–48 h depending on the
strain. Liquid cultures were performed in brain-heart infu-
sion medium (Oxoid) supplemented with 10% fetal bovine
serum andDent.H. pylori plates and liquid cultures were in-
cubated at 37◦C under microaerobic conditions (10% CO2,
6% O2, 84% N2) using an Anoxomat (MART microbiol-
ogy) atmosphere generator. For liquid cultures, bacteria
harvested from plates were inoculated at an optical den-
sity at 600 nm of 0.05 (OD600 = 0.05) into 5 ml (tubes,
shaking at 175 rpm) brain-heart infusion medium supple-
mented with 10% fetal bovine serum and Dent supplement.
After 12–24 h, pre-cultures were diluted to an OD600 of
0.05 into 25 ml (lasks, shaking at 125 rpm). Plasmids used
for cloning were ampliied in Escherichia coli strain JM109,
which was grown in Luria–Bertani medium, supplemented
either with kanamycin (50!g.ml−1) or chloramphenicol (30
!g.ml−1). For H. pylori mutant selection and culture, an-
tibiotics were used at the following inal concentrations 20
!g.ml−1 kanamycine (Sigma) and 8!g.ml−1 chlorampheni-
col (Sigma).
Construction of H. pylori mutant strains
Chromosomal mutants of H. pylori (Supplementary Table
S1) were obtained by natural transformation as previously
described (15). The !aapA1/IsoA1, !rnc, aapA1!-10 box
mutants and X47-2AL aapA126695 or aapA1B128 comple-
mentation strains were constructed by homologous recom-
bination using a PCR cassette carrying an antibiotic resis-
tance gene (aphA-3 or catGC gene conferring kanamycin
or chloramphenicol resistance, respectively), lanked by
approximately 500 base-pairs (bp) regions upstream and
downstream of the gene of interest, as previously described
(16). For the aapA1/IsoA1 deletion, the region between nt
1 245 653 to 1 245 866 (encompassing the Shine–Dalgarno
(SD) sequence and the ATG and TAG codons) was re-
moved, placing aphA-3 (from its own SD to its own stop
codon) under the control of the aapA1 promoter and up-
stream of a transcriptional terminator (Supplementary Fig-
ure S8). The B128 and X47-2AL !rnc strains were con-
structed by replacing the rnc Open Reading Frame (ORF)
(from the ATG to 24 nt before its stop codon) by the aphA-3
gene ampliied from its own ATG to its own TAG (Supple-
mentary Figure S11). The aapA1!-10 box mutant was con-
structed by removing the two last nt of the aapA1 -10 box
sequence (TAAAAT) (Supplementary Figure S9). To con-
struct the X47-2AL aapA126695/ aapA1B128 complementa-
tion strains, the aapA1 locus (nt 1 245 624 to 1 245 986
for 26695 strain and 287 085 to 286 691 for B128 strain)
with its own promoter (either from strain 26695 or B128)
was fused to the catGC resistance gene and inserted into
the rdxA locus of the X47-2AL strain. RdxA is a non-
essential gene routinely used for complementation in H.
pylori (17). The X47-2AL has a non-homologous copy
of the aapA1/IsoA1 module (Supplementary Figure S10).
The genomic DNA of H. pylori strain 26695, B128, P12
repG::aphA-3 (5) and the vectors pUC18K2 (kanamycin re-
sistance gene) and pILL2150 (chloramphenicol resistance
gene) were used as template for all PCR ampliications (see
plasmids and primers list, Supplementary Table S2 and S3,
respectively).
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Plasmids constructions
Three plasmids carrying different isoforms of the
aapA1/IsoA1 locus (from the start codon to the 3′
UTR) were generated for this study. The pA1-IsoA1
plasmid contains the wild-type aapA1/IsoA1 sequence;
the pA1 plasmid carries two mutations that inactivate the
isoA1 promoter without changing the coding sequence of
the peptide and pA1* is a derivative of pA1 containing an
additional mutation in the start codon of AapA1 (ATG→
ATT). The pA1-IsoA1 and pA1 plasmids were obtained by
PCR ampliication of genomic DNA from the 26695 strain,
with the primer pairs FD213/FD180 and FD212/FD180,
respectively. These products were cloned into pILL2157bis
(18) between the NdeI and BamHI restriction sites (Sup-
plementary Table S2). The pA1* plasmid was obtained by
site-directed mutagenesis of the pA1 plasmid using primers
FD608/FD609. The resulting plasmids were introduced
into H. pylori strain B128 by mobilization, as described in
Backert et al. (19).
Total RNA extraction
For RNA extraction, bacterial growth was stopped at the
desired OD600 by adding 1.25 ml cold stop solution (95%
ethanol, 5% acidic phenol) to 10 ml of culture, which was
placed on ice. Cells were then centrifuged for 10 min at 3500
rpmat 4◦C, and the pellets were stored at−80◦C.Cell pellets
were resuspended in 600 !l lysis solution (20 mMNaAc pH
5.2, 0.5% sodium dodecyl sulphate (SDS), 1 mM ethylene-
diaminetetraacetics acid (EDTA)) and added to 600 !l hot
acidic phenol. After 6–10 min incubation at 65◦C, the mix-
ture was centrifuged for 10 min at 13 000 rpm at room tem-
perature. Next the aqueous phase was transferred to a phase
locked gel tube (Eppendorf) with an equal volume of chlo-
roform and centrifuged 10 min at 13 000 rpm at room tem-
perature. Total RNA was then precipitated from the aque-
ous phase by adding 2.5 volumes of EtOH 100% and 10%
3 M NaOAc pH 5.2. For RNA half-life determinations, ri-
fampicin (Sigma, prepared at 34 mg.ml−1 in methanol) was
added to the culture at a inal concentration of 80 !g.ml−1
and cells were harvested after 0, 2, 5, 10, 20, 30, 60, 120
and 240 min of incubation. A culture where rifampicin was
replaced by the same volume of methanol served as a non-
treated control.
Northern blot
ForNorthern blot analysis, 5–20 !g of total RNAwere sep-
arated on an 8% polyacrylamide (PAA), 7 M urea, 1X Tris
Borate EDTA (TBE) gel. RNA was transferred to a nylon
membrane (HybondTM-N, GE Healthcare Life Science) by
electroblotting in TBE 1X at 8V overnight. Then RNA was
cross-linked to the membrane by UV irradiation and hy-
bridized with 5′-labeled (" 32P) oligodeoxynucleotides (see
Supplementary Table S3) in a modiied Church buffer (1
mM EDTA, 0.5 M NaPO4 pH 7.2, 7% SDS) overnight at
42◦C. Membranes were washed two times for 5 min in 2X
SSC, 0.1% SDS and revealed using a Pharos FX phospho-
rimager (Biorad).
For riboprobe synthesis, a DNA template containing a
T7 promoter sequence was ampliied by PCR with primers
FD671/FD672 from the 26695 strain genomic DNA as
template. The AapA1 riboprobe was prepared as described
in theMaxiscript Kit (Ambion) and puriied on a Sephadex
G50 column. Hybridization was performed in the modiied
Church buffer at 64◦C and the membrane was washed 2
times for 5 min in 2X SSC, 0.1% SDS at 64◦C.
In vitro transcription and translation assays
For in vitro synthesis of the AapA and IsoA RNAs,
DNA templates were ampliied from H. pylori 26695
genomic DNA using the primer pairs FD54/FD452
(AapA1 FL), FD54/FD55 (AapA1 Tr1), FD9 /FD15
(IsoA1 wt), FD205/FD234 (IsoA1L1L2), each forward
primer carrying a T7 promoter sequence (see Supplemen-
tary Table S3). FD205/FD234 primers carry both threemu-
tations resulting in the synthesis of the IsoA1L1L2 RNA
that contains three mutations in each loop. In vitro tran-
scription was carried out using the MEGAscript® T7
Transcription Kit (Ambion #AM1334) according to the
manufacturer’s protocol. After phenol:chloroform extrac-
tion followed by isopropanol precipitation, the RNA sam-
ples were desalted by gel iltration using a sephadex G-50 or
G-25 (GEHealthcare) column, depending on theRNA size.
For in vitro translation of the AapA1 FL and AapA1 Tr1
mRNAs, 0.05 to 1 !g of RNA was added to the E. coli S30
kit (Promega, #L1030) as previously described (4).
In vitro structure probing
AapA1 transcripts were irst dephosphorylated by the CIP
alkaline phosphatase (NEB) and then labeled with 10 pmol
of " 32P-ATP and T4 PNK enzyme (NEB). Labeled RNA
was puriied on an 8% PAA containing 7 M urea 1X TBE
and eluted overnight at 4◦C under shaking in 750 !l elu-
tion buffer (0.1 M NaOAc pH 5.2, 0.1% SDS). Then, RNA
was extracted by phenol:chloroform, desalted and concen-
trated by ethanol precipitation, pellets were resuspended in
50 !l H2O and stored at −20
◦C. Before use, each in vitro
transcribed RNA was denatured by incubation at 90◦C for
2 min in the absence of magnesium and salt, then chilled on
ice for 1 min, followed by a renaturation step at room tem-
perature for 15min in 1XStructure Buffer (10mMTris-HCl
pH 7.0, 10 mM MgCl2, 100 mM KCl).
Structures probing analyses were performed as described
previously (4,20), using 0.1 pmol of labeled AapA1 RNA.
To determine the secondary structure of RNA in native
conditions (N), 1 !l RNase T1 (0.01 U.!l−1; Ambion,
#AM2283), 1 !l RNase TA (0.005 !g.ml−1; Ambion,
#AM2275) and 1 !l of RNase V1 (0.0005 U.!l−1; Am-
bion, #AM2275)) were added to the labeled RNA and in-
cubated in 1X Structure Buffer for 1 to 2 min at 37◦C. For
the denaturing conditions (D), 1X Sequencing Buffer (20
mM Sodium Citrate, pH 5.0, 1 mM EDTA, 7M Urea) was
used, with the same RNase T1 concentration and 1 !l of
RNase TA (0.01U.!l-1) and incubation was performed at
37◦C for 5min.We performed lead acetate (5 mM inal con-
centration) digestions on both aapA1 Tr1 and aapA1 FL in
the absence or in the presence of a 2- or 10-fold excess of
wild-type or mutated IsoA1 RNAs. All the reactions were
stopped by adding 10 !l of 2X Loading Buffer (95% for-
mamide, 18 mM EDTA, Xylene Blue and Bromophenol
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Blue) and stored at−20◦C.Cleaved fragments were then an-
alyzed on an 8% denaturing PAA gel containing 7 M urea
and 1X TBE. Gels were dried 45 min at 80◦C, and revealed
using a Pharos FX phosphorimager (Biorad).
Sequence conservation analysis
A sequence similarity search for AapA mRNA homologs
was carried out on the Helicobacter and Campylobac-
ter genomes using the Geneious program on an iterative
process (Geneious version 8.1.3 http://www.geneious.com
(21)). Genome sequences used are listed in Supplementary
Table S4. A sequence similarity with a threshold of 60%was
used as a irst restraint with theH. pylori 26695 aapA/IsoA
nucleotide (nt) sequence (see Supplementary Figure S12 for
more details). Once identiied, the secondary structure of
the AapA and IsoA RNAs were analyzed via the RNA fold
plugin (22) implemented in Geneious. Finally, each locus
was manually inspected for the presence of a promoter for
both aapA and IsoA RNAs, as well as the presence of a SD
sequence upstream of the AapAORF. Every new result was
added to the query database and the process was completed
when no new result was found (Supplementary Figure S13).
RESULTS
The expression of AapA1 peptide is toxic to H. pylori
In the present study, our irst goal was to establish whether
the aapA1/IsoA1 module located at the locus I of the H.
pylori strain 26695 encodes a type I TA system (Figure 1).
Indeed, we previously reported that in vitro translation of
the AapA1 mRNA leads to the synthesis of a small pep-
tide of 30 amino acids whose expression is repressed in
vitro by a small antisense RNA named IsoA1 (4). To this
end, we cloned the coding sequence of this peptide into an
E. coli/H. pylori shuttle vector (18) under the control of
an isopropyl-!-D-thiogalactopyranoside (IPTG)-inducible
promoter to generate plasmid pA1-IsoA1 (Figure 2A). Two
mutated variants of this plasmid were also constructed. The
irst one carries two mutations in the IsoA1 antisense pro-
moter (TATAAT → TACAAG) that prevents the expres-
sion of the antisense RNA without changing the peptide
sequence (pA1 plasmid). The second one contains an ad-
ditional mutation in the AapA1 mRNA start codon (ATG
→ ATT), which prevents the expression of the AapA1 pep-
tide (plasmid pA1*) (Figure 2A). Each plasmid was trans-
formed intoH. pylori B128 strain deleted for the chromoso-
mal copy of aapA1/IsoA1. The transcripts expressed from
the different constructs were analyzed by Northern blot
(Supplementary Figure S1A). We conirmed the inducible
expression of the AapA1 transcripts in presence of IPTG
despite some leakiness of the promoter in absence of IPTG.
We also showed that themutated isoA1 promoter is inactive,
as shown by the absence of IsoA1 (Supplementary Figure
S1A).
We next analyzed the effects of the AapA1 peptide ex-
pression on both growth rate (Figure 2B) and cell viabil-
ity (Figure 2C). In the strain carrying plasmid pA1, induc-
tion of AapA1 expression caused an immediate growth ar-
rest and a 104-fold decrease in cell number (Figure 2B and
C). When IPTG was washed out from the cultures after 8
h of induction, cells expressing AapA1 were not able to re-
cover growth (data not shown). Thus, expression of AapA1
is strongly toxic and bactericidal, and the onset of toxicity
is fast relative to the generation time (3.8 h for pA1 express-
ing strain compared to 3.6 h for pA1-IsoA1 and pA1*).
Of note, no cell lysis was observed upon expression of the
toxin (Figure 2B). Interestingly, this lethality was correlated
with a dramatic degradation of the 23S and 16S ribosomal
RNAs while the toxin-encoding mRNA was still present
(Figure 2D and Supplementary Figure S1B). The toxicity
was not observed in the strain carrying the pA1-IsoA1 plas-
mid, demonstrating that transcription of IsoA1 prevents the
toxicity of AapA1 and thus indeed acts as an RNA an-
titoxin. In addition, the absence of toxicity of the pA1*
plasmid (in which the translation of the AapA1 mRNA is
abolished) demonstrates that the toxicity is speciically due
to the AapA1 peptide expression and not to the AapA1-
encoding mRNA. The same results were obtained when us-
ing the wild-type background instead of the !aapA1 B128
strain, indicating that the chromosomal copy of IsoA1 can-
not neutralize the ectopic expression of AapA1 (Supple-
mentary Figure S1B).
Altogether these experiments demonstrate that the
aapA1/IsoA1 module functions like a type I TA system in
which the expression of a toxic peptide is prevented by the
expression of an RNA antitoxin.
3′-processing ofAapA1mRNA triggers translation activation
Type I TA systems are often characterized by a differential
stability between the toxin-encoding mRNA and the anti-
toxin. To analyze the stability of both AapA1 and IsoA1
transcripts, cultures of H. pylori 26695 strain were treated
with rifampicin to block transcription, and total RNA was
extracted at different time points and analyzed by North-
ern Blot (Figure 3A). An oligonucleotide probe (FD47) tar-
geting the AapA1 coding region detected several species
from 175 to 250 nucleotides (nt) (Figure 3A, left panel).
A similar pattern of expression was conirmed with a ribo-
probe directed against the irst 225 nt of the mRNA (Sup-
plementary Figure S2). None of these transcripts were de-
tected in a strain deleted for the aapA1 promoter (Figure
3A right panel) showing that they are all produced from the
same transcription start site at the position 1245705 (4). The
strongest signal corresponds to the FL transcript of 250 nt
(designated AapA1 FL), which displays a very slow decay
with a half-life longer than 3 h. In contrast, the IsoA1 RNA
has a relative short half-life of 15 min (Figure 3B). Most in-
terestingly, 120 min after rifampicin addition, a transcript
of around 225 nt appears. Since transcription is blocked,
this transcript is the result ofAapA1 FL processing and was
consequently designated asAapA1 Tr1 (for truncated) (Fig-
ure 3A). Different probes targeting either the 5′ or 3′ end of
the aapA1 FL revealed that the truncation occurs around 25
nt upstreamof the 3′ end of the FLmessage (Supplementary
Figure S3). Another transcript of 172 nt, namedAapA1 Tr2
was detected with FD47 but not with FA115 and FA116
probes (corresponding to the 5′ and 3′ ends of AapA1) in-
dicating that this transcript is the result of cleavages of the
FL message at both ends. Another faint band correspond-
ing to a transcript of ∼200 nt was detected. However, since
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Figure 1. Genetic organization of the aapA1/IsoA1 locus in the H. pylori 26695 strain. (A) Localization of the six different loci (I–VI) containing an
homolog of the IsoA sRNA on the chromosome of H. pylori 26695 strain. The locus I containing the AapA1/IsoA1 module is shown in red. All loci
are in the same orientation on the chromosome, the aapA gene being always on the positive strand (forward). (B) Genomic organization of the locus I.
The open reading frame encoding the 30 amino acids peptide AapA1 (in black) and IsoA1 small RNA (in red) are transcribed from the intergenic region
between the deoD gene (HP1178, purine nucleotide phosphorylase) and the omp27 gene (HP1177, outer membrane protein). Arrows indicate the respective
transcriptional start sites of each transcript and black and red bars their approximate length determined by RNA-seq analysis (4). (C) The sequence of the
intergenic region containing the aapA1/IsoA1 module in 26695H. pylori strain is shown. The AapA1 fragment cloned into the pILL2157 vector is shown
in italic. Promoter sequences (boxes) of aapA1 and isoA1 genes are shown in black and red, respectively. The Shine–Dalgarno sequence (SD), the start and
stop codons are indicated by bold letters.
it was not observed in otherH. pylori strains tested with the
riboprobe (Supplementary Figure S2), we did not explore it
in the present study. During the course of the rifampicin ex-
periment we observed that AapA1 Tr1 appears at the same
time that IsoA1 disappears. Since AapA1 mRNA expres-
sion leads to toxicity when the antitoxin is absent (Figure
2), we propose that AapA1 Tr1 is the active message. To
test this hypothesis, the translatability of AapA1 FL and
AapA1 Tr1 transcripts was assessed by in vitro translation
assays (Figure 3C). Whereas a very faint signal correspond-
ing to AapA1 peptide was observed with the FL transcript,
a strong signal was detected with the Tr1 species (Figure 3C
and 3D). These results demonstrate that a 3′-end process-
ing is required for a fully eficient in vitro translation of the
AapA1 peptide.
The SD sequence is accessible in the truncated mRNA and
sequestered in the full-length transcript
To investigate the reasons for the differential translation ef-
iciency of the two AapA1 transcripts (FL and Tr1), we per-
formed in vitro structure probing by combining chemical
and enzymatic footprinting (Figure 4). RNAstructure soft-
ware 5.2 (22) was used to generate secondary structure pre-
dictions of both transcripts according to the experimental
data obtained (see the structures Figure 5). Lead cleavage
showed a strong structural rearrangement of the 5′ UTRbe-
tween the two transcripts. Indeed while the cleavage pattern
of AapA1 FL (Figure 4A, lane 7) its very well with the for-
mation of two internal loops (IL I and IL II, Figure 5), this
region folds as two apical loops (AL I and AL II, Figure 5)
connected by a 14 nt linker in AapA1 Tr1 (Figure 4B, lane
7). AapA1 FL folding involves a long distance interaction
between the 5′ and 3′ ends of the transcript where the SD
sequence is sequestered (Figure 5). This structure predic-
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Figure 2. Expression of the AapA1 peptide in H. pylori induces cell growth arrest, loss of viability and ribosomal RNA degradation. (A) Schematic
representation of the aapA1 gene cloned into the pILL2157-bis plasmid (Supplementary Table S2). The fragment encompassing the region from the start
codon to the 3′ untranslated end of the aapA1 gene (202 nucleotides, the precise coordinates of the genomic DNA cloned in the vector are indicated, see
the sequence in Figure 1C) was cloned downstream a ureI-derived promoter and two LacI repressor sequences (black boxes) (18). Thus the transcription
of this construct leads to the production of a recombinant form of AapA1 mRNA and of an IsoA1 RNA that only shares 30 nucleotides with the original
sequence and was therefore renamed IsoA1-rec (see expression in Supplementary Figure S1). The pA1 vector carries the samemodule except that two point
mutations have been introduced to inactivate the isoA1 promoter without changing the AapA1 amino acids sequence. In pA1*, both the isoA1 promoter
and the AapA1 start codon are mutated. Each vector has been introduced intoH. pylori B128 strain deleted for the endogenous aapA1/IsoA1 module (B)
Growth curves of the strains carrying either pA1, pA1* or pA1-IsoA1 vectors, in presence (black) or absence (white) of IPTG. IPTG was added at 16 h
of culture. Data shown are the mean values ± standard deviations of three biological replicates. (C) Cell viability of the strains collected at 0 or 8 h after
IPTG addition. Serial dilutions of the culture were plated on CAB-chloramphenicol agar plates. (D) Expression of AapA1 in B128 !aapA1/IsoA1 strain
results in the degradation of rRNA. Ethidium-bromide 1% agarose gel was used to analyze rRNA (RNA samples were extracted after 8 h induction as
shown in B and C). One microgram of total RNA was loaded in each lane. The positions of 23S, 16S and 5S rRNAs are indicated.
tion explains the high stability of the transcript (few single
stranded nucleotides accessible toRNases) but also why it is
poorly translated. On the contrary, the 3′-end truncation of
AapA1 FL leads to an important structural rearrangement
in the 5′ UTR in which the SD sequence becomes accessible
to ribosomes (Figure 5). In addition we also observed in-
creased lead cleavages in the residues 66–75 in Tr1 versus the
FL transcript, indicating that the second stem-loop might
be more accessible to ribosomes in the truncated transcript
than in the full length mRNA.
This structural analysis provides the basis for the much
higher translation eficiency observed with the truncated
formof theAapA1 transcript as compared to the full-length
message.
The truncated AapA1 mRNA and IsoA1 RNAs interact via
loop–loop interactions to form a full duplex
To characterize the interaction between AapA Tr1 and
IsoA1 RNA, we performed lead probing on 5′end-labeled
AapA Tr1 transcript in absence or presence of IsoA1 RNA
(Figure 4B, lanes 7, 8 and 10). A comparison of the cleav-
age patterns showed that a 2-fold excess of IsoA1 resulted
in a complete protection of the mRNA region that is com-
plementary to IsoA1 (Figure 4B, lane 8). Indeed, lead cleav-
age was strongly reduced in the 5′ UTR encompassing AL
I, the 14 nt linker and AL II and this was even more pro-
nounced when IsoA1 was added in a 10-fold excess (Fig-
ure 4B, lane 10).Moreover, other structural rearrangements
(highlighted with a star) were observed indicating a re-
folding of the AapA1 Tr1 transcript upon the formation
of an extended duplex with IsoA1 (Figure 4B). Under the
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Figure 3. A truncated AapA1mRNA species revealed by rifampicin treat-
ment is eficiently translated in vitro (A)AapA1 and IsoA1 transcripts half-
lives were determined in the 26695H. pylori strain (left panel) or in an iso-
genic mutant deleted for aapA1 promoter (!-10 box, right panel). After
rifampicin addition (at OD600 = 1.7), aliquots of cultures were collected
at several time points (as indicated on top of the gel), RNA extracted
and subjected to Northern blot analysis. The same membrane was suc-
cessively probed with FD47 and FD198 labeled oligonucleotides to detect
eitherAapA1 or IsoA1 transcripts, respectively. Arrows indicate the differ-
ent transcripts: AapA1 FL (one star), AapA1 Tr1 (two stars), AapA1 Tr2
(three stars) and IsoA1 full-length and processed transcripts. A labeled
DNA marker (lane M) was used for size estimation. Proper loading was
assessed by staining the membrane with methylene blue (level of 5S rRNA
is shown). The Northern blot shown here is a representative of more than
three independent experiments using several biological replicates. (B) RNA
decay was determined by plotting normalized intensities (RNA signal rela-
tive to time 0) of band corresponding toAapA1 FL* and IsoA1 transcripts,
either in the wild-type or !-10 box mutated strains, as function of time af-
ter rifampicin addition. Approximate half-lives (t1/2, in min) are indicated
for each transcript analyzed. (C) In vitro translations assays of AapA1 FL
(left) and AapA1 Tr1 (right). Increasing amounts of in vitro synthesized
mRNAs (!g) were added to E. coli S30 extracts in presence of 35S me-
thionine. Control lane (Ctrl) shows the translation background obtained
without exogenous mRNA. Here is a representative experiment out of sev-
eral independent assays. (D) The amount of AapA1 peptide produced from
both transcripts (AapA1 FL and Tr1) was quantiied and the intensity of
the band at the highest AapA Tr1 quantity (1 !g) was set to 100%. Data
are the average and standard deviations of three independent experiments.
same conditions, no interaction could be detected between
AapA1 FL and IsoA1 (Figure 4A, lanes 8 and 10), indicat-
ing that the antisense RNA speciically targets the 3′end-
processedmRNA.Additionally, structuremapping and sec-
ondary structure predictions performed on IsoA1 RNA
(Supplementary Figure S4) showed that the AapA1 Tr1 5′
UTR and IsoA1 both fold into two complementary stem-
loops that could favor the formation of loop–loop interac-
tions.
To determine whether such kissing-loop complexes could
represent the initial step of the AapA1/IsoA1 hybrid for-
mation, we performed in vitro footprinting experiments in
presence of neomycin. This antibiotic of the aminoglyco-
side family is known to stabilize kissing complexes and to
prevent the formation of extended duplexes (23). In pres-
ence of increasing concentration of neomycin, the LK re-
gion of AapA1 Tr1 was no longer base-paired whereas the
ALI and ALII loops were still protected (Supplementary
Figure S5A), conirming that loop–loop interactions are
promoting the interaction between the two transcripts. In
addition, we could map neomycin’s binding regions at the
boundaries of the helices (Supplementary Figure S5A, lanes
6 and 7), explaining why this antibiotic prevents the Aa-
paA Tr1/IsoA1 hybrid to extend into a full duplex (Supple-
mentary Figure S5A lanes 10–11). No interaction was ob-
served with IsoA3 which displays a similar fold than IsoA1
but a different sequence in the loop (Supplementary Figure
S4B).
To further conirm that the initial interaction is medi-
ated via loop–loop interaction, we constructed an IsoA1
variant mutated in its two apical loops L1 and L2 (named
IsoA1 L1L2) and tested its ability to bind the AapA1 Tr1
transcript (Figure 4 and Supplementary Figure S6). We
irst veriied that the three nt mutations introduced in each
loop of IsoA1 did not alter its folding (Supplementary Fig-
ure S6). In contrast to the wild-type (wt) IsoA1, the addi-
tion of IsoA1 L1L2 did not change the digestion proile
of AapA1 Tr1 (Figure 4B, lanes 9 and 11) indicating that
this mutant cannot bind despite a strong sequence comple-
mentarity. This result conirms that the interaction between
AapA1 Tr1 and IsoA1 is mediated via a loop–loop interac-
tion. Finally, we performed the reverse experiment, i.e lead
cleavage of 5′ end-labeled IsoA1 uponAapA1 Tr1 addition.
The results conirmed the duplex formation between IsoA1
and the irst 76 nt of AapA1 Tr1 mRNA (Supplementary
Figure S6A).This very long hybrid is masking the ribosome
binding site (RBS) of AapA1 Tr1 (Supplementary Figure
S5B) suggesting that the primary role of the antitoxin is to
inhibit the translation of the toxin.
Taken together these data indicate that IsoA1 antisense
RNA binds speciically to the AapA1 Tr1 active transcript
via kissing-loop interactions (Supplementary Figure S5B).
These short interactions are key determinants in the speci-
icity of the interaction and explain why each IsoA RNA
only represses the translation of its cognate mRNA, as
shown previously (4).
CHAPTER 8. Appendices 
 192 
 
 
8 Nucleic Acids Research, 2017
Figure 4. Structure probing of (A) AapA1 FL and (B) AapA1 Tr1 RNAs in presence or absence of IsoA1. The secondary structure of each in vitro
transcribed RNA was probed by submitting ∼0.1 pmol 32P- labeled RNA to partial enzymatic digestion either under native (N) or denaturing conditions
(D) (RNase T1 cleaving single stranded G residues, lanes 3 and 4 ; RNase TA cleaving single stranded A residues, lanes 5 and 6). The interaction between
AapA1 and IsoA1 was mapped using lead probing (lanes 7–11) in the absence (lane 7) or presence of either 2 or 10 times excess of wild-type IsoA1 (wt,
lanes 8 and 10) or IsoA1 mutated in its apical loop (L1L2, lanes 9 and 11). Structure mapping, as well as secondary structures of IsoA1 wt and L1L2,
are shown in Supplementary Figure S4. Untreated RNA (lane 1, denoted C) and partially alkali digested RNA (lane 2, denoted OH) served as control
and ladder, respectively. Cleaved fragments were analyzed on an 8% denaturing polyacrylamide gel. Positions of all G residues are indicated relative to the
transcription start site of the aapA1 gene (left of the gel). Single stranded regions involved in the 5′ structural rearrangement are indicated by vertical black
bars (right of the gel). The internal loops I and II (IL I, IL II) present in AapA1 FL are replaced by an apical loop (AL II) and a 14-nucleotides linker (LK)
in AapA1 Tr1. Black stars on the right of the gel indicate other structural rearrangements observed following IsoA1 RNA binding.
RNase III cleavage ensures rapid turnover of the translation-
ally active message
Base-pairing between AapA1 Tr1 and IsoA1 creates a long
duplex of 76 bp (Supplementary Figure S5B), which could
be a good substrate for the double-stranded speciic ribonu-
clease RNase III. To investigate the role of this ribonucle-
ase in aapA1/IsoA1 regulation in vivo, we compared both
transcripts in wt and RNase III-deicient H. pylori strains.
Since we could not delete the rnc (HP0662) gene encoding
RNase III in the 26695 strain, we used two other strains,
B128 and X47-2AL, for which the deletion of rnc could
be obtained. We inserted the complete aapA1/IsoA1 mod-
ule of either the 26695 or the B128 strain into the rdxA
gene of the wt and !rnc X47-2AL strains (see Supplemen-
tary Figure S10 for details). We then analyzed the expres-
sion of AapA1 and IsoA1 RNAs by Northern blot (Fig-
ure 6). The introduction of either aapA1/IsoA1 module in
the X47-2AL background resulted in the expression pat-
tern observed for the parental strain (Figure 6, compare
lanes 2 and 3 with lanes 7 and 8). Thus, transcription of
the aapA1/IsoA1 module is not inluenced by the recipi-
ent strain under these conditions. In both the X47-2AL and
B128 backgrounds, the rnc deletion led to a strong accumu-
lation of the AapA1 Tr1 truncated form (two stars) while
the levels of AapA1 FL (one star) were unaffected (Figure
6, lanes 5, 6 and 9). Same samples were run longer for a bet-
ter separation of the different species (Supplementary Fig-
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Figure 5. mRNA folding predictions of the different AapA1 transcripts. The sequences of the three different AapA1 mRNA species were inferred from
the RNA-seq data (4) and from Northern Blot analyzed with a combination of various probes (Supplementary Figure S3). Each secondary structure was
predicted using RNAstructure 5.2 software (22) in agreement with the experimental data obtained by enzymatic and chemical footprinting (Figure 4 and
Supplementary Figure S5). The secondary structures were visualized and designed with the VARNA applet (46). The AapA1-FL transcript corresponds
to a 253 nt transcript in which most of the 5′ UTR is engaged in a long distance interaction with the 3′ end of the message. A 3′ processing event removing
the last 30 nt leads to the formation of a truncated transcript (AapA1 Tr1) that undergoes a structural rearrangement, rendering the SD accessible to the
ribosome. The irst 76 nt of this translationally active message interact with IsoA1 to form an extended duplex (not shown here, see Supplementary Figure
S5). This long duplex is then cleaved by RNase III to generate the AapA1 Tr2 transcript. The start and stop codons of the AapA1 ORF are indicated in
orange and the SD sequence is in red. Apical loops (AL) are shown in blue. Two internal loops (IL) are shown in the AapA1 FL transcript.
ure S7). In addition AapA1 Tr2 (three stars) was absent in
the !rnc strains, indicating that this transcript results from
RNase III cleavage of AapA1 Tr1 (Supplementary Figures
S2 and S7). In contrast, the amount of the full-length IsoA1
RNA seemed unaffected in absence of RNase III. We have
shown that, in wild-type cells, IsoA1 RNA is in large ex-
cess over AapA1 Tr1. Therefore, the proportion of IsoA1
transcripts base-paired withAapA Tr1mRNA is negligible,
explaining why the global level of IsoA1 full-length RNA
appears unchanged in wt and !rnc backgrounds (Figure 6,
compare lanes 2, 3 and 8with lanes 5, 6 and 9). Interestingly,
in absence of RNase III, two other transcripts (highlighted
by open circles) of a size similar to AapA1 Tr2 accumulate
(Figure 6, lanes 5, 6 and 9) and are probably the result of an
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Figure 6. RNase III prevents accumulation of the active AapA1 Tr1
mRNA. Expression of AapA1 and IsoA1 RNAs in wild type and iso-
genic ∆rnc H. pylori strains (X47-2AL, 26695 and B128) were analyzed by
Northern blot. The aapA1/IsoA1 locus of the 26695 strain (AapA126695)
or of the B128 strain (AapA1B128) was inserted in the X47-2AL strain and
its ∆rnc derivative. Samples from each strain were collected when culture
reached OD600 ≈ 1. tRNA Val (t34) served as a loading control and was
probed with the FD499 radiolabeled oligonucleotide. Upper panel:AapA1
transcripts revealed with FD47 probe; middle panel: IsoA1 transcripts re-
vealed with FD198 probe.
alternative degradation of AapA1 Tr1mRNA by unknown
ribonucleases.
Overall these data indicate thatRNase III is themajor en-
zyme responsible for the AapA1 Tr1/IsoA1 duplex degra-
dation thereby ensuring the rapid turnover of the AapA1
active message.
Identiication of new aapA/IsoA systems in otherHelicobac-
ter and Campylobacter species through structural conserva-
tion
We analyzed the conservation of the newly characterized
type I aapA/IsoA TA system among the H. pylori strains.
A PSI-BLAST search to detect small peptides (as described
in (24)) resulted in very few positive hits because few ORFs
encoding small proteins have been annotated. We next con-
ducted a TBLASTN search against nucleotide database.
This search revealed the presence of aapA/IsoA homologs
in almost every H. pylori genome and in the closely related
genomes of Helicobacter acinonychis and Helicobacter ce-
torum (Supplementary Table S4). Moreover, the synteny as-
sociated with the different loci was strongly conserved be-
tween the various strains (Supplementary Figure S12). The
aapA/IsoA loci were thus classiied according to their po-
sition at the 5 loci named I, III, IV, V and VI (Figure 7A).
Although IsoA2 at locus II is conserved, no functional pro-
moter upstream of a putative AapA2 mRNA nor a con-
served small ORF longer than four amino acids were de-
tected. Thus, this locus seems not functional and therefore
was no longer considered in this study. Among the 66H. py-
Figure 7. Conservation of aapA/isoATA systems in 66Helicobacter pylori
strains. (A) Each genome is stacked according to the decreasing number of
systems present at each locus and aligned to the origin of replication (next
to the dnaA gene). Each locus containing at least one copy of a functional
aapA/IsoA module (presence of both promoters and of a small peptide
with the consensus length of 30 amino acids) is represented according to
the following color code: locus I (red), III (light green), IV (dark green),
V (blue) and VI (purple). Most systems have the mRNA on the positive
strand; the few ones on the minus strand are shown as open dots. A thick
orange line shows the presence of an integrative and conjugative element
(ICE) next to an aapA/isoA module. (B) Schematic representation of the
locus III alignment inH. pylori strains 26695, J99 and Gambia94/24. Blue
and green colored genes represent the 5′ and 3′ side of the locus III, respec-
tively. The aapA gene is in red. All the ORF contained in the ICE Hptfs3
are shown in orange. Left (LJ) and right (RJ) junctions of the ICE are
indicated.
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lori complete genomes analyzed, the aapA/IsoA modules
were present in one or multiple copies at the 5 conserved
loci in all but 6 genomes that are free of intact aapA/IsoA
systems (Figure 7A and Supplementary Table S4). We then
hypothesized that, given the importance of mRNA fold-
ing in the control of the AapA1 toxin expression, this fold-
ing should be conserved. We thus carried out a search for
structural mRNAhomologs against all availableHelicobac-
ter complete genomes and other closely related species such
as Campylobacter (Supplementary Figure S13). This search
identiied many new loci that were all manually inspected
for features such as mRNA folding, presence of a conserved
SD sequence, start and stop codons, as well as a promoter
for the antisense RNA (Supplementary Figure S13). This
manual inspection allowed us to dismiss a considerable frac-
tion of detected loci. Each new positive locus was imple-
mented for the next search in an iterative manner (see the
detail of this search in Supplementary Figure S13). Inter-
estingly, this new search identiied many AapA mRNA ho-
mologs in other Helicobacter species that were not found
with the TBLASTN or PSI-BLAST searches. Since the syn-
teny was not conserved in these Helicobacter species, these
systems were named aapA/IsoA without any speciic num-
ber associated (Supplementary Table S4). Surprisingly, this
search revealed the presence of this system near prophage
encoding genes in H. felis ATC 49179 and H. bizzozeronii
CIII-1 or near a transposon in H. cetorum MIT-99 5656
(Supplementary Figure S14). A closer look at the H. pylori
loci revealed that some of them were associated with an-
other type of MGE such as the ICE recently characterized
inH. pylori genomes (25,26). For instance in Gambia94/24,
a complete ICE of 46 kb named ICEHptfs3 was present in
the intergenic region corresponding to the locus III, creat-
ing a much larger genomic region (Figure 7B). Finally, al-
though no aapA/IsoA system was detected in Helicobacter
plasmids, one was identiied on aCampylobacter jejuni plas-
mid as well on the chromosome of some C. jejuni strains in
a region involved in plasmid stabilization (Supplementary
Figure S15).
Altogether these results indicate that while these TA sys-
tems have been discovered initially on the chromosome of
H. pylori, their localization near MGEs such as ICE, trans-
poson and prophage suggests that they might have been ac-
quired via horizontal gene transfer and played a role in sta-
bilizing these mobile elements.
DISCUSSION
In this article we characterize for the irst time a type I
toxin–antitoxin system in H. pylori. We have shown that
the aapA1 gene encodes a small peptide whose expression
is toxic to H. pylori and found that several layers of post-
transcriptional regulation are preventing the expression of
this toxin, as described in our working model in Figure 8.
The transcription of the aapA1 gene generates a full-length
mRNA of 250 nt, denoted AapA1 FL that is translation-
ally inactive. This inert form is constitutively processed at
its 3′ end to generate a truncated transcript of 225 nt which
is translatable. This active form denoted AapA1 Tr1, base
pairs with the IsoA1 antisense RNA to form an extended
duplex that is rapidly degraded by RNase III to generate
Figure 8. Model of the aapA1/IsoA1 TA system regulation. This model is
based on all experimental data presented and is described in the text (see
discussion). Simpliied structures of AapA1 transcripts (FL, Tr1 and Tr2)
are based on Figure 5. The region encoding the AapA1 ORF in the tran-
script is shown with a thick black line. The Shine-Dalgarno sequence is
indicated as SD. The translationally active and inactive states of the differ-
ent mRNA species are also indicated.
AapA1 Tr2. In absence of IsoA1, the synthesis of AapA1
toxin can occur leading to a growth arrest and cell death.
Metastable structures prevent premature toxin expression
during mRNA synthesis
While most TA systems including type II, III, IV and
V, have adopted a speciic operon organization allowing
the production of the antitoxin before that of the toxin,
type I TA systems are using an alternative strategy to pre-
vent toxin production. Most type I toxin encoding mR-
NAs have their SD sequence sequestered in a stable double-
stranded region that prevents expression of the toxin while
the RNA is transcribed (20,27–31). In some cases, this se-
questration involves a long distance base-pairing between
the 5′- and 3′- UTRs (31,32). However due to transcription–
translation coupling that occurs in bacteria, the RBS could
be, in principle, available before the 3′ region is synthesized.
This particular mode of regulation implies that metastable
structures sequestering the RBS are formed during tran-
scription in order to prevent translation initiation on the
nascent mRNA (31,32). To predict such transient sec-
ondary structures that are formed during transcription, we
used the Kinefold stochastic simulations that predict co-
transcriptional folding paths of functional RNAs (33). This
simulation showed that three successive structures masking
the RBS can potentially form at various stages of mRNA
transcription (Supplementary Figure S16 and Video SM1
forAapA1 FLmRNA, data not shown for the other loci). A
more stable structure replaces the irst twometastable struc-
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tures when transcription reaches the end of the message.
Besides sequestration of the RBS, the 5′ to 3′ end-pairing
of the full-length mRNA forms an 11 bp helix including 6
GC pairs (Figure 5) that induces an eficient transcription
termination at this position. Another putative terminator
stem-loop was previously annotated at the position +225
(4) but our work shows that it is not able to induce tran-
scription termination very eficiently. In addition, the IsoA1
could, in principle, bind to the nascent AapA1 mRNA, be-
fore the RNA polymerase reaches the end of the message.
This interaction could then promote the production of the
Tr1 transcript. However, we believe this scenario quite un-
likely because theAapA1 Tr1 is only visible after rifampicin
treatment at late stages when IsoA1 is completely degraded.
In addition we would never observed accumulation of the
full length mRNA. Altogether our results clearly indicate
that IsoA1 is required for the degradation of Tr1 but not
for its production.
AapA1 mRNA requires a 3′ end processing to be translated
For type I toxin mRNAs having their SD sequence se-
questered, the mechanism by which the toxin mRNA gains
activation is still poorly documented. Our results show that
for AapA1, a 3′ end-processing event is required to refold
the mRNA and to unmask the SD (Figure 5). Until now,
two examples of type I TA systems for which the toxin is
produced after the cleavage of the mRNA have been de-
scribed (either in 5′ for TisB or 3′ end for Hok (20,34)). In
contrast to the 3′ end processing involved in the maturation
of theHokmRNA, the 3′ to 5′ exonucleolytic activity of the
polynucleotide phosphorylase and of the ribonuclease II is
not suficient to process the 3′ end of theAapA1 FLmRNA
(H. Arnion, unpublished results). As for TisB (20), the en-
zymatic activity responsible for the processing remains to
be identiied.
IsoA1 inhibits toxin expression primarily at the translational
level
In order to avoid toxin expression, IsoA1 is constitutively
synthesized in a large excess over AapA1 Tr1. The double
stem-loop structure in the 5′UTR of AapA1-Tr1 mRNA
mediates a speciic recognition by the IsoA1RNA via loop–
loop interactions. In vitro this hybrid is then extended into
a full duplex that is cleaved by the double-stranded speciic
RNase III. In vivo this degradation is very rapid since the
AapA1 Tr1 does not accumulate. However, RNase III is not
essential in the B128 strain despite the presence of several
aapA/IsoA systems in its genome, suggesting that, at least
in this strain, RNase III cleavage is not mandatory for the
repression of the toxin. The binding of IsoA1 toAapA1 Tr1
is completely masking the RBS and in absence of RNase
III, the stability of the long duplex formed (76 bp) is proba-
bly suficient to prevent ribosome binding. Thus, the repres-
sion of AapA1 toxin expression by IsoA1 RNA may pri-
marily occur at the translational level, as previously shown
for other type I toxins (i.e. Hok (35), TisB (20), Fst (29) and
BsrG (28)). In contrast, in B. subtilis, the degradation of the
TxpA and YonT toxin mRNAs by RNase III is essential to
prevent toxin synthesis (27,36).
Analogy with other type I TA systems
This new system identiied in epsilon proteobacter species
shares many similarities with other type I TA previously
identiied in enterobacteria. For instance the aapA1/IsoA1
system share common features with the overlapping cis-
encoded antisense RNA regulating TA systems character-
ized in E. coli (37). Similar to hok/Sok and ldr/Rdl TA
systems, this system encodes a small toxic protein (size <
50 aa) that is synthesized from a highly stable mRNA and
which production is repressed by a small unstable antisense
RNA. In addition, as for hok/Sok, the aapA1/IsoA1 re-
quires a 3′ processing to get activated (34). However, in con-
trast to these two TA systems, its translation activation does
not seem to require the translation of an overlapping small
ORF (like the mok and ldrX peptides of the hok/Sok and
ldr/Rdl systems, respectively) (38,39). Another major dif-
ference with other TA systems relies on the fact that the
IsoA1 antitoxin is directly targeting the translation initia-
tion region of the toxin gene. This speciicity is due to the ge-
nomic organization of this TA system, where the antitoxin
is fully complementary to the 5′ UTR of the toxin-encoding
mRNA, as also shown for the symE/SymRTA system in E.
coli (40).
Conservation of aapA/IsoA TA systems inHelicobacter and
Campylobacter
Few reports have highlighted the dificulties in predicting
the presence of type I TA system in bacterial genomes
(24,41). Indeed the large diversity of toxin sequences as well
as their small nucleotide size complicates the inding of new
type I TA systems. In this report we present a new strat-
egy taking advantage of the speciic folding adopted by the
AapA mRNA to identify more representatives of these sys-
tems. Our search revealed the presence of a large number of
these systems in Helicobacter genomes, larger than antici-
pated (4). With the exception of a few strains that only have
ghost copies of aapA/IsoA (i.e. with either no functional
promoter and/or no SD and/or no ORF longer than 5–6
amino acids), most H. pylori strains contain one or multi-
ple copies of these systems at conserved loci on the chro-
mosome. At a given locus, they can be present in single or
multiple copies, depending on the strains. The locus IV, lo-
cated close to the replication origin is the most conserved
one, as it is found in all the strains analyzed. Our data show
that these TA systems are sometimes inactivated by point
mutations, genomic rearrangements or insertion of an IS
(insertion sequence) element. This is similar to what was
observed for the hok/Sok systems present on the chromo-
some of E. coli (41). However, we also found that in some
cases, the aapA/IsoA systems are associated with MGE.
For instance our search reveals their presence on Campy-
lobacter plasmids and within genomic islands coding either
for an ICE element (strains shown in bold in Figure 7A)
or prophage genes (Helicobacter felis ATCC49179 and He-
licobacter bizozzeroni MIT 99–5656). In these cases, these
newly identiied TA systems may be part of a plasmid stabi-
lization and/or addiction system as was reported for several
TA systems (42). This phenomenon, also known as post-
segregational killing, was irst described for hok/Sok system
(43). If a plasmid bearing a TAmodule is not transmitted to
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a daughter cell, the unstable antitoxin is degraded while the
stable toxin acts on cellular targets and kill the plasmid-free
cells. For instance type II systems have already been shown
to promote the maintenance of ICE element and conjuga-
tive plasmids (44,45).Whether a similar role could be played
by the aapA/IsoA systems remains to be explored.
CONCLUSION
To conclude, the characterization of a new TA system inH.
pylori revealed the importance of mRNA folding in type I
TA regulation. We propose that the AapA mRNA requires
two structural RNA switches to gain activation. The irst
one consists of a spontaneous conformational rearrange-
ment, in which metastable 5′-end structures are disrupted
in favor of a more stable 5′ end/3′ end interaction. The sec-
ond switch is induced after a processing event done by a yet
unknown RNase, which renders the mRNA translationally
active. This sophisticated mechanism may be conserved for
other TA systems. Another interesting characteristic of the
aapA/IsoA system, is the high stability of themRNAversus
the instability of the antitoxin thatmakes it a particularly ef-
icient addiction module. Indeed, the cell should not be able
to get rid of such TA system unless a non-sense mutation is
present in the toxin gene. Finally our bioinformatic analysis
revealed that the aapA/IsoA system belongs to a novel large
family of type I TA system that is not only present on the
chromosome but also associated withMGEs. Although our
data provide some hints for a role in stabilizingMGEs, these
systemsmight have diverse functions depending on their ge-
netic localization or on the organisms that host them.
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